(19349,19349,1,NULL,NULL,NULL,NULL,1,'2024-05-31 16:16:57','2024-05-31 16:16:57','e44a8d2f-8e62-4486-86cd-a1464dbf37c3'),(19350,19350,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>The Burkholderia cepacia complex (Bcc) is a group of closely related Gram negative, rod-shaped bacteria that can be found in soil and water. </p><p>Bcc can be spread by person-to-person contact, contact with contaminated surfaces, and environmental exposure. Outbreaks have been linked to intrinsic and extrinsic contamination of various products used in healthcare settings. These products usually have an aqueous component or are exposed to tap water. Contaminated medical products which have led to outbreaks in healthcare facilities include saline flushes, mouthwash, oral liquid docusate, skin cleanser, ultrasound gel, nasal spray, nebulizers, antiseptics, disinfectant solutions, balloon pumps, and temperature probes. </p><p><strong>Key Point: </strong>Maintain a low threshold (e.g., single case or small cluster) for reporting a Bcc outbreak or product concern.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Burkholderia cepacia\"}',1,'2024-05-31 16:16:57','2024-05-31 16:16:57','024acdc8-081c-469d-aaaf-0d77a439279c'),(19351,19351,1,NULL,NULL,NULL,NULL,1,'2024-05-31 16:16:57','2024-05-31 16:16:57','4b6b02de-c4d6-4b15-a85b-76a44793c3bb'),(19352,19352,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about Burkholderia cepacia\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Bcc have intrinsic resistance to antimicrobials and preservatives which enhance their ability to contaminate aqueous products. </p><p>Bcc can form biofilms in building water systems, including healthcare facilities and product manufacturing sites. </p><p>Bcc emerged in the healthcare setting as a significant and transmissible pathogen causing pulmonary infections among pediatric patients with cystic fibrosis.</p>\"}',1,'2024-05-31 16:16:57','2024-05-31 16:16:57','6dc4e7ac-e9dc-4b68-abaa-a89c7c9f0b51'),(19353,19353,1,NULL,NULL,NULL,NULL,1,'2024-05-31 16:16:57','2024-05-31 16:16:57','ef11cd34-986c-4016-9e52-377104505559'),(19354,19354,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"MedWatch Online Voluntary Reporting Form\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.accessdata.fda.gov/scripts/medwatch/index.cfm\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"Use this form to report a Bcc-related outbreak or product concern.\"}',1,'2024-05-31 16:16:57','2024-05-31 16:16:57','4661527d-a68e-43f8-9e34-7613108a7c28'),(19355,19355,1,NULL,NULL,NULL,NULL,1,'2024-05-31 16:16:57','2024-05-31 16:16:57','8eb09a55-b571-4450-9566-9920d2fc3376'),(19356,19356,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"About Burkholderia cepacia complex\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/b-cepacia/about/index.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"CDC website on Bcc\"}',1,'2024-05-31 16:16:57','2024-05-31 16:16:57','84a3ca68-02f3-4abc-813b-87e0dd78c512'),(19357,19357,1,NULL,NULL,NULL,NULL,1,'2024-05-31 16:16:57','2024-05-31 16:16:57','0a0afa10-44ae-4a43-9bfa-fc2b6b3e8758'),(19358,19358,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Best practices for manufacturers of non-sterile, water-based drug products\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.fda.gov/drugs/drug-safety-and-availability/fda-advises-drug-manufacturers-burkholderia-cepacia-complex-poses-contamination-risk-non-sterile\"}',1,'2024-05-31 16:16:57','2024-05-31 16:16:57','6569bd13-f530-4a8a-9f3f-7b7cc09768a6'),(19359,19359,1,NULL,NULL,NULL,NULL,1,'2024-05-31 16:16:57','2024-05-31 16:16:57','6357711d-95d1-44dd-a3f1-0f0860627573'),(19360,19360,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Burkholderia cepacia: This Decision Is Overdue\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.fda.gov/media/81867/download\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"FDA authors reviewed the regulatory and scientific impact of Bcc, describing FDA guidance, manufacturing control measures, and possible points of origin for microbial contamination.\"}',1,'2024-05-31 16:16:57','2024-05-31 16:16:57','0803052f-475c-492e-987d-ab42c74479b7'),(19361,19361,1,NULL,NULL,NULL,NULL,1,'2024-05-31 16:16:57','2024-05-31 16:16:57','3806bb9f-8c28-4b3e-a4da-578c90ef70ff'),(19362,19362,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Bcc: a Feared Contamination Risk in Water-Based Pharmaceutical Products\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7194853/pdf/CMR.00139-19.pdf\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This article summarizes Bcc outbreaks and describes the mechanisms behind pharmaceutical product contamination.\"}',1,'2024-05-31 16:16:57','2024-05-31 16:16:57','4e14c132-ea15-4006-8f66-50ef1c1bc36d'),(19363,19363,1,NULL,NULL,NULL,NULL,1,'2024-05-31 16:16:57','2024-05-31 16:16:57','8e182a29-9496-4782-b624-6edbb333756c'),(19364,19364,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Systematic review of healthcare-associated B. cepacia\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8335909/pdf/main.pdf\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This systematic review summarizes the investigation and control of 111 Bcc healthcare-associated outbreaks.\"}',1,'2024-05-31 16:16:57','2024-05-31 16:16:57','e867368b-2490-4178-9a4f-193d07f10cf9'),(19365,19365,1,NULL,NULL,NULL,NULL,1,'2024-05-31 16:16:57','2024-05-31 16:16:57','3c1ebfc6-ca3d-4ee9-8331-0763b2c08c4d'),(19366,19366,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Bcc outbreak linked to a no-rinse cleansing foam product, United States – 2017–2018\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cambridge.org/core/journals/epidemiology-and-infection/article/burkholderia-cepacia-complex-outbreak-linked-to-a-norinse-cleansing-foam-product-united-states-20172018/8ADC180852BDAB19E3E15512EDC248D5\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"An outbreak due to intrinsic contamination of a non-sterile skin cleanser product\"}',1,'2024-05-31 16:16:57','2024-05-31 16:16:57','77ee3232-cd5e-4e2e-bea8-a1d5866ef171'),(19367,19367,1,NULL,NULL,NULL,NULL,1,'2024-05-31 16:16:58','2024-05-31 16:16:58','b7d9f6f8-b2db-49e2-aa4b-2df38dc3194b'),(19368,19368,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Multistate Outbreak of Bcc Bloodstream Infections After Exposure to Contaminated Saline Flush Syringes — United States, 2016–2017\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6476681/\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"An outbreak due to intrinsic contamination of injectable (sterile medical product) saline flushes\"}',1,'2024-05-31 16:16:58','2024-05-31 16:16:58','5e7bf30d-e334-4891-8188-1756524cc525'),(19369,19369,1,NULL,NULL,NULL,NULL,1,'2024-05-31 16:16:58','2024-05-31 16:16:58','e8c64726-f5cd-4c0c-9f15-ede4d1c35d69'),(19370,19370,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"A multistate investigation of health care–associated Bcc infections related to liquid docusate sodium\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.sciencedirect.com/science/article/abs/pii/S0196655317312877?\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"An outbreak due to an intrinsically contaminated non-sterile oral medication\"}',1,'2024-05-31 16:16:58','2024-05-31 16:16:58','b42e764e-79f4-4550-98d2-c2acd8b6c38f'),(19381,19381,1,'Measles','measles','diseases-pathogens/measles',NULL,1,'2024-05-31 19:12:56','2024-05-31 19:12:56','0329e040-312e-43f5-ae11-31199fe338f2'),(19382,19382,1,NULL,NULL,NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"<p>Also called rubeola or measles virus</p>\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Measles\"}',1,'2024-05-31 19:12:56','2024-05-31 19:12:56','75272cae-d358-4cd4-909a-520588d48dd7'),(19383,19383,1,NULL,NULL,NULL,NULL,1,'2024-05-31 19:12:56','2024-05-31 19:12:56','101db235-c48e-4d15-bb3c-19cdc196f31f'),(19384,19384,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Healthcare Personnel, Public Health\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Interim Infection Prevention and Control Recommendations for Measles in Healthcare Settings\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-28 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/infection-control/hcp/measles/?CDC_AAref_Val=https://www.cdc.gov/infectioncontrol/guidelines/measles/index.html\"}',1,'2024-05-31 19:12:56','2024-05-31 19:12:56','dc0b957d-cc55-485f-afc7-e4a0facaeae9'),(19385,19385,1,NULL,NULL,NULL,NULL,1,'2024-05-31 19:12:56','2024-05-31 19:12:56','21857b0c-7fd9-4b8b-91e2-17160139889f'),(19386,19386,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Healthcare Personnel, Public Health\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Quick Reference: Minimize Measles Transmission in Healthcare Settings\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-28 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.health.state.mn.us/diseases/measles/hcp/minimize.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This two-page flyer addresses key interventions for healthcare settings which can aid in measles preparedness planning and serve as a reference during potential measles care or exposure events.\"}',1,'2024-05-31 19:12:56','2024-05-31 19:12:56','fd8cebac-07f4-4826-8da6-6f5a14d80ecf'),(19387,19387,1,NULL,NULL,NULL,NULL,1,'2024-05-31 19:12:56','2024-05-31 19:12:56','ce883ede-6947-4e50-a065-9f3cb4187b51'),(19388,19388,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Measles Outbreak Toolkit for Health Departments\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-28 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/measles/resources/?CDC_AAref_Val=https://www.cdc.gov/measles/toolkit/state-health-departments.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This page includes guidance and template resources focused on communicating with the public during measles outbreaks.\"}',1,'2024-05-31 19:12:56','2024-05-31 19:12:56','8f475fbc-883c-4c7e-b4ed-2e2d23871d64'),(19389,19389,1,NULL,NULL,NULL,NULL,1,'2024-05-31 19:12:56','2024-05-31 19:12:56','7dbe139b-a208-4761-8891-76313b42f3ba'),(19390,19390,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Healthcare Personnel\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Measles Information for Healthcare Providers\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-28 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/measles/hcp/clinical-overview/?CDC_AAref_Val=https://www.cdc.gov/measles/hcp/index.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This page includes information on measles relevant to clinicians, with sections such as clinical features, laboratory testing, and vaccination.\"}',1,'2024-05-31 19:12:56','2024-05-31 19:12:56','49527c0f-e93e-460b-a6a6-e5fbbc44f05a'),(19403,19403,1,'Viral Hepatitis','hepatitis','diseases-pathogens/hepatitis',NULL,1,'2024-05-31 19:13:58','2024-05-31 19:13:58','3c8647b1-0c23-445c-8d7d-5615497ac087'),(19404,19404,1,NULL,NULL,NULL,'{\"0faa63e9-a47b-42c2-95ee-2cfd55201441\": \"Virus\", \"d057632f-79c8-4652-8fd8-748ac6166ec6\": {\"date\": \"2024-05-28 07:00:00\"}, \"f395977f-9fbd-4439-be7d-6e235b6699ac\": {\"date\": \"2024-05-28 07:00:00\"}}',1,'2024-05-31 19:13:58','2024-05-31 19:13:58','1f19e1c3-96ac-46da-8c01-9a6b80714c09'),(19405,19405,1,NULL,NULL,NULL,NULL,1,'2024-05-31 19:13:58','2024-05-31 19:13:58','37e60d67-4642-49c0-ba28-6e5888a8e958'),(19406,19406,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Viral Hepatitis: Healthcare Investigation Guide\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-28 07:00:00\"}, \"6b9fa6e8-a0d8-49b0-a33f-871f787ec3ba\": \"Health Departments, Healthcare Facilities\", \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/hepatitis/outbreaks/healthcareinvestigationguide.htm\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This toolkit provides a framework to investigate possible healthcare-associated viral hepatitis transmission events. This resource includes a summary of recommended investigation steps, a sample questionnaire to help identify healthcare exposures, and considerations regarding patient notifications.\"}',1,'2024-05-31 19:13:58','2024-05-31 19:13:58','f31cf109-76ec-4030-8d51-31bd95f9f5a9'),(19407,19407,1,NULL,NULL,NULL,NULL,1,'2024-05-31 19:13:58','2024-05-31 19:13:58','df413a8f-5490-4912-aee4-0ee0129fb33b'),(19408,19408,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Hepatitis B and C Outbreaks Reported to CDC\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-28 07:00:00\"}, \"6b9fa6e8-a0d8-49b0-a33f-871f787ec3ba\": \"Health Departments, Healthcare Facilities\", \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/hepatitis/outbreaks/healthcarehepoutbreaktable.htm\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This webpage summarizes healthcare-associated outbreaks of hepatitis B virus (HBV) and hepatitis C virus (HCV) infection reported in the United States during 2008-2019.\"}',1,'2024-05-31 19:13:58','2024-05-31 19:13:58','4dfd3466-5ca7-4900-98a8-4aec19a87ecc'),(19409,19409,1,NULL,NULL,NULL,NULL,1,'2024-05-31 19:13:58','2024-05-31 19:13:58','9f883a52-2c17-41be-a0da-91f1688983ef'),(19410,19410,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Viral Hepatitis: Healthcare Settings\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-28 07:00:00\"}, \"6b9fa6e8-a0d8-49b0-a33f-871f787ec3ba\": \"Health Departments, Healthcare Facilities\", \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/hepatitis/Populations/HealthcareSettings.htm\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This webpage provides links to key scientific guidelines and recommendations regarding viral hepatitis infection control, occupational health, and vaccination.\"}',1,'2024-05-31 19:13:58','2024-05-31 19:13:58','2947b8fa-d856-42b9-9cfc-2dc45587819c'),(19411,19411,1,NULL,NULL,NULL,NULL,1,'2024-05-31 19:13:58','2024-05-31 19:13:58','371cb61a-bf0a-4a26-b4e7-c6d0b30a24be'),(19412,19412,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Healthcare Providers\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Injection Safety\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-28 07:00:00\"}, \"6b9fa6e8-a0d8-49b0-a33f-871f787ec3ba\": \"Health Departments, Healthcare Facilities\", \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/injection-safety/about/index.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This website includes injection safety guidelines and recommendations, publications, and resources for patients and providers. Resource spotlights risk of bloodborne pathogen transmission associated with drug diversion and blood glucose monitoring.\"}',1,'2024-05-31 19:13:58','2024-05-31 19:13:58','7fd74a9d-014c-4ed5-a278-ba646f0c33cc'),(19413,19413,1,NULL,NULL,NULL,NULL,1,'2024-05-31 19:13:58','2024-05-31 19:13:58','2648873e-d68d-4e71-8333-6051dec89a94'),(19414,19414,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Healthcare Providers\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"US Outbreak Investigations Highlight the Need for Safe Injection Practices and Basic Infection Control\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-28 07:00:00\"}, \"6b9fa6e8-a0d8-49b0-a33f-871f787ec3ba\": \"Health Departments, Healthcare Facilities,\", \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/injection-safety/about/index.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This article summarizes U.S. outbreak investigations involving healthcare-associated HBV and HCV, including examples involving unsafe injections, dialysis and diabetes care.\"}',1,'2024-05-31 19:13:58','2024-05-31 19:13:58','d0be0c2a-c1c6-4e15-a1c2-577eb9dc1a80'),(19415,19415,1,'Ebola','ebola','diseases-pathogens/ebola',NULL,1,'2024-05-31 19:15:21','2024-05-31 19:15:21','0a21956a-cf48-4261-ab04-dc1613c3dc2e'),(19416,19416,1,NULL,NULL,NULL,'{\"0faa63e9-a47b-42c2-95ee-2cfd55201441\": \"Test\", \"d057632f-79c8-4652-8fd8-748ac6166ec6\": {\"date\": \"2024-05-24 07:00:00\"}, \"f395977f-9fbd-4439-be7d-6e235b6699ac\": {\"date\": \"2024-05-24 07:00:00\"}}',1,'2024-05-31 19:15:21','2024-05-31 19:15:21','42748726-9bcb-44fa-896a-d8b202b1c74e'),(19417,19417,1,NULL,NULL,NULL,NULL,1,'2024-05-31 19:15:21','2024-05-31 19:15:21','3ec1b722-d7b2-4d0e-9751-5ad19e87d512'),(19418,19418,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Clinicians, Public Health Professionals\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Infection Prevention and Control Recommendations for U.S. Hospital Patients with Suspected or Confirmed Viral Hemorrhagic Fevers\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/viral-hemorrhagic-fevers/hcp/infection-control/?CDC_AAref_Val=https://www.cdc.gov/vhf/ebola/clinicians/evd/infection-control.html\"}',1,'2024-05-31 19:15:21','2024-05-31 19:15:21','55c2eefe-caed-4dc4-bd28-ef57e47ffa26'),(19419,19419,1,NULL,NULL,NULL,NULL,1,'2024-05-31 19:15:21','2024-05-31 19:15:21','51433828-ee4c-4bc7-abe2-7248f7772291'),(19420,19420,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Clinicians, Public Health Professionals\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"WHO’s health topics page on Ebola Virus Disease\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-31 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.who.int/health-topics/ebola#tab=tab_1\"}',1,'2024-05-31 19:15:21','2024-05-31 19:15:21','a33169ce-d5f3-4a74-9e1a-d94854504f93'),(19421,19421,1,NULL,NULL,NULL,NULL,1,'2024-05-31 19:15:21','2024-05-31 19:15:21','292cebbb-bd5b-433e-ac45-02fec8491565'),(19422,19422,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health Professionals\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"CDC’s Top 10 Ebola Response Planning Tips: Ebola Readiness Self-Assessment for State and Local Public Health Officials\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/viral-hemorrhagic-fevers/php/public-health-strategy/vhf-response-planning.html?CDC_AAref_Val=https://www.cdc.gov/vhf/ebola/outbreaks/preparedness/planning-tips-top10.html\"}',1,'2024-05-31 19:15:21','2024-05-31 19:15:21','22130503-b7f3-4863-bb5c-a66751eaecaf'),(19423,19423,1,NULL,NULL,NULL,NULL,1,'2024-05-31 19:15:22','2024-05-31 19:15:22','e3c9b8c6-860c-44fb-91ae-7031c8ff3135'),(19424,19424,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Clinicians\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"CDC’s State & Territorial Health Department Directories\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/public-health-gateway/php/communications-resources/health-department-directories.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This website provides links to health department websites in all 50 states and the District of Columbia\"}',1,'2024-05-31 19:15:22','2024-05-31 19:15:22','7001de5e-641c-48c6-a552-c80d7ba2135c'),(19435,19435,1,'Ebola','ebola','diseases-pathogens/ebola',NULL,1,'2024-05-31 19:15:40','2024-05-31 19:15:40','2039ca01-8fc8-43b8-b914-dfda643154b8'),(19436,19436,1,NULL,NULL,NULL,'{\"0faa63e9-a47b-42c2-95ee-2cfd55201441\": \"Virus\", \"d057632f-79c8-4652-8fd8-748ac6166ec6\": {\"date\": \"2024-05-24 07:00:00\"}, \"f395977f-9fbd-4439-be7d-6e235b6699ac\": {\"date\": \"2024-05-24 07:00:00\"}}',1,'2024-05-31 19:15:40','2024-05-31 19:15:40','70dd5ab2-d179-4388-9dc3-7870eab3e975'),(19437,19437,1,NULL,NULL,NULL,NULL,1,'2024-05-31 19:15:40','2024-05-31 19:15:40','1057164f-d60b-4bcd-ad68-061b7d9a65f4'),(19438,19438,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Clinicians, Public Health Professionals\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Infection Prevention and Control Recommendations for U.S. Hospital Patients with Suspected or Confirmed Viral Hemorrhagic Fevers\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/viral-hemorrhagic-fevers/hcp/infection-control/?CDC_AAref_Val=https://www.cdc.gov/vhf/ebola/clinicians/evd/infection-control.html\"}',1,'2024-05-31 19:15:40','2024-05-31 19:15:40','c10864d6-5163-4d3f-b2bf-3a3ef72c281a'),(19439,19439,1,NULL,NULL,NULL,NULL,1,'2024-05-31 19:15:40','2024-05-31 19:15:40','0734f081-a0e6-4096-9967-3a7e88ca052a'),(19440,19440,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Clinicians, Public Health Professionals\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"WHO’s health topics page on Ebola Virus Disease\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-31 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.who.int/health-topics/ebola#tab=tab_1\"}',1,'2024-05-31 19:15:40','2024-05-31 19:15:40','809bb0f5-9236-4ab1-b593-2b0ec7711642'),(19441,19441,1,NULL,NULL,NULL,NULL,1,'2024-05-31 19:15:40','2024-05-31 19:15:40','9d1ba02a-a166-4d89-a782-3f2ad078fbbc'),(19442,19442,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health Professionals\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"CDC’s Top 10 Ebola Response Planning Tips: Ebola Readiness Self-Assessment for State and Local Public Health Officials\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/viral-hemorrhagic-fevers/php/public-health-strategy/vhf-response-planning.html?CDC_AAref_Val=https://www.cdc.gov/vhf/ebola/outbreaks/preparedness/planning-tips-top10.html\"}',1,'2024-05-31 19:15:40','2024-05-31 19:15:40','bb2fd4c6-3520-49a1-aac4-95fdf29ff0c6'),(19443,19443,1,NULL,NULL,NULL,NULL,1,'2024-05-31 19:15:40','2024-05-31 19:15:40','9b039065-b619-42a4-b7d1-996277177e9a'),(19444,19444,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Clinicians\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"CDC’s State & Territorial Health Department Directories\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/public-health-gateway/php/communications-resources/health-department-directories.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This website provides links to health department websites in all 50 states and the District of Columbia\"}',1,'2024-05-31 19:15:40','2024-05-31 19:15:40','6b35c987-c49a-4e3a-8edd-c961caffbcc6'),(19455,19455,1,'Measles','measles','diseases-pathogens/measles',NULL,1,'2024-05-31 19:16:58','2024-05-31 19:16:58','03f9fa82-c9ea-4fb0-a188-aa5d613ba9a9'),(19456,19456,1,NULL,NULL,NULL,'{\"0faa63e9-a47b-42c2-95ee-2cfd55201441\": \"Virus\", \"d057632f-79c8-4652-8fd8-748ac6166ec6\": {\"date\": \"2024-05-28 07:00:00\"}, \"f395977f-9fbd-4439-be7d-6e235b6699ac\": {\"date\": \"2024-05-28 07:00:00\"}}',1,'2024-05-31 19:16:58','2024-05-31 19:16:58','0cc5d5a4-e2fe-433f-91ec-50d68630ce4f'),(19457,19457,1,NULL,NULL,NULL,NULL,1,'2024-05-31 19:16:58','2024-05-31 19:16:58','bfabacd3-3a48-4a4e-98dc-eba9152d7c6c'),(19458,19458,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Healthcare Personnel, Public Health\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Interim Infection Prevention and Control Recommendations for Measles in Healthcare Settings\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-28 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/infection-control/hcp/measles/?CDC_AAref_Val=https://www.cdc.gov/infectioncontrol/guidelines/measles/index.html\"}',1,'2024-05-31 19:16:58','2024-05-31 19:16:58','08dc66e1-4a31-4b58-85a1-912379a600e2'),(19459,19459,1,NULL,NULL,NULL,NULL,1,'2024-05-31 19:16:58','2024-05-31 19:16:58','61cbb0b4-bee4-4a03-9785-76a0ff9e1287'),(19460,19460,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Healthcare Personnel, Public Health\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Quick Reference: Minimize Measles Transmission in Healthcare Settings\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-28 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.health.state.mn.us/diseases/measles/hcp/minimize.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This two-page flyer addresses key interventions for healthcare settings which can aid in measles preparedness planning and serve as a reference during potential measles care or exposure events.\"}',1,'2024-05-31 19:16:58','2024-05-31 19:16:58','8e6b73c1-cf27-4725-801c-ab093b6c49e6'),(19461,19461,1,NULL,NULL,NULL,NULL,1,'2024-05-31 19:16:58','2024-05-31 19:16:58','9a6b956e-525e-4457-8a73-cc52d0436cf3'),(19462,19462,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Public Health\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Measles Outbreak Toolkit for Health Departments\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-28 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/measles/resources/?CDC_AAref_Val=https://www.cdc.gov/measles/toolkit/state-health-departments.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This page includes guidance and template resources focused on communicating with the public during measles outbreaks.\"}',1,'2024-05-31 19:16:59','2024-05-31 19:16:59','9ede78aa-bea0-4598-a83b-c2f5271e0c96'),(19463,19463,1,NULL,NULL,NULL,NULL,1,'2024-05-31 19:16:59','2024-05-31 19:16:59','c508b035-5910-4345-b57a-ebdf6f4cd33a'),(19464,19464,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Healthcare Personnel\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Measles Information for Healthcare Providers\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-28 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/measles/hcp/clinical-overview/?CDC_AAref_Val=https://www.cdc.gov/measles/hcp/index.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This page includes information on measles relevant to clinicians, with sections such as clinical features, laboratory testing, and vaccination.\"}',1,'2024-05-31 19:16:59','2024-05-31 19:16:59','75904def-4e90-42b5-a926-fb35dcad5f46'),(19487,19487,1,'Burkholderia Cepacia','burkholderia-cepacia','diseases-pathogens/burkholderia-cepacia',NULL,1,'2024-05-31 20:28:27','2024-05-31 20:28:27','7fcef074-3ac0-4e89-b9a5-df10b79c478c'),(19488,19488,1,NULL,NULL,NULL,NULL,1,'2024-05-31 20:28:27','2024-05-31 20:28:27','9f9bc620-43ff-49ff-a4c8-b4f200e1eb1d'),(19489,19489,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"MedWatch Online Voluntary Reporting Form\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.accessdata.fda.gov/scripts/medwatch/index.cfm\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"Use this form to report a Bcc-related outbreak or product concern.\"}',1,'2024-05-31 20:28:27','2024-05-31 20:28:27','b21e9f18-d864-4ce2-9db5-01fb2622a1fd'),(19490,19490,1,NULL,NULL,NULL,NULL,1,'2024-05-31 20:28:27','2024-05-31 20:28:27','01a63b8e-7e4d-4a9f-97bf-de4b52422d97'),(19491,19491,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"About Burkholderia cepacia complex\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/b-cepacia/about/index.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"CDC website on Bcc\"}',1,'2024-05-31 20:28:27','2024-05-31 20:28:27','510ecb92-c314-4677-beef-dc8748275e29'),(19492,19492,1,NULL,NULL,NULL,NULL,1,'2024-05-31 20:28:27','2024-05-31 20:28:27','f43dc8bc-4736-4daf-adb4-b4cf61cf6665'),(19493,19493,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Best practices for manufacturers of non-sterile, water-based drug products\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.fda.gov/drugs/drug-safety-and-availability/fda-advises-drug-manufacturers-burkholderia-cepacia-complex-poses-contamination-risk-non-sterile\"}',1,'2024-05-31 20:28:27','2024-05-31 20:28:27','1358457e-c10a-4691-b754-f7c4d994ffe8'),(19494,19494,1,NULL,NULL,NULL,NULL,1,'2024-05-31 20:28:27','2024-05-31 20:28:27','a3355fea-2789-4f67-a046-f028c2b9c378'),(19495,19495,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Burkholderia cepacia: This Decision Is Overdue\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.fda.gov/media/81867/download\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"FDA authors reviewed the regulatory and scientific impact of Bcc, describing FDA guidance, manufacturing control measures, and possible points of origin for microbial contamination.\"}',1,'2024-05-31 20:28:27','2024-05-31 20:28:27','f0ab70ef-c44c-4108-baed-2075685f7dec'),(19496,19496,1,NULL,NULL,NULL,NULL,1,'2024-05-31 20:28:27','2024-05-31 20:28:27','a1c54962-23cd-40a5-8f4b-0029941f2794'),(19497,19497,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Bcc: a Feared Contamination Risk in Water-Based Pharmaceutical Products\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7194853/pdf/CMR.00139-19.pdf\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This article summarizes Bcc outbreaks and describes the mechanisms behind pharmaceutical product contamination.\"}',1,'2024-05-31 20:28:27','2024-05-31 20:28:27','27edb534-d262-40ae-a2e4-8363348ab887'),(19498,19498,1,NULL,NULL,NULL,NULL,1,'2024-05-31 20:28:27','2024-05-31 20:28:27','193f8445-a8ff-47ae-9ebb-03aebe38d3d2'),(19499,19499,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Systematic review of healthcare-associated B. cepacia\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8335909/pdf/main.pdf\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This systematic review summarizes the investigation and control of 111 Bcc healthcare-associated outbreaks.\"}',1,'2024-05-31 20:28:27','2024-05-31 20:28:27','6c9b6a07-5089-4792-8e12-7ac377500fca'),(19500,19500,1,NULL,NULL,NULL,NULL,1,'2024-05-31 20:28:27','2024-05-31 20:28:27','1392fda9-020f-4696-a7a8-e7bc8a6c798c'),(19501,19501,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Bcc outbreak linked to a no-rinse cleansing foam product, United States – 2017–2018\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cambridge.org/core/journals/epidemiology-and-infection/article/burkholderia-cepacia-complex-outbreak-linked-to-a-norinse-cleansing-foam-product-united-states-20172018/8ADC180852BDAB19E3E15512EDC248D5\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"An outbreak due to intrinsic contamination of a non-sterile skin cleanser product\"}',1,'2024-05-31 20:28:28','2024-05-31 20:28:28','2cd90e93-afbb-415a-b69a-c747171330d8'),(19502,19502,1,NULL,NULL,NULL,NULL,1,'2024-05-31 20:28:28','2024-05-31 20:28:28','c0901acd-de2d-4547-8199-6c29789ce70e'),(19503,19503,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Multistate Outbreak of Bcc Bloodstream Infections After Exposure to Contaminated Saline Flush Syringes — United States, 2016–2017\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6476681/\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"An outbreak due to intrinsic contamination of injectable (sterile medical product) saline flushes\"}',1,'2024-05-31 20:28:28','2024-05-31 20:28:28','a9240c3b-f10c-4f70-8ffd-65620a043739'),(19504,19504,1,NULL,NULL,NULL,NULL,1,'2024-05-31 20:28:28','2024-05-31 20:28:28','1422f019-e085-4e1a-b7b7-e4e85a7ce526'),(19505,19505,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"A multistate investigation of health care–associated Bcc infections related to liquid docusate sodium\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.sciencedirect.com/science/article/abs/pii/S0196655317312877?\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"An outbreak due to an intrinsically contaminated non-sterile oral medication\"}',1,'2024-05-31 20:28:28','2024-05-31 20:28:28','975dd2a1-7fa2-41c4-84b5-d2d62d949be2'),(19507,19507,1,'Resources for Pathogens & Diseases','diseases-pathogens','diseases-pathogens',NULL,1,'2024-05-31 20:31:12','2024-05-31 20:31:12','77aeba70-ece0-4b30-aa8d-60ef23221a53'),(19515,19515,1,'CRE','1',NULL,'{\"b16fbf8b-59fc-49b9-bfd8-054caa73163e\": \"topicsDropdown\"}',1,'2024-05-31 20:39:46','2024-05-31 20:39:46','8711a7a5-3865-4e1f-8518-a15b407a4cb8'),(19519,19519,1,'Epidemic Keratoconjunctivitis (EKC)','ekc','diseases-pathogens/ekc',NULL,1,'2024-05-31 20:41:40','2024-05-31 20:41:40','a59956b0-81ad-4836-af27-653afa6c4730'),(19520,19520,1,NULL,NULL,NULL,NULL,1,'2024-05-31 20:41:40','2024-05-31 20:41:40','b0b37636-8cff-4598-b9c4-200ba643d10f'),(19521,19521,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Prevent Epidemic Keratoconjunctivitis\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/conjunctivitis/hcp/infection-control-ekc/?CDC_AAref_Val=https://www.cdc.gov/conjunctivitis/clinical/prevent-ekc.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This resource provides cleaning and disinfection guidance for opthalmologic healthcare settings.\"}',1,'2024-05-31 20:41:40','2024-05-31 20:41:40','99ee75e0-fb32-4dee-95ec-b891169a76d0'),(19522,19522,1,NULL,NULL,NULL,NULL,1,'2024-05-31 20:41:40','2024-05-31 20:41:40','33e84983-ee2f-43a5-afd7-8a62331b65d2'),(19523,19523,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Sample Line List\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2023-09-02 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"http://#\"}',1,'2024-05-31 20:41:40','2024-05-31 20:41:40','15f9551e-8a3e-4743-995b-9baa8120270f'),(19524,19524,1,NULL,NULL,NULL,NULL,1,'2024-05-31 20:41:40','2024-05-31 20:41:40','06a8aca4-eb7c-4288-9ea9-4a84ffc7bb4b'),(19525,19525,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Prevent EKC: How to Disinfect Surfaces and Equipment\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2020-04-03 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"http://#\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This is a ready-to-use template to document epidemic keratoconjunctivitis (EKC) outbreak information.\"}',1,'2024-05-31 20:41:40','2024-05-31 20:41:40','e6422718-70f2-41f8-a738-86cf40857a07'),(19526,19526,1,NULL,NULL,NULL,NULL,1,'2024-05-31 20:41:40','2024-05-31 20:41:40','affabb32-a748-4a4a-9dd3-b57560e72869'),(19527,19527,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Sample Epidemic Keratoconjunctivitis (EKC) Outbreak Patient Letter\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-06-22 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"http://#\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This resource provides sample language for healthcare facilities communicating with patients on epidemic keratoconjunctivitis (EKC) outbreaks.\"}',1,'2024-05-31 20:41:41','2024-05-31 20:41:41','87789ccc-3b20-4825-9fb9-73227e94e5f4'),(19528,19528,1,NULL,NULL,NULL,NULL,1,'2024-05-31 20:41:41','2024-05-31 20:41:41','11924ca8-c739-497f-b62c-32332cd7a6b6'),(19529,19529,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Adenovirus-Associated Epidemic Keratoconjunctivitis Outbreaks — Four States, 2008–2010\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2013-08-16 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6232a1.htm\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This CDC MMWR summarizes EKC investigations across four states and recommends outbreak control measures.\"}',1,'2024-05-31 20:41:41','2024-05-31 20:41:41','2cfdd515-c056-446c-a655-5e62f55e52c4'),(19531,19531,1,'C. Auris','c-auris','diseases-pathogens/c-auris',NULL,1,'2024-05-31 21:11:15','2024-05-31 21:11:15','2a018ca1-452b-4ae2-baa1-86d63f66fe76'),(19532,19532,1,NULL,NULL,NULL,NULL,1,'2024-05-31 21:11:15','2024-05-31 21:11:15','9e35b625-2f6c-4954-aef5-d4c36b6fd2af'),(19533,19533,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"For infection prevention specialists\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Prevent C. Auris: How to disinfect Surfaces and Equipment\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-01 07:00:00\"}, \"6b9fa6e8-a0d8-49b0-a33f-871f787ec3ba\": \"For local health departments, healthcare facilities\", \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://my-craft-project.ddev.site/diseases-pathogens/C-Auris\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This summary or excerpt should describe the contents in enough detail that users do not have to guess when such a resource should be used, and by whom.\"}',1,'2024-05-31 21:11:15','2024-05-31 21:11:15','64f52507-4f26-4be2-981c-82fc63e1f8de'),(19534,19534,1,NULL,NULL,NULL,NULL,1,'2024-05-31 21:11:15','2024-05-31 21:11:15','94f403b2-9374-4ffa-8f73-5063381b9d0b'),(19535,19535,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"Lorem ipsum\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"C. Auris Resource\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-02 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"http://google.com\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This summary or excerpt should describe the contents in enough detail that users do not have to guess when such a resource should be used, and by whom.\"}',1,'2024-05-31 21:11:15','2024-05-31 21:11:15','95cf073a-faea-4991-a2b5-b0457ddc8001'),(19537,19537,1,'Resources for Pathogens & Diseases','resources-for-pathogens-diseases','resources-for-pathogens-diseases',NULL,1,'2024-05-31 22:41:11','2024-05-31 22:41:11','990fee3a-949a-4303-9a50-a7e9f9499b9c'),(19538,19538,1,'Resources for Pathogens & Diseases','diseases-pathogens','diseases-pathogens',NULL,1,'2024-05-31 22:52:44','2024-05-31 22:52:44','64ce5813-b251-47d8-9788-20bf5a76e40a'),(19541,19541,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"MedWatch Online Voluntary Reporting Form\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.accessdata.fda.gov/scripts/medwatch/index.cfm\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"Use this form to report a Bcc-related outbreak or product concern.\"}',1,'2024-06-02 08:58:15','2024-06-02 08:58:15','fa1a3729-c316-4a9b-9429-cfa4f245026a'),(19543,19543,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"About Burkholderia cepacia complex\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/b-cepacia/about/index.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"CDC website on Bcc\"}',1,'2024-06-02 08:58:15','2024-06-02 08:58:15','56fad3be-c900-4cd0-9c5a-101bec4f8922'),(19545,19545,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Best practices for manufacturers of non-sterile, water-based drug products\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.fda.gov/drugs/drug-safety-and-availability/fda-advises-drug-manufacturers-burkholderia-cepacia-complex-poses-contamination-risk-non-sterile\"}',1,'2024-06-02 08:58:15','2024-06-02 08:58:15','20e4a9a7-68c7-4fb9-a037-7e1757ecc28a'),(19547,19547,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Burkholderia cepacia: This Decision Is Overdue\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.fda.gov/media/81867/download\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"FDA authors reviewed the regulatory and scientific impact of Bcc, describing FDA guidance, manufacturing control measures, and possible points of origin for microbial contamination.\"}',1,'2024-06-02 08:58:15','2024-06-02 08:58:15','e0eede59-4ae4-49ef-ad88-6565b72a9cb8'),(19549,19549,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Bcc: a Feared Contamination Risk in Water-Based Pharmaceutical Products\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7194853/pdf/CMR.00139-19.pdf\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This article summarizes Bcc outbreaks and describes the mechanisms behind pharmaceutical product contamination.\"}',1,'2024-06-02 08:58:15','2024-06-02 08:58:15','394e33e2-409d-4737-b403-6d74f64e4104'),(19551,19551,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Systematic review of healthcare-associated B. cepacia\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8335909/pdf/main.pdf\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This systematic review summarizes the investigation and control of 111 Bcc healthcare-associated outbreaks.\"}',1,'2024-06-02 08:58:15','2024-06-02 08:58:15','287831ba-02ba-4723-818a-4fc05a0bc7cb'),(19553,19553,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Bcc outbreak linked to a no-rinse cleansing foam product, United States – 2017–2018\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cambridge.org/core/journals/epidemiology-and-infection/article/burkholderia-cepacia-complex-outbreak-linked-to-a-norinse-cleansing-foam-product-united-states-20172018/8ADC180852BDAB19E3E15512EDC248D5\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"An outbreak due to intrinsic contamination of a non-sterile skin cleanser product\"}',1,'2024-06-02 08:58:15','2024-06-02 08:58:15','843407dd-4573-400b-96a4-4df74937b717'),(19555,19555,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Multistate Outbreak of Bcc Bloodstream Infections After Exposure to Contaminated Saline Flush Syringes — United States, 2016–2017\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6476681/\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"An outbreak due to intrinsic contamination of injectable (sterile medical product) saline flushes\"}',1,'2024-06-02 08:58:15','2024-06-02 08:58:15','c40876b3-466e-4a22-ba87-1aa94f4ea565'),(19557,19557,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"A multistate investigation of health care–associated Bcc infections related to liquid docusate sodium\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.sciencedirect.com/science/article/abs/pii/S0196655317312877?\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"An outbreak due to an intrinsically contaminated non-sterile oral medication\"}',1,'2024-06-02 08:58:15','2024-06-02 08:58:15','c2c8690b-b8ee-4ce8-a7a2-2e655aabae9c'),(19558,19558,1,'Burkholderia Cepacia','b-cepacia','diseases-pathogens/b-cepacia',NULL,1,'2024-06-02 08:58:22','2024-06-02 08:58:22','2d8612d3-5e76-4a28-8de3-06061558e17d'),(19559,19559,1,NULL,NULL,NULL,NULL,1,'2024-06-02 08:58:22','2024-06-02 08:58:22','3fa7a330-b438-453a-a638-f6f8183dde12'),(19560,19560,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"MedWatch Online Voluntary Reporting Form\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.accessdata.fda.gov/scripts/medwatch/index.cfm\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"Use this form to report a Bcc-related outbreak or product concern.\"}',1,'2024-06-02 08:58:22','2024-06-02 08:58:22','ccbc9fd2-c9de-48ea-a4c1-1d5bff5747a6'),(19561,19561,1,NULL,NULL,NULL,NULL,1,'2024-06-02 08:58:22','2024-06-02 08:58:22','a3943fd7-0313-454c-b576-dd99268c5117'),(19562,19562,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"About Burkholderia cepacia complex\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/b-cepacia/about/index.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"CDC website on Bcc\"}',1,'2024-06-02 08:58:22','2024-06-02 08:58:22','993982f6-3428-49f8-a10c-9b143be78a88'),(19563,19563,1,NULL,NULL,NULL,NULL,1,'2024-06-02 08:58:22','2024-06-02 08:58:22','a0a43f0c-6bc8-4d61-b934-7961674c5050'),(19564,19564,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Best practices for manufacturers of non-sterile, water-based drug products\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.fda.gov/drugs/drug-safety-and-availability/fda-advises-drug-manufacturers-burkholderia-cepacia-complex-poses-contamination-risk-non-sterile\"}',1,'2024-06-02 08:58:22','2024-06-02 08:58:22','df5d6f6b-3a90-4957-b46b-c38223757690'),(19565,19565,1,NULL,NULL,NULL,NULL,1,'2024-06-02 08:58:22','2024-06-02 08:58:22','70a5d5e7-5052-4b7d-816c-81fbe90b5981'),(19566,19566,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Burkholderia cepacia: This Decision Is Overdue\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.fda.gov/media/81867/download\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"FDA authors reviewed the regulatory and scientific impact of Bcc, describing FDA guidance, manufacturing control measures, and possible points of origin for microbial contamination.\"}',1,'2024-06-02 08:58:22','2024-06-02 08:58:22','1fc8e708-df31-477a-a042-11fbfe80fb27'),(19567,19567,1,NULL,NULL,NULL,NULL,1,'2024-06-02 08:58:22','2024-06-02 08:58:22','2bc88912-bffb-46ce-aeb3-1ad209cb0e08'),(19568,19568,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Bcc: a Feared Contamination Risk in Water-Based Pharmaceutical Products\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7194853/pdf/CMR.00139-19.pdf\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This article summarizes Bcc outbreaks and describes the mechanisms behind pharmaceutical product contamination.\"}',1,'2024-06-02 08:58:22','2024-06-02 08:58:22','726d1b00-7202-4a0d-b71a-8cfcc53195c3'),(19569,19569,1,NULL,NULL,NULL,NULL,1,'2024-06-02 08:58:22','2024-06-02 08:58:22','c86ff038-e620-41b0-8359-19609f8e96ba'),(19570,19570,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Systematic review of healthcare-associated B. cepacia\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8335909/pdf/main.pdf\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This systematic review summarizes the investigation and control of 111 Bcc healthcare-associated outbreaks.\"}',1,'2024-06-02 08:58:22','2024-06-02 08:58:22','2640bb70-2d26-404d-8c9b-4f17262bf4f1'),(19571,19571,1,NULL,NULL,NULL,NULL,1,'2024-06-02 08:58:23','2024-06-02 08:58:23','324370f6-c295-4ab2-861e-a21a18f98d74'),(19572,19572,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Bcc outbreak linked to a no-rinse cleansing foam product, United States – 2017–2018\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cambridge.org/core/journals/epidemiology-and-infection/article/burkholderia-cepacia-complex-outbreak-linked-to-a-norinse-cleansing-foam-product-united-states-20172018/8ADC180852BDAB19E3E15512EDC248D5\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"An outbreak due to intrinsic contamination of a non-sterile skin cleanser product\"}',1,'2024-06-02 08:58:23','2024-06-02 08:58:23','658bf718-f37c-4b34-a50e-775e69427376'),(19573,19573,1,NULL,NULL,NULL,NULL,1,'2024-06-02 08:58:23','2024-06-02 08:58:23','4f099b60-4576-40d9-ad7e-28fbabb0ddd3'),(19574,19574,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Multistate Outbreak of Bcc Bloodstream Infections After Exposure to Contaminated Saline Flush Syringes — United States, 2016–2017\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6476681/\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"An outbreak due to intrinsic contamination of injectable (sterile medical product) saline flushes\"}',1,'2024-06-02 08:58:23','2024-06-02 08:58:23','ee072c53-bb12-4f06-802c-1e9ebca7bd70'),(19575,19575,1,NULL,NULL,NULL,NULL,1,'2024-06-02 08:58:23','2024-06-02 08:58:23','344e9c38-7bb7-4626-b979-7248ec1f8e3b'),(19576,19576,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"A multistate investigation of health care–associated Bcc infections related to liquid docusate sodium\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.sciencedirect.com/science/article/abs/pii/S0196655317312877?\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"An outbreak due to an intrinsically contaminated non-sterile oral medication\"}',1,'2024-06-02 08:58:23','2024-06-02 08:58:23','baf6c480-11f0-432e-be66-69bc004666e5'),(19581,19581,1,'2 - Fundamental Concepts','fundamental-concepts','chapters/fundamental-concepts','{\"0c9be173-318a-42f5-b27d-86204f3dfa65\": \"Fundamental Concepts\", \"68c04e47-b499-4e50-88f0-a409394e673e\": 2, \"ee09d78e-63c3-4bdf-aaf4-4c05789851fb\": \"Chapter Two\"}',1,'2024-06-02 19:12:09','2024-06-02 19:12:09','755a9b0c-434e-4052-a10a-3f4cb3530ccc'),(19582,19582,1,NULL,NULL,NULL,NULL,1,'2024-06-02 19:12:09','2024-06-02 19:12:09','f5a5229c-f6b8-401f-8fa6-3d8a1dd2b2ea'),(19583,19583,1,'1 - Overview','overview','chapters/overview','{\"0c9be173-318a-42f5-b27d-86204f3dfa65\": \"Overview\", \"68c04e47-b499-4e50-88f0-a409394e673e\": 1, \"ee09d78e-63c3-4bdf-aaf4-4c05789851fb\": \"Chapter One\"}',1,'2024-06-02 19:12:46','2024-06-13 15:17:04','cc4ffd63-81bc-4511-9f9d-f89e0ff4adbd'),(19584,19584,1,NULL,NULL,NULL,NULL,1,'2024-06-02 19:12:46','2024-06-02 19:12:46','f9fed38d-ebaf-40d6-9eae-269577861c0b'),(19587,19587,1,'Medical Products','medical-products','tools/medical-products',NULL,1,'2024-06-02 21:10:57','2024-06-02 21:10:57','a1a3bfbd-9285-47c9-8279-324e114ea588'),(19588,19588,1,NULL,NULL,NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"<p>Medical products, such as devices, drugs, and biologics, play crucial roles in medical diagnosis and treatment.</p>\"}',1,'2024-06-02 21:10:57','2024-06-02 21:10:57','2f59aa9d-c7b6-4495-9d5f-930993d162d2'),(19589,19589,1,'Collaborative Workgroups','1',NULL,NULL,1,'2024-06-02 22:45:45','2024-06-02 22:45:48','9c6d7d44-68e6-470d-9ddb-3360149cf101'),(19590,19590,1,'Member Organizations','1',NULL,NULL,1,'2024-06-02 22:46:02','2024-06-02 22:46:05','6cc3ab27-e13d-4a58-87cf-313a329afc7a'),(19592,19592,1,'Strategic Map','1',NULL,NULL,1,'2024-06-02 22:46:28','2024-06-02 22:46:36','45b9de59-f78d-44c2-98fc-111458464b49'),(19598,19598,1,'Methodologic challenges and lessons learned through conducting a hospital-based Salmonella Javiana case-control study','methodologic-challenges-and-lessons-learned-through-conducting-a-hospital-based-salmonella-javiana-case-control-study','outbreak-news/methodologic-challenges-and-lessons-learned-through-conducting-a-hospital-based-salmonella-javiana-case-control-study',NULL,1,'2024-06-03 01:40:56','2024-06-03 01:40:56','cbbca629-a557-408d-a6a8-43e101e848ed'),(19599,19599,1,NULL,NULL,NULL,'{\"46f8fcfe-c756-437a-ab02-62c34cb70433\": \"American Journal of Infection Control\", \"d327c84a-a0ba-403a-932c-9a807624e3ef\": {\"date\": \"2023-11-15 08:00:00\"}, \"f9e1c7bb-0351-432a-beb2-a1562d8f7e7e\": \"https://pubmed.ncbi.nlm.nih.gov/36965777/\"}',1,'2024-06-03 01:40:56','2024-06-03 01:40:56','e7114468-b9e8-4ea6-9a34-4cdc2513bd67'),(19604,19604,1,'Bacterial Infection Outbreak After Double Cataract Surgery Tied to Sterility Breach','bacterial-infection-outbreak-after-double-cataract-surgery-tied-to-sterility-breach','outbreak-news/bacterial-infection-outbreak-after-double-cataract-surgery-tied-to-sterility-breach',NULL,1,'2024-06-03 01:41:14','2024-06-03 01:41:14','8bccfde0-007f-4ae0-9900-454e0dced982'),(19605,19605,1,NULL,NULL,NULL,'{\"46f8fcfe-c756-437a-ab02-62c34cb70433\": \"Medpage today\", \"d327c84a-a0ba-403a-932c-9a807624e3ef\": {\"date\": \"2023-02-22 08:00:00\"}, \"f9e1c7bb-0351-432a-beb2-a1562d8f7e7e\": \"https://www.medpagetoday.com/ophthalmology/generalophthalmology/106975\"}',1,'2024-06-03 01:41:14','2024-06-03 01:41:14','4114f2b8-2640-496f-8aef-07facd7eaecf'),(19608,19608,1,'Outbreak Sample Link','outbreak-sample-link','outbreak-news/outbreak-sample-link',NULL,1,'2024-06-03 01:41:26','2024-06-03 01:41:26','a4ada5d5-1e19-4530-bce0-2c6ad1260495'),(19609,19609,1,NULL,NULL,NULL,'{\"46f8fcfe-c756-437a-ab02-62c34cb70433\": \"CDC\", \"d327c84a-a0ba-403a-932c-9a807624e3ef\": {\"date\": \"2024-03-12 07:00:00\"}, \"f9e1c7bb-0351-432a-beb2-a1562d8f7e7e\": \"https://www.cdc.gov/scabies/about/index.html\"}',1,'2024-06-03 01:41:26','2024-06-03 01:41:26','e9d3acdf-1cb4-4db6-ba09-5b084ad30716'),(19610,19610,1,'News','news','news',NULL,1,'2024-06-03 01:58:40','2024-06-03 01:58:40','7f3184de-29a2-401b-9f9d-99f5c213b382'),(19611,19611,1,NULL,NULL,NULL,'{\"d34ad5d6-4524-4c40-8376-ad2cf3772110\": \"narrowWidth\"}',1,'2024-06-03 01:58:40','2024-06-03 01:58:40','4a093097-6446-433b-b032-883f695e0ee4'),(19613,19613,1,'News','news','news',NULL,1,'2024-06-03 01:58:57','2024-06-03 01:58:57','7331a6d1-9687-4a58-b697-51660fb3de16'),(19616,19616,1,NULL,NULL,NULL,'{\"74e584f9-0d74-40d9-b2c5-1549b72be6c2\": \"<p>CORHA is a multidisciplinary collaboration of national associations and federal agencies working together since  2015 to improve methods to detect, investigate, control and prevent HAI/AR outbreaks. </p><p>Council member representatives bring expertise in healthcare epidemiology and infection prevention, environmental health, public health laboratory activities and HAI/AR reporting and regulation at the local, state and federal levels.</p><p><a class=\\\"arrow-link\\\" href=\\\"/about-corha/\\\">More About Corha</a></p>\", \"d2a00b89-80a2-4a8f-bef0-994bb6e54e03\": \"Meet CORHA\"}',1,'2024-06-03 04:10:51','2024-06-03 04:10:51','69e06a6e-6dfb-4374-9794-5627d896a2b9'),(19617,19617,1,'Welcome to Public Health Research at Lancaster',NULL,NULL,NULL,1,'2024-06-03 04:12:09','2024-06-03 04:12:09','463d336e-0278-4ab2-b50f-ebfd9cc42e28'),(19618,19618,1,'Home','home','__home__',NULL,1,'2024-06-03 04:12:32','2024-06-03 04:12:32','b07ed011-b321-4476-9339-abefbfb508a5'),(19619,19619,1,NULL,NULL,NULL,NULL,1,'2024-06-03 04:12:32','2024-06-03 04:12:32','9de86759-685f-499f-8035-05cccb2ceb87'),(19620,19620,1,NULL,NULL,NULL,'{\"74e584f9-0d74-40d9-b2c5-1549b72be6c2\": \"<p>CORHA is a multidisciplinary collaboration of national associations and federal agencies working together since  2015 to improve methods to detect, investigate, control and prevent HAI/AR outbreaks. </p><p>Council member representatives bring expertise in healthcare epidemiology and infection prevention, environmental health, public health laboratory activities and HAI/AR reporting and regulation at the local, state and federal levels.</p><p><a class=\\\"arrow-link\\\" href=\\\"/about-corha/\\\">More About Corha</a></p>\", \"d2a00b89-80a2-4a8f-bef0-994bb6e54e03\": \"Meet CORHA\"}',1,'2024-06-03 04:12:32','2024-06-03 04:12:32','3d336ba3-c205-414c-99f4-c2d1acc0e8e5'),(19621,19621,1,'Icon search vibrant blue',NULL,NULL,NULL,1,'2024-06-03 04:32:57','2024-06-03 04:32:57','f11bbb51-547e-4fad-897f-89eeae3804f2'),(19622,19622,1,'Welcome to Public Health Research at Lancaster',NULL,NULL,NULL,1,'2024-06-03 05:06:46','2024-06-03 05:06:46','cedbe27d-e7ad-4697-acdf-ce86e4231b4e'),(19625,19625,1,NULL,NULL,NULL,'{\"74e584f9-0d74-40d9-b2c5-1549b72be6c2\": \"<p>CORHA is a multidisciplinary collaboration of national associations and federal agencies working together since  2015 to improve methods to detect, investigate, control and prevent HAI/AR outbreaks. </p><p>Council member representatives bring expertise in healthcare epidemiology and infection prevention, environmental health, public health laboratory activities and HAI/AR reporting and regulation at the local, state and federal levels.</p><p><a class=\\\"arrow-link\\\" href=\\\"/about-corha/\\\">More About Corha</a></p>\", \"d2a00b89-80a2-4a8f-bef0-994bb6e54e03\": \"Meet CORHA\"}',1,'2024-06-03 05:07:37','2024-06-03 05:07:37','29fb7390-2771-457f-82ac-f231d53ff418'),(19626,19626,1,'Home','home','__home__',NULL,1,'2024-06-03 05:07:41','2024-06-03 05:07:41','060b1ff8-8e44-4d2c-bfd1-dfadbeadc6de'),(19627,19627,1,NULL,NULL,NULL,NULL,1,'2024-06-03 05:07:41','2024-06-03 05:07:41','fa27803a-d1eb-4813-9868-4f0fd95f10d1'),(19628,19628,1,NULL,NULL,NULL,'{\"74e584f9-0d74-40d9-b2c5-1549b72be6c2\": \"<p>CORHA is a multidisciplinary collaboration of national associations and federal agencies working together since  2015 to improve methods to detect, investigate, control and prevent HAI/AR outbreaks. </p><p>Council member representatives bring expertise in healthcare epidemiology and infection prevention, environmental health, public health laboratory activities and HAI/AR reporting and regulation at the local, state and federal levels.</p><p><a class=\\\"arrow-link\\\" href=\\\"/about-corha/\\\">More About Corha</a></p>\", \"d2a00b89-80a2-4a8f-bef0-994bb6e54e03\": \"Meet CORHA\"}',1,'2024-06-03 05:07:41','2024-06-03 05:07:41','2f4728d8-facc-4acb-b928-fe22880abe2a'),(19629,19629,1,'White arrow up',NULL,NULL,NULL,1,'2024-06-03 16:09:18','2024-06-03 16:09:18','daf2f824-5f2c-41b6-acda-8c6b10002963'),(19630,19630,1,'Mosalli RSV NICU Outbreaks Review AJIC 2022','1710','news/1710','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"jabramson\"}',1,'2024-06-03 21:41:05','2024-06-03 21:41:05','3a4b76a8-fb69-45b8-ac98-ed526e86612a'),(19631,19631,1,NULL,'mosalli-rsv-nicu-outbreaks-review-ajic-2022',NULL,'{\"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Mosalli RSV NICU Outbreaks Review AJIC 2022\"}',1,'2024-06-03 21:41:05','2024-06-03 21:41:05','47da113c-cabd-46e0-9d55-12fd85762e75'),(19632,19632,1,'Mosalli RSV NICU Outbreaks Review AJIC 2022','1710','news/1710','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"jabramson\"}',1,'2024-06-03 21:41:05','2024-06-03 21:41:05','60be2d5a-895a-47c4-93b2-e742e08b63db'),(19633,19633,1,NULL,'mosalli-rsv-nicu-outbreaks-review-ajic-2022',NULL,'{\"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Mosalli RSV NICU Outbreaks Review AJIC 2022\"}',1,'2024-06-03 21:41:05','2024-06-03 21:41:05','d4e3e0dd-f684-417d-af17-92a14672b16e'),(19634,19634,1,'Patient Notification in Mold Investigations ICHE','1766','news/1766','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"jabramson\"}',1,'2024-06-03 21:41:05','2024-06-03 21:41:05','413fbae0-d686-4554-96e5-7ec0b060850a'),(19635,19635,1,NULL,'patient-notification-in-mold-investigations-iche',NULL,'{\"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Patient Notification in Mold Investigations ICHE\"}',1,'2024-06-03 21:41:05','2024-06-03 21:41:05','6768de27-b94a-4470-9b7b-f30241a0ecf4'),(19636,19636,1,'Patient Notification in Mold Investigations ICHE','1766','news/1766','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"jabramson\"}',1,'2024-06-03 21:41:05','2024-06-03 21:41:05','05dafa8b-a8ad-4bd2-ad21-8a260b04ba54'),(19637,19637,1,NULL,'patient-notification-in-mold-investigations-iche',NULL,'{\"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Patient Notification in Mold Investigations ICHE\"}',1,'2024-06-03 21:41:05','2024-06-03 21:41:05','e2d26654-1ac8-4b1f-8733-3f3a99ce1b16'),(19638,19638,1,'Trump Administration Announces New Nursing Homes COVID-19 Transparency Effort','trump-administration-announces-new-nursing-homes-covid-19-transparency-effort','news/trump-administration-announces-new-nursing-homes-covid-19-transparency-effort','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"New CMS requirement for nursing homes to inform residents, their families and representatives of COVID-19 cases in their facilities.\"}',1,'2024-06-03 21:51:11','2024-06-03 21:51:11','0030dd01-d817-4d6a-a00d-cf605f0b0443'),(19639,19639,1,NULL,'trump-administration-announces-new-nursing-homes-covid-19-transparency-effort',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"New CMS requirement for nursing homes to inform residents, their families and representatives of COVID-19 cases in their facilities.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Trump Administration Announces New Nursing Homes COVID-19 Transparency Effort\"}',1,'2024-06-03 21:51:11','2024-06-03 21:51:11','ba1d7a3a-3540-4873-a54d-7e2988ea83a2'),(19640,19640,1,'Trump Administration Announces New Nursing Homes COVID-19 Transparency Effort','trump-administration-announces-new-nursing-homes-covid-19-transparency-effort','news/trump-administration-announces-new-nursing-homes-covid-19-transparency-effort','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"New CMS requirement for nursing homes to inform residents, their families and representatives of COVID-19 cases in their facilities.\"}',1,'2024-06-03 21:51:11','2024-06-03 21:51:11','d92e56cb-24c3-4aa2-9e7b-81784776562d'),(19641,19641,1,NULL,'trump-administration-announces-new-nursing-homes-covid-19-transparency-effort',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"New CMS requirement for nursing homes to inform residents, their families and representatives of COVID-19 cases in their facilities.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Trump Administration Announces New Nursing Homes COVID-19 Transparency Effort\"}',1,'2024-06-03 21:51:11','2024-06-03 21:51:11','87c4c4dd-9bc4-4c7d-b5ab-3aad4b860c94'),(19642,19642,1,'Trends in U.S. Burden of Clostridioides difficile Infection and Outcomes','trends-in-u-s-burden-of-clostridioides-difficile-infection-and-outcomes','news/trends-in-u-s-burden-of-clostridioides-difficile-infection-and-outcomes','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"A New England Journal of Medicine (NEJM) report on Trends in U.S. Burden of Clostridioides difficile Infection and Outcomes.\"}',1,'2024-06-03 21:51:11','2024-06-03 21:51:11','e5689137-2fd2-477e-89d3-a10b36ba6052'),(19643,19643,1,NULL,'trends-in-u-s-burden-of-clostridioides-difficile-infection-and-outcomes',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"A New England Journal of Medicine (NEJM) report on Trends in U.S. Burden of Clostridioides difficile Infection and Outcomes.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Trends in U.S. Burden of Clostridioides difficile Infection and Outcomes\"}',1,'2024-06-03 21:51:11','2024-06-03 21:51:11','77933a63-1c92-4f21-b496-c510d592b556'),(19644,19644,1,'Trends in U.S. Burden of Clostridioides difficile Infection and Outcomes','trends-in-u-s-burden-of-clostridioides-difficile-infection-and-outcomes','news/trends-in-u-s-burden-of-clostridioides-difficile-infection-and-outcomes','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"A New England Journal of Medicine (NEJM) report on Trends in U.S. Burden of Clostridioides difficile Infection and Outcomes.\"}',1,'2024-06-03 21:51:11','2024-06-03 21:51:11','2be127ca-30ba-4ad8-87b7-0d5a2aa07727'),(19645,19645,1,NULL,'trends-in-u-s-burden-of-clostridioides-difficile-infection-and-outcomes',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"A New England Journal of Medicine (NEJM) report on Trends in U.S. Burden of Clostridioides difficile Infection and Outcomes.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Trends in U.S. Burden of Clostridioides difficile Infection and Outcomes\"}',1,'2024-06-03 21:51:11','2024-06-03 21:51:11','2d211ddb-5c62-474d-859a-9b665b98c374'),(19646,19646,1,'Multidrug-Resistant Bacterial Infections in U.S. Hospitalized Patients, 2012–2017','multidrug-resistant-bacterial-infections-in-u-s-hospitalized-patients-2012-2017','news/multidrug-resistant-bacterial-infections-in-u-s-hospitalized-patients-2012-2017','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"A New England Journal of Medicine (NEMJ) report on Multidrug-Resistant Bacterial Infections in U.S. Hospitalized Patients, 2012–2017.\"}',1,'2024-06-03 21:51:11','2024-06-03 21:51:11','f1704ded-0d68-470d-8a32-9b2980650952'),(19647,19647,1,NULL,'multidrug-resistant-bacterial-infections-in-u-s-hospitalized-patients-2012-2017',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"A New England Journal of Medicine (NEMJ) report on Multidrug-Resistant Bacterial Infections in U.S. Hospitalized Patients, 2012–2017.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Multidrug-Resistant Bacterial Infections in U.S. Hospitalized Patients, 2012–2017\"}',1,'2024-06-03 21:51:11','2024-06-03 21:51:11','6ae053d0-abf9-4f73-833a-4e39bd146dee'),(19648,19648,1,'Multidrug-Resistant Bacterial Infections in U.S. Hospitalized Patients, 2012–2017','multidrug-resistant-bacterial-infections-in-u-s-hospitalized-patients-2012-2017','news/multidrug-resistant-bacterial-infections-in-u-s-hospitalized-patients-2012-2017','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"A New England Journal of Medicine (NEMJ) report on Multidrug-Resistant Bacterial Infections in U.S. Hospitalized Patients, 2012–2017.\"}',1,'2024-06-03 21:51:11','2024-06-03 21:51:11','a91b6f9b-e364-429e-8941-a6935ef2ad06'),(19649,19649,1,NULL,'multidrug-resistant-bacterial-infections-in-u-s-hospitalized-patients-2012-2017',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"A New England Journal of Medicine (NEMJ) report on Multidrug-Resistant Bacterial Infections in U.S. Hospitalized Patients, 2012–2017.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Multidrug-Resistant Bacterial Infections in U.S. Hospitalized Patients, 2012–2017\"}',1,'2024-06-03 21:51:11','2024-06-03 21:51:11','2561c678-548f-4504-99d4-acf7adf768af'),(19650,19650,1,'CORHA Insider - October 2019','corha-insider-october-2019','news/corha-insider-october-2019','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"The October 2019 CORHA newsletter contains a recap of the CORHA June 2019 in-person meeting, announces CORHA\'s commitment to participating in the Global Antimicrobial Resistance (AMR) Challenge, as well as shares new products and research.\"}',1,'2024-06-03 21:51:12','2024-06-03 21:51:12','27c8ac0a-bbc7-4609-9ee1-2a143132b797'),(19651,19651,1,NULL,'corha-insider-october-2019',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"The October 2019 CORHA newsletter contains a recap of the CORHA June 2019 in-person meeting, announces CORHA\'s commitment to participating in the Global Antimicrobial Resistance (AMR) Challenge, as well as shares new products and research.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"CORHA Insider - October 2019\"}',1,'2024-06-03 21:51:12','2024-06-03 21:51:12','be5d4bc0-b4fd-4165-af5e-da3edb6b6492'),(19652,19652,1,'CORHA Insider - October 2019','corha-insider-october-2019','news/corha-insider-october-2019','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"The October 2019 CORHA newsletter contains a recap of the CORHA June 2019 in-person meeting, announces CORHA\'s commitment to participating in the Global Antimicrobial Resistance (AMR) Challenge, as well as shares new products and research.\"}',1,'2024-06-03 21:51:12','2024-06-03 21:51:12','6b7af467-1cc0-40a4-9a9a-0257e0879da4'),(19653,19653,1,NULL,'corha-insider-october-2019',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"The October 2019 CORHA newsletter contains a recap of the CORHA June 2019 in-person meeting, announces CORHA\'s commitment to participating in the Global Antimicrobial Resistance (AMR) Challenge, as well as shares new products and research.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"CORHA Insider - October 2019\"}',1,'2024-06-03 21:51:12','2024-06-03 21:51:12','e716eed1-2d1f-48a7-b9f8-33390a739dbc'),(19654,19654,1,'CORHA Insider - June 2019','corha-insider-june-2019','news/corha-insider-june-2019','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"The June 2019 CORHA newsletter contains a recap of CORHA\'s participation at the 2019 SHEA Spring meeting, as well as shares new resources and research.\"}',1,'2024-06-03 21:51:12','2024-06-03 21:51:12','32407309-e20e-4f1a-bef9-931984fb7032'),(19655,19655,1,NULL,'corha-insider-june-2019',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"The June 2019 CORHA newsletter contains a recap of CORHA\'s participation at the 2019 SHEA Spring meeting, as well as shares new resources and research.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"CORHA Insider - June 2019\"}',1,'2024-06-03 21:51:12','2024-06-03 21:51:12','b5124ce5-86c3-4220-a046-d4776d1dce18'),(19656,19656,1,'CORHA Insider - June 2019','corha-insider-june-2019','news/corha-insider-june-2019','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"The June 2019 CORHA newsletter contains a recap of CORHA\'s participation at the 2019 SHEA Spring meeting, as well as shares new resources and research.\"}',1,'2024-06-03 21:51:12','2024-06-03 21:51:12','2d453e52-f04a-46f8-99ed-5f10d5c62325'),(19657,19657,1,NULL,'corha-insider-june-2019',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"The June 2019 CORHA newsletter contains a recap of CORHA\'s participation at the 2019 SHEA Spring meeting, as well as shares new resources and research.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"CORHA Insider - June 2019\"}',1,'2024-06-03 21:51:12','2024-06-03 21:51:12','c2bac93e-87a4-4fc5-8e40-a45693da04fd'),(19658,19658,1,'CORHA Insider - April 2019','corha-insider-april-2019','news/corha-insider-april-2019','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"The April 2019 CORHA newsletter contains the latest CORHA news and spotlights new resources.\"}',1,'2024-06-03 21:51:12','2024-06-03 21:51:12','5db8e5d7-171f-4738-904e-3a7a01bc76de'),(19659,19659,1,NULL,'corha-insider-april-2019',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"The April 2019 CORHA newsletter contains the latest CORHA news and spotlights new resources.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"CORHA Insider - April 2019\"}',1,'2024-06-03 21:51:12','2024-06-03 21:51:12','2df5d69e-f59e-42c1-885b-409d88318f00'),(19660,19660,1,'CORHA Insider - April 2019','corha-insider-april-2019','news/corha-insider-april-2019','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"The April 2019 CORHA newsletter contains the latest CORHA news and spotlights new resources.\"}',1,'2024-06-03 21:51:12','2024-06-03 21:51:12','3cf5327d-5313-4e53-8631-f6e6ab9c51cd'),(19661,19661,1,NULL,'corha-insider-april-2019',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"The April 2019 CORHA newsletter contains the latest CORHA news and spotlights new resources.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"CORHA Insider - April 2019\"}',1,'2024-06-03 21:51:12','2024-06-03 21:51:12','088e60e4-84ad-4bbf-83fd-e3a48f153a18'),(19662,19662,1,'CORHA Insider - January 2019','corha-insider-january-2019','news/corha-insider-january-2019','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"The January 2019 CORHA newsletter contains a recap of the CORHA Fall 2018 meeting in Atlanta, as well as shares new resources and research.\"}',1,'2024-06-03 21:51:12','2024-06-03 21:51:12','33a11ce6-254e-4589-b812-e9e65e11273f'),(19663,19663,1,NULL,'corha-insider-january-2019',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"The January 2019 CORHA newsletter contains a recap of the CORHA Fall 2018 meeting in Atlanta, as well as shares new resources and research.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"CORHA Insider - January 2019\"}',1,'2024-06-03 21:51:12','2024-06-03 21:51:12','7b30e309-8d08-448f-8e85-aa412345c3f3'),(19664,19664,1,'CORHA Insider - January 2019','corha-insider-january-2019','news/corha-insider-january-2019','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"The January 2019 CORHA newsletter contains a recap of the CORHA Fall 2018 meeting in Atlanta, as well as shares new resources and research.\"}',1,'2024-06-03 21:51:12','2024-06-03 21:51:12','676fa139-db72-4029-aa54-9e194ba8201d'),(19665,19665,1,NULL,'corha-insider-january-2019',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"The January 2019 CORHA newsletter contains a recap of the CORHA Fall 2018 meeting in Atlanta, as well as shares new resources and research.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"CORHA Insider - January 2019\"}',1,'2024-06-03 21:51:12','2024-06-03 21:51:12','54c10608-7be7-4486-aee7-a3812e23f28d'),(19666,19666,1,'CORHA Insider - October 2018','corha-insider-october-2018','news/corha-insider-october-2018','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"The October 2018 CORHA newsletter contains presentation information from the International Conference on Emerging Infectious Disease, announces the kick off of a new workgroup on legal and policy considerations related to outbreaks (policy workgroup), spotlights the Antimicrobial Resistance Surveillance Task Force (ARSTF)\'s recent work, as well as shares recent journal and news articles.\"}',1,'2024-06-03 21:51:12','2024-06-03 21:51:12','8715ac97-4cb3-4032-9ca9-2ce8efdb0d08'),(19667,19667,1,NULL,'corha-insider-october-2018',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"The October 2018 CORHA newsletter contains presentation information from the International Conference on Emerging Infectious Disease, announces the kick off of a new workgroup on legal and policy considerations related to outbreaks (policy workgroup), spotlights the Antimicrobial Resistance Surveillance Task Force (ARSTF)\'s recent work, as well as shares recent journal and news articles.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"CORHA Insider - October 2018\"}',1,'2024-06-03 21:51:12','2024-06-03 21:51:12','2b9f3b5c-4882-42db-aca6-a0200109def9'),(19668,19668,1,'CORHA Insider - October 2018','corha-insider-october-2018','news/corha-insider-october-2018','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"The October 2018 CORHA newsletter contains presentation information from the International Conference on Emerging Infectious Disease, announces the kick off of a new workgroup on legal and policy considerations related to outbreaks (policy workgroup), spotlights the Antimicrobial Resistance Surveillance Task Force (ARSTF)\'s recent work, as well as shares recent journal and news articles.\"}',1,'2024-06-03 21:51:12','2024-06-03 21:51:12','d77e896a-5000-47b3-a140-5fb4c975e4ee'),(19669,19669,1,NULL,'corha-insider-october-2018',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"The October 2018 CORHA newsletter contains presentation information from the International Conference on Emerging Infectious Disease, announces the kick off of a new workgroup on legal and policy considerations related to outbreaks (policy workgroup), spotlights the Antimicrobial Resistance Surveillance Task Force (ARSTF)\'s recent work, as well as shares recent journal and news articles.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"CORHA Insider - October 2018\"}',1,'2024-06-03 21:51:12','2024-06-03 21:51:12','aba98df3-0dc4-42eb-b6c7-cbc6017126d9'),(19670,19670,1,'Key Strategies to Prepare for COVID-19 in Long-term Care Facilities (LTCFs)','key-strategies-to-prepare-for-covid-19-in-long-term-care-facilities-ltcfs','news/key-strategies-to-prepare-for-covid-19-in-long-term-care-facilities-ltcfs','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"The CDC offers key strategies for long-term care facilities on ways to keep COVID-19 from entering your facility, identifying infections early, preventing spread of COVID-19, assessing supply of PPE and initiating measures to optimize current supply, and identifying and managing severe illness.\"}',1,'2024-06-03 21:51:12','2024-06-03 21:51:12','7d995ab2-569d-49cd-856e-e8086cd0bf1e'),(19671,19671,1,NULL,'key-strategies-to-prepare-for-covid-19-in-long-term-care-facilities-ltcfs',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"The CDC offers key strategies for long-term care facilities on ways to keep COVID-19 from entering your facility, identifying infections early, preventing spread of COVID-19, assessing supply of PPE and initiating measures to optimize current supply, and identifying and managing severe illness.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Key Strategies to Prepare for COVID-19 in Long-term Care Facilities (LTCFs)\"}',1,'2024-06-03 21:51:12','2024-06-03 21:51:12','9b5ae6a1-5bfb-424a-821f-fdbd1f33b649'),(19672,19672,1,'Key Strategies to Prepare for COVID-19 in Long-term Care Facilities (LTCFs)','key-strategies-to-prepare-for-covid-19-in-long-term-care-facilities-ltcfs','news/key-strategies-to-prepare-for-covid-19-in-long-term-care-facilities-ltcfs','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"The CDC offers key strategies for long-term care facilities on ways to keep COVID-19 from entering your facility, identifying infections early, preventing spread of COVID-19, assessing supply of PPE and initiating measures to optimize current supply, and identifying and managing severe illness.\"}',1,'2024-06-03 21:51:12','2024-06-03 21:51:12','ea4d5a43-6e74-4fad-9b02-d862cf8745c3'),(19673,19673,1,NULL,'key-strategies-to-prepare-for-covid-19-in-long-term-care-facilities-ltcfs',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"The CDC offers key strategies for long-term care facilities on ways to keep COVID-19 from entering your facility, identifying infections early, preventing spread of COVID-19, assessing supply of PPE and initiating measures to optimize current supply, and identifying and managing severe illness.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Key Strategies to Prepare for COVID-19 in Long-term Care Facilities (LTCFs)\"}',1,'2024-06-03 21:51:12','2024-06-03 21:51:12','02947485-1df6-4005-937f-9716a4c99aa9'),(19674,19674,1,'Elastomeric Respirators: Strategies During Conventional and Surge Demand Situations','elastomeric-respirators-strategies-during-conventional-and-surge-demand-situations','news/elastomeric-respirators-strategies-during-conventional-and-surge-demand-situations','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"The CDC offers guidance on the use of reusable elastomeric particulate respirators to provide respiratory protection to healthcare practitioners against pathogens as a component of a formally developed and implemented written respiratory protection program.\"}',1,'2024-06-03 21:51:12','2024-06-03 21:51:12','5c4ec882-9aa7-4a96-9096-0a16581ff4a1'),(19675,19675,1,NULL,'elastomeric-respirators-strategies-during-conventional-and-surge-demand-situations',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"The CDC offers guidance on the use of reusable elastomeric particulate respirators to provide respiratory protection to healthcare practitioners against pathogens as a component of a formally developed and implemented written respiratory protection program.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Elastomeric Respirators: Strategies During Conventional and Surge Demand Situations\"}',1,'2024-06-03 21:51:12','2024-06-03 21:51:12','5508405b-becf-477a-a9fa-1be3d71874ae'),(19676,19676,1,'Elastomeric Respirators: Strategies During Conventional and Surge Demand Situations','elastomeric-respirators-strategies-during-conventional-and-surge-demand-situations','news/elastomeric-respirators-strategies-during-conventional-and-surge-demand-situations','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"The CDC offers guidance on the use of reusable elastomeric particulate respirators to provide respiratory protection to healthcare practitioners against pathogens as a component of a formally developed and implemented written respiratory protection program.\"}',1,'2024-06-03 21:51:12','2024-06-03 21:51:12','373c33ba-8438-4909-b9b3-a02ee0bfa320'),(19677,19677,1,NULL,'elastomeric-respirators-strategies-during-conventional-and-surge-demand-situations',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"The CDC offers guidance on the use of reusable elastomeric particulate respirators to provide respiratory protection to healthcare practitioners against pathogens as a component of a formally developed and implemented written respiratory protection program.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Elastomeric Respirators: Strategies During Conventional and Surge Demand Situations\"}',1,'2024-06-03 21:51:12','2024-06-03 21:51:12','81a9bf62-aa7d-450f-8513-e5c71b75efd8'),(19678,19678,1,'Preparing Nursing Homes and Assisted Living Facilities for COVID-19 (YouTube Video)','preparing-nursing-homes-and-assisted-living-facilities-for-covid-19-youtube-video','news/preparing-nursing-homes-and-assisted-living-facilities-for-covid-19-youtube-video','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"This CDC video presentation, led by Dr. Kara Jacobs Slifka, describes action that nursing homes and assisted living facilities can take to protect residents and staff from COVID-19.\"}',1,'2024-06-03 21:51:13','2024-06-03 21:51:13','3f58f685-1160-423d-a905-6b38d51f4cc6'),(19679,19679,1,NULL,'preparing-nursing-homes-and-assisted-living-facilities-for-covid-19-youtube-video',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"This CDC video presentation, led by Dr. Kara Jacobs Slifka, describes action that nursing homes and assisted living facilities can take to protect residents and staff from COVID-19.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Preparing Nursing Homes and Assisted Living Facilities for COVID-19 (YouTube Video)\"}',1,'2024-06-03 21:51:13','2024-06-03 21:51:13','fc4291c7-0891-4da7-b88c-7039c136ec80'),(19680,19680,1,'Preparing Nursing Homes and Assisted Living Facilities for COVID-19 (YouTube Video)','preparing-nursing-homes-and-assisted-living-facilities-for-covid-19-youtube-video','news/preparing-nursing-homes-and-assisted-living-facilities-for-covid-19-youtube-video','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"This CDC video presentation, led by Dr. Kara Jacobs Slifka, describes action that nursing homes and assisted living facilities can take to protect residents and staff from COVID-19.\"}',1,'2024-06-03 21:51:13','2024-06-03 21:51:13','431656d5-6100-40a0-81fe-a5e05798dda8'),(19681,19681,1,NULL,'preparing-nursing-homes-and-assisted-living-facilities-for-covid-19-youtube-video',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"This CDC video presentation, led by Dr. Kara Jacobs Slifka, describes action that nursing homes and assisted living facilities can take to protect residents and staff from COVID-19.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Preparing Nursing Homes and Assisted Living Facilities for COVID-19 (YouTube Video)\"}',1,'2024-06-03 21:51:13','2024-06-03 21:51:13','7921a589-c646-46e6-aba7-590697df70f2'),(19682,19682,1,'A Trial of Automated Outbreak Detection to Reduce Hospital Pathogen Spread','a-trial-of-automated-outbreak-detection-to-reduce-hospital-pathogen-spread','news/a-trial-of-automated-outbreak-detection-to-reduce-hospital-pathogen-spread','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"Ihalferty\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"A cluster-randomized trial was conducted in 82 community hospitals within a larger healthcare system to assess whether automated statistical surveillance and standardized response protocols could facilitate earlier containment efforts that would reduce the size of outbreaks. While the trial’s overall findings were negative, a post-hoc analysis comparing the prepandemic intervention period with baseline periods found that the statistical outbreak surveillance group was associated with a 64.1% reduction in additional cases.\"}',1,'2024-06-03 21:51:13','2024-06-03 21:51:13','24affbe3-6f3f-4f15-9087-fe76456cad15'),(19683,19683,1,NULL,'a-trial-of-automated-outbreak-detection-to-reduce-hospital-pathogen-spread',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"A cluster-randomized trial was conducted in 82 community hospitals within a larger healthcare system to assess whether automated statistical surveillance and standardized response protocols could facilitate earlier containment efforts that would reduce the size of outbreaks. While the trial’s overall findings were negative, a post-hoc analysis comparing the prepandemic intervention period with baseline periods found that the statistical outbreak surveillance group was associated with a 64.1% reduction in additional cases.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"A Trial of Automated Outbreak Detection to Reduce Hospital Pathogen Spread\"}',1,'2024-06-03 21:51:13','2024-06-03 21:51:13','7a3f17f4-788d-43e9-b286-ca86ed342dc1'),(19684,19684,1,'A Trial of Automated Outbreak Detection to Reduce Hospital Pathogen Spread','a-trial-of-automated-outbreak-detection-to-reduce-hospital-pathogen-spread','news/a-trial-of-automated-outbreak-detection-to-reduce-hospital-pathogen-spread','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"Ihalferty\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"A cluster-randomized trial was conducted in 82 community hospitals within a larger healthcare system to assess whether automated statistical surveillance and standardized response protocols could facilitate earlier containment efforts that would reduce the size of outbreaks. While the trial’s overall findings were negative, a post-hoc analysis comparing the prepandemic intervention period with baseline periods found that the statistical outbreak surveillance group was associated with a 64.1% reduction in additional cases.\"}',1,'2024-06-03 21:51:13','2024-06-03 21:51:13','b0c2b2e4-7f51-4247-9c23-db7171aa67a2'),(19685,19685,1,NULL,'a-trial-of-automated-outbreak-detection-to-reduce-hospital-pathogen-spread',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"A cluster-randomized trial was conducted in 82 community hospitals within a larger healthcare system to assess whether automated statistical surveillance and standardized response protocols could facilitate earlier containment efforts that would reduce the size of outbreaks. While the trial’s overall findings were negative, a post-hoc analysis comparing the prepandemic intervention period with baseline periods found that the statistical outbreak surveillance group was associated with a 64.1% reduction in additional cases.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"A Trial of Automated Outbreak Detection to Reduce Hospital Pathogen Spread\"}',1,'2024-06-03 21:51:13','2024-06-03 21:51:13','53a6c33b-6a42-4d67-8e6c-2f14c43844e3'),(19686,19686,1,'Can Patient Safety Be Improved by Using WHONET-SaTScan to Identify Outbreaks?','can-patient-safety-be-improved-by-using-whonet-satscan-to-identify-outbreaks','news/can-patient-safety-be-improved-by-using-whonet-satscan-to-identify-outbreaks','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"Ihalferty\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"While rates of healthcare-associated infections (HAIs) have decreased in past decades, they remain a pervasive problem in U.S. hospitals. Hospital infection prevention teams work to identify and manage HAI outbreaks to prevent undue burdens on patients and healthcare facilities. Rapid identification is a key strategy to control infectious disease outbreaks in healthcare settings.\"}',1,'2024-06-03 21:51:13','2024-06-03 21:51:13','c0c9f14a-677b-426e-a839-f64e929ad263'),(19687,19687,1,NULL,'can-patient-safety-be-improved-by-using-whonet-satscan-to-identify-outbreaks',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"While rates of healthcare-associated infections (HAIs) have decreased in past decades, they remain a pervasive problem in U.S. hospitals. Hospital infection prevention teams work to identify and manage HAI outbreaks to prevent undue burdens on patients and healthcare facilities. Rapid identification is a key strategy to control infectious disease outbreaks in healthcare settings.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Can Patient Safety Be Improved by Using WHONET-SaTScan to Identify Outbreaks?\"}',1,'2024-06-03 21:51:13','2024-06-03 21:51:13','6204d3b9-272c-43c5-b78e-f2076ab61b6e'),(19688,19688,1,'Can Patient Safety Be Improved by Using WHONET-SaTScan to Identify Outbreaks?','can-patient-safety-be-improved-by-using-whonet-satscan-to-identify-outbreaks','news/can-patient-safety-be-improved-by-using-whonet-satscan-to-identify-outbreaks','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"Ihalferty\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"While rates of healthcare-associated infections (HAIs) have decreased in past decades, they remain a pervasive problem in U.S. hospitals. Hospital infection prevention teams work to identify and manage HAI outbreaks to prevent undue burdens on patients and healthcare facilities. Rapid identification is a key strategy to control infectious disease outbreaks in healthcare settings.\"}',1,'2024-06-03 21:51:13','2024-06-03 21:51:13','fba9de9c-a055-45b0-928a-4833689e916b'),(19689,19689,1,NULL,'can-patient-safety-be-improved-by-using-whonet-satscan-to-identify-outbreaks',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"While rates of healthcare-associated infections (HAIs) have decreased in past decades, they remain a pervasive problem in U.S. hospitals. Hospital infection prevention teams work to identify and manage HAI outbreaks to prevent undue burdens on patients and healthcare facilities. Rapid identification is a key strategy to control infectious disease outbreaks in healthcare settings.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Can Patient Safety Be Improved by Using WHONET-SaTScan to Identify Outbreaks?\"}',1,'2024-06-03 21:51:13','2024-06-03 21:51:13','821cb70f-7af1-4874-96dd-5e5984c66bd3'),(19690,19690,1,'Notes from the Field: Potential Outbreak of Extrapulmonary Mycobacterium abscessus subspecies massiliense Infections from Stem Cell Treatment Clinics in Mexico — Arizona and Colorado, 2022','notes-from-the-field-potential-outbreak-of-extrapulmonary-mycobacterium-abscessus-subspecies-massiliense-infections-from-stem-cell-treatment-clinics-in-mexico-arizona-and-colorado-2022','news/notes-from-the-field-potential-outbreak-of-extrapulmonary-mycobacterium-abscessus-subspecies-massiliense-infections-from-stem-cell-treatment-clinics-in-mexico-arizona-and-colorado-2022','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"Ihalferty\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"In 2022, three patients developed extrapulmonary M. abscessus infections after receiving embryonic stem cell injections in three cities in Mexico. Through whole genome sequencing, isolates from two patients were identified as M. abscessus subspecies massiliense of a single clone, distinct from known dominant circulating clones, indicating a common infected source associated with the injections is possible.\"}',1,'2024-06-03 21:51:13','2024-06-03 21:51:13','0ad4b2a6-c061-459c-9e9c-94dbe505982d'),(19691,19691,1,NULL,'notes-from-the-field-potential-outbreak-of-extrapulmonary-mycobacterium-abscessus-subspecies-massiliense-infections-from-stem-cell-treatment-clinics-in-mexico-arizona-and-colorado-2022',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"In 2022, three patients developed extrapulmonary M. abscessus infections after receiving embryonic stem cell injections in three cities in Mexico. Through whole genome sequencing, isolates from two patients were identified as M. abscessus subspecies massiliense of a single clone, distinct from known dominant circulating clones, indicating a common infected source associated with the injections is possible.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Notes from the Field: Potential Outbreak of Extrapulmonary Mycobacterium abscessus subspecies massiliense Infections from Stem Cell Treatment Clinics in Mexico — Arizona and Colorado, 2022\"}',1,'2024-06-03 21:51:13','2024-06-03 21:51:13','841cc948-121c-424d-90f7-f69e7da496d9'),(19692,19692,1,'Notes from the Field: Potential Outbreak of Extrapulmonary Mycobacterium abscessus subspecies massiliense Infections from Stem Cell Treatment Clinics in Mexico — Arizona and Colorado, 2022','notes-from-the-field-potential-outbreak-of-extrapulmonary-mycobacterium-abscessus-subspecies-massiliense-infections-from-stem-cell-treatment-clinics-in-mexico-arizona-and-colorado-2022','news/notes-from-the-field-potential-outbreak-of-extrapulmonary-mycobacterium-abscessus-subspecies-massiliense-infections-from-stem-cell-treatment-clinics-in-mexico-arizona-and-colorado-2022','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"Ihalferty\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"In 2022, three patients developed extrapulmonary M. abscessus infections after receiving embryonic stem cell injections in three cities in Mexico. Through whole genome sequencing, isolates from two patients were identified as M. abscessus subspecies massiliense of a single clone, distinct from known dominant circulating clones, indicating a common infected source associated with the injections is possible.\"}',1,'2024-06-03 21:51:13','2024-06-03 21:51:13','d7366835-a3fc-42f8-8389-f853981a1f36'),(19693,19693,1,NULL,'notes-from-the-field-potential-outbreak-of-extrapulmonary-mycobacterium-abscessus-subspecies-massiliense-infections-from-stem-cell-treatment-clinics-in-mexico-arizona-and-colorado-2022',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"In 2022, three patients developed extrapulmonary M. abscessus infections after receiving embryonic stem cell injections in three cities in Mexico. Through whole genome sequencing, isolates from two patients were identified as M. abscessus subspecies massiliense of a single clone, distinct from known dominant circulating clones, indicating a common infected source associated with the injections is possible.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Notes from the Field: Potential Outbreak of Extrapulmonary Mycobacterium abscessus subspecies massiliense Infections from Stem Cell Treatment Clinics in Mexico — Arizona and Colorado, 2022\"}',1,'2024-06-03 21:51:13','2024-06-03 21:51:13','00efaac9-b74c-4c61-9734-b4b1b586f197'),(19694,19694,1,'Investigation of Presumptive HIV Transmission Associated with Receipt of Platelet-Rich Plasma Microneedling Facials at a Spa Among Former Spa Clients — New Mexico, 2018–2023','investigation-of-presumptive-hiv-transmission-associated-with-receipt-of-platelet-rich-plasma-microneedling-facials-at-a-spa-among-former-spa-clients-new-mexico-2018-2023','news/investigation-of-presumptive-hiv-transmission-associated-with-receipt-of-platelet-rich-plasma-microneedling-facials-at-a-spa-among-former-spa-clients-new-mexico-2018-2023','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"Ihalferty\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"During summer 2018, an investigation by the New Mexico Department of Health identified multiple HIV infections among persons with no known HIV risk factors who received platelet-rich plasma with microneedling (vampire facials) at an unlicensed New Mexico spa, revealing likely HIV transmission associated with these cosmetic injection services.\"}',1,'2024-06-03 21:51:13','2024-06-03 21:51:13','d492aea8-28f6-4d3a-b0b9-f90fa241af3a'),(19695,19695,1,NULL,'investigation-of-presumptive-hiv-transmission-associated-with-receipt-of-platelet-rich-plasma-microneedling-facials-at-a-spa-among-former-spa-clients-new-mexico-2018-2023',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"During summer 2018, an investigation by the New Mexico Department of Health identified multiple HIV infections among persons with no known HIV risk factors who received platelet-rich plasma with microneedling (vampire facials) at an unlicensed New Mexico spa, revealing likely HIV transmission associated with these cosmetic injection services.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Investigation of Presumptive HIV Transmission Associated with Receipt of Platelet-Rich Plasma Microneedling Facials at a Spa Among Former Spa Clients — New Mexico, 2018–2023\"}',1,'2024-06-03 21:51:13','2024-06-03 21:51:13','80edbcbf-2b64-4838-8adb-726131a1ba49'),(19696,19696,1,'Investigation of Presumptive HIV Transmission Associated with Receipt of Platelet-Rich Plasma Microneedling Facials at a Spa Among Former Spa Clients — New Mexico, 2018–2023','investigation-of-presumptive-hiv-transmission-associated-with-receipt-of-platelet-rich-plasma-microneedling-facials-at-a-spa-among-former-spa-clients-new-mexico-2018-2023','news/investigation-of-presumptive-hiv-transmission-associated-with-receipt-of-platelet-rich-plasma-microneedling-facials-at-a-spa-among-former-spa-clients-new-mexico-2018-2023','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"Ihalferty\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"During summer 2018, an investigation by the New Mexico Department of Health identified multiple HIV infections among persons with no known HIV risk factors who received platelet-rich plasma with microneedling (vampire facials) at an unlicensed New Mexico spa, revealing likely HIV transmission associated with these cosmetic injection services.\"}',1,'2024-06-03 21:51:13','2024-06-03 21:51:13','ca07452b-dcd3-4245-92cc-8577f56e62d7'),(19697,19697,1,NULL,'investigation-of-presumptive-hiv-transmission-associated-with-receipt-of-platelet-rich-plasma-microneedling-facials-at-a-spa-among-former-spa-clients-new-mexico-2018-2023',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"During summer 2018, an investigation by the New Mexico Department of Health identified multiple HIV infections among persons with no known HIV risk factors who received platelet-rich plasma with microneedling (vampire facials) at an unlicensed New Mexico spa, revealing likely HIV transmission associated with these cosmetic injection services.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Investigation of Presumptive HIV Transmission Associated with Receipt of Platelet-Rich Plasma Microneedling Facials at a Spa Among Former Spa Clients — New Mexico, 2018–2023\"}',1,'2024-06-03 21:51:13','2024-06-03 21:51:13','6e011f44-d9ae-4039-951e-48c4e5bd1b2c'),(19698,19698,1,'Investigation of a pseudo-outbreak of Mycobacterium franklinni','investigation-of-a-pseudo-outbreak-of-mycobacterium-franklinni','news/investigation-of-a-pseudo-outbreak-of-mycobacterium-franklinni','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"Ihalferty\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"Mycobacterium franklinni is a ubiquitous organism that can cause lung, skin, and soft tissue infections. Due to its pervasive nature, it can be a source of outbreaks via contamination of shared medical equipment or tools. When investigating outbreaks of this type of organism it is important to consider the clinical picture of the patient when evaluating if there is a pseudo-outbreak as well as identifying if treatment is needed for patients.\"}',1,'2024-06-03 21:51:13','2024-06-03 21:51:13','2ef26962-3f7c-464f-b01c-907f4a57673f'),(19699,19699,1,NULL,'investigation-of-a-pseudo-outbreak-of-mycobacterium-franklinni',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"Mycobacterium franklinni is a ubiquitous organism that can cause lung, skin, and soft tissue infections. Due to its pervasive nature, it can be a source of outbreaks via contamination of shared medical equipment or tools. When investigating outbreaks of this type of organism it is important to consider the clinical picture of the patient when evaluating if there is a pseudo-outbreak as well as identifying if treatment is needed for patients.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Investigation of a pseudo-outbreak of Mycobacterium franklinni\"}',1,'2024-06-03 21:51:14','2024-06-03 21:51:14','26d21303-618e-4b53-9aef-024d8c91173b'),(19700,19700,1,'Investigation of a pseudo-outbreak of Mycobacterium franklinni','investigation-of-a-pseudo-outbreak-of-mycobacterium-franklinni','news/investigation-of-a-pseudo-outbreak-of-mycobacterium-franklinni','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"Ihalferty\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"Mycobacterium franklinni is a ubiquitous organism that can cause lung, skin, and soft tissue infections. Due to its pervasive nature, it can be a source of outbreaks via contamination of shared medical equipment or tools. When investigating outbreaks of this type of organism it is important to consider the clinical picture of the patient when evaluating if there is a pseudo-outbreak as well as identifying if treatment is needed for patients.\"}',1,'2024-06-03 21:51:14','2024-06-03 21:51:14','2b8b4dc0-e2b4-4185-a924-e3129f7a732e'),(19701,19701,1,NULL,'investigation-of-a-pseudo-outbreak-of-mycobacterium-franklinni',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"Mycobacterium franklinni is a ubiquitous organism that can cause lung, skin, and soft tissue infections. Due to its pervasive nature, it can be a source of outbreaks via contamination of shared medical equipment or tools. When investigating outbreaks of this type of organism it is important to consider the clinical picture of the patient when evaluating if there is a pseudo-outbreak as well as identifying if treatment is needed for patients.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Investigation of a pseudo-outbreak of Mycobacterium franklinni\"}',1,'2024-06-03 21:51:14','2024-06-03 21:51:14','2bcc43b9-30f0-4c51-a5ed-dc5801a7b78e'),(19702,19702,1,'Investigation of air dispersal during a rhinovirus outbreak in a pediatric intensive care unit','investigation-of-air-dispersal-during-a-rhinovirus-outbreak-in-a-pediatric-intensive-care-unit','news/investigation-of-air-dispersal-during-a-rhinovirus-outbreak-in-a-pediatric-intensive-care-unit','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"Ihalferty\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"An outbreak of rhinovirus in a pediatric intensive care unit (PICU) was investigated to assess air dispersal, and a case-control analysis was performed to identify nosocomial rhinovirus risk factors. Findings suggest that air dispersal of rhinovirus was not documented in the well-ventilated PICU during the outbreak. Further research is needed to better understand the dynamics of rhinovirus transmission in healthcare settings.\"}',1,'2024-06-03 21:51:14','2024-06-03 21:51:14','c0f0cc11-51c0-4a28-8c28-ee672de17d26'),(19703,19703,1,NULL,'investigation-of-air-dispersal-during-a-rhinovirus-outbreak-in-a-pediatric-intensive-care-unit',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"An outbreak of rhinovirus in a pediatric intensive care unit (PICU) was investigated to assess air dispersal, and a case-control analysis was performed to identify nosocomial rhinovirus risk factors. Findings suggest that air dispersal of rhinovirus was not documented in the well-ventilated PICU during the outbreak. Further research is needed to better understand the dynamics of rhinovirus transmission in healthcare settings.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Investigation of air dispersal during a rhinovirus outbreak in a pediatric intensive care unit\"}',1,'2024-06-03 21:51:14','2024-06-03 21:51:14','e7e51845-5fa5-435a-b5ab-846b9e0693ff'),(19704,19704,1,'Investigation of air dispersal during a rhinovirus outbreak in a pediatric intensive care unit','investigation-of-air-dispersal-during-a-rhinovirus-outbreak-in-a-pediatric-intensive-care-unit','news/investigation-of-air-dispersal-during-a-rhinovirus-outbreak-in-a-pediatric-intensive-care-unit','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"Ihalferty\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"An outbreak of rhinovirus in a pediatric intensive care unit (PICU) was investigated to assess air dispersal, and a case-control analysis was performed to identify nosocomial rhinovirus risk factors. Findings suggest that air dispersal of rhinovirus was not documented in the well-ventilated PICU during the outbreak. Further research is needed to better understand the dynamics of rhinovirus transmission in healthcare settings.\"}',1,'2024-06-03 21:51:14','2024-06-03 21:51:14','d1c3c0d7-8454-4a8e-8119-f7eda81871a7'),(19705,19705,1,NULL,'investigation-of-air-dispersal-during-a-rhinovirus-outbreak-in-a-pediatric-intensive-care-unit',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"An outbreak of rhinovirus in a pediatric intensive care unit (PICU) was investigated to assess air dispersal, and a case-control analysis was performed to identify nosocomial rhinovirus risk factors. Findings suggest that air dispersal of rhinovirus was not documented in the well-ventilated PICU during the outbreak. Further research is needed to better understand the dynamics of rhinovirus transmission in healthcare settings.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Investigation of air dispersal during a rhinovirus outbreak in a pediatric intensive care unit\"}',1,'2024-06-03 21:51:14','2024-06-03 21:51:14','79332f13-27aa-4daf-ba0f-f6f8c844504c'),(19706,19706,1,'Category A waste processing and disposal is a critical weakness in the United States response plans for outbreaks of high consequence infectious diseases','category-a-waste-processing-and-disposal-is-a-critical-weakness-in-the-united-states-response-plans-for-outbreaks-of-high-consequence-infectious-diseases','news/category-a-waste-processing-and-disposal-is-a-critical-weakness-in-the-united-states-response-plans-for-outbreaks-of-high-consequence-infectious-diseases','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"Ihalferty\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"Significant amounts of Category A infectious substance waste (Cat-A) may be generated during the treatment of patients with a high consequence infection disease (HCID). During the treatment of a patient with Ebola virus disease, one facility documented generating over a thousand pounds of Cat-A. The processing and disposal of Cat-A in the treatment of patients with HCID highlights how this issue is affecting the development of the National Special Pathogen System and the United States’ ability to respond to a national HCID epidemic.\"}',1,'2024-06-03 21:51:14','2024-06-03 21:51:14','64cd0771-9f1d-4252-93ac-77c9fba18de2'),(19707,19707,1,NULL,'category-a-waste-processing-and-disposal-is-a-critical-weakness-in-the-united-states-response-plans-for-outbreaks-of-high-consequence-infectious-diseases',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"<p>Significant amounts of Category A infectious substance waste (Cat-A) may be generated during the treatment of patients with a high consequence infection disease (HCID). During the treatment of a patient with Ebola virus disease, one facility documented generating over a thousand pounds of Cat-A. The processing and disposal of Cat-A.c.</p>\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Category A waste processing and disposal is a critical weakness in the United States\"}',1,'2024-06-03 21:51:14','2024-06-03 21:56:50','32f20fe4-b1c3-4cbf-918f-3746927ac27f'),(19708,19708,1,'Category A waste processing and disposal is a critical weakness in the United States response plans for outbreaks of high consequence infectious diseases','category-a-waste-processing-and-disposal-is-a-critical-weakness-in-the-united-states-response-plans-for-outbreaks-of-high-consequence-infectious-diseases','news/category-a-waste-processing-and-disposal-is-a-critical-weakness-in-the-united-states-response-plans-for-outbreaks-of-high-consequence-infectious-diseases','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"Ihalferty\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"Significant amounts of Category A infectious substance waste (Cat-A) may be generated during the treatment of patients with a high consequence infection disease (HCID). During the treatment of a patient with Ebola virus disease, one facility documented generating over a thousand pounds of Cat-A. The processing and disposal of Cat-A in the treatment of patients with HCID highlights how this issue is affecting the development of the National Special Pathogen System and the United States’ ability to respond to a national HCID epidemic.\"}',1,'2024-06-03 21:51:14','2024-06-03 21:51:14','412d9211-c9d8-463f-bf22-879ffb57405b'),(19709,19709,1,NULL,'category-a-waste-processing-and-disposal-is-a-critical-weakness-in-the-united-states-response-plans-for-outbreaks-of-high-consequence-infectious-diseases',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"Significant amounts of Category A infectious substance waste (Cat-A) may be generated during the treatment of patients with a high consequence infection disease (HCID). During the treatment of a patient with Ebola virus disease, one facility documented generating over a thousand pounds of Cat-A. The processing and disposal of Cat-A in the treatment of patients with HCID highlights how this issue is affecting the development of the National Special Pathogen System and the United States’ ability to respond to a national HCID epidemic.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Category A waste processing and disposal is a critical weakness in the United States response plans for outbreaks of high consequence infectious diseases\"}',1,'2024-06-03 21:51:14','2024-06-03 21:51:14','2ca10dd8-ce68-444b-a7a6-0374c5216336'),(19710,19710,1,'CORHA Interim Framework for Healthcare-Associated Infection Outbreak Notification','corha-interim-framework-for-healthcare-associated-infection-outbreak-notification','news/corha-interim-framework-for-healthcare-associated-infection-outbreak-notification','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"This CORHA-produced document provides guidance for notification in the context of a suspected healthcare-associated infection (HAI) outbreak.\"}',1,'2024-06-03 21:51:14','2024-06-03 21:51:14','f57bbe16-6c9e-4b32-b4e2-6ed5c99d7d92'),(19711,19711,1,NULL,'corha-interim-framework-for-healthcare-associated-infection-outbreak-notification',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"This CORHA-produced document provides guidance for notification in the context of a suspected healthcare-associated infection (HAI) outbreak.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"CORHA Interim Framework for Healthcare-Associated Infection Outbreak Notification\"}',1,'2024-06-03 21:51:14','2024-06-03 21:51:14','8a673e2f-cbe2-4acd-b1d8-55e6fae81209'),(19712,19712,1,'CORHA Interim Framework for Healthcare-Associated Infection Outbreak Notification','corha-interim-framework-for-healthcare-associated-infection-outbreak-notification','news/corha-interim-framework-for-healthcare-associated-infection-outbreak-notification','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"This CORHA-produced document provides guidance for notification in the context of a suspected healthcare-associated infection (HAI) outbreak.\"}',1,'2024-06-03 21:51:14','2024-06-03 21:51:14','3bd13841-541d-4270-a1a3-5d79e2e74c4c'),(19713,19713,1,NULL,'corha-interim-framework-for-healthcare-associated-infection-outbreak-notification',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"This CORHA-produced document provides guidance for notification in the context of a suspected healthcare-associated infection (HAI) outbreak.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"CORHA Interim Framework for Healthcare-Associated Infection Outbreak Notification\"}',1,'2024-06-03 21:51:14','2024-06-03 21:51:14','7676e2eb-827c-4cd0-a09a-4dea792a58ba'),(19714,19714,1,'Video Demonstration on How to Safely Put On Personal Protective Equipment (PPE)','video-demonstration-on-how-to-safely-put-on-personal-protective-equipment-ppe','news/video-demonstration-on-how-to-safely-put-on-personal-protective-equipment-ppe','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"This video demonstrates the procedures described in CDC guidance for donning or putting on personal protective equipment for people who use PPE in a healthcare setting.\"}',1,'2024-06-03 21:51:14','2024-06-03 21:51:14','9c4daf50-93a4-4d84-8f69-a91c79c1027c'),(19715,19715,1,NULL,'video-demonstration-on-how-to-safely-put-on-personal-protective-equipment-ppe',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"This video demonstrates the procedures described in CDC guidance for donning or putting on personal protective equipment for people who use PPE in a healthcare setting.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Video Demonstration on How to Safely Put On Personal Protective Equipment (PPE)\"}',1,'2024-06-03 21:51:14','2024-06-03 21:51:14','c4e3d0a8-ba57-41a1-af4d-78523c68d297'),(19716,19716,1,'Video Demonstration on How to Safely Put On Personal Protective Equipment (PPE)','video-demonstration-on-how-to-safely-put-on-personal-protective-equipment-ppe','news/video-demonstration-on-how-to-safely-put-on-personal-protective-equipment-ppe','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"This video demonstrates the procedures described in CDC guidance for donning or putting on personal protective equipment for people who use PPE in a healthcare setting.\"}',1,'2024-06-03 21:51:14','2024-06-03 21:51:14','b2371827-b332-4279-a395-f45f172a59ab'),(19717,19717,1,NULL,'video-demonstration-on-how-to-safely-put-on-personal-protective-equipment-ppe',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"This video demonstrates the procedures described in CDC guidance for donning or putting on personal protective equipment for people who use PPE in a healthcare setting.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Video Demonstration on How to Safely Put On Personal Protective Equipment (PPE)\"}',1,'2024-06-03 21:51:14','2024-06-03 21:51:14','d69340e5-7ebf-49ee-b256-303a5c5a9da7'),(19718,19718,1,'Video Demonstration on How to Safely Take Off Personal Protective Equipment (PPE)','video-demonstration-on-how-to-safely-take-off-personal-protective-equipment-ppe','news/video-demonstration-on-how-to-safely-take-off-personal-protective-equipment-ppe','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"This video demonstrates the procedures described in CDC guidance for doffing or taking off personal protective equipment for people who use PPE in a healthcare setting.\"}',1,'2024-06-03 21:51:14','2024-06-03 21:51:14','50debf4b-f710-415e-9c8b-2c480c6a2289'),(19719,19719,1,NULL,'video-demonstration-on-how-to-safely-take-off-personal-protective-equipment-ppe',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"This video demonstrates the procedures described in CDC guidance for doffing or taking off personal protective equipment for people who use PPE in a healthcare setting.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Video Demonstration on How to Safely Take Off Personal Protective Equipment (PPE)\"}',1,'2024-06-03 21:51:14','2024-06-03 21:51:14','4326806e-216a-4ede-85ce-f7b907d9216e'),(19720,19720,1,'Video Demonstration on How to Safely Take Off Personal Protective Equipment (PPE)','video-demonstration-on-how-to-safely-take-off-personal-protective-equipment-ppe','news/video-demonstration-on-how-to-safely-take-off-personal-protective-equipment-ppe','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"This video demonstrates the procedures described in CDC guidance for doffing or taking off personal protective equipment for people who use PPE in a healthcare setting.\"}',1,'2024-06-03 21:51:14','2024-06-03 21:51:14','adb56889-81d0-4991-be0d-47000254bc19'),(19721,19721,1,NULL,'video-demonstration-on-how-to-safely-take-off-personal-protective-equipment-ppe',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"This video demonstrates the procedures described in CDC guidance for doffing or taking off personal protective equipment for people who use PPE in a healthcare setting.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Video Demonstration on How to Safely Take Off Personal Protective Equipment (PPE)\"}',1,'2024-06-03 21:51:14','2024-06-03 21:51:14','d06ad106-8bc9-4bff-9535-364ac4834a19'),(19722,19722,1,'Healthcare Infection Prevention and Control FAQs for COVID-19','healthcare-infection-prevention-and-control-faqs-for-covid-19','news/healthcare-infection-prevention-and-control-faqs-for-covid-19','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"This page was created for healthcare personnel who may care for patients who are confirmed with or under investigation for COVID-19 and contains FAQs to support the existing Healthcare Infection Prevention and Control Guidance for COVID-19.  The page was updated on April 23, 2020 to align with the revised Interim Infection Prevention and Control Recommendations for Patients with Suspected or Confirmed Coronavirus Disease 2019 (COVID-19) in Healthcare Settings, .\"}',1,'2024-06-03 21:51:15','2024-06-03 21:51:15','a0a1a87b-b798-4300-b7b0-890dbc7f41bd'),(19723,19723,1,NULL,'healthcare-infection-prevention-and-control-faqs-for-covid-19',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"This page was created for healthcare personnel who may care for patients who are confirmed with or under investigation for COVID-19 and contains FAQs to support the existing Healthcare Infection Prevention and Control Guidance for COVID-19.  The page was updated on April 23, 2020 to align with the revised Interim Infection Prevention and Control Recommendations for Patients with Suspected or Confirmed Coronavirus Disease 2019 (COVID-19) in Healthcare Settings, .\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Healthcare Infection Prevention and Control FAQs for COVID-19\"}',1,'2024-06-03 21:51:15','2024-06-03 21:51:15','8dd0a311-eb18-47fa-8031-a7095c6eee65'),(19724,19724,1,'Healthcare Infection Prevention and Control FAQs for COVID-19','healthcare-infection-prevention-and-control-faqs-for-covid-19','news/healthcare-infection-prevention-and-control-faqs-for-covid-19','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"This page was created for healthcare personnel who may care for patients who are confirmed with or under investigation for COVID-19 and contains FAQs to support the existing Healthcare Infection Prevention and Control Guidance for COVID-19.  The page was updated on April 23, 2020 to align with the revised Interim Infection Prevention and Control Recommendations for Patients with Suspected or Confirmed Coronavirus Disease 2019 (COVID-19) in Healthcare Settings, .\"}',1,'2024-06-03 21:51:15','2024-06-03 21:51:15','a2a504c4-480d-4650-bb0d-8c78cb7a8c78'),(19725,19725,1,NULL,'healthcare-infection-prevention-and-control-faqs-for-covid-19',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"This page was created for healthcare personnel who may care for patients who are confirmed with or under investigation for COVID-19 and contains FAQs to support the existing Healthcare Infection Prevention and Control Guidance for COVID-19.  The page was updated on April 23, 2020 to align with the revised Interim Infection Prevention and Control Recommendations for Patients with Suspected or Confirmed Coronavirus Disease 2019 (COVID-19) in Healthcare Settings, .\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Healthcare Infection Prevention and Control FAQs for COVID-19\"}',1,'2024-06-03 21:51:15','2024-06-03 21:51:15','3cc556ec-0f6c-4bae-900b-ef1fef182fe5'),(19726,19726,1,'Infection Prevention and Control Considerations for Alternate Care Sites','infection-prevention-and-control-considerations-for-alternate-care-sites','news/infection-prevention-and-control-considerations-for-alternate-care-sites','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"The CDC shares infection prevention and control considerations for alternate care sites. The page was recently updated to align with the level of care categories defined in the Federal Healthcare Resilience Task Force Alternate Care Sites (ACS) Toolkit: Second Edition, which include Non-Acute Care, Hospital Care, and Acute Care.\"}',1,'2024-06-03 21:51:15','2024-06-03 21:51:15','4af25e43-aede-4acc-8621-234038479a53'),(19727,19727,1,NULL,'infection-prevention-and-control-considerations-for-alternate-care-sites',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"The CDC shares infection prevention and control considerations for alternate care sites. The page was recently updated to align with the level of care categories defined in the Federal Healthcare Resilience Task Force Alternate Care Sites (ACS) Toolkit: Second Edition, which include Non-Acute Care, Hospital Care, and Acute Care.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Infection Prevention and Control Considerations for Alternate Care Sites\"}',1,'2024-06-03 21:51:15','2024-06-03 21:51:15','e47ccd18-16e3-443f-9813-661ecda215d8'),(19728,19728,1,'Infection Prevention and Control Considerations for Alternate Care Sites','infection-prevention-and-control-considerations-for-alternate-care-sites','news/infection-prevention-and-control-considerations-for-alternate-care-sites','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"The CDC shares infection prevention and control considerations for alternate care sites. The page was recently updated to align with the level of care categories defined in the Federal Healthcare Resilience Task Force Alternate Care Sites (ACS) Toolkit: Second Edition, which include Non-Acute Care, Hospital Care, and Acute Care.\"}',1,'2024-06-03 21:51:15','2024-06-03 21:51:15','52f72be4-9cdc-4d81-8163-b80049606e0f'),(19729,19729,1,NULL,'infection-prevention-and-control-considerations-for-alternate-care-sites',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"The CDC shares infection prevention and control considerations for alternate care sites. The page was recently updated to align with the level of care categories defined in the Federal Healthcare Resilience Task Force Alternate Care Sites (ACS) Toolkit: Second Edition, which include Non-Acute Care, Hospital Care, and Acute Care.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Infection Prevention and Control Considerations for Alternate Care Sites\"}',1,'2024-06-03 21:51:15','2024-06-03 21:51:15','48246af9-e8ce-4224-9aa2-fe3651658ad4'),(19730,19730,1,'Characteristics and Clinical Outcomes of Adult Patients Hospitalized with COVID-19 — Georgia, March 2020','characteristics-and-clinical-outcomes-of-adult-patients-hospitalized-with-covid-19-georgia-march-2020','news/characteristics-and-clinical-outcomes-of-adult-patients-hospitalized-with-covid-19-georgia-march-2020','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"This Morbidity and Mortality Weekly Report (MMWR) shares information on a cohort of 305 hospitalized adults with COVID-19 in Georgia (primarily metropolitan Atlanta). In the cohort, black patients were overrepresented, and their clinical outcomes were similar to those of nonblack patients. One in four hospitalized patients had no recognized risk factors for severe COVID-19.\"}',1,'2024-06-03 21:51:15','2024-06-03 21:51:15','3da5fb50-d9ec-428d-bdc9-e5b54759a813'),(19731,19731,1,NULL,'characteristics-and-clinical-outcomes-of-adult-patients-hospitalized-with-covid-19-georgia-march-2020',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"This Morbidity and Mortality Weekly Report (MMWR) shares information on a cohort of 305 hospitalized adults with COVID-19 in Georgia (primarily metropolitan Atlanta). In the cohort, black patients were overrepresented, and their clinical outcomes were similar to those of nonblack patients. One in four hospitalized patients had no recognized risk factors for severe COVID-19.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Characteristics and Clinical Outcomes of Adult Patients Hospitalized with COVID-19 — Georgia, March 2020\"}',1,'2024-06-03 21:51:15','2024-06-03 21:51:15','a65db01c-73e5-4dc1-8ebe-bb93d7d082af'),(19732,19732,1,'Characteristics and Clinical Outcomes of Adult Patients Hospitalized with COVID-19 — Georgia, March 2020','characteristics-and-clinical-outcomes-of-adult-patients-hospitalized-with-covid-19-georgia-march-2020','news/characteristics-and-clinical-outcomes-of-adult-patients-hospitalized-with-covid-19-georgia-march-2020','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"This Morbidity and Mortality Weekly Report (MMWR) shares information on a cohort of 305 hospitalized adults with COVID-19 in Georgia (primarily metropolitan Atlanta). In the cohort, black patients were overrepresented, and their clinical outcomes were similar to those of nonblack patients. One in four hospitalized patients had no recognized risk factors for severe COVID-19.\"}',1,'2024-06-03 21:51:15','2024-06-03 21:51:15','07bf6fe3-8ee5-4d62-bbf9-a27e330498e2'),(19733,19733,1,NULL,'characteristics-and-clinical-outcomes-of-adult-patients-hospitalized-with-covid-19-georgia-march-2020',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"This Morbidity and Mortality Weekly Report (MMWR) shares information on a cohort of 305 hospitalized adults with COVID-19 in Georgia (primarily metropolitan Atlanta). In the cohort, black patients were overrepresented, and their clinical outcomes were similar to those of nonblack patients. One in four hospitalized patients had no recognized risk factors for severe COVID-19.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Characteristics and Clinical Outcomes of Adult Patients Hospitalized with COVID-19 — Georgia, March 2020\"}',1,'2024-06-03 21:51:15','2024-06-03 21:51:15','9433812a-e379-42ae-98da-52487ec0b336'),(19734,19734,1,'NHSN COVID-19 Module Data Dashboard','nhsn-covid-19-module-data-dashboard','news/nhsn-covid-19-module-data-dashboard','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"CDC\'s National Health Safety Network (NHSN) COVID-19 Module Data Dashboard shows the number of facilities reporting by state, percent of inpatient hospital beds occupied, and the percent of intensive care unit (ICU) beds occupied by state. The data is reported by acute care facilities participating in the Patient Impact and Hospital Capacity pathway of the NHSN COVID-19 module and is updated by 9:00 am ET each day.\"}',1,'2024-06-03 21:51:15','2024-06-03 21:51:15','1c1a37f8-2cc6-460c-8b76-3396d7a8bfdb'),(19735,19735,1,NULL,'nhsn-covid-19-module-data-dashboard',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"CDC\'s National Health Safety Network (NHSN) COVID-19 Module Data Dashboard shows the number of facilities reporting by state, percent of inpatient hospital beds occupied, and the percent of intensive care unit (ICU) beds occupied by state. The data is reported by acute care facilities participating in the Patient Impact and Hospital Capacity pathway of the NHSN COVID-19 module and is updated by 9:00 am ET each day.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"NHSN COVID-19 Module Data Dashboard\"}',1,'2024-06-03 21:51:15','2024-06-03 21:51:15','48987735-4dbe-4641-9749-76c219f4c650'),(19736,19736,1,'NHSN COVID-19 Module Data Dashboard','nhsn-covid-19-module-data-dashboard','news/nhsn-covid-19-module-data-dashboard','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"CDC\'s National Health Safety Network (NHSN) COVID-19 Module Data Dashboard shows the number of facilities reporting by state, percent of inpatient hospital beds occupied, and the percent of intensive care unit (ICU) beds occupied by state. The data is reported by acute care facilities participating in the Patient Impact and Hospital Capacity pathway of the NHSN COVID-19 module and is updated by 9:00 am ET each day.\"}',1,'2024-06-03 21:51:15','2024-06-03 21:51:15','90fc60e1-6089-49b7-bb6d-83675ef1f667'),(19737,19737,1,NULL,'nhsn-covid-19-module-data-dashboard',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"CDC\'s National Health Safety Network (NHSN) COVID-19 Module Data Dashboard shows the number of facilities reporting by state, percent of inpatient hospital beds occupied, and the percent of intensive care unit (ICU) beds occupied by state. The data is reported by acute care facilities participating in the Patient Impact and Hospital Capacity pathway of the NHSN COVID-19 module and is updated by 9:00 am ET each day.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"NHSN COVID-19 Module Data Dashboard\"}',1,'2024-06-03 21:51:15','2024-06-03 21:51:15','8f424ee9-b788-48eb-a045-fc967ef4a733'),(19738,19738,1,'LTCF COVID-19 Module','ltcf-covid-19-module','news/ltcf-covid-19-module','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"CDC\'s National Health Safety Network COVID-19 Module for Long Term Care Facilities (LTCFs) enables an assessment of the impact of COVID-19 in LTCFs through facility reported information such as counts of residents and facility personnel with suspected and laboratory positive COVID-19, staffing shortages, status of personal protective equipment (PPE), ventilator capacity, and more. View the page for information on eligibility, enrollment, training, data collection forms and instructions, and additional resources.\"}',1,'2024-06-03 21:51:15','2024-06-03 21:51:15','5214237e-7e47-4a29-9b1d-0437c3aaebc8'),(19739,19739,1,NULL,'ltcf-covid-19-module',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"CDC\'s National Health Safety Network COVID-19 Module for Long Term Care Facilities (LTCFs) enables an assessment of the impact of COVID-19 in LTCFs through facility reported information such as counts of residents and facility personnel with suspected and laboratory positive COVID-19, staffing shortages, status of personal protective equipment (PPE), ventilator capacity, and more. View the page for information on eligibility, enrollment, training, data collection forms and instructions, and additional resources.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"LTCF COVID-19 Module\"}',1,'2024-06-03 21:51:15','2024-06-03 21:51:15','e4feaa92-040c-4470-b96a-1213b370210c'),(19740,19740,1,'LTCF COVID-19 Module','ltcf-covid-19-module','news/ltcf-covid-19-module','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"CDC\'s National Health Safety Network COVID-19 Module for Long Term Care Facilities (LTCFs) enables an assessment of the impact of COVID-19 in LTCFs through facility reported information such as counts of residents and facility personnel with suspected and laboratory positive COVID-19, staffing shortages, status of personal protective equipment (PPE), ventilator capacity, and more. View the page for information on eligibility, enrollment, training, data collection forms and instructions, and additional resources.\"}',1,'2024-06-03 21:51:15','2024-06-03 21:51:15','ab9e004c-e780-42c3-8ea6-14f7341f2195'),(19741,19741,1,NULL,'ltcf-covid-19-module',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"CDC\'s National Health Safety Network COVID-19 Module for Long Term Care Facilities (LTCFs) enables an assessment of the impact of COVID-19 in LTCFs through facility reported information such as counts of residents and facility personnel with suspected and laboratory positive COVID-19, staffing shortages, status of personal protective equipment (PPE), ventilator capacity, and more. View the page for information on eligibility, enrollment, training, data collection forms and instructions, and additional resources.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"LTCF COVID-19 Module\"}',1,'2024-06-03 21:51:15','2024-06-03 21:51:15','e6c23d26-6589-4496-bb65-f1c39155cf89'),(19742,19742,1,'Recommendations for a Metropolitan COVID-19 Response—Special Area of Emphasis: Guidance on Protecting Individuals Residing in Long-Term Care Facilities','recommendations-for-a-metropolitan-covid-19-response-special-area-of-emphasis-guidance-on-protecting-individuals-residing-in-long-term-care-facilities','news/recommendations-for-a-metropolitan-covid-19-response-special-area-of-emphasis-guidance-on-protecting-individuals-residing-in-long-term-care-facilities','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"This Johns Hopkins Bloomberg School of Public Health document shares recommendations for how, through the establishment of a long-term care support team, local municipalities can help support Coronavirus-2019 (COVID-19) pandemic preparedness and response efforts within long-term care facilities (including skilled nursing facilities, nursing homes, and assisted living facilities) in the United States as of April 21, 2020.\"}',1,'2024-06-03 21:51:15','2024-06-03 21:51:15','31d060e4-9d29-46ec-b720-7c1e04465d8c'),(19743,19743,1,NULL,'recommendations-for-a-metropolitan-covid-19-response-special-area-of-emphasis-guidance-on-protecting-individuals-residing-in-long-term-care-facilities',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"This Johns Hopkins Bloomberg School of Public Health document shares recommendations for how, through the establishment of a long-term care support team, local municipalities can help support Coronavirus-2019 (COVID-19) pandemic preparedness and response efforts within long-term care facilities (including skilled nursing facilities, nursing homes, and assisted living facilities) in the United States as of April 21, 2020.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Recommendations for a Metropolitan COVID-19 Response—Special Area of Emphasis: Guidance on Protecting Individuals Residing in Long-Term Care Facilities\"}',1,'2024-06-03 21:51:15','2024-06-03 21:51:15','7a7cd74a-12c5-47d1-a423-ce1f464cf731'),(19744,19744,1,'Recommendations for a Metropolitan COVID-19 Response—Special Area of Emphasis: Guidance on Protecting Individuals Residing in Long-Term Care Facilities','recommendations-for-a-metropolitan-covid-19-response-special-area-of-emphasis-guidance-on-protecting-individuals-residing-in-long-term-care-facilities','news/recommendations-for-a-metropolitan-covid-19-response-special-area-of-emphasis-guidance-on-protecting-individuals-residing-in-long-term-care-facilities','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"This Johns Hopkins Bloomberg School of Public Health document shares recommendations for how, through the establishment of a long-term care support team, local municipalities can help support Coronavirus-2019 (COVID-19) pandemic preparedness and response efforts within long-term care facilities (including skilled nursing facilities, nursing homes, and assisted living facilities) in the United States as of April 21, 2020.\"}',1,'2024-06-03 21:51:15','2024-06-03 21:51:15','22bc2fc1-7222-4830-8b2b-b2037f78cb77'),(19745,19745,1,NULL,'recommendations-for-a-metropolitan-covid-19-response-special-area-of-emphasis-guidance-on-protecting-individuals-residing-in-long-term-care-facilities',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"This Johns Hopkins Bloomberg School of Public Health document shares recommendations for how, through the establishment of a long-term care support team, local municipalities can help support Coronavirus-2019 (COVID-19) pandemic preparedness and response efforts within long-term care facilities (including skilled nursing facilities, nursing homes, and assisted living facilities) in the United States as of April 21, 2020.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Recommendations for a Metropolitan COVID-19 Response—Special Area of Emphasis: Guidance on Protecting Individuals Residing in Long-Term Care Facilities\"}',1,'2024-06-03 21:51:15','2024-06-03 21:51:15','7d466c03-1a64-4781-96f3-37aa6c6f6ca8'),(19746,19746,1,'CDC COVID-19 Prevention Messages: Mini Webinar Series for Long-Term Care Staff','cdc-covid-19-prevention-messages-mini-webinar-series-for-long-term-care-staff','news/cdc-covid-19-prevention-messages-mini-webinar-series-for-long-term-care-staff','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"CDC\'s mini webinar training series for frontline long-term care and nursing home staff is a series of 5 short webinars that review basic infection prevention steps including: proper use of personal protective equipment (PPE) and facemasks, how and when to perform hand hygiene, how and when to clean surfaces, and the need to check residents and staff daily for symptoms of COVID-19.\"}',1,'2024-06-03 21:51:16','2024-06-03 21:51:16','23eaae8f-9b7d-4e17-bdc7-7c102e33fc36'),(19747,19747,1,NULL,'cdc-covid-19-prevention-messages-mini-webinar-series-for-long-term-care-staff',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"CDC\'s mini webinar training series for frontline long-term care and nursing home staff is a series of 5 short webinars that review basic infection prevention steps including: proper use of personal protective equipment (PPE) and facemasks, how and when to perform hand hygiene, how and when to clean surfaces, and the need to check residents and staff daily for symptoms of COVID-19.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"CDC COVID-19 Prevention Messages: Mini Webinar Series for Long-Term Care Staff\"}',1,'2024-06-03 21:51:16','2024-06-03 21:51:16','4fe475c3-fd66-4178-a406-14c3b11e5603'),(19748,19748,1,'CDC COVID-19 Prevention Messages: Mini Webinar Series for Long-Term Care Staff','cdc-covid-19-prevention-messages-mini-webinar-series-for-long-term-care-staff','news/cdc-covid-19-prevention-messages-mini-webinar-series-for-long-term-care-staff','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"CDC\'s mini webinar training series for frontline long-term care and nursing home staff is a series of 5 short webinars that review basic infection prevention steps including: proper use of personal protective equipment (PPE) and facemasks, how and when to perform hand hygiene, how and when to clean surfaces, and the need to check residents and staff daily for symptoms of COVID-19.\"}',1,'2024-06-03 21:51:16','2024-06-03 21:51:16','8929c155-21b2-4f94-b50b-7212142c94f3'),(19749,19749,1,NULL,'cdc-covid-19-prevention-messages-mini-webinar-series-for-long-term-care-staff',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"CDC\'s mini webinar training series for frontline long-term care and nursing home staff is a series of 5 short webinars that review basic infection prevention steps including: proper use of personal protective equipment (PPE) and facemasks, how and when to perform hand hygiene, how and when to clean surfaces, and the need to check residents and staff daily for symptoms of COVID-19.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"CDC COVID-19 Prevention Messages: Mini Webinar Series for Long-Term Care Staff\"}',1,'2024-06-03 21:51:16','2024-06-03 21:51:16','846479ff-ef3f-4406-ae6c-45ddd35354ed'),(19750,19750,1,'Ten Ways Healthcare Systems Can Operate Effectively during the COVID-19 Pandemic','ten-ways-healthcare-systems-can-operate-effectively-during-the-covid-19-pandemic','news/ten-ways-healthcare-systems-can-operate-effectively-during-the-covid-19-pandemic','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"In this document, the CDC provides practical approaches that can be used to protect healthcare personnel, patients, and communities.\"}',1,'2024-06-03 21:51:16','2024-06-03 21:51:16','3f11dd4a-1405-4282-aa82-95062b0327f1'),(19751,19751,1,NULL,'ten-ways-healthcare-systems-can-operate-effectively-during-the-covid-19-pandemic',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"In this document, the CDC provides practical approaches that can be used to protect healthcare personnel, patients, and communities.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Ten Ways Healthcare Systems Can Operate Effectively during the COVID-19 Pandemic\"}',1,'2024-06-03 21:51:16','2024-06-03 21:51:16','8b4cfddf-d355-485d-9223-a965d8e3bf92'),(19752,19752,1,'Ten Ways Healthcare Systems Can Operate Effectively during the COVID-19 Pandemic','ten-ways-healthcare-systems-can-operate-effectively-during-the-covid-19-pandemic','news/ten-ways-healthcare-systems-can-operate-effectively-during-the-covid-19-pandemic','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"In this document, the CDC provides practical approaches that can be used to protect healthcare personnel, patients, and communities.\"}',1,'2024-06-03 21:51:16','2024-06-03 21:51:16','0f20681d-8f15-4e2c-ba79-1b016d1de24b'),(19753,19753,1,NULL,'ten-ways-healthcare-systems-can-operate-effectively-during-the-covid-19-pandemic',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"In this document, the CDC provides practical approaches that can be used to protect healthcare personnel, patients, and communities.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Ten Ways Healthcare Systems Can Operate Effectively during the COVID-19 Pandemic\"}',1,'2024-06-03 21:51:16','2024-06-03 21:51:16','e20a23ae-d64d-47ea-bb30-8d2def5af97f'),(19754,19754,1,'Frontline Staff Toolkit - Tips for Outpatient Hemodialysis Facilities During COVID-19','frontline-staff-toolkit-tips-for-outpatient-hemodialysis-facilities-during-covid-19','news/frontline-staff-toolkit-tips-for-outpatient-hemodialysis-facilities-during-covid-19','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"This CDC Frontline Staff Toolkit for Outpatient Hemodialysis Facilities is a set of three brief educational videos that highlight the importance of infection prevention and control practices in outpatient dialysis facilities to slow the spread of COVID-19.  The three videos cover infection prevention basics: hand hygiene and environmental disinfection, personal protective equipment (PPE), and screening and patient placement.\"}',1,'2024-06-03 21:51:16','2024-06-03 21:51:16','595ef0fa-1d73-4c1f-b4e9-98ac3f1278a6'),(19755,19755,1,NULL,'frontline-staff-toolkit-tips-for-outpatient-hemodialysis-facilities-during-covid-19',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"This CDC Frontline Staff Toolkit for Outpatient Hemodialysis Facilities is a set of three brief educational videos that highlight the importance of infection prevention and control practices in outpatient dialysis facilities to slow the spread of COVID-19.  The three videos cover infection prevention basics: hand hygiene and environmental disinfection, personal protective equipment (PPE), and screening and patient placement.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Frontline Staff Toolkit - Tips for Outpatient Hemodialysis Facilities During COVID-19\"}',1,'2024-06-03 21:51:16','2024-06-03 21:51:16','f848a6b3-6b88-44ed-989f-7a435cc92b89'),(19756,19756,1,'Frontline Staff Toolkit - Tips for Outpatient Hemodialysis Facilities During COVID-19','frontline-staff-toolkit-tips-for-outpatient-hemodialysis-facilities-during-covid-19','news/frontline-staff-toolkit-tips-for-outpatient-hemodialysis-facilities-during-covid-19','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"This CDC Frontline Staff Toolkit for Outpatient Hemodialysis Facilities is a set of three brief educational videos that highlight the importance of infection prevention and control practices in outpatient dialysis facilities to slow the spread of COVID-19.  The three videos cover infection prevention basics: hand hygiene and environmental disinfection, personal protective equipment (PPE), and screening and patient placement.\"}',1,'2024-06-03 21:51:16','2024-06-03 21:51:16','365ed4d0-65d5-4ba4-964e-2a9c72f3ef70'),(19757,19757,1,NULL,'frontline-staff-toolkit-tips-for-outpatient-hemodialysis-facilities-during-covid-19',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"This CDC Frontline Staff Toolkit for Outpatient Hemodialysis Facilities is a set of three brief educational videos that highlight the importance of infection prevention and control practices in outpatient dialysis facilities to slow the spread of COVID-19.  The three videos cover infection prevention basics: hand hygiene and environmental disinfection, personal protective equipment (PPE), and screening and patient placement.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Frontline Staff Toolkit - Tips for Outpatient Hemodialysis Facilities During COVID-19\"}',1,'2024-06-03 21:51:16','2024-06-03 21:51:16','48cd5e5a-a14c-4ef4-9713-05767a06aea9'),(19758,19758,1,'Responding to COVID-19 in Nursing Homes','responding-to-covid-19-in-nursing-homes','news/responding-to-covid-19-in-nursing-homes','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"CDC\'s guidance on responding to COVID-19 in nursing homes is intended to assist nursing homes and public health authorities with response and cohorting decisions in nursing homes. \"}',1,'2024-06-03 21:51:16','2024-06-03 21:51:16','6c453286-3eab-48ff-b3d8-9e54c2c54322'),(19759,19759,1,NULL,'responding-to-covid-19-in-nursing-homes',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"CDC\'s guidance on responding to COVID-19 in nursing homes is intended to assist nursing homes and public health authorities with response and cohorting decisions in nursing homes. \", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Responding to COVID-19 in Nursing Homes\"}',1,'2024-06-03 21:51:16','2024-06-03 21:51:16','a8f75b96-e02f-4718-af93-ab9cdadafdf4'),(19760,19760,1,'Responding to COVID-19 in Nursing Homes','responding-to-covid-19-in-nursing-homes','news/responding-to-covid-19-in-nursing-homes','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"CDC\'s guidance on responding to COVID-19 in nursing homes is intended to assist nursing homes and public health authorities with response and cohorting decisions in nursing homes. \"}',1,'2024-06-03 21:51:16','2024-06-03 21:51:16','ae6f8d07-7b54-4620-9870-0a1190eb99f4'),(19761,19761,1,NULL,'responding-to-covid-19-in-nursing-homes',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"CDC\'s guidance on responding to COVID-19 in nursing homes is intended to assist nursing homes and public health authorities with response and cohorting decisions in nursing homes. \", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Responding to COVID-19 in Nursing Homes\"}',1,'2024-06-03 21:51:16','2024-06-03 21:51:16','da42bd26-9d26-4005-852a-d18bd0fdde0d'),(19762,19762,1,'Testing for COVID-19 in Nursing Homes','testing-for-covid-19-in-nursing-homes','news/testing-for-covid-19-in-nursing-homes','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"Reverse transcription polymerase chain reaction (RT-PCR) testing for SARS-CoV-2 infection among residents and healthcare personnel in nursing homes has become a priority to help inform prevention and control in the facility. This page includes considerations for use of test-based strategies for preventing SARS-CoV-2 transmission in nursing homes.\"}',1,'2024-06-03 21:51:16','2024-06-03 21:51:16','e14ddda1-b6a0-4aac-bb9c-7cafd518c7df'),(19763,19763,1,NULL,'testing-for-covid-19-in-nursing-homes',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"Reverse transcription polymerase chain reaction (RT-PCR) testing for SARS-CoV-2 infection among residents and healthcare personnel in nursing homes has become a priority to help inform prevention and control in the facility. This page includes considerations for use of test-based strategies for preventing SARS-CoV-2 transmission in nursing homes.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Testing for COVID-19 in Nursing Homes\"}',1,'2024-06-03 21:51:16','2024-06-03 21:51:16','ac6bac41-c8ce-4ba6-a27f-64a3bf5723ed'),(19764,19764,1,'Testing for COVID-19 in Nursing Homes','testing-for-covid-19-in-nursing-homes','news/testing-for-covid-19-in-nursing-homes','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"Reverse transcription polymerase chain reaction (RT-PCR) testing for SARS-CoV-2 infection among residents and healthcare personnel in nursing homes has become a priority to help inform prevention and control in the facility. This page includes considerations for use of test-based strategies for preventing SARS-CoV-2 transmission in nursing homes.\"}',1,'2024-06-03 21:51:16','2024-06-03 21:51:16','9589faa1-1d66-4d64-9f9f-7466edeb446c'),(19765,19765,1,NULL,'testing-for-covid-19-in-nursing-homes',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"Reverse transcription polymerase chain reaction (RT-PCR) testing for SARS-CoV-2 infection among residents and healthcare personnel in nursing homes has become a priority to help inform prevention and control in the facility. This page includes considerations for use of test-based strategies for preventing SARS-CoV-2 transmission in nursing homes.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Testing for COVID-19 in Nursing Homes\"}',1,'2024-06-03 21:51:16','2024-06-03 21:51:16','4eaa2494-9f29-4a33-9780-c58f54ae6367'),(19766,19766,1,'Factors to Consider When Planning to Purchase Respirators from Another Country','factors-to-consider-when-planning-to-purchase-respirators-from-another-country','news/factors-to-consider-when-planning-to-purchase-respirators-from-another-country','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"When possible, NIOSH recommends the use of NIOSH-approved reusable elastomeric respirators and powered air-purifying respirators (PAPRs) as alternatives to filtering facepiece respirators (FFRs). If a facility needs additional FFRs, CDC and the U.S. Food and Drug Administration (FDA) have determined that other options may be appropriate to protect workers during the pandemic. View this CDC page to learn more about factors to consider when planning to purchase respirators from another country.\"}',1,'2024-06-03 21:51:16','2024-06-03 21:51:16','c8d68586-949b-425c-8788-f49ded82ba85'),(19767,19767,1,NULL,'factors-to-consider-when-planning-to-purchase-respirators-from-another-country',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"When possible, NIOSH recommends the use of NIOSH-approved reusable elastomeric respirators and powered air-purifying respirators (PAPRs) as alternatives to filtering facepiece respirators (FFRs). If a facility needs additional FFRs, CDC and the U.S. Food and Drug Administration (FDA) have determined that other options may be appropriate to protect workers during the pandemic. View this CDC page to learn more about factors to consider when planning to purchase respirators from another country.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Factors to Consider When Planning to Purchase Respirators from Another Country\"}',1,'2024-06-03 21:51:16','2024-06-03 21:51:16','b2cd8466-0840-42a1-b3d1-41ce985de714'),(19768,19768,1,'Factors to Consider When Planning to Purchase Respirators from Another Country','factors-to-consider-when-planning-to-purchase-respirators-from-another-country','news/factors-to-consider-when-planning-to-purchase-respirators-from-another-country','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"When possible, NIOSH recommends the use of NIOSH-approved reusable elastomeric respirators and powered air-purifying respirators (PAPRs) as alternatives to filtering facepiece respirators (FFRs). If a facility needs additional FFRs, CDC and the U.S. Food and Drug Administration (FDA) have determined that other options may be appropriate to protect workers during the pandemic. View this CDC page to learn more about factors to consider when planning to purchase respirators from another country.\"}',1,'2024-06-03 21:51:16','2024-06-03 21:51:16','efcead41-016f-44b1-9d91-e4ed3cf3c34b'),(19769,19769,1,NULL,'factors-to-consider-when-planning-to-purchase-respirators-from-another-country',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"When possible, NIOSH recommends the use of NIOSH-approved reusable elastomeric respirators and powered air-purifying respirators (PAPRs) as alternatives to filtering facepiece respirators (FFRs). If a facility needs additional FFRs, CDC and the U.S. Food and Drug Administration (FDA) have determined that other options may be appropriate to protect workers during the pandemic. View this CDC page to learn more about factors to consider when planning to purchase respirators from another country.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Factors to Consider When Planning to Purchase Respirators from Another Country\"}',1,'2024-06-03 21:51:16','2024-06-03 21:51:16','8b36489e-f7f0-4cc9-b6cf-6501dbab5105'),(19770,19770,1,'Discontinuation of Transmission-Based Precautions and Disposition of Patients with COVID-19 in Healthcare Settings (Interim Guidance)','discontinuation-of-transmission-based-precautions-and-disposition-of-patients-with-covid-19-in-healthcare-settings-interim-guidance','news/discontinuation-of-transmission-based-precautions-and-disposition-of-patients-with-covid-19-in-healthcare-settings-interim-guidance','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"CDC\'s interim guidance on discontinuing transmission-based precautions and disposition with patients with COVID-19 in healthcare settings.\"}',1,'2024-06-03 21:51:16','2024-06-03 21:51:16','420776fb-f3db-4278-8926-2d40901604a6'),(19771,19771,1,NULL,'discontinuation-of-transmission-based-precautions-and-disposition-of-patients-with-covid-19-in-healthcare-settings-interim-guidance',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"CDC\'s interim guidance on discontinuing transmission-based precautions and disposition with patients with COVID-19 in healthcare settings.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Discontinuation of Transmission-Based Precautions and Disposition of Patients with COVID-19 in Healthcare Settings (Interim Guidance)\"}',1,'2024-06-03 21:51:16','2024-06-03 21:51:16','92bda5da-3bf0-400d-a252-0ad569209472'),(19772,19772,1,'Discontinuation of Transmission-Based Precautions and Disposition of Patients with COVID-19 in Healthcare Settings (Interim Guidance)','discontinuation-of-transmission-based-precautions-and-disposition-of-patients-with-covid-19-in-healthcare-settings-interim-guidance','news/discontinuation-of-transmission-based-precautions-and-disposition-of-patients-with-covid-19-in-healthcare-settings-interim-guidance','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"CDC\'s interim guidance on discontinuing transmission-based precautions and disposition with patients with COVID-19 in healthcare settings.\"}',1,'2024-06-03 21:51:16','2024-06-03 21:51:16','3f4d5afd-07c5-431a-8c34-bf6778344b38'),(19773,19773,1,NULL,'discontinuation-of-transmission-based-precautions-and-disposition-of-patients-with-covid-19-in-healthcare-settings-interim-guidance',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"CDC\'s interim guidance on discontinuing transmission-based precautions and disposition with patients with COVID-19 in healthcare settings.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Discontinuation of Transmission-Based Precautions and Disposition of Patients with COVID-19 in Healthcare Settings (Interim Guidance)\"}',1,'2024-06-03 21:51:16','2024-06-03 21:51:16','b429814a-296b-42de-bea3-4c5cb53186b8'),(19774,19774,1,'Criteria for Return to Work for Healthcare Personnel with Suspected or Confirmed COVID-19 (Interim Guidance)','criteria-for-return-to-work-for-healthcare-personnel-with-suspected-or-confirmed-covid-19-interim-guidance','news/criteria-for-return-to-work-for-healthcare-personnel-with-suspected-or-confirmed-covid-19-interim-guidance','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"CDC\'s interim guidance on the criteria for returning to work for healthcare personnel with suspected or confirmed COVID-19\"}',1,'2024-06-03 21:51:17','2024-06-03 21:51:17','63cd6267-5f83-4bdd-afff-0c9762816157'),(19775,19775,1,NULL,'criteria-for-return-to-work-for-healthcare-personnel-with-suspected-or-confirmed-covid-19-interim-guidance',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"CDC\'s interim guidance on the criteria for returning to work for healthcare personnel with suspected or confirmed COVID-19\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Criteria for Return to Work for Healthcare Personnel with Suspected or Confirmed COVID-19 (Interim Guidance)\"}',1,'2024-06-03 21:51:17','2024-06-03 21:51:17','c10a08a7-9cc0-43e2-a827-75eaedac255a'),(19776,19776,1,'Criteria for Return to Work for Healthcare Personnel with Suspected or Confirmed COVID-19 (Interim Guidance)','criteria-for-return-to-work-for-healthcare-personnel-with-suspected-or-confirmed-covid-19-interim-guidance','news/criteria-for-return-to-work-for-healthcare-personnel-with-suspected-or-confirmed-covid-19-interim-guidance','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"CDC\'s interim guidance on the criteria for returning to work for healthcare personnel with suspected or confirmed COVID-19\"}',1,'2024-06-03 21:51:17','2024-06-03 21:51:17','ed9ae132-0e34-4167-a156-53cf058de5f0'),(19777,19777,1,NULL,'criteria-for-return-to-work-for-healthcare-personnel-with-suspected-or-confirmed-covid-19-interim-guidance',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"CDC\'s interim guidance on the criteria for returning to work for healthcare personnel with suspected or confirmed COVID-19\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Criteria for Return to Work for Healthcare Personnel with Suspected or Confirmed COVID-19 (Interim Guidance)\"}',1,'2024-06-03 21:51:17','2024-06-03 21:51:17','5cdb2710-0f5e-4354-8eb5-d76260d392a6'),(19778,19778,1,'Implementation Guide on Non-Ventilator Healthcare-Associated Pneumonia (NV-HAP)','implementation-guide-on-non-ventilator-healthcare-associated-pneumonia-nv-hap','news/implementation-guide-on-non-ventilator-healthcare-associated-pneumonia-nv-hap','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"American Journal of Infection Control published implementation guidelines intended for IPs, nurses, and others who are involved in infection prevention efforts across the continuum of care. It reviews current literature, suggested prevention strategies, and potential tools and techniques to guide surveillance, detection, and prevention efforts for NV-HAP.\"}',1,'2024-06-03 21:51:17','2024-06-03 21:51:17','4f0666c2-71c3-4d5b-9323-b0d306c6fe62'),(19779,19779,1,NULL,'implementation-guide-on-non-ventilator-healthcare-associated-pneumonia-nv-hap',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"American Journal of Infection Control published implementation guidelines intended for IPs, nurses, and others who are involved in infection prevention efforts across the continuum of care. It reviews current literature, suggested prevention strategies, and potential tools and techniques to guide surveillance, detection, and prevention efforts for NV-HAP.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Implementation Guide on Non-Ventilator Healthcare-Associated Pneumonia (NV-HAP)\"}',1,'2024-06-03 21:51:17','2024-06-03 21:51:17','5ec597f6-a379-48a1-84f4-791a091a6849'),(19780,19780,1,'Implementation Guide on Non-Ventilator Healthcare-Associated Pneumonia (NV-HAP)','implementation-guide-on-non-ventilator-healthcare-associated-pneumonia-nv-hap','news/implementation-guide-on-non-ventilator-healthcare-associated-pneumonia-nv-hap','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"American Journal of Infection Control published implementation guidelines intended for IPs, nurses, and others who are involved in infection prevention efforts across the continuum of care. It reviews current literature, suggested prevention strategies, and potential tools and techniques to guide surveillance, detection, and prevention efforts for NV-HAP.\"}',1,'2024-06-03 21:51:17','2024-06-03 21:51:17','784573c2-fd3d-4891-a44e-cb2cf840c448'),(19781,19781,1,NULL,'implementation-guide-on-non-ventilator-healthcare-associated-pneumonia-nv-hap',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"American Journal of Infection Control published implementation guidelines intended for IPs, nurses, and others who are involved in infection prevention efforts across the continuum of care. It reviews current literature, suggested prevention strategies, and potential tools and techniques to guide surveillance, detection, and prevention efforts for NV-HAP.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Implementation Guide on Non-Ventilator Healthcare-Associated Pneumonia (NV-HAP)\"}',1,'2024-06-03 21:51:17','2024-06-03 21:51:17','1023b2c7-695e-41f2-ba98-a5f290f9a033'),(19782,19782,1,'Raising Awareness: Many Roads Lead to Sepsis, Even for COVID-19 Patients','raising-awareness-many-roads-lead-to-sepsis-even-for-covid-19-patients','news/raising-awareness-many-roads-lead-to-sepsis-even-for-covid-19-patients','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"This ASPR blog post discusses COVID-19 patients, the many roads that lead to sepsis, and why it is important.\"}',1,'2024-06-03 21:51:17','2024-06-03 21:51:17','21698df0-ba55-4681-9881-d9d7c4782f51'),(19783,19783,1,NULL,'raising-awareness-many-roads-lead-to-sepsis-even-for-covid-19-patients',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"This ASPR blog post discusses COVID-19 patients, the many roads that lead to sepsis, and why it is important.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Raising Awareness: Many Roads Lead to Sepsis, Even for COVID-19 Patients\"}',1,'2024-06-03 21:51:17','2024-06-03 21:51:17','eba78230-d906-42b1-a71b-c5abdd158ba8'),(19784,19784,1,'Raising Awareness: Many Roads Lead to Sepsis, Even for COVID-19 Patients','raising-awareness-many-roads-lead-to-sepsis-even-for-covid-19-patients','news/raising-awareness-many-roads-lead-to-sepsis-even-for-covid-19-patients','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"This ASPR blog post discusses COVID-19 patients, the many roads that lead to sepsis, and why it is important.\"}',1,'2024-06-03 21:51:17','2024-06-03 21:51:17','fe5213c2-9971-4206-a8d6-169b48c23d22'),(19785,19785,1,NULL,'raising-awareness-many-roads-lead-to-sepsis-even-for-covid-19-patients',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"This ASPR blog post discusses COVID-19 patients, the many roads that lead to sepsis, and why it is important.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Raising Awareness: Many Roads Lead to Sepsis, Even for COVID-19 Patients\"}',1,'2024-06-03 21:51:17','2024-06-03 21:51:17','e86aa5df-10f7-4d71-81cc-bb0af04541bf'),(19786,19786,1,'Nursing Home Reopening Recommendations for State and Local Officials','nursing-home-reopening-recommendations-for-state-and-local-officials','news/nursing-home-reopening-recommendations-for-state-and-local-officials','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"The Centers for Medicare and Medicaid Services provides these nursing home reopening recommendations to help state and local officials determine the level of mitigation needed to prevent the transmission of COVID-19 in nursing homes. Recommendations cover criteria for relaxing certain restrictions and mitigating the risk of resurgence, visitation and service considerations, and restoration of survey activities.\"}',1,'2024-06-03 21:51:17','2024-06-03 21:51:17','d238ede3-89cd-405f-ad1c-a1d71ef8213c'),(19787,19787,1,NULL,'nursing-home-reopening-recommendations-for-state-and-local-officials',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"The Centers for Medicare and Medicaid Services provides these nursing home reopening recommendations to help state and local officials determine the level of mitigation needed to prevent the transmission of COVID-19 in nursing homes. Recommendations cover criteria for relaxing certain restrictions and mitigating the risk of resurgence, visitation and service considerations, and restoration of survey activities.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Nursing Home Reopening Recommendations for State and Local Officials\"}',1,'2024-06-03 21:51:17','2024-06-03 21:51:17','e217a6b4-ab26-4a44-b394-f3a0d287b44d'),(19788,19788,1,'Nursing Home Reopening Recommendations for State and Local Officials','nursing-home-reopening-recommendations-for-state-and-local-officials','news/nursing-home-reopening-recommendations-for-state-and-local-officials','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"The Centers for Medicare and Medicaid Services provides these nursing home reopening recommendations to help state and local officials determine the level of mitigation needed to prevent the transmission of COVID-19 in nursing homes. Recommendations cover criteria for relaxing certain restrictions and mitigating the risk of resurgence, visitation and service considerations, and restoration of survey activities.\"}',1,'2024-06-03 21:51:17','2024-06-03 21:51:17','f8fbd557-0fe6-4bf6-a6da-8f06d8470fbc'),(19789,19789,1,NULL,'nursing-home-reopening-recommendations-for-state-and-local-officials',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"The Centers for Medicare and Medicaid Services provides these nursing home reopening recommendations to help state and local officials determine the level of mitigation needed to prevent the transmission of COVID-19 in nursing homes. Recommendations cover criteria for relaxing certain restrictions and mitigating the risk of resurgence, visitation and service considerations, and restoration of survey activities.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Nursing Home Reopening Recommendations for State and Local Officials\"}',1,'2024-06-03 21:51:17','2024-06-03 21:51:17','ebf0caa8-3c1a-458e-9aec-3473f971b6f0'),(19790,19790,1,'FDA Approves Antibiotic to Treat Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia','fda-approves-antibiotic-to-treat-hospital-acquired-bacterial-pneumonia-and-ventilator-associated-bacterial-pneumonia','news/fda-approves-antibiotic-to-treat-hospital-acquired-bacterial-pneumonia-and-ventilator-associated-bacterial-pneumonia','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"This is a FDA news release on the approval of Recarbrio (a combination of imipenem-cilastatin and relebactam) to treat hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia (HABP/VABP) in patients 18 years of age and older. Recarbrio was previously FDA-approved to treat patients with complicated urinary tract infections and complicated intra-abdominal infections who have limited or no alternative treatment options.\"}',1,'2024-06-03 21:51:17','2024-06-03 21:51:17','c076418e-2ea4-488c-9eaf-dc7a86038fec'),(19791,19791,1,NULL,'fda-approves-antibiotic-to-treat-hospital-acquired-bacterial-pneumonia-and-ventilator-associated-bacterial-pneumonia',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"This is a FDA news release on the approval of Recarbrio (a combination of imipenem-cilastatin and relebactam) to treat hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia (HABP/VABP) in patients 18 years of age and older. Recarbrio was previously FDA-approved to treat patients with complicated urinary tract infections and complicated intra-abdominal infections who have limited or no alternative treatment options.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"FDA Approves Antibiotic to Treat Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia\"}',1,'2024-06-03 21:51:17','2024-06-03 21:51:17','4cfe979c-25a3-483c-8259-a994fcf1e2b2'),(19792,19792,1,'FDA Approves Antibiotic to Treat Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia','fda-approves-antibiotic-to-treat-hospital-acquired-bacterial-pneumonia-and-ventilator-associated-bacterial-pneumonia','news/fda-approves-antibiotic-to-treat-hospital-acquired-bacterial-pneumonia-and-ventilator-associated-bacterial-pneumonia','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"This is a FDA news release on the approval of Recarbrio (a combination of imipenem-cilastatin and relebactam) to treat hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia (HABP/VABP) in patients 18 years of age and older. Recarbrio was previously FDA-approved to treat patients with complicated urinary tract infections and complicated intra-abdominal infections who have limited or no alternative treatment options.\"}',1,'2024-06-03 21:51:17','2024-06-03 21:51:17','979ce813-0314-4cb8-832b-206795a37b63'),(19793,19793,1,NULL,'fda-approves-antibiotic-to-treat-hospital-acquired-bacterial-pneumonia-and-ventilator-associated-bacterial-pneumonia',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"This is a FDA news release on the approval of Recarbrio (a combination of imipenem-cilastatin and relebactam) to treat hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia (HABP/VABP) in patients 18 years of age and older. Recarbrio was previously FDA-approved to treat patients with complicated urinary tract infections and complicated intra-abdominal infections who have limited or no alternative treatment options.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"FDA Approves Antibiotic to Treat Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia\"}',1,'2024-06-03 21:51:17','2024-06-03 21:51:17','a99adf13-397b-49f4-a276-48dea64c30cd'),(19794,19794,1,'Nursing Home COVID-19 Data and Inspections Results Available on Nursing Home Compare','nursing-home-covid-19-data-and-inspections-results-available-on-nursing-home-compare','news/nursing-home-covid-19-data-and-inspections-results-available-on-nursing-home-compare','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"A press release from Centers for Medicare & Medicaid Services (CMS) posting the first set of underlying coronavirus disease 2019 (COVID-19) nursing home data.\"}',1,'2024-06-03 21:51:17','2024-06-03 21:51:17','2a1f56ee-d7b1-4fee-b4dc-4cb138631a69'),(19795,19795,1,NULL,'nursing-home-covid-19-data-and-inspections-results-available-on-nursing-home-compare',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"A press release from Centers for Medicare &amp; Medicaid Services (CMS) posting the first set of underlying coronavirus disease 2019 (COVID-19) nursing home data.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Nursing Home COVID-19 Data and Inspections Results Available on Nursing Home Compare\"}',1,'2024-06-03 21:51:17','2024-06-03 21:51:17','b201e7f1-bb75-4bab-b311-aef80b39da48'),(19796,19796,1,'Nursing Home COVID-19 Data and Inspections Results Available on Nursing Home Compare','nursing-home-covid-19-data-and-inspections-results-available-on-nursing-home-compare','news/nursing-home-covid-19-data-and-inspections-results-available-on-nursing-home-compare','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"A press release from Centers for Medicare & Medicaid Services (CMS) posting the first set of underlying coronavirus disease 2019 (COVID-19) nursing home data.\"}',1,'2024-06-03 21:51:17','2024-06-03 21:51:17','9ce832b4-ad06-469b-923c-2fe86a644ba8'),(19797,19797,1,NULL,'nursing-home-covid-19-data-and-inspections-results-available-on-nursing-home-compare',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"A press release from Centers for Medicare &amp; Medicaid Services (CMS) posting the first set of underlying coronavirus disease 2019 (COVID-19) nursing home data.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Nursing Home COVID-19 Data and Inspections Results Available on Nursing Home Compare\"}',1,'2024-06-03 21:51:17','2024-06-03 21:51:17','799fe13b-f4cb-4bfc-bc2b-ab2b34bed41b'),(19798,19798,1,'HHS Announces New Laboratory Data Reporting Guidance for COVID-19 Testing','hhs-announces-new-laboratory-data-reporting-guidance-for-covid-19-testing','news/hhs-announces-new-laboratory-data-reporting-guidance-for-covid-19-testing','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"The U.S. Department of Health and Human Services (HHS) press release announcing new guidance that specifies what additional data must be reported to HHS by laboratories along with Coronavirus Disease 2019 (COVID-19) test results.\"}',1,'2024-06-03 21:51:17','2024-06-03 21:51:17','944ce1cd-3700-4a13-bbf8-1a9d8c0bca3b'),(19799,19799,1,NULL,'hhs-announces-new-laboratory-data-reporting-guidance-for-covid-19-testing',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"The U.S. Department of Health and Human Services (HHS) press release announcing new guidance that specifies what additional data must be reported to HHS by laboratories along with Coronavirus Disease 2019 (COVID-19) test results.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"HHS Announces New Laboratory Data Reporting Guidance for COVID-19 Testing\"}',1,'2024-06-03 21:51:17','2024-06-03 21:51:17','6bc4c5f0-a67c-44fa-80be-903b5051eed7'),(19800,19800,1,'HHS Announces New Laboratory Data Reporting Guidance for COVID-19 Testing','hhs-announces-new-laboratory-data-reporting-guidance-for-covid-19-testing','news/hhs-announces-new-laboratory-data-reporting-guidance-for-covid-19-testing','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"The U.S. Department of Health and Human Services (HHS) press release announcing new guidance that specifies what additional data must be reported to HHS by laboratories along with Coronavirus Disease 2019 (COVID-19) test results.\"}',1,'2024-06-03 21:51:17','2024-06-03 21:51:17','9dd83228-5e3d-47b3-b9b5-da11605b7cc5'),(19801,19801,1,NULL,'hhs-announces-new-laboratory-data-reporting-guidance-for-covid-19-testing',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"The U.S. Department of Health and Human Services (HHS) press release announcing new guidance that specifies what additional data must be reported to HHS by laboratories along with Coronavirus Disease 2019 (COVID-19) test results.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"HHS Announces New Laboratory Data Reporting Guidance for COVID-19 Testing\"}',1,'2024-06-03 21:51:17','2024-06-03 21:51:17','494b339b-fdca-4534-a191-f9dac2c2f38f'),(19802,19802,1,'Preparing Your Dialysis Facility for Coronavirus Disease 2019 (COVID-19)','preparing-your-dialysis-facility-for-coronavirus-disease-2019-covid-19','news/preparing-your-dialysis-facility-for-coronavirus-disease-2019-covid-19','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"Recommendations from the CDC on how to prepare your dialysis facility for COVID-19.\"}',1,'2024-06-03 21:51:18','2024-06-03 21:51:18','75597f66-b23f-4f69-8005-2b909ca0e55f'),(19803,19803,1,NULL,'preparing-your-dialysis-facility-for-coronavirus-disease-2019-covid-19',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"Recommendations from the CDC on how to prepare your dialysis facility for COVID-19.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Preparing Your Dialysis Facility for Coronavirus Disease 2019 (COVID-19)\"}',1,'2024-06-03 21:51:18','2024-06-03 21:51:18','62d869ce-4d1d-4055-9bea-84dde8cdab10'),(19804,19804,1,'Preparing Your Dialysis Facility for Coronavirus Disease 2019 (COVID-19)','preparing-your-dialysis-facility-for-coronavirus-disease-2019-covid-19','news/preparing-your-dialysis-facility-for-coronavirus-disease-2019-covid-19','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"Recommendations from the CDC on how to prepare your dialysis facility for COVID-19.\"}',1,'2024-06-03 21:51:18','2024-06-03 21:51:18','794af799-7c84-4d06-a53a-add2ffc0519c'),(19805,19805,1,NULL,'preparing-your-dialysis-facility-for-coronavirus-disease-2019-covid-19',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"Recommendations from the CDC on how to prepare your dialysis facility for COVID-19.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Preparing Your Dialysis Facility for Coronavirus Disease 2019 (COVID-19)\"}',1,'2024-06-03 21:51:18','2024-06-03 21:51:18','99d0bfc3-f4b7-4830-aa09-b84ab967b27b'),(19806,19806,1,'Preparing for COVID-19 in Nursing Homes','preparing-for-covid-19-in-nursing-homes','news/preparing-for-covid-19-in-nursing-homes','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"CDC\'s guidance on preparing for COVID-19 in nursing homes.\"}',1,'2024-06-03 21:51:18','2024-06-03 21:51:18','7dee2690-0da1-432f-86fa-91972fe670e4'),(19807,19807,1,NULL,'preparing-for-covid-19-in-nursing-homes',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"CDC\'s guidance on preparing for COVID-19 in nursing homes.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Preparing for COVID-19 in Nursing Homes\"}',1,'2024-06-03 21:51:18','2024-06-03 21:51:18','c5a93b56-a8db-4dcc-9682-e86c6e1aaaef'),(19808,19808,1,'Preparing for COVID-19 in Nursing Homes','preparing-for-covid-19-in-nursing-homes','news/preparing-for-covid-19-in-nursing-homes','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"CDC\'s guidance on preparing for COVID-19 in nursing homes.\"}',1,'2024-06-03 21:51:18','2024-06-03 21:51:18','94df0d2a-e400-4ac4-96bc-15de3b1037f5'),(19809,19809,1,NULL,'preparing-for-covid-19-in-nursing-homes',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"CDC\'s guidance on preparing for COVID-19 in nursing homes.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Preparing for COVID-19 in Nursing Homes\"}',1,'2024-06-03 21:51:18','2024-06-03 21:51:18','2ea33318-8063-4ff0-8599-1e6eddf7e099'),(19810,19810,1,'COVID-19 Initial Lessons Learned: Recommendations to Prepare for a Fall Surge of COVID-19 Cases','covid-19-initial-lessons-learned-recommendations-to-prepare-for-a-fall-surge-of-covid-19-cases','news/covid-19-initial-lessons-learned-recommendations-to-prepare-for-a-fall-surge-of-covid-19-cases','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"This report from IDSA, HIVMA, and SHEA provides federal, state and local leaders a critical opportunity to prepare for an upcoming wave of infections to ensure a successful response that minimizes the numbers of new infections, hospitalizations and deaths. Information includes lessons learned and recommendations on topics such as PPE and other medical supplies, testing capacity, physical distancing and wearing masks/face coverings, contact tracing, telehealth, workforce capacity, access to care and treatment, health disparities, antimicrobial resistance, increasing immunization rates, preparing for a COVID-19 vaccine, minimizing viral spread during large gatherings, safe elections, comprehensive data collection, protections for frontline workers, and global cooperation.\"}',1,'2024-06-03 21:51:18','2024-06-03 21:51:18','87b210d7-7438-4d2b-9f18-49ff4d3ba2df'),(19811,19811,1,NULL,'covid-19-initial-lessons-learned-recommendations-to-prepare-for-a-fall-surge-of-covid-19-cases',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"This report from IDSA, HIVMA, and SHEA provides federal, state and local leaders a critical opportunity to prepare for an upcoming wave of infections to ensure a successful response that minimizes the numbers of new infections, hospitalizations and deaths. Information includes lessons learned and recommendations on topics such as PPE and other medical supplies, testing capacity, physical distancing and wearing masks/face coverings, contact tracing, telehealth, workforce capacity, access to care and treatment, health disparities, antimicrobial resistance, increasing immunization rates, preparing for a COVID-19 vaccine, minimizing viral spread during large gatherings, safe elections, comprehensive data collection, protections for frontline workers, and global cooperation.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"COVID-19 Initial Lessons Learned: Recommendations to Prepare for a Fall Surge of COVID-19 Cases\"}',1,'2024-06-03 21:51:18','2024-06-03 21:51:18','5266e419-3b30-4c6b-ba8a-6d3f62deb256'),(19812,19812,1,'COVID-19 Initial Lessons Learned: Recommendations to Prepare for a Fall Surge of COVID-19 Cases','covid-19-initial-lessons-learned-recommendations-to-prepare-for-a-fall-surge-of-covid-19-cases','news/covid-19-initial-lessons-learned-recommendations-to-prepare-for-a-fall-surge-of-covid-19-cases','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"This report from IDSA, HIVMA, and SHEA provides federal, state and local leaders a critical opportunity to prepare for an upcoming wave of infections to ensure a successful response that minimizes the numbers of new infections, hospitalizations and deaths. Information includes lessons learned and recommendations on topics such as PPE and other medical supplies, testing capacity, physical distancing and wearing masks/face coverings, contact tracing, telehealth, workforce capacity, access to care and treatment, health disparities, antimicrobial resistance, increasing immunization rates, preparing for a COVID-19 vaccine, minimizing viral spread during large gatherings, safe elections, comprehensive data collection, protections for frontline workers, and global cooperation.\"}',1,'2024-06-03 21:51:18','2024-06-03 21:51:18','cd1fc5d3-70c6-484b-898a-23a16d720948'),(19813,19813,1,NULL,'covid-19-initial-lessons-learned-recommendations-to-prepare-for-a-fall-surge-of-covid-19-cases',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"This report from IDSA, HIVMA, and SHEA provides federal, state and local leaders a critical opportunity to prepare for an upcoming wave of infections to ensure a successful response that minimizes the numbers of new infections, hospitalizations and deaths. Information includes lessons learned and recommendations on topics such as PPE and other medical supplies, testing capacity, physical distancing and wearing masks/face coverings, contact tracing, telehealth, workforce capacity, access to care and treatment, health disparities, antimicrobial resistance, increasing immunization rates, preparing for a COVID-19 vaccine, minimizing viral spread during large gatherings, safe elections, comprehensive data collection, protections for frontline workers, and global cooperation.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"COVID-19 Initial Lessons Learned: Recommendations to Prepare for a Fall Surge of COVID-19 Cases\"}',1,'2024-06-03 21:51:18','2024-06-03 21:51:18','9b9fffe5-2c9e-42a7-b7c6-cd6b0df48b06'),(19814,19814,1,'Outbreak Investigation of COVID-19 Among Residents and Staff of an Independent and Assisted Living Community for Older Adults in Seattle, Washington','outbreak-investigation-of-covid-19-among-residents-and-staff-of-an-independent-and-assisted-living-community-for-older-adults-in-seattle-washington','news/outbreak-investigation-of-covid-19-among-residents-and-staff-of-an-independent-and-assisted-living-community-for-older-adults-in-seattle-washington','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused epidemic spread of coronavirus disease 2019 (COVID-19) in the Seattle, Washington, metropolitan area, with morbidity and mortality concentrated among residents of skilled nursing facilities. The prevalence of COVID-19 among older adults in independent/assisted living is not understood.\"}',1,'2024-06-03 21:51:18','2024-06-03 21:51:18','8f0bb964-1bf8-4ec0-870a-2f507903eba2'),(19815,19815,1,NULL,'outbreak-investigation-of-covid-19-among-residents-and-staff-of-an-independent-and-assisted-living-community-for-older-adults-in-seattle-washington',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused epidemic spread of coronavirus disease 2019 (COVID-19) in the Seattle, Washington, metropolitan area, with morbidity and mortality concentrated among residents of skilled nursing facilities. The prevalence of COVID-19 among older adults in independent/assisted living is not understood.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Outbreak Investigation of COVID-19 Among Residents and Staff of an Independent and Assisted Living Community for Older Adults in Seattle, Washington\"}',1,'2024-06-03 21:51:18','2024-06-03 21:51:18','e6cd3315-c071-4648-b74a-546390282f53'),(19816,19816,1,'Outbreak Investigation of COVID-19 Among Residents and Staff of an Independent and Assisted Living Community for Older Adults in Seattle, Washington','outbreak-investigation-of-covid-19-among-residents-and-staff-of-an-independent-and-assisted-living-community-for-older-adults-in-seattle-washington','news/outbreak-investigation-of-covid-19-among-residents-and-staff-of-an-independent-and-assisted-living-community-for-older-adults-in-seattle-washington','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused epidemic spread of coronavirus disease 2019 (COVID-19) in the Seattle, Washington, metropolitan area, with morbidity and mortality concentrated among residents of skilled nursing facilities. The prevalence of COVID-19 among older adults in independent/assisted living is not understood.\"}',1,'2024-06-03 21:51:18','2024-06-03 21:51:18','cb589d22-604a-4329-9899-52f0335badae'),(19817,19817,1,NULL,'outbreak-investigation-of-covid-19-among-residents-and-staff-of-an-independent-and-assisted-living-community-for-older-adults-in-seattle-washington',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused epidemic spread of coronavirus disease 2019 (COVID-19) in the Seattle, Washington, metropolitan area, with morbidity and mortality concentrated among residents of skilled nursing facilities. The prevalence of COVID-19 among older adults in independent/assisted living is not understood.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Outbreak Investigation of COVID-19 Among Residents and Staff of an Independent and Assisted Living Community for Older Adults in Seattle, Washington\"}',1,'2024-06-03 21:51:18','2024-06-03 21:51:18','2ac0bff3-212b-43e2-8d49-7f9e621e5ab5'),(19818,19818,1,'CORHA Member, Linda Greene (APIC), a 2020 APIC Award Recipient','corha-member-linda-greene-apic-a-2020-apic-award-recipient','news/corha-member-linda-greene-apic-a-2020-apic-award-recipient','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"Linda R. Greene, RN, MPS, CIC, FAPIC, received the prestigious Carole DeMille Achievement Award for her visionary leadership and significant contributions to the field of infection prevention and control.\"}',1,'2024-06-03 21:51:18','2024-06-03 21:51:18','bdc64dd5-8c9d-4e7d-a344-a747e5f5c4e9'),(19819,19819,1,NULL,'corha-member-linda-greene-apic-a-2020-apic-award-recipient',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"Linda R. Greene, RN, MPS, CIC, FAPIC, received the prestigious Carole DeMille Achievement Award for her visionary leadership and significant contributions to the field of infection prevention and control.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"CORHA Member, Linda Greene (APIC), a 2020 APIC Award Recipient\"}',1,'2024-06-03 21:51:18','2024-06-03 21:51:18','02aab850-376b-4b4a-8577-42385410dfea'),(19820,19820,1,'CORHA Member, Linda Greene (APIC), a 2020 APIC Award Recipient','corha-member-linda-greene-apic-a-2020-apic-award-recipient','news/corha-member-linda-greene-apic-a-2020-apic-award-recipient','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"Linda R. Greene, RN, MPS, CIC, FAPIC, received the prestigious Carole DeMille Achievement Award for her visionary leadership and significant contributions to the field of infection prevention and control.\"}',1,'2024-06-03 21:51:18','2024-06-03 21:51:18','d87a2102-d9e7-4214-9d4b-aab0d048d930'),(19821,19821,1,NULL,'corha-member-linda-greene-apic-a-2020-apic-award-recipient',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"Linda R. Greene, RN, MPS, CIC, FAPIC, received the prestigious Carole DeMille Achievement Award for her visionary leadership and significant contributions to the field of infection prevention and control.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"CORHA Member, Linda Greene (APIC), a 2020 APIC Award Recipient\"}',1,'2024-06-03 21:51:18','2024-06-03 21:51:18','60731904-6fe7-415c-a8f7-4dcc8b7dc24f'),(19822,19822,1,'New Data Featured on CDC\'s Antibiotic Resistance and Patient Safety Portal (AR&amp;PSP)','antibiotic-resistance-and-patient-safety-portal-arpsp','news/antibiotic-resistance-and-patient-safety-portal-arpsp','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"This interactive web-based application was created by CDC and displays AR, Use and Stewardship data as well as Healthcare-Associated Infection data for the nation and states.\"}',1,'2024-06-03 21:51:18','2024-06-03 21:51:18','9e240612-5419-4b2f-9ce3-a037629399f2'),(19823,19823,1,NULL,'antibiotic-resistance-and-patient-safety-portal-arpsp',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"This interactive web-based application was created by CDC and displays AR, Use and Stewardship data as well as Healthcare-Associated Infection data for the nation and states.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"New Data Featured on CDC\'s Antibiotic Resistance and Patient Safety Portal (AR&amp;PSP)\"}',1,'2024-06-03 21:51:18','2024-06-03 21:51:18','e8e47a0b-8dc4-4279-9e04-d1e9bdea89cd'),(19824,19824,1,'New Data Featured on CDC\'s Antibiotic Resistance and Patient Safety Portal (AR&amp;PSP)','antibiotic-resistance-and-patient-safety-portal-arpsp','news/antibiotic-resistance-and-patient-safety-portal-arpsp','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"This interactive web-based application was created by CDC and displays AR, Use and Stewardship data as well as Healthcare-Associated Infection data for the nation and states.\"}',1,'2024-06-03 21:51:18','2024-06-03 21:51:18','e22fb7aa-d88a-429e-9526-7e067c2fbc0a'),(19825,19825,1,NULL,'antibiotic-resistance-and-patient-safety-portal-arpsp',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"This interactive web-based application was created by CDC and displays AR, Use and Stewardship data as well as Healthcare-Associated Infection data for the nation and states.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"New Data Featured on CDC\'s Antibiotic Resistance and Patient Safety Portal (AR&amp;PSP)\"}',1,'2024-06-03 21:51:18','2024-06-03 21:51:18','359eda62-cc90-4f2c-b295-271804d92e96'),(19826,19826,1,'AR&PSP Now Includes the Number of Reported C. difficile Infections Among Hospitalized Patients','arpsp-now-includes-the-number-of-reported-c-difficile-infections-among-hospitalized-patients','news/arpsp-now-includes-the-number-of-reported-c-difficile-infections-among-hospitalized-patients','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"CDC\'s Antibiotic Resistance & Patient Safety Portal (AR&PSP), an interactive web-based application, now includes the number of hospitalized patients with C. difficile infection, including community-onset and hospital-onset infections, across U.S. general acute care hospitals reported in CDC’s National Healthcare Safety Network.\"}',1,'2024-06-03 21:51:18','2024-06-03 21:51:18','9e7ba8b7-cbe9-4179-8b97-40c113247efb'),(19827,19827,1,NULL,'arpsp-now-includes-the-number-of-reported-c-difficile-infections-among-hospitalized-patients',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"CDC\'s Antibiotic Resistance &amp; Patient Safety Portal (AR&amp;PSP), an interactive web-based application, now includes the number of hospitalized patients with C. difficile infection, including community-onset and hospital-onset infections, across U.S. general acute care hospitals reported in CDC’s National Healthcare Safety Network.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"AR&PSP Now Includes the Number of Reported C. difficile Infections Among Hospitalized Patients\"}',1,'2024-06-03 21:51:18','2024-06-03 21:51:18','bd26db70-74b7-4140-9185-307dc89f916a'),(19828,19828,1,'AR&PSP Now Includes the Number of Reported C. difficile Infections Among Hospitalized Patients','arpsp-now-includes-the-number-of-reported-c-difficile-infections-among-hospitalized-patients','news/arpsp-now-includes-the-number-of-reported-c-difficile-infections-among-hospitalized-patients','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"CDC\'s Antibiotic Resistance & Patient Safety Portal (AR&PSP), an interactive web-based application, now includes the number of hospitalized patients with C. difficile infection, including community-onset and hospital-onset infections, across U.S. general acute care hospitals reported in CDC’s National Healthcare Safety Network.\"}',1,'2024-06-03 21:51:18','2024-06-03 21:51:18','7b20ba4d-0415-46f1-ba9f-6963f4ff16fa'),(19829,19829,1,NULL,'arpsp-now-includes-the-number-of-reported-c-difficile-infections-among-hospitalized-patients',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"CDC\'s Antibiotic Resistance &amp; Patient Safety Portal (AR&amp;PSP), an interactive web-based application, now includes the number of hospitalized patients with C. difficile infection, including community-onset and hospital-onset infections, across U.S. general acute care hospitals reported in CDC’s National Healthcare Safety Network.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"AR&PSP Now Includes the Number of Reported C. difficile Infections Among Hospitalized Patients\"}',1,'2024-06-03 21:51:19','2024-06-03 21:51:19','b29aff1e-0ed6-4d98-82a2-33b349c1d749'),(19830,19830,1,'Considerations for COVID-19 Testing in Long-Term Care Facilities','considerations-for-covid-19-testing-in-long-term-care-facilities','news/considerations-for-covid-19-testing-in-long-term-care-facilities','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"This NGA brief provides considerations for developing a strategy for COVID-19 testing in long-term care (LTC) facilities and a review of state actions to date. Additional details on testing and other state strategies for LTC facilities, including specific state resources, are also included.\"}',1,'2024-06-03 21:51:19','2024-06-03 21:51:19','80c552e0-2f58-469c-8bb4-bbb5e9bfd2c8'),(19831,19831,1,NULL,'considerations-for-covid-19-testing-in-long-term-care-facilities',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"This NGA brief provides considerations for developing a strategy for COVID-19 testing in long-term care (LTC) facilities and a review of state actions to date. Additional details on testing and other state strategies for LTC facilities, including specific state resources, are also included.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Considerations for COVID-19 Testing in Long-Term Care Facilities\"}',1,'2024-06-03 21:51:19','2024-06-03 21:51:19','13a6f828-2458-45bb-9f69-c482e48227f8'),(19832,19832,1,'Considerations for COVID-19 Testing in Long-Term Care Facilities','considerations-for-covid-19-testing-in-long-term-care-facilities','news/considerations-for-covid-19-testing-in-long-term-care-facilities','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"This NGA brief provides considerations for developing a strategy for COVID-19 testing in long-term care (LTC) facilities and a review of state actions to date. Additional details on testing and other state strategies for LTC facilities, including specific state resources, are also included.\"}',1,'2024-06-03 21:51:19','2024-06-03 21:51:19','3828db54-8c42-43a3-8e7c-a6f9117a280d'),(19833,19833,1,NULL,'considerations-for-covid-19-testing-in-long-term-care-facilities',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"This NGA brief provides considerations for developing a strategy for COVID-19 testing in long-term care (LTC) facilities and a review of state actions to date. Additional details on testing and other state strategies for LTC facilities, including specific state resources, are also included.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Considerations for COVID-19 Testing in Long-Term Care Facilities\"}',1,'2024-06-03 21:51:19','2024-06-03 21:51:19','6fa6657b-03a1-49cd-a860-a65ac6f091d7'),(19834,19834,1,'Essential Caregiver Guidance for Long-term Care Facilities','essential-caregiver-guidance-for-long-term-care-facilities','news/essential-caregiver-guidance-for-long-term-care-facilities','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"Recognizing the critical role family members and other close, outside caregivers have in the care and support of residents, and recognizing how they advocate for the resident, it is strongly recommended\\nlong-term care (LTC) facilities develop a process to designate essential caregivers (EC) where appropriate. An EC could be an individual who was previously actively engaged with the resident or is committed to providing\\ncompanionship and/or assistance with activities of daily living. LTC facilities are not required to implement an EC program, but this guidance provides recommendations for those facilities that choose\\nto do so. The goal of such a designation is to help ensure these high-risk residents continue to receive individualized, person-centered care.\"}',1,'2024-06-03 21:51:19','2024-06-03 21:51:19','3aef9c9d-c513-42dd-9beb-8fe006919151'),(19835,19835,1,NULL,'essential-caregiver-guidance-for-long-term-care-facilities',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"Recognizing the critical role family members and other close, outside caregivers have in the care and support of residents, and recognizing how they advocate for the resident, it is strongly recommended\\nlong-term care (LTC) facilities develop a process to designate essential caregivers (EC) where appropriate. An EC could be an individual who was previously actively engaged with the resident or is committed to providing\\ncompanionship and/or assistance with activities of daily living. LTC facilities are not required to implement an EC program, but this guidance provides recommendations for those facilities that choose\\nto do so. The goal of such a designation is to help ensure these high-risk residents continue to receive individualized, person-centered care.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Essential Caregiver Guidance for Long-term Care Facilities\"}',1,'2024-06-03 21:51:19','2024-06-03 21:51:19','2dd67c40-c479-44af-a89f-e3b4db123507'),(19836,19836,1,'Essential Caregiver Guidance for Long-term Care Facilities','essential-caregiver-guidance-for-long-term-care-facilities','news/essential-caregiver-guidance-for-long-term-care-facilities','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"Recognizing the critical role family members and other close, outside caregivers have in the care and support of residents, and recognizing how they advocate for the resident, it is strongly recommended\\nlong-term care (LTC) facilities develop a process to designate essential caregivers (EC) where appropriate. An EC could be an individual who was previously actively engaged with the resident or is committed to providing\\ncompanionship and/or assistance with activities of daily living. LTC facilities are not required to implement an EC program, but this guidance provides recommendations for those facilities that choose\\nto do so. The goal of such a designation is to help ensure these high-risk residents continue to receive individualized, person-centered care.\"}',1,'2024-06-03 21:51:19','2024-06-03 21:51:19','6c72ab71-bfc6-43e3-8740-4be3e4a341b6'),(19837,19837,1,NULL,'essential-caregiver-guidance-for-long-term-care-facilities',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"Recognizing the critical role family members and other close, outside caregivers have in the care and support of residents, and recognizing how they advocate for the resident, it is strongly recommended\\nlong-term care (LTC) facilities develop a process to designate essential caregivers (EC) where appropriate. An EC could be an individual who was previously actively engaged with the resident or is committed to providing\\ncompanionship and/or assistance with activities of daily living. LTC facilities are not required to implement an EC program, but this guidance provides recommendations for those facilities that choose\\nto do so. The goal of such a designation is to help ensure these high-risk residents continue to receive individualized, person-centered care.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Essential Caregiver Guidance for Long-term Care Facilities\"}',1,'2024-06-03 21:51:19','2024-06-03 21:51:19','f1662e45-f3b7-4a41-82f3-d9e94a809409'),(19838,19838,1,'Initiative for More and Faster COVID-19 Testing in Nursing Homes','initiative-for-more-and-faster-covid-19-testing-in-nursing-homes','news/initiative-for-more-and-faster-covid-19-testing-in-nursing-homes','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"The U.S. Department of Health and Human Services (HHS) announces a large-scale procurement of U.S. Food and Drug Administration (FDA) -authorized rapid point-of-care diagnostic test instruments and tests to be distributed to nursing homes in COVID-19 hotspot geographic areas with the United States.\"}',1,'2024-06-03 21:51:19','2024-06-03 21:51:19','a3452565-e9c6-4a6c-adde-ef3f8c793fe1'),(19839,19839,1,NULL,'initiative-for-more-and-faster-covid-19-testing-in-nursing-homes',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"The U.S. Department of Health and Human Services (HHS) announces a large-scale procurement of U.S. Food and Drug Administration (FDA) -authorized rapid point-of-care diagnostic test instruments and tests to be distributed to nursing homes in COVID-19 hotspot geographic areas with the United States.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Initiative for More and Faster COVID-19 Testing in Nursing Homes\"}',1,'2024-06-03 21:51:19','2024-06-03 21:51:19','cf508823-0c54-4316-b565-9a2820141064'),(19840,19840,1,'Initiative for More and Faster COVID-19 Testing in Nursing Homes','initiative-for-more-and-faster-covid-19-testing-in-nursing-homes','news/initiative-for-more-and-faster-covid-19-testing-in-nursing-homes','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"The U.S. Department of Health and Human Services (HHS) announces a large-scale procurement of U.S. Food and Drug Administration (FDA) -authorized rapid point-of-care diagnostic test instruments and tests to be distributed to nursing homes in COVID-19 hotspot geographic areas with the United States.\"}',1,'2024-06-03 21:51:19','2024-06-03 21:51:19','0cecea93-542e-4445-923f-30a976397255'),(19841,19841,1,NULL,'initiative-for-more-and-faster-covid-19-testing-in-nursing-homes',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"The U.S. Department of Health and Human Services (HHS) announces a large-scale procurement of U.S. Food and Drug Administration (FDA) -authorized rapid point-of-care diagnostic test instruments and tests to be distributed to nursing homes in COVID-19 hotspot geographic areas with the United States.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Initiative for More and Faster COVID-19 Testing in Nursing Homes\"}',1,'2024-06-03 21:51:19','2024-06-03 21:51:19','df4754c0-11c0-4701-bfed-d60ecae6eab4'),(19842,19842,1,'Toolkit on State Actions to Mitigate COVID-19 Prevalence in Nursing Homes','toolkit-on-state-actions-to-mitigate-covid-19-prevalence-in-nursing-homes','news/toolkit-on-state-actions-to-mitigate-covid-19-prevalence-in-nursing-homes','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"This Centers for Medicare & Medicaid Services toolkit catalogs the many innovative solutions designed at the state level to protect our nation’s vulnerable nursing home residents during the Coronavirus disease 2019 (COVID-19) pandemic.\"}',1,'2024-06-03 21:51:19','2024-06-03 21:51:19','9505e701-fd9b-4871-a5c8-b6280f900ae8'),(19843,19843,1,NULL,'toolkit-on-state-actions-to-mitigate-covid-19-prevalence-in-nursing-homes',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"This Centers for Medicare &amp; Medicaid Services toolkit catalogs the many innovative solutions designed at the state level to protect our nation’s vulnerable nursing home residents during the Coronavirus disease 2019 (COVID-19) pandemic.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Toolkit on State Actions to Mitigate COVID-19 Prevalence in Nursing Homes\"}',1,'2024-06-03 21:51:19','2024-06-03 21:51:19','83d5a2e3-4732-44c5-a2e9-c2fff7c21dd1'),(19844,19844,1,'Toolkit on State Actions to Mitigate COVID-19 Prevalence in Nursing Homes','toolkit-on-state-actions-to-mitigate-covid-19-prevalence-in-nursing-homes','news/toolkit-on-state-actions-to-mitigate-covid-19-prevalence-in-nursing-homes','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"This Centers for Medicare & Medicaid Services toolkit catalogs the many innovative solutions designed at the state level to protect our nation’s vulnerable nursing home residents during the Coronavirus disease 2019 (COVID-19) pandemic.\"}',1,'2024-06-03 21:51:19','2024-06-03 21:51:19','0652f8e5-d7cd-4197-8177-b562a22c1ec5'),(19845,19845,1,NULL,'toolkit-on-state-actions-to-mitigate-covid-19-prevalence-in-nursing-homes',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"This Centers for Medicare &amp; Medicaid Services toolkit catalogs the many innovative solutions designed at the state level to protect our nation’s vulnerable nursing home residents during the Coronavirus disease 2019 (COVID-19) pandemic.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Toolkit on State Actions to Mitigate COVID-19 Prevalence in Nursing Homes\"}',1,'2024-06-03 21:51:19','2024-06-03 21:51:19','ec982040-c4f3-48aa-8bb0-f44795215af5'),(19846,19846,1,'Interim Guidance Criteria for Return to Work for Healthcare Personnel with SARS-CoV-2  Infection','interim-guidance-criteria-for-return-to-work-for-healthcare-personnel-with-sars-cov-2-infection','news/interim-guidance-criteria-for-return-to-work-for-healthcare-personnel-with-sars-cov-2-infection','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"This updated CDC guidance is for occupational health programs and public health officials making decisions about return to work for healthcare personnel (HCP) with confirmed SARS-CoV-2 infection, or who have suspected SARS-CoV-2 infection (e.g., developed symptoms of COVID-19) but were never tested for SARS-CoV-2.\"}',1,'2024-06-03 21:51:19','2024-06-03 21:51:19','6f1afc8c-2f25-4c62-a881-e9d73ba3b417'),(19847,19847,1,NULL,'interim-guidance-criteria-for-return-to-work-for-healthcare-personnel-with-sars-cov-2-infection',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"This updated CDC guidance is for occupational health programs and public health officials making decisions about return to work for healthcare personnel (HCP) with confirmed SARS-CoV-2 infection, or who have suspected SARS-CoV-2 infection (e.g., developed symptoms of COVID-19) but were never tested for SARS-CoV-2.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Interim Guidance Criteria for Return to Work for Healthcare Personnel with SARS-CoV-2  Infection\"}',1,'2024-06-03 21:51:19','2024-06-03 21:51:19','c7dd3417-7cab-4436-903d-4d7612a878d8'),(19848,19848,1,'Interim Guidance Criteria for Return to Work for Healthcare Personnel with SARS-CoV-2  Infection','interim-guidance-criteria-for-return-to-work-for-healthcare-personnel-with-sars-cov-2-infection','news/interim-guidance-criteria-for-return-to-work-for-healthcare-personnel-with-sars-cov-2-infection','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"This updated CDC guidance is for occupational health programs and public health officials making decisions about return to work for healthcare personnel (HCP) with confirmed SARS-CoV-2 infection, or who have suspected SARS-CoV-2 infection (e.g., developed symptoms of COVID-19) but were never tested for SARS-CoV-2.\"}',1,'2024-06-03 21:51:19','2024-06-03 21:51:19','388b1a98-851d-4ea9-a3ac-6535fe2180a1'),(19849,19849,1,NULL,'interim-guidance-criteria-for-return-to-work-for-healthcare-personnel-with-sars-cov-2-infection',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"This updated CDC guidance is for occupational health programs and public health officials making decisions about return to work for healthcare personnel (HCP) with confirmed SARS-CoV-2 infection, or who have suspected SARS-CoV-2 infection (e.g., developed symptoms of COVID-19) but were never tested for SARS-CoV-2.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Interim Guidance Criteria for Return to Work for Healthcare Personnel with SARS-CoV-2  Infection\"}',1,'2024-06-03 21:51:19','2024-06-03 21:51:19','3e0a3b1d-5a0b-4225-94d0-69d827c7c954'),(19850,19850,1,'Updated Interim Guidance for Discontinuation of Transmission-Based Precautions and Disposition of Patients with COVID-19 in Healthcare Settings','updated-interim-guidance-for-discontinuation-of-transmission-based-precautions-and-disposition-of-patients-with-covid-19-in-healthcare-settings','news/updated-interim-guidance-for-discontinuation-of-transmission-based-precautions-and-disposition-of-patients-with-covid-19-in-healthcare-settings','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"CDC\'s updated interim guidance on the discontinuation of  transmission-based precautions and disposition of patients with COVID-19 in healthcare settings.\"}',1,'2024-06-03 21:51:20','2024-06-03 21:51:20','486540cc-61c4-4aa9-989d-ad09d0f41914'),(19851,19851,1,NULL,'updated-interim-guidance-for-discontinuation-of-transmission-based-precautions-and-disposition-of-patients-with-covid-19-in-healthcare-settings',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"CDC\'s updated interim guidance on the discontinuation of  transmission-based precautions and disposition of patients with COVID-19 in healthcare settings.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Updated Interim Guidance for Discontinuation of Transmission-Based Precautions and Disposition of Patients with COVID-19 in Healthcare Settings\"}',1,'2024-06-03 21:51:20','2024-06-03 21:51:20','45263332-7df6-4e9f-8f13-f5f9ba994487'),(19852,19852,1,'Updated Interim Guidance for Discontinuation of Transmission-Based Precautions and Disposition of Patients with COVID-19 in Healthcare Settings','updated-interim-guidance-for-discontinuation-of-transmission-based-precautions-and-disposition-of-patients-with-covid-19-in-healthcare-settings','news/updated-interim-guidance-for-discontinuation-of-transmission-based-precautions-and-disposition-of-patients-with-covid-19-in-healthcare-settings','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"CDC\'s updated interim guidance on the discontinuation of  transmission-based precautions and disposition of patients with COVID-19 in healthcare settings.\"}',1,'2024-06-03 21:51:20','2024-06-03 21:51:20','24e6cf0b-0e1c-4b10-9ea8-1b89bdbd9aca'),(19853,19853,1,NULL,'updated-interim-guidance-for-discontinuation-of-transmission-based-precautions-and-disposition-of-patients-with-covid-19-in-healthcare-settings',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"CDC\'s updated interim guidance on the discontinuation of  transmission-based precautions and disposition of patients with COVID-19 in healthcare settings.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Updated Interim Guidance for Discontinuation of Transmission-Based Precautions and Disposition of Patients with COVID-19 in Healthcare Settings\"}',1,'2024-06-03 21:51:20','2024-06-03 21:51:20','cba6fae2-bc5b-438f-a015-333c77245e9e'),(19854,19854,1,'Considerations for Release of Stockpiled N95s Beyond the Manufacturer-Designated Shelf Life','considerations-for-release-of-stockpiled-n95s-beyond-the-manufacturer-designated-shelf-life','news/considerations-for-release-of-stockpiled-n95s-beyond-the-manufacturer-designated-shelf-life','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"CDC\'s considerations for using expired N95 respirators during COVID-19.\"}',1,'2024-06-03 21:51:20','2024-06-03 21:51:20','be414ef2-7f84-4ac5-a4d3-b8335f441e54'),(19855,19855,1,NULL,'considerations-for-release-of-stockpiled-n95s-beyond-the-manufacturer-designated-shelf-life',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"CDC\'s considerations for using expired N95 respirators during COVID-19.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Considerations for Release of Stockpiled N95s Beyond the Manufacturer-Designated Shelf Life\"}',1,'2024-06-03 21:51:20','2024-06-03 21:51:20','41c8b2d3-4d93-490f-813a-5c8afde79cf0'),(19856,19856,1,'Considerations for Release of Stockpiled N95s Beyond the Manufacturer-Designated Shelf Life','considerations-for-release-of-stockpiled-n95s-beyond-the-manufacturer-designated-shelf-life','news/considerations-for-release-of-stockpiled-n95s-beyond-the-manufacturer-designated-shelf-life','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"CDC\'s considerations for using expired N95 respirators during COVID-19.\"}',1,'2024-06-03 21:51:20','2024-06-03 21:51:20','6b87d65b-8154-4872-a1d5-cf3bce80aab9'),(19857,19857,1,NULL,'considerations-for-release-of-stockpiled-n95s-beyond-the-manufacturer-designated-shelf-life',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"CDC\'s considerations for using expired N95 respirators during COVID-19.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Considerations for Release of Stockpiled N95s Beyond the Manufacturer-Designated Shelf Life\"}',1,'2024-06-03 21:51:20','2024-06-03 21:51:20','17035326-a3f7-420c-b146-4b9fc0743851'),(19858,19858,1,'Frequently Asked Questions: Laboratory Data Reporting for COVID-19 Testing','frequently-asked-questions-laboratory-data-reporting-for-covid-19-testing','news/frequently-asked-questions-laboratory-data-reporting-for-covid-19-testing','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"This 3-page PDF from HHS provides answers to frequently asked questions on laboratory data reporting for COVID-19 testing.\"}',1,'2024-06-03 21:51:20','2024-06-03 21:51:20','7fb14d5b-ee0a-4583-b467-703573134cfa'),(19859,19859,1,NULL,'frequently-asked-questions-laboratory-data-reporting-for-covid-19-testing',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"This 3-page PDF from HHS provides answers to frequently asked questions on laboratory data reporting for COVID-19 testing.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Frequently Asked Questions: Laboratory Data Reporting for COVID-19 Testing\"}',1,'2024-06-03 21:51:20','2024-06-03 21:51:20','2ca94b0a-6988-4f48-89e8-c2e927907619'),(19860,19860,1,'Frequently Asked Questions: Laboratory Data Reporting for COVID-19 Testing','frequently-asked-questions-laboratory-data-reporting-for-covid-19-testing','news/frequently-asked-questions-laboratory-data-reporting-for-covid-19-testing','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"This 3-page PDF from HHS provides answers to frequently asked questions on laboratory data reporting for COVID-19 testing.\"}',1,'2024-06-03 21:51:20','2024-06-03 21:51:20','73231f69-b684-43d9-8f7c-6a41079e3023'),(19861,19861,1,NULL,'frequently-asked-questions-laboratory-data-reporting-for-covid-19-testing',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"This 3-page PDF from HHS provides answers to frequently asked questions on laboratory data reporting for COVID-19 testing.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Frequently Asked Questions: Laboratory Data Reporting for COVID-19 Testing\"}',1,'2024-06-03 21:51:20','2024-06-03 21:51:20','751c1140-6653-4b4e-88d7-7986b2dfef4c'),(19862,19862,1,'HHS Announces New Laboratory Data Reporting Guidance for COVID-19 Testing','hhs-announces-new-laboratory-data-reporting-guidance-for-covid-19-testing-2','news/hhs-announces-new-laboratory-data-reporting-guidance-for-covid-19-testing-2','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"HHS\' press release announcing new laboratory data reporting guidance for COVID-19 testing.\"}',1,'2024-06-03 21:51:20','2024-06-03 21:51:20','270e0545-e034-40e7-9dcb-0f443be842b4'),(19863,19863,1,NULL,'hhs-announces-new-laboratory-data-reporting-guidance-for-covid-19-testing-2',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"HHS\' press release announcing new laboratory data reporting guidance for COVID-19 testing.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"HHS Announces New Laboratory Data Reporting Guidance for COVID-19 Testing\"}',1,'2024-06-03 21:51:20','2024-06-03 21:51:20','d3d918a1-4394-49fe-ad09-7e3d637645a7'),(19864,19864,1,'HHS Announces New Laboratory Data Reporting Guidance for COVID-19 Testing','hhs-announces-new-laboratory-data-reporting-guidance-for-covid-19-testing-2','news/hhs-announces-new-laboratory-data-reporting-guidance-for-covid-19-testing-2','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"HHS\' press release announcing new laboratory data reporting guidance for COVID-19 testing.\"}',1,'2024-06-03 21:51:20','2024-06-03 21:51:20','194a69c4-4b49-454f-8fad-d66b0650dbb8'),(19865,19865,1,NULL,'hhs-announces-new-laboratory-data-reporting-guidance-for-covid-19-testing-2',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"HHS\' press release announcing new laboratory data reporting guidance for COVID-19 testing.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"HHS Announces New Laboratory Data Reporting Guidance for COVID-19 Testing\"}',1,'2024-06-03 21:51:20','2024-06-03 21:51:20','dba5ac5b-992d-4a9f-9df6-7e01ac24759e'),(19866,19866,1,'CARES Act Section 18115 Laboratory Data Reporting Guidance','cares-act-section-18115-laboratory-data-reporting-guidance','news/cares-act-section-18115-laboratory-data-reporting-guidance','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"HHS\' CARES Act Section 18115 Laboratory Data Reporting Guidance includes information on entities required to report, method for submission, required data elements, data reporting and transmission requirements, and more.\"}',1,'2024-06-03 21:51:20','2024-06-03 21:51:20','0b48cff6-8b3c-4e00-b8dd-e45765d082ac'),(19867,19867,1,NULL,'cares-act-section-18115-laboratory-data-reporting-guidance',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"HHS\' CARES Act Section 18115 Laboratory Data Reporting Guidance includes information on entities required to report, method for submission, required data elements, data reporting and transmission requirements, and more.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"CARES Act Section 18115 Laboratory Data Reporting Guidance\"}',1,'2024-06-03 21:51:20','2024-06-03 21:51:20','93d73042-ce43-4406-97ec-1f730680e45e'),(19868,19868,1,'CARES Act Section 18115 Laboratory Data Reporting Guidance','cares-act-section-18115-laboratory-data-reporting-guidance','news/cares-act-section-18115-laboratory-data-reporting-guidance','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"HHS\' CARES Act Section 18115 Laboratory Data Reporting Guidance includes information on entities required to report, method for submission, required data elements, data reporting and transmission requirements, and more.\"}',1,'2024-06-03 21:51:20','2024-06-03 21:51:20','42859825-118f-4bd2-af45-61bea2dfe7b9'),(19869,19869,1,NULL,'cares-act-section-18115-laboratory-data-reporting-guidance',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"HHS\' CARES Act Section 18115 Laboratory Data Reporting Guidance includes information on entities required to report, method for submission, required data elements, data reporting and transmission requirements, and more.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"CARES Act Section 18115 Laboratory Data Reporting Guidance\"}',1,'2024-06-03 21:51:20','2024-06-03 21:51:20','e19087f0-52ad-4d2f-a103-30efe5434290'),(19870,19870,1,'Proposed Investigation/Reporting Thresholds and Outbreak Definition for COVID-19 in Acute Care Hospitals, Critical Access Hospitals, Long-Term Care Facilities (LCTFs) and Long-Term Care Acute Hospitals','proposed-investigation-reporting-thresholds-and-outbreak-definition-for-covid-19-in-acute-care-hospitals-critical-access-hospitals-long-term-care-facilities-lctfs-and-long-term-care-acute-hospital','news/proposed-investigation-reporting-thresholds-and-outbreak-definition-for-covid-19-in-acute-care-hospitals-critical-access-hospitals-long-term-care-facilities-lctfs-and-long-term-care-acute-hospital','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"CORHA/CSTE\'s proposed thresholds and outbreak definition for COVID-19 in acute care hospitals, critical access hospitals, long-term care facilities, and long-term care acute hospitals.\"}',1,'2024-06-03 21:51:20','2024-06-03 21:51:20','83d2ab25-c460-44f9-94dd-0621ac8042c9'),(19871,19871,1,NULL,'proposed-investigation-reporting-thresholds-and-outbreak-definition-for-covid-19-in-acute-care-hospitals-critical-access-hospitals-long-term-care-facilities-lctfs-and-long-term-care-acute-hospital',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"CORHA/CSTE\'s proposed thresholds and outbreak definition for COVID-19 in acute care hospitals, critical access hospitals, long-term care facilities, and long-term care acute hospitals.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Proposed Investigation/Reporting Thresholds and Outbreak Definition for COVID-19 in Acute Care Hospitals, Critical Access Hospitals, Long-Term Care Facilities (LCTFs) and Long-Term Care Acute Hospitals\"}',1,'2024-06-03 21:51:20','2024-06-03 21:51:20','fd95b01f-6ebc-4358-ac25-ab56355c41a0'),(19872,19872,1,'Proposed Investigation/Reporting Thresholds and Outbreak Definition for COVID-19 in Acute Care Hospitals, Critical Access Hospitals, Long-Term Care Facilities (LCTFs) and Long-Term Care Acute Hospitals','proposed-investigation-reporting-thresholds-and-outbreak-definition-for-covid-19-in-acute-care-hospitals-critical-access-hospitals-long-term-care-facilities-lctfs-and-long-term-care-acute-hospital','news/proposed-investigation-reporting-thresholds-and-outbreak-definition-for-covid-19-in-acute-care-hospitals-critical-access-hospitals-long-term-care-facilities-lctfs-and-long-term-care-acute-hospital','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"CORHA/CSTE\'s proposed thresholds and outbreak definition for COVID-19 in acute care hospitals, critical access hospitals, long-term care facilities, and long-term care acute hospitals.\"}',1,'2024-06-03 21:51:20','2024-06-03 21:51:20','7f445264-51d1-4fea-95ea-427e429c8cfa'),(19873,19873,1,NULL,'proposed-investigation-reporting-thresholds-and-outbreak-definition-for-covid-19-in-acute-care-hospitals-critical-access-hospitals-long-term-care-facilities-lctfs-and-long-term-care-acute-hospital',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"CORHA/CSTE\'s proposed thresholds and outbreak definition for COVID-19 in acute care hospitals, critical access hospitals, long-term care facilities, and long-term care acute hospitals.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Proposed Investigation/Reporting Thresholds and Outbreak Definition for COVID-19 in Acute Care Hospitals, Critical Access Hospitals, Long-Term Care Facilities (LCTFs) and Long-Term Care Acute Hospitals\"}',1,'2024-06-03 21:51:20','2024-06-03 21:51:20','2dae3385-06da-406f-ba29-3387a6900ede'),(19874,19874,1,'CSTE\'s Update to the Standardized Surveillance Case Definition and National Notification for 2019 Novel Coronavirus Disease (COVID-19)','cstes-update-to-the-standardized-surveillance-case-definition-and-national-notification-for-2019-novel-coronavirus-disease-covid-19','news/cstes-update-to-the-standardized-surveillance-case-definition-and-national-notification-for-2019-novel-coronavirus-disease-covid-19','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"This position statement updates the standardized case definition for 2019 novel coronavirus disease (COVID-19), including asymptomatic infections caused by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), and retains COVID-19 as a nationally notifiable condition. Updates clarify clinical, laboratory, epidemiologic linkage, and vital records criteria for case ascertainment and case classification based on the\\ncontinued evolution of the COVID-19 pandemic. Updates probable case classifications and adds suspect case classifications.\"}',1,'2024-06-03 21:51:21','2024-06-03 21:51:21','aa04b8be-e935-4988-92de-d2c3372a08b8'),(19875,19875,1,NULL,'cstes-update-to-the-standardized-surveillance-case-definition-and-national-notification-for-2019-novel-coronavirus-disease-covid-19',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"This position statement updates the standardized case definition for 2019 novel coronavirus disease (COVID-19), including asymptomatic infections caused by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), and retains COVID-19 as a nationally notifiable condition. Updates clarify clinical, laboratory, epidemiologic linkage, and vital records criteria for case ascertainment and case classification based on the\\ncontinued evolution of the COVID-19 pandemic. Updates probable case classifications and adds suspect case classifications.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"CSTE\'s Update to the Standardized Surveillance Case Definition and National Notification for 2019 Novel Coronavirus Disease (COVID-19)\"}',1,'2024-06-03 21:51:21','2024-06-03 21:51:21','898c5924-358d-4f0f-bb4c-0068b9e31b9a'),(19876,19876,1,'CSTE\'s Update to the Standardized Surveillance Case Definition and National Notification for 2019 Novel Coronavirus Disease (COVID-19)','cstes-update-to-the-standardized-surveillance-case-definition-and-national-notification-for-2019-novel-coronavirus-disease-covid-19','news/cstes-update-to-the-standardized-surveillance-case-definition-and-national-notification-for-2019-novel-coronavirus-disease-covid-19','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"This position statement updates the standardized case definition for 2019 novel coronavirus disease (COVID-19), including asymptomatic infections caused by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), and retains COVID-19 as a nationally notifiable condition. Updates clarify clinical, laboratory, epidemiologic linkage, and vital records criteria for case ascertainment and case classification based on the\\ncontinued evolution of the COVID-19 pandemic. Updates probable case classifications and adds suspect case classifications.\"}',1,'2024-06-03 21:51:21','2024-06-03 21:51:21','691e7988-16d0-4ded-bcd4-f4af48576b9a'),(19877,19877,1,NULL,'cstes-update-to-the-standardized-surveillance-case-definition-and-national-notification-for-2019-novel-coronavirus-disease-covid-19',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"This position statement updates the standardized case definition for 2019 novel coronavirus disease (COVID-19), including asymptomatic infections caused by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), and retains COVID-19 as a nationally notifiable condition. Updates clarify clinical, laboratory, epidemiologic linkage, and vital records criteria for case ascertainment and case classification based on the\\ncontinued evolution of the COVID-19 pandemic. Updates probable case classifications and adds suspect case classifications.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"CSTE\'s Update to the Standardized Surveillance Case Definition and National Notification for 2019 Novel Coronavirus Disease (COVID-19)\"}',1,'2024-06-03 21:51:21','2024-06-03 21:51:21','981fbdfa-5095-49ab-a83f-cb309845040f'),(19878,19878,1,'Recommended IPC practices When Providing Dental Healthcare for a Patient with Suspected or Confirmed SARS-CoV-2 Infection','recommended-infection-prevention-and-control-ipc-practices-for-routine-dental-healthcare-delivery-during-the-pandemic','news/recommended-infection-prevention-and-control-ipc-practices-for-routine-dental-healthcare-delivery-during-the-pandemic','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"CDC\'s recommended infection prevention and control (IPC) practices when providing dental healthcare for a patient with suspected or confirmed SARS-CoV-2 infection.\"}',1,'2024-06-03 21:51:21','2024-06-03 21:51:21','6c6ed2a6-9536-4196-a6d1-7161b125b03a'),(19879,19879,1,NULL,'recommended-infection-prevention-and-control-ipc-practices-for-routine-dental-healthcare-delivery-during-the-pandemic',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"CDC\'s recommended infection prevention and control (IPC) practices when providing dental healthcare for a patient with suspected or confirmed SARS-CoV-2 infection.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Recommended IPC practices When Providing Dental Healthcare for a Patient with Suspected or Confirmed SARS-CoV-2 Infection\"}',1,'2024-06-03 21:51:21','2024-06-03 21:51:21','4b179b0c-76cd-46ac-b7d8-a819ff4e4bdb'),(19880,19880,1,'Recommended IPC practices When Providing Dental Healthcare for a Patient with Suspected or Confirmed SARS-CoV-2 Infection','recommended-infection-prevention-and-control-ipc-practices-for-routine-dental-healthcare-delivery-during-the-pandemic','news/recommended-infection-prevention-and-control-ipc-practices-for-routine-dental-healthcare-delivery-during-the-pandemic','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"CDC\'s recommended infection prevention and control (IPC) practices when providing dental healthcare for a patient with suspected or confirmed SARS-CoV-2 infection.\"}',1,'2024-06-03 21:51:21','2024-06-03 21:51:21','7cf5e792-2c2b-4ebc-9cf6-dd21b2517bbb'),(19881,19881,1,NULL,'recommended-infection-prevention-and-control-ipc-practices-for-routine-dental-healthcare-delivery-during-the-pandemic',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"CDC\'s recommended infection prevention and control (IPC) practices when providing dental healthcare for a patient with suspected or confirmed SARS-CoV-2 infection.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Recommended IPC practices When Providing Dental Healthcare for a Patient with Suspected or Confirmed SARS-CoV-2 Infection\"}',1,'2024-06-03 21:51:21','2024-06-03 21:51:21','9bbfce2e-bec7-4a1a-9984-8cf4a4115f50'),(19882,19882,1,'Recommended Infection Prevention and Control (IPC) Practices for Routine Dental Healthcare Delivery During the Pandemic','recommended-infection-prevention-and-control-ipc-practices-for-routine-dental-healthcare-delivery-during-the-pandemic-2','news/recommended-infection-prevention-and-control-ipc-practices-for-routine-dental-healthcare-delivery-during-the-pandemic-2','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"CDC\'s recommended infection prevention and control (IPC) practices for routine dental healthcare delivery during the pandemic.\"}',1,'2024-06-03 21:51:21','2024-06-03 21:51:21','12afaebe-ff71-4ea5-9ab1-1ef5faf1a3cb'),(19883,19883,1,NULL,'recommended-infection-prevention-and-control-ipc-practices-for-routine-dental-healthcare-delivery-during-the-pandemic-2',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"CDC\'s recommended infection prevention and control (IPC) practices for routine dental healthcare delivery during the pandemic.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Recommended Infection Prevention and Control (IPC) Practices for Routine Dental Healthcare Delivery During the Pandemic\"}',1,'2024-06-03 21:51:21','2024-06-03 21:51:21','77da46b9-5ab4-4872-b19f-4812d06382cf'),(19884,19884,1,'Recommended Infection Prevention and Control (IPC) Practices for Routine Dental Healthcare Delivery During the Pandemic','recommended-infection-prevention-and-control-ipc-practices-for-routine-dental-healthcare-delivery-during-the-pandemic-2','news/recommended-infection-prevention-and-control-ipc-practices-for-routine-dental-healthcare-delivery-during-the-pandemic-2','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"CDC\'s recommended infection prevention and control (IPC) practices for routine dental healthcare delivery during the pandemic.\"}',1,'2024-06-03 21:51:21','2024-06-03 21:51:21','449da659-40e2-4cd3-802d-57502d622c36'),(19885,19885,1,NULL,'recommended-infection-prevention-and-control-ipc-practices-for-routine-dental-healthcare-delivery-during-the-pandemic-2',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"CDC\'s recommended infection prevention and control (IPC) practices for routine dental healthcare delivery during the pandemic.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Recommended Infection Prevention and Control (IPC) Practices for Routine Dental Healthcare Delivery During the Pandemic\"}',1,'2024-06-03 21:51:21','2024-06-03 21:51:21','f96f4b63-1453-43c1-b062-8797f3cb55b7'),(19886,19886,1,'Updated Evaluation and Management Considerations for Neonates At Risk for COVID-19','updated-evaluation-and-management-considerations-for-neonates-at-risk-for-covid-19','news/updated-evaluation-and-management-considerations-for-neonates-at-risk-for-covid-19','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"This guidance from the CDC is intended to inform healthcare providers in the United States about the diagnosis, evaluation, infection prevention and control practices, and disposition of neonates (≤28 days old) with suspected or confirmed SARS-CoV-2 infection or known SARS-CoV-2 exposure, including birth to a mother with suspected or confirmed COVID-19.\"}',1,'2024-06-03 21:51:21','2024-06-03 21:51:21','f283fe3f-610d-4665-b10e-c33e6ff14e84'),(19887,19887,1,NULL,'updated-evaluation-and-management-considerations-for-neonates-at-risk-for-covid-19',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"This guidance from the CDC is intended to inform healthcare providers in the United States about the diagnosis, evaluation, infection prevention and control practices, and disposition of neonates (≤28 days old) with suspected or confirmed SARS-CoV-2 infection or known SARS-CoV-2 exposure, including birth to a mother with suspected or confirmed COVID-19.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Updated Evaluation and Management Considerations for Neonates At Risk for COVID-19\"}',1,'2024-06-03 21:51:21','2024-06-03 21:51:21','756d0ddc-7826-4bae-97e3-3c50c442b7dc'),(19888,19888,1,'Updated Evaluation and Management Considerations for Neonates At Risk for COVID-19','updated-evaluation-and-management-considerations-for-neonates-at-risk-for-covid-19','news/updated-evaluation-and-management-considerations-for-neonates-at-risk-for-covid-19','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"This guidance from the CDC is intended to inform healthcare providers in the United States about the diagnosis, evaluation, infection prevention and control practices, and disposition of neonates (≤28 days old) with suspected or confirmed SARS-CoV-2 infection or known SARS-CoV-2 exposure, including birth to a mother with suspected or confirmed COVID-19.\"}',1,'2024-06-03 21:51:21','2024-06-03 21:51:21','1e2b1409-0617-4b0f-b2b8-92f538fbcb52'),(19889,19889,1,NULL,'updated-evaluation-and-management-considerations-for-neonates-at-risk-for-covid-19',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"This guidance from the CDC is intended to inform healthcare providers in the United States about the diagnosis, evaluation, infection prevention and control practices, and disposition of neonates (≤28 days old) with suspected or confirmed SARS-CoV-2 infection or known SARS-CoV-2 exposure, including birth to a mother with suspected or confirmed COVID-19.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Updated Evaluation and Management Considerations for Neonates At Risk for COVID-19\"}',1,'2024-06-03 21:51:21','2024-06-03 21:51:21','c21e6e50-0069-4d18-8fbf-72baea419c40'),(19890,19890,1,'Updated Guidance on Infection Prevention and Control','updated-guidance-on-infection-prevention-and-control','news/updated-guidance-on-infection-prevention-and-control','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"CDC\'s updated guidance on infection prevention and control.\"}',1,'2024-06-03 21:51:21','2024-06-03 21:51:21','e7bc6f81-6575-4869-bd25-256ebdb3aad5'),(19891,19891,1,NULL,'updated-guidance-on-infection-prevention-and-control',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"CDC\'s updated guidance on infection prevention and control.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Updated Guidance on Infection Prevention and Control\"}',1,'2024-06-03 21:51:21','2024-06-03 21:51:21','66ad90fb-129a-4872-9b9a-79a513d063d5'),(19892,19892,1,'Updated Guidance on Infection Prevention and Control','updated-guidance-on-infection-prevention-and-control','news/updated-guidance-on-infection-prevention-and-control','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"CDC\'s updated guidance on infection prevention and control.\"}',1,'2024-06-03 21:51:21','2024-06-03 21:51:21','2671f80a-17cf-4958-bc77-7545078923ff'),(19893,19893,1,NULL,'updated-guidance-on-infection-prevention-and-control',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"CDC\'s updated guidance on infection prevention and control.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Updated Guidance on Infection Prevention and Control\"}',1,'2024-06-03 21:51:21','2024-06-03 21:51:21','84939f11-9a0e-46f7-bb5b-9309e2618c7d'),(19894,19894,1,'Report on Facility-Wide Testing for SARS-CoV-2 in Nursing Homes - Seven U.S. Jurisdictions, March-June, 2020','report-on-facility-wide-testing-for-sars-cov-2-in-nursing-homes-seven-u-s-jurisdictions-march-june-2020','news/report-on-facility-wide-testing-for-sars-cov-2-in-nursing-homes-seven-u-s-jurisdictions-march-june-2020','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"This Morbidity and Mortality Weekly Report (MMWR) covers facility-wide testing for SARS-CoV-2 in nursing homes from seven U.S. jurisdictions from March - June, 2020.\"}',1,'2024-06-03 21:51:21','2024-06-03 21:51:21','c317fb6b-cfb5-48bf-ac04-f1e43d341b92'),(19895,19895,1,NULL,'report-on-facility-wide-testing-for-sars-cov-2-in-nursing-homes-seven-u-s-jurisdictions-march-june-2020',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"This Morbidity and Mortality Weekly Report (MMWR) covers facility-wide testing for SARS-CoV-2 in nursing homes from seven U.S. jurisdictions from March - June, 2020.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Report on Facility-Wide Testing for SARS-CoV-2 in Nursing Homes - Seven U.S. Jurisdictions, March-June, 2020\"}',1,'2024-06-03 21:51:21','2024-06-03 21:51:21','2abae65d-ce98-4b26-aac5-40bace1dcff7'),(19896,19896,1,'Report on Facility-Wide Testing for SARS-CoV-2 in Nursing Homes - Seven U.S. Jurisdictions, March-June, 2020','report-on-facility-wide-testing-for-sars-cov-2-in-nursing-homes-seven-u-s-jurisdictions-march-june-2020','news/report-on-facility-wide-testing-for-sars-cov-2-in-nursing-homes-seven-u-s-jurisdictions-march-june-2020','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"This Morbidity and Mortality Weekly Report (MMWR) covers facility-wide testing for SARS-CoV-2 in nursing homes from seven U.S. jurisdictions from March - June, 2020.\"}',1,'2024-06-03 21:51:21','2024-06-03 21:51:21','cf03b705-42a7-4c7d-9e5e-ce1647fd3f3a'),(19897,19897,1,NULL,'report-on-facility-wide-testing-for-sars-cov-2-in-nursing-homes-seven-u-s-jurisdictions-march-june-2020',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"This Morbidity and Mortality Weekly Report (MMWR) covers facility-wide testing for SARS-CoV-2 in nursing homes from seven U.S. jurisdictions from March - June, 2020.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Report on Facility-Wide Testing for SARS-CoV-2 in Nursing Homes - Seven U.S. Jurisdictions, March-June, 2020\"}',1,'2024-06-03 21:51:21','2024-06-03 21:51:21','a86213f4-0271-4143-b7f5-8e79a48e5719'),(19898,19898,1,'Considerations for Use of SARS-CoV-2 Antigen Testing in Nursing Homes','considerations-for-use-of-sars-cov-2-antigen-testing-in-nursing-homes','news/considerations-for-use-of-sars-cov-2-antigen-testing-in-nursing-homes','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"This CDC document provides a summary of considerations for use of SARS-CoV-2 (the virus that causes COVID-19) antigen testing in nursing homes and is intended for nursing home providers and state and local public health departments.\"}',1,'2024-06-03 21:51:21','2024-06-03 21:51:21','4d60e37b-a217-4f2a-be5a-6eb99b4a0e95'),(19899,19899,1,NULL,'considerations-for-use-of-sars-cov-2-antigen-testing-in-nursing-homes',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"This CDC document provides a summary of considerations for use of SARS-CoV-2 (the virus that causes COVID-19) antigen testing in nursing homes and is intended for nursing home providers and state and local public health departments.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Considerations for Use of SARS-CoV-2 Antigen Testing in Nursing Homes\"}',1,'2024-06-03 21:51:21','2024-06-03 21:51:21','1cf31ee5-b472-415f-93e2-4d2dbd042c0e'),(19900,19900,1,'Considerations for Use of SARS-CoV-2 Antigen Testing in Nursing Homes','considerations-for-use-of-sars-cov-2-antigen-testing-in-nursing-homes','news/considerations-for-use-of-sars-cov-2-antigen-testing-in-nursing-homes','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"This CDC document provides a summary of considerations for use of SARS-CoV-2 (the virus that causes COVID-19) antigen testing in nursing homes and is intended for nursing home providers and state and local public health departments.\"}',1,'2024-06-03 21:51:21','2024-06-03 21:51:21','ec120076-4a58-4489-991b-6dc18752ead7'),(19901,19901,1,NULL,'considerations-for-use-of-sars-cov-2-antigen-testing-in-nursing-homes',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"This CDC document provides a summary of considerations for use of SARS-CoV-2 (the virus that causes COVID-19) antigen testing in nursing homes and is intended for nursing home providers and state and local public health departments.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Considerations for Use of SARS-CoV-2 Antigen Testing in Nursing Homes\"}',1,'2024-06-03 21:51:22','2024-06-03 21:51:22','a391a800-6490-494c-921e-84101de778ad'),(19902,19902,1,'Considerations for Interpreting Antigen Test Results in Nursing Homes','considerations-for-interpreting-antigen-test-results-in-nursing-homes','news/considerations-for-interpreting-antigen-test-results-in-nursing-homes','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"These are considerations from the CDC for interpreting antigen test results in nursing homes.\"}',1,'2024-06-03 21:51:22','2024-06-03 21:51:22','997a0be2-5c05-4f70-9c0d-f46d9086f350'),(19903,19903,1,NULL,'considerations-for-interpreting-antigen-test-results-in-nursing-homes',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"These are considerations from the CDC for interpreting antigen test results in nursing homes.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Considerations for Interpreting Antigen Test Results in Nursing Homes\"}',1,'2024-06-03 21:51:22','2024-06-03 21:51:22','ab786554-301b-4227-b504-9dc84809abd1'),(19904,19904,1,'Considerations for Interpreting Antigen Test Results in Nursing Homes','considerations-for-interpreting-antigen-test-results-in-nursing-homes','news/considerations-for-interpreting-antigen-test-results-in-nursing-homes','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"These are considerations from the CDC for interpreting antigen test results in nursing homes.\"}',1,'2024-06-03 21:51:22','2024-06-03 21:51:22','8fc705a2-a7e5-4f97-b02a-546daf168363'),(19905,19905,1,NULL,'considerations-for-interpreting-antigen-test-results-in-nursing-homes',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"These are considerations from the CDC for interpreting antigen test results in nursing homes.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Considerations for Interpreting Antigen Test Results in Nursing Homes\"}',1,'2024-06-03 21:51:22','2024-06-03 21:51:22','cc0c595c-8fa8-4c2d-97bd-180c1ccfab79'),(19906,19906,1,'Interim Additional Guidance for Infection Prevention and Control Recommendations for Patients with Suspected or Confirmed COVID-19 in Outpatient Hemodialysis Facilities','interim-additional-guidance-for-infection-prevention-and-control-recommendations-for-patients-with-suspected-or-confirmed-covid-19-in-outpatient-hemodialysis-facilities','news/interim-additional-guidance-for-infection-prevention-and-control-recommendations-for-patients-with-suspected-or-confirmed-covid-19-in-outpatient-hemodialysis-facilities','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"This information provided by the CDC is provided to clarify SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19), infection prevention and control (IPC) recommendations that are specific to outpatient hemodialysis facilities. It includes changes to the guidance as of August 24, 2020.\"}',1,'2024-06-03 21:51:22','2024-06-03 21:51:22','7ef4d6cb-c925-49ef-8eac-39613b22bdec'),(19907,19907,1,NULL,'interim-additional-guidance-for-infection-prevention-and-control-recommendations-for-patients-with-suspected-or-confirmed-covid-19-in-outpatient-hemodialysis-facilities',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"This information provided by the CDC is provided to clarify SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19), infection prevention and control (IPC) recommendations that are specific to outpatient hemodialysis facilities. It includes changes to the guidance as of August 24, 2020.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Interim Additional Guidance for Infection Prevention and Control Recommendations for Patients with Suspected or Confirmed COVID-19 in Outpatient Hemodialysis Facilities\"}',1,'2024-06-03 21:51:22','2024-06-03 21:51:22','25387b31-ccf6-45ef-a535-f2270dda37c2'),(19908,19908,1,'Interim Additional Guidance for Infection Prevention and Control Recommendations for Patients with Suspected or Confirmed COVID-19 in Outpatient Hemodialysis Facilities','interim-additional-guidance-for-infection-prevention-and-control-recommendations-for-patients-with-suspected-or-confirmed-covid-19-in-outpatient-hemodialysis-facilities','news/interim-additional-guidance-for-infection-prevention-and-control-recommendations-for-patients-with-suspected-or-confirmed-covid-19-in-outpatient-hemodialysis-facilities','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"This information provided by the CDC is provided to clarify SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19), infection prevention and control (IPC) recommendations that are specific to outpatient hemodialysis facilities. It includes changes to the guidance as of August 24, 2020.\"}',1,'2024-06-03 21:51:22','2024-06-03 21:51:22','29cad63e-bf8f-47c1-b181-456153d7694d'),(19909,19909,1,NULL,'interim-additional-guidance-for-infection-prevention-and-control-recommendations-for-patients-with-suspected-or-confirmed-covid-19-in-outpatient-hemodialysis-facilities',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"This information provided by the CDC is provided to clarify SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19), infection prevention and control (IPC) recommendations that are specific to outpatient hemodialysis facilities. It includes changes to the guidance as of August 24, 2020.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Interim Additional Guidance for Infection Prevention and Control Recommendations for Patients with Suspected or Confirmed COVID-19 in Outpatient Hemodialysis Facilities\"}',1,'2024-06-03 21:51:22','2024-06-03 21:51:22','5427b377-42a4-4771-8e10-9d31b61b9e10'),(19910,19910,1,'National Training Program to Strengthen Nursing Home Infection Control Practices','national-training-program-to-strengthen-nursing-home-infection-control-practices','news/national-training-program-to-strengthen-nursing-home-infection-control-practices','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"The Quality, Safety &amp; Education Portal (QSEP) from CMS provides the full curriculum of surveyor training and guidance on health care facility regulations.\"}',1,'2024-06-03 21:51:22','2024-06-03 21:51:22','079f83e2-616a-4768-9f31-b8bd283e9829'),(19911,19911,1,NULL,'national-training-program-to-strengthen-nursing-home-infection-control-practices',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"The Quality, Safety &amp; Education Portal (QSEP) from CMS provides the full curriculum of surveyor training and guidance on health care facility regulations.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"National Training Program to Strengthen Nursing Home Infection Control Practices\"}',1,'2024-06-03 21:51:22','2024-06-03 21:51:22','d9fff880-45c1-4f07-8907-876220fe5691'),(19912,19912,1,'National Training Program to Strengthen Nursing Home Infection Control Practices','national-training-program-to-strengthen-nursing-home-infection-control-practices','news/national-training-program-to-strengthen-nursing-home-infection-control-practices','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"The Quality, Safety &amp; Education Portal (QSEP) from CMS provides the full curriculum of surveyor training and guidance on health care facility regulations.\"}',1,'2024-06-03 21:51:22','2024-06-03 21:51:22','b428dff6-e954-4cc8-817b-c8cb914dcb51'),(19913,19913,1,NULL,'national-training-program-to-strengthen-nursing-home-infection-control-practices',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"The Quality, Safety &amp; Education Portal (QSEP) from CMS provides the full curriculum of surveyor training and guidance on health care facility regulations.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"National Training Program to Strengthen Nursing Home Infection Control Practices\"}',1,'2024-06-03 21:51:22','2024-06-03 21:51:22','c569fa23-9359-48e6-a5b6-a38c12113103'),(19914,19914,1,'New Reporting and Testing Requirements for Nursing Homes, Other Providers','new-reporting-and-testing-requirements-for-nursing-homes-other-providers','news/new-reporting-and-testing-requirements-for-nursing-homes-other-providers','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"CMS\' press release announced sweeping regulatory changes that require nursing homes to test staff and offer testing to residents for coronavirus disease 2019 (COVID-19).\"}',1,'2024-06-03 21:51:22','2024-06-03 21:51:22','b41d23a2-8e03-4438-8cd3-87a2f12f34dc'),(19915,19915,1,NULL,'new-reporting-and-testing-requirements-for-nursing-homes-other-providers',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"CMS\' press release announced sweeping regulatory changes that require nursing homes to test staff and offer testing to residents for coronavirus disease 2019 (COVID-19).\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"New Reporting and Testing Requirements for Nursing Homes, Other Providers\"}',1,'2024-06-03 21:51:22','2024-06-03 21:51:22','2e945674-e059-488f-93e0-fb39cfeccf8c'),(19916,19916,1,'New Reporting and Testing Requirements for Nursing Homes, Other Providers','new-reporting-and-testing-requirements-for-nursing-homes-other-providers','news/new-reporting-and-testing-requirements-for-nursing-homes-other-providers','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"CMS\' press release announced sweeping regulatory changes that require nursing homes to test staff and offer testing to residents for coronavirus disease 2019 (COVID-19).\"}',1,'2024-06-03 21:51:22','2024-06-03 21:51:22','b629816e-3cb8-4b96-8803-142ac3480557'),(19917,19917,1,NULL,'new-reporting-and-testing-requirements-for-nursing-homes-other-providers',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"CMS\' press release announced sweeping regulatory changes that require nursing homes to test staff and offer testing to residents for coronavirus disease 2019 (COVID-19).\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"New Reporting and Testing Requirements for Nursing Homes, Other Providers\"}',1,'2024-06-03 21:51:22','2024-06-03 21:51:22','6b0eca06-8a04-410a-a481-becefd13ccff'),(19918,19918,1,'Surveyors Complete 115 Infection Control Surveys in Idaho Nursing Homes','surveyors-complete-115-infection-control-surveys-in-idaho-nursing-homes','news/surveyors-complete-115-infection-control-surveys-in-idaho-nursing-homes','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"Results of 115 targeted infection control surveys in Idaho nursing homes, as of Aug. 21, 2020.\"}',1,'2024-06-03 21:51:23','2024-06-03 21:51:23','30d141d9-df9f-45ba-8e56-9afd1f062c46'),(19919,19919,1,NULL,'surveyors-complete-115-infection-control-surveys-in-idaho-nursing-homes',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"Results of 115 targeted infection control surveys in Idaho nursing homes, as of Aug. 21, 2020.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Surveyors Complete 115 Infection Control Surveys in Idaho Nursing Homes\"}',1,'2024-06-03 21:51:23','2024-06-03 21:51:23','033039c7-c5ca-4f22-9dd5-6502ee18770d'),(19920,19920,1,'Surveyors Complete 115 Infection Control Surveys in Idaho Nursing Homes','surveyors-complete-115-infection-control-surveys-in-idaho-nursing-homes','news/surveyors-complete-115-infection-control-surveys-in-idaho-nursing-homes','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"Results of 115 targeted infection control surveys in Idaho nursing homes, as of Aug. 21, 2020.\"}',1,'2024-06-03 21:51:23','2024-06-03 21:51:23','c71a71ca-ad95-40f6-b475-121d637c755c'),(19921,19921,1,NULL,'surveyors-complete-115-infection-control-surveys-in-idaho-nursing-homes',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"Results of 115 targeted infection control surveys in Idaho nursing homes, as of Aug. 21, 2020.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Surveyors Complete 115 Infection Control Surveys in Idaho Nursing Homes\"}',1,'2024-06-03 21:51:23','2024-06-03 21:51:23','c685c5ca-be8c-4345-8a7a-1e0fc3a0b569'),(19922,19922,1,'CORHA Member, Linda Green, Recipient of APIC\'s Carole DeMille Achievement Award','corha-member-linda-green-recipient-of-apics-carole-demille-achievement-award','news/corha-member-linda-green-recipient-of-apics-carole-demille-achievement-award','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"CORHA member Linda Greene, RN, MPS, CIC, FAPIC was awarded the prestigious 2020 Carole DeMille Achievement Award for her visionary leadership and significant contributions to the field of infection prevention and control.\"}',1,'2024-06-03 21:51:23','2024-06-03 21:51:23','83374fff-ebc6-4621-baa4-0f062311f370'),(19923,19923,1,NULL,'corha-member-linda-green-recipient-of-apics-carole-demille-achievement-award',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"CORHA member Linda Greene, RN, MPS, CIC, FAPIC was awarded the prestigious 2020 Carole DeMille Achievement Award for her visionary leadership and significant contributions to the field of infection prevention and control.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"CORHA Member, Linda Green, Recipient of APIC\'s Carole DeMille Achievement Award\"}',1,'2024-06-03 21:51:23','2024-06-03 21:51:23','4dc79447-3b0a-4dc7-9eaa-520c12251b0c'),(19924,19924,1,'CORHA Member, Linda Green, Recipient of APIC\'s Carole DeMille Achievement Award','corha-member-linda-green-recipient-of-apics-carole-demille-achievement-award','news/corha-member-linda-green-recipient-of-apics-carole-demille-achievement-award','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"CORHA member Linda Greene, RN, MPS, CIC, FAPIC was awarded the prestigious 2020 Carole DeMille Achievement Award for her visionary leadership and significant contributions to the field of infection prevention and control.\"}',1,'2024-06-03 21:51:23','2024-06-03 21:51:23','a8cf9f14-0863-4252-b33d-84b33b3490f4'),(19925,19925,1,NULL,'corha-member-linda-green-recipient-of-apics-carole-demille-achievement-award',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"CORHA member Linda Greene, RN, MPS, CIC, FAPIC was awarded the prestigious 2020 Carole DeMille Achievement Award for her visionary leadership and significant contributions to the field of infection prevention and control.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"CORHA Member, Linda Green, Recipient of APIC\'s Carole DeMille Achievement Award\"}',1,'2024-06-03 21:51:23','2024-06-03 21:51:23','b1b0bfbb-16d2-4d18-afed-f72a47ac59e7'),(19926,19926,1,'Opportunity to Comment on COVID-19 Hospital Data Collection','opportunity-to-comment-on-covid-19-hospital-data-collection','news/opportunity-to-comment-on-covid-19-hospital-data-collection','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"HHS sent out this notice for comment on HHS Teletracking COVID-19 Portal (U.S. Healthcare COVID-19 Portal). Comments on this request must be received on or before November 23, 2020.\"}',1,'2024-06-03 21:51:23','2024-06-03 21:51:23','b4a87dff-7a5f-4384-9a9b-cf962810e4bf'),(19927,19927,1,NULL,'opportunity-to-comment-on-covid-19-hospital-data-collection',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"HHS sent out this notice for comment on HHS Teletracking COVID-19 Portal (U.S. Healthcare COVID-19 Portal). Comments on this request must be received on or before November 23, 2020.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Opportunity to Comment on COVID-19 Hospital Data Collection\"}',1,'2024-06-03 21:51:23','2024-06-03 21:51:23','adc8b859-849e-4241-b5d3-7fa52be1689f'),(19928,19928,1,'Opportunity to Comment on COVID-19 Hospital Data Collection','opportunity-to-comment-on-covid-19-hospital-data-collection','news/opportunity-to-comment-on-covid-19-hospital-data-collection','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"HHS sent out this notice for comment on HHS Teletracking COVID-19 Portal (U.S. Healthcare COVID-19 Portal). Comments on this request must be received on or before November 23, 2020.\"}',1,'2024-06-03 21:51:23','2024-06-03 21:51:23','5457075a-2c0e-4f6e-9de6-94f490d5002e'),(19929,19929,1,NULL,'opportunity-to-comment-on-covid-19-hospital-data-collection',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"HHS sent out this notice for comment on HHS Teletracking COVID-19 Portal (U.S. Healthcare COVID-19 Portal). Comments on this request must be received on or before November 23, 2020.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Opportunity to Comment on COVID-19 Hospital Data Collection\"}',1,'2024-06-03 21:51:23','2024-06-03 21:51:23','f40cf195-9da1-4370-aeaf-100f0361f21f'),(19930,19930,1,'Update: Characteristics of Health Care Personnel with COVID-19 — United States, February 12–July 16, 2020','update-characteristics-of-health-care-personnel-with-covid-19-united-states-february-12-july-16-2020','news/update-characteristics-of-health-care-personnel-with-covid-19-united-states-february-12-july-16-2020','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"Information added by this updated MMWR report include: health care personnel (HCP) with COVID-19 who died tended to be older, male, Asian, Black, and have an underlying medical condition when compared with HCP who did not die; and nursing and residential care facilities were the most commonly reported job setting and nursing the most common single occupation type of HCP with COVID-19 in six jurisdictions.\"}',1,'2024-06-03 21:51:23','2024-06-03 21:51:23','d55d93f8-4203-4266-aa38-a09dd501665b'),(19931,19931,1,NULL,'update-characteristics-of-health-care-personnel-with-covid-19-united-states-february-12-july-16-2020',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"Information added by this updated MMWR report include: health care personnel (HCP) with COVID-19 who died tended to be older, male, Asian, Black, and have an underlying medical condition when compared with HCP who did not die; and nursing and residential care facilities were the most commonly reported job setting and nursing the most common single occupation type of HCP with COVID-19 in six jurisdictions.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Update: Characteristics of Health Care Personnel with COVID-19 — United States, February 12–July 16, 2020\"}',1,'2024-06-03 21:51:23','2024-06-03 21:51:23','f4b99a14-22f6-49c8-a287-575997a9aaa0'),(19932,19932,1,'Update: Characteristics of Health Care Personnel with COVID-19 — United States, February 12–July 16, 2020','update-characteristics-of-health-care-personnel-with-covid-19-united-states-february-12-july-16-2020','news/update-characteristics-of-health-care-personnel-with-covid-19-united-states-february-12-july-16-2020','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"Information added by this updated MMWR report include: health care personnel (HCP) with COVID-19 who died tended to be older, male, Asian, Black, and have an underlying medical condition when compared with HCP who did not die; and nursing and residential care facilities were the most commonly reported job setting and nursing the most common single occupation type of HCP with COVID-19 in six jurisdictions.\"}',1,'2024-06-03 21:51:23','2024-06-03 21:51:23','1641b6c5-277c-4518-b80d-3a26a32930c8'),(19933,19933,1,NULL,'update-characteristics-of-health-care-personnel-with-covid-19-united-states-february-12-july-16-2020',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"Information added by this updated MMWR report include: health care personnel (HCP) with COVID-19 who died tended to be older, male, Asian, Black, and have an underlying medical condition when compared with HCP who did not die; and nursing and residential care facilities were the most commonly reported job setting and nursing the most common single occupation type of HCP with COVID-19 in six jurisdictions.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Update: Characteristics of Health Care Personnel with COVID-19 — United States, February 12–July 16, 2020\"}',1,'2024-06-03 21:51:23','2024-06-03 21:51:23','925ade47-c2bb-4d8f-904f-86ac808b8412'),(19934,19934,1,'FDA Approves Cefiderocol for Hospital-Acquired, Ventilator-Associated Pneumonia','fda-approves-cefiderocol-for-hospital-acquired-ventilator-associated-pneumonia','news/fda-approves-cefiderocol-for-hospital-acquired-ventilator-associated-pneumonia','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"FDA\'s approval means that cefiderocol, sold under the brand name Fetroja, can be used to treat patients who have hospital-acquired and ventilator-associated bacterial pneumonia (HABP/VABP) caused by gram-negative pathogens. The antibiotic was initially approved for treatment of complicated urinary tract infections.\"}',1,'2024-06-03 21:51:23','2024-06-03 21:51:23','09069249-254d-4b9e-82b7-4d7d6a4345fc'),(19935,19935,1,NULL,'fda-approves-cefiderocol-for-hospital-acquired-ventilator-associated-pneumonia',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"FDA\'s approval means that cefiderocol, sold under the brand name Fetroja, can be used to treat patients who have hospital-acquired and ventilator-associated bacterial pneumonia (HABP/VABP) caused by gram-negative pathogens. The antibiotic was initially approved for treatment of complicated urinary tract infections.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"FDA Approves Cefiderocol for Hospital-Acquired, Ventilator-Associated Pneumonia\"}',1,'2024-06-03 21:51:23','2024-06-03 21:51:23','81fcb1ba-7577-4d92-8d4d-067573e86ba5'),(19936,19936,1,'FDA Approves Cefiderocol for Hospital-Acquired, Ventilator-Associated Pneumonia','fda-approves-cefiderocol-for-hospital-acquired-ventilator-associated-pneumonia','news/fda-approves-cefiderocol-for-hospital-acquired-ventilator-associated-pneumonia','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"FDA\'s approval means that cefiderocol, sold under the brand name Fetroja, can be used to treat patients who have hospital-acquired and ventilator-associated bacterial pneumonia (HABP/VABP) caused by gram-negative pathogens. The antibiotic was initially approved for treatment of complicated urinary tract infections.\"}',1,'2024-06-03 21:51:23','2024-06-03 21:51:23','99828928-9b9b-4e1d-aa22-7ab5b0c986cc'),(19937,19937,1,NULL,'fda-approves-cefiderocol-for-hospital-acquired-ventilator-associated-pneumonia',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"FDA\'s approval means that cefiderocol, sold under the brand name Fetroja, can be used to treat patients who have hospital-acquired and ventilator-associated bacterial pneumonia (HABP/VABP) caused by gram-negative pathogens. The antibiotic was initially approved for treatment of complicated urinary tract infections.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"FDA Approves Cefiderocol for Hospital-Acquired, Ventilator-Associated Pneumonia\"}',1,'2024-06-03 21:51:23','2024-06-03 21:51:23','ff436e31-076f-4a65-b73b-262ecf9bf211'),(19938,19938,1,'Reimagining Nursing Homes in the Wake of COVID-19','reimagining-nursing-homes-in-the-wake-of-covid-19','news/reimagining-nursing-homes-in-the-wake-of-covid-19','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"In the wake of COVID-19, authors of the National Academy of Medicine call for nursing homes to match patients with appropriate care models, increase training and payment for staff, and investigate better financing models.\"}',1,'2024-06-03 21:51:23','2024-06-03 21:51:23','29afb4a1-800d-4ae0-a306-0eaf13de433f'),(19939,19939,1,NULL,'reimagining-nursing-homes-in-the-wake-of-covid-19',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"In the wake of COVID-19, authors of the National Academy of Medicine call for nursing homes to match patients with appropriate care models, increase training and payment for staff, and investigate better financing models.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Reimagining Nursing Homes in the Wake of COVID-19\"}',1,'2024-06-03 21:51:23','2024-06-03 21:51:23','e34250b8-2682-4dee-8462-bbe1e380b3f8'),(19940,19940,1,'Reimagining Nursing Homes in the Wake of COVID-19','reimagining-nursing-homes-in-the-wake-of-covid-19','news/reimagining-nursing-homes-in-the-wake-of-covid-19','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"In the wake of COVID-19, authors of the National Academy of Medicine call for nursing homes to match patients with appropriate care models, increase training and payment for staff, and investigate better financing models.\"}',1,'2024-06-03 21:51:23','2024-06-03 21:51:23','95a822f2-e1df-4633-a614-514c4c75a1c9'),(19941,19941,1,NULL,'reimagining-nursing-homes-in-the-wake-of-covid-19',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"In the wake of COVID-19, authors of the National Academy of Medicine call for nursing homes to match patients with appropriate care models, increase training and payment for staff, and investigate better financing models.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Reimagining Nursing Homes in the Wake of COVID-19\"}',1,'2024-06-03 21:51:23','2024-06-03 21:51:23','2b6afe0f-0453-482d-b134-70f4f2b4e84e'),(19942,19942,1,'Morbidity and Mortality Weekly Report (MMWR) — Trends in COVID-19 Incidence After Implementation of Mitigation Measures — Arizona, January 22–August 7, 2020','morbidity-and-mortality-weekly-report-mmwr-trends-in-covid-19-incidence-after-implementation-of-mitigation-measures-arizona-january-22-august-7-2020','news/morbidity-and-mortality-weekly-report-mmwr-trends-in-covid-19-incidence-after-implementation-of-mitigation-measures-arizona-january-22-august-7-2020','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"The number of COVID-19 cases in Arizona stabilized and then decreased after sustained implementation and enforcement of statewide and locally enhanced mitigation measures, beginning approximately 2 weeks after implementation and enforcement of mask mandates and enhanced sanitations practices began on June 17; further decreases were observed during July 13–August 7, after statewide limitations and closures of certain services and businesses.\"}',1,'2024-06-03 21:51:24','2024-06-03 21:51:24','24b753d0-9489-42c1-af16-68db425426d9'),(19943,19943,1,NULL,'morbidity-and-mortality-weekly-report-mmwr-trends-in-covid-19-incidence-after-implementation-of-mitigation-measures-arizona-january-22-august-7-2020',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"The number of COVID-19 cases in Arizona stabilized and then decreased after sustained implementation and enforcement of statewide and locally enhanced mitigation measures, beginning approximately 2 weeks after implementation and enforcement of mask mandates and enhanced sanitations practices began on June 17; further decreases were observed during July 13–August 7, after statewide limitations and closures of certain services and businesses.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Morbidity and Mortality Weekly Report (MMWR) — Trends in COVID-19 Incidence After Implementation of Mitigation Measures — Arizona, January 22–August 7, 2020\"}',1,'2024-06-03 21:51:24','2024-06-03 21:51:24','0f3c0f04-a315-4b5e-8da3-799b0b64ffa0'),(19944,19944,1,'Morbidity and Mortality Weekly Report (MMWR) — Trends in COVID-19 Incidence After Implementation of Mitigation Measures — Arizona, January 22–August 7, 2020','morbidity-and-mortality-weekly-report-mmwr-trends-in-covid-19-incidence-after-implementation-of-mitigation-measures-arizona-january-22-august-7-2020','news/morbidity-and-mortality-weekly-report-mmwr-trends-in-covid-19-incidence-after-implementation-of-mitigation-measures-arizona-january-22-august-7-2020','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"The number of COVID-19 cases in Arizona stabilized and then decreased after sustained implementation and enforcement of statewide and locally enhanced mitigation measures, beginning approximately 2 weeks after implementation and enforcement of mask mandates and enhanced sanitations practices began on June 17; further decreases were observed during July 13–August 7, after statewide limitations and closures of certain services and businesses.\"}',1,'2024-06-03 21:51:24','2024-06-03 21:51:24','c401839f-4a42-4f50-b1b7-c4f22195ca4b'),(19945,19945,1,NULL,'morbidity-and-mortality-weekly-report-mmwr-trends-in-covid-19-incidence-after-implementation-of-mitigation-measures-arizona-january-22-august-7-2020',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"The number of COVID-19 cases in Arizona stabilized and then decreased after sustained implementation and enforcement of statewide and locally enhanced mitigation measures, beginning approximately 2 weeks after implementation and enforcement of mask mandates and enhanced sanitations practices began on June 17; further decreases were observed during July 13–August 7, after statewide limitations and closures of certain services and businesses.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Morbidity and Mortality Weekly Report (MMWR) — Trends in COVID-19 Incidence After Implementation of Mitigation Measures — Arizona, January 22–August 7, 2020\"}',1,'2024-06-03 21:51:24','2024-06-03 21:51:24','40acb857-e7cc-48dd-8c11-f4a31a7bb89a'),(19946,19946,1,'FDA Issues Warning Letter to Battelle Memorial Institute, a Manufacturer of an Authorized Decontamination System Used on Respirators','fda-issues-warning-letter-to-battelle-memorial-institute-a-manufacturer-of-an-authorized-decontamination-system-used-on-respirators','news/fda-issues-warning-letter-to-battelle-memorial-institute-a-manufacturer-of-an-authorized-decontamination-system-used-on-respirators','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"The U.S. Food and Drug Administration issued a warning letter to Battelle Memorial Institute for failure to comply with regulatory requirements for medical device reporting as specified in the Emergency Use Authorization (EUA) for the Battelle Critical Care Decontamination System.\"}',1,'2024-06-03 21:51:24','2024-06-03 21:51:24','28004e15-4aa5-4690-af8d-ddee0f80fe1c'),(19947,19947,1,NULL,'fda-issues-warning-letter-to-battelle-memorial-institute-a-manufacturer-of-an-authorized-decontamination-system-used-on-respirators',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"The U.S. Food and Drug Administration issued a warning letter to Battelle Memorial Institute for failure to comply with regulatory requirements for medical device reporting as specified in the Emergency Use Authorization (EUA) for the Battelle Critical Care Decontamination System.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"FDA Issues Warning Letter to Battelle Memorial Institute, a Manufacturer of an Authorized Decontamination System Used on Respirators\"}',1,'2024-06-03 21:51:24','2024-06-03 21:51:24','9abe200e-a8bf-4d29-903a-097016a58984'),(19948,19948,1,'FDA Issues Warning Letter to Battelle Memorial Institute, a Manufacturer of an Authorized Decontamination System Used on Respirators','fda-issues-warning-letter-to-battelle-memorial-institute-a-manufacturer-of-an-authorized-decontamination-system-used-on-respirators','news/fda-issues-warning-letter-to-battelle-memorial-institute-a-manufacturer-of-an-authorized-decontamination-system-used-on-respirators','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"The U.S. Food and Drug Administration issued a warning letter to Battelle Memorial Institute for failure to comply with regulatory requirements for medical device reporting as specified in the Emergency Use Authorization (EUA) for the Battelle Critical Care Decontamination System.\"}',1,'2024-06-03 21:51:24','2024-06-03 21:51:24','dd9da1a3-4c97-43bf-a517-eafb5a9a3282'),(19949,19949,1,NULL,'fda-issues-warning-letter-to-battelle-memorial-institute-a-manufacturer-of-an-authorized-decontamination-system-used-on-respirators',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"The U.S. Food and Drug Administration issued a warning letter to Battelle Memorial Institute for failure to comply with regulatory requirements for medical device reporting as specified in the Emergency Use Authorization (EUA) for the Battelle Critical Care Decontamination System.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"FDA Issues Warning Letter to Battelle Memorial Institute, a Manufacturer of an Authorized Decontamination System Used on Respirators\"}',1,'2024-06-03 21:51:24','2024-06-03 21:51:24','81e91bd3-6bd8-411c-bde1-b638625573d5'),(19950,19950,1,'Clinical Questions about COVID-19: New FAQs on Testing in Nursing Homes','clinical-questions-about-covid-19-new-faqs-on-testing-in-nursing-homes','news/clinical-questions-about-covid-19-new-faqs-on-testing-in-nursing-homes','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"FAQs from the CDC on testing in nursing homes.\"}',1,'2024-06-03 21:51:24','2024-06-03 21:51:24','9108a5c2-5ea7-4ac7-ad50-fb12d78c60ec'),(19951,19951,1,NULL,'clinical-questions-about-covid-19-new-faqs-on-testing-in-nursing-homes',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"FAQs from the CDC on testing in nursing homes.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Clinical Questions about COVID-19: New FAQs on Testing in Nursing Homes\"}',1,'2024-06-03 21:51:24','2024-06-03 21:51:24','6dfceb51-a6f7-43be-8160-24b64586bdf9'),(19952,19952,1,'Clinical Questions about COVID-19: New FAQs on Testing in Nursing Homes','clinical-questions-about-covid-19-new-faqs-on-testing-in-nursing-homes','news/clinical-questions-about-covid-19-new-faqs-on-testing-in-nursing-homes','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"FAQs from the CDC on testing in nursing homes.\"}',1,'2024-06-03 21:51:24','2024-06-03 21:51:24','94e2de90-991c-4922-bb9a-3fac02d416d0'),(19953,19953,1,NULL,'clinical-questions-about-covid-19-new-faqs-on-testing-in-nursing-homes',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"FAQs from the CDC on testing in nursing homes.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Clinical Questions about COVID-19: New FAQs on Testing in Nursing Homes\"}',1,'2024-06-03 21:51:24','2024-06-03 21:51:24','72cfe5a8-c4fa-434b-bdfe-c27ab0ff89cb'),(19954,19954,1,'National Action Plan for Combating Antibiotic-Resistant Bacteria, 2020-2025','national-action-plan-for-combating-antibiotic-resistant-bacteria-2020-2025','news/national-action-plan-for-combating-antibiotic-resistant-bacteria-2020-2025','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"The National Action Plan for Combating Antibiotic-Resistant Bacteria (CARB), 2020-2025, presents coordinated, strategic actions that the United States Government will take in the next five years to improve the health and wellbeing of all Americans by changing the course of antibiotic resistance. This Plan is based on the U.S. Government’s 2014 National Strategy for CARB, and builds on the first National Action Plan released in 2015 by expanding evidence-based activities that have already been shown to reduce antibiotic resistance, such as optimizing the use of antibiotics in human and animal health settings.\"}',1,'2024-06-03 21:51:24','2024-06-03 21:51:24','f729c2e0-9526-4e8e-81ce-ecb548ce91d6'),(19955,19955,1,NULL,'national-action-plan-for-combating-antibiotic-resistant-bacteria-2020-2025',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"The National Action Plan for Combating Antibiotic-Resistant Bacteria (CARB), 2020-2025, presents coordinated, strategic actions that the United States Government will take in the next five years to improve the health and wellbeing of all Americans by changing the course of antibiotic resistance. This Plan is based on the U.S. Government’s 2014 National Strategy for CARB, and builds on the first National Action Plan released in 2015 by expanding evidence-based activities that have already been shown to reduce antibiotic resistance, such as optimizing the use of antibiotics in human and animal health settings.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"National Action Plan for Combating Antibiotic-Resistant Bacteria, 2020-2025\"}',1,'2024-06-03 21:51:24','2024-06-03 21:51:24','60b6d83a-acd6-4c5b-808b-2036e4480739'),(19956,19956,1,'National Action Plan for Combating Antibiotic-Resistant Bacteria, 2020-2025','national-action-plan-for-combating-antibiotic-resistant-bacteria-2020-2025','news/national-action-plan-for-combating-antibiotic-resistant-bacteria-2020-2025','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"The National Action Plan for Combating Antibiotic-Resistant Bacteria (CARB), 2020-2025, presents coordinated, strategic actions that the United States Government will take in the next five years to improve the health and wellbeing of all Americans by changing the course of antibiotic resistance. This Plan is based on the U.S. Government’s 2014 National Strategy for CARB, and builds on the first National Action Plan released in 2015 by expanding evidence-based activities that have already been shown to reduce antibiotic resistance, such as optimizing the use of antibiotics in human and animal health settings.\"}',1,'2024-06-03 21:51:24','2024-06-03 21:51:24','e54b4fa3-2273-4c58-91e7-414e5a76beac'),(19957,19957,1,NULL,'national-action-plan-for-combating-antibiotic-resistant-bacteria-2020-2025',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"The National Action Plan for Combating Antibiotic-Resistant Bacteria (CARB), 2020-2025, presents coordinated, strategic actions that the United States Government will take in the next five years to improve the health and wellbeing of all Americans by changing the course of antibiotic resistance. This Plan is based on the U.S. Government’s 2014 National Strategy for CARB, and builds on the first National Action Plan released in 2015 by expanding evidence-based activities that have already been shown to reduce antibiotic resistance, such as optimizing the use of antibiotics in human and animal health settings.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"National Action Plan for Combating Antibiotic-Resistant Bacteria, 2020-2025\"}',1,'2024-06-03 21:51:24','2024-06-03 21:51:24','9b974ed8-3ebe-4a74-8f4c-5aed396b0eaf'),(19958,19958,1,'Outcomes of Neonates Born to Mothers With Severe Acute Respiratory Syndrome Coronavirus 2 Infection at a Large Medical Center in New York City','outcomes-of-neonates-born-to-mothers-with-severe-acute-respiratory-syndrome-coronavirus-2-infection-at-a-large-medical-center-in-new-york-city','news/outcomes-of-neonates-born-to-mothers-with-severe-acute-respiratory-syndrome-coronavirus-2-infection-at-a-large-medical-center-in-new-york-city','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"In this cohort analysis of the first 101 neonates born to mothers with perinatal SARS-CoV-2 infections at a single institution, 2 (2.0%) had positive test results for SARS-CoV-2, but none had clinical evidence of coronavirus disease 2019 (COVID-19), despite most infants rooming-in with mothers and direct breastfeeding. Fifty-five infants were followed up in the first 2 weeks of life in a new COVID-19 Newborn Follow-up Clinic, all of whom remained healthy.\"}',1,'2024-06-03 21:51:25','2024-06-03 21:51:25','cf8ae571-bf93-4c04-b2d7-49162bb1d895'),(19959,19959,1,NULL,'outcomes-of-neonates-born-to-mothers-with-severe-acute-respiratory-syndrome-coronavirus-2-infection-at-a-large-medical-center-in-new-york-city',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"In this cohort analysis of the first 101 neonates born to mothers with perinatal SARS-CoV-2 infections at a single institution, 2 (2.0%) had positive test results for SARS-CoV-2, but none had clinical evidence of coronavirus disease 2019 (COVID-19), despite most infants rooming-in with mothers and direct breastfeeding. Fifty-five infants were followed up in the first 2 weeks of life in a new COVID-19 Newborn Follow-up Clinic, all of whom remained healthy.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Outcomes of Neonates Born to Mothers With Severe Acute Respiratory Syndrome Coronavirus 2 Infection at a Large Medical Center in New York City\"}',1,'2024-06-03 21:51:25','2024-06-03 21:51:25','f4d006df-f6b0-4a67-a695-55bfa48a4e2c'),(19960,19960,1,'Outcomes of Neonates Born to Mothers With Severe Acute Respiratory Syndrome Coronavirus 2 Infection at a Large Medical Center in New York City','outcomes-of-neonates-born-to-mothers-with-severe-acute-respiratory-syndrome-coronavirus-2-infection-at-a-large-medical-center-in-new-york-city','news/outcomes-of-neonates-born-to-mothers-with-severe-acute-respiratory-syndrome-coronavirus-2-infection-at-a-large-medical-center-in-new-york-city','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"In this cohort analysis of the first 101 neonates born to mothers with perinatal SARS-CoV-2 infections at a single institution, 2 (2.0%) had positive test results for SARS-CoV-2, but none had clinical evidence of coronavirus disease 2019 (COVID-19), despite most infants rooming-in with mothers and direct breastfeeding. Fifty-five infants were followed up in the first 2 weeks of life in a new COVID-19 Newborn Follow-up Clinic, all of whom remained healthy.\"}',1,'2024-06-03 21:51:25','2024-06-03 21:51:25','0659d948-691f-4ff1-a485-b49799796fb5'),(19961,19961,1,NULL,'outcomes-of-neonates-born-to-mothers-with-severe-acute-respiratory-syndrome-coronavirus-2-infection-at-a-large-medical-center-in-new-york-city',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"In this cohort analysis of the first 101 neonates born to mothers with perinatal SARS-CoV-2 infections at a single institution, 2 (2.0%) had positive test results for SARS-CoV-2, but none had clinical evidence of coronavirus disease 2019 (COVID-19), despite most infants rooming-in with mothers and direct breastfeeding. Fifty-five infants were followed up in the first 2 weeks of life in a new COVID-19 Newborn Follow-up Clinic, all of whom remained healthy.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Outcomes of Neonates Born to Mothers With Severe Acute Respiratory Syndrome Coronavirus 2 Infection at a Large Medical Center in New York City\"}',1,'2024-06-03 21:51:25','2024-06-03 21:51:25','76235d19-c9ba-451f-a806-8aed80d7e8f5'),(19962,19962,1,'Assessing SARS-CoV-2 Preparedness in US Community Hospitals: A Forgotten Entity','assessing-sars-cov-2-preparedness-in-us-community-hospitals-a-forgotten-entity','news/assessing-sars-cov-2-preparedness-in-us-community-hospitals-a-forgotten-entity','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"This cross-sectional survey of infection preventionists in 60 US community hospitals was conducted between April 22 and May 8, 2020, and found several differences in hospital preparedness for SARS-CoV-2 with respect to personal protective equipment conservation strategies, protocols related to testing, universal masking and restarting elective procedures.\"}',1,'2024-06-03 21:51:25','2024-06-03 21:51:25','1ef71cab-cc0c-4e84-b577-5a21f6b627d1'),(19963,19963,1,NULL,'assessing-sars-cov-2-preparedness-in-us-community-hospitals-a-forgotten-entity',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"This cross-sectional survey of infection preventionists in 60 US community hospitals was conducted between April 22 and May 8, 2020, and found several differences in hospital preparedness for SARS-CoV-2 with respect to personal protective equipment conservation strategies, protocols related to testing, universal masking and restarting elective procedures.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Assessing SARS-CoV-2 Preparedness in US Community Hospitals: A Forgotten Entity\"}',1,'2024-06-03 21:51:25','2024-06-03 21:51:25','cdbd2b60-2639-4243-84c9-4ad8a006ea9e'),(19964,19964,1,'Assessing SARS-CoV-2 Preparedness in US Community Hospitals: A Forgotten Entity','assessing-sars-cov-2-preparedness-in-us-community-hospitals-a-forgotten-entity','news/assessing-sars-cov-2-preparedness-in-us-community-hospitals-a-forgotten-entity','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"This cross-sectional survey of infection preventionists in 60 US community hospitals was conducted between April 22 and May 8, 2020, and found several differences in hospital preparedness for SARS-CoV-2 with respect to personal protective equipment conservation strategies, protocols related to testing, universal masking and restarting elective procedures.\"}',1,'2024-06-03 21:51:25','2024-06-03 21:51:25','5d5e8f8e-0ce8-4603-a2f5-deb29b9d71fe'),(19965,19965,1,NULL,'assessing-sars-cov-2-preparedness-in-us-community-hospitals-a-forgotten-entity',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"This cross-sectional survey of infection preventionists in 60 US community hospitals was conducted between April 22 and May 8, 2020, and found several differences in hospital preparedness for SARS-CoV-2 with respect to personal protective equipment conservation strategies, protocols related to testing, universal masking and restarting elective procedures.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Assessing SARS-CoV-2 Preparedness in US Community Hospitals: A Forgotten Entity\"}',1,'2024-06-03 21:51:25','2024-06-03 21:51:25','262846fc-da55-421c-b252-a984419b0065'),(19966,19966,1,'Prevention Course in Healthcare Associated Infections (HAI) Knowledge and Control Now Available','prevention-course-in-healthcare-associated-infections-hai-knowledge-and-control-now-available','news/prevention-course-in-healthcare-associated-infections-hai-knowledge-and-control-now-available','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"Prevention CHKC is designed to train frontline healthcare personnel, defined as those “responsible for direct patient care” in best practices to prevent and control HAIs and pathogens that can spread in the healthcare setting. The course is free through December 31 with the use of the discount code - COVID19.\"}',1,'2024-06-03 21:51:25','2024-06-03 21:51:25','ce3209ce-4504-4eff-8544-5b925658826a'),(19967,19967,1,NULL,'prevention-course-in-healthcare-associated-infections-hai-knowledge-and-control-now-available',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"Prevention CHKC is designed to train frontline healthcare personnel, defined as those “responsible for direct patient care” in best practices to prevent and control HAIs and pathogens that can spread in the healthcare setting. The course is free through December 31 with the use of the discount code - COVID19.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Prevention Course in Healthcare Associated Infections (HAI) Knowledge and Control Now Available\"}',1,'2024-06-03 21:51:25','2024-06-03 21:51:25','437af9f3-f9c1-4400-9547-f0567c02b2f0'),(19968,19968,1,'Prevention Course in Healthcare Associated Infections (HAI) Knowledge and Control Now Available','prevention-course-in-healthcare-associated-infections-hai-knowledge-and-control-now-available','news/prevention-course-in-healthcare-associated-infections-hai-knowledge-and-control-now-available','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"Prevention CHKC is designed to train frontline healthcare personnel, defined as those “responsible for direct patient care” in best practices to prevent and control HAIs and pathogens that can spread in the healthcare setting. The course is free through December 31 with the use of the discount code - COVID19.\"}',1,'2024-06-03 21:51:25','2024-06-03 21:51:25','6ffe0282-a376-48e9-a204-20042f2bffe8'),(19969,19969,1,NULL,'prevention-course-in-healthcare-associated-infections-hai-knowledge-and-control-now-available',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"Prevention CHKC is designed to train frontline healthcare personnel, defined as those “responsible for direct patient care” in best practices to prevent and control HAIs and pathogens that can spread in the healthcare setting. The course is free through December 31 with the use of the discount code - COVID19.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Prevention Course in Healthcare Associated Infections (HAI) Knowledge and Control Now Available\"}',1,'2024-06-03 21:51:25','2024-06-03 21:51:25','4d6ed8e5-385c-4cf6-b211-b993709f6a59'),(19970,19970,1,'Point of Care Laboratory Reporting Pathway within the NHSN Long-Term Care COVID-19 Module Now Available','point-of-care-laboratory-reporting-pathway-within-the-nhsn-long-term-care-covid-19-module-now-available','news/point-of-care-laboratory-reporting-pathway-within-the-nhsn-long-term-care-covid-19-module-now-available','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"CDC’s NHSN provides healthcare facilities, such as long-term care facilities (LTCFs), with a customized system to track infections and prevention process measures in a systematic way.\"}',1,'2024-06-03 21:51:25','2024-06-03 21:51:25','14172f50-f25b-4fed-91ff-a402ccd63fdd'),(19971,19971,1,NULL,'point-of-care-laboratory-reporting-pathway-within-the-nhsn-long-term-care-covid-19-module-now-available',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"CDC’s NHSN provides healthcare facilities, such as long-term care facilities (LTCFs), with a customized system to track infections and prevention process measures in a systematic way.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Point of Care Laboratory Reporting Pathway within the NHSN Long-Term Care COVID-19 Module Now Available\"}',1,'2024-06-03 21:51:25','2024-06-03 21:51:25','4e533d22-3a64-48ea-bcc3-3a643d9fab56'),(19972,19972,1,'Point of Care Laboratory Reporting Pathway within the NHSN Long-Term Care COVID-19 Module Now Available','point-of-care-laboratory-reporting-pathway-within-the-nhsn-long-term-care-covid-19-module-now-available','news/point-of-care-laboratory-reporting-pathway-within-the-nhsn-long-term-care-covid-19-module-now-available','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"CDC’s NHSN provides healthcare facilities, such as long-term care facilities (LTCFs), with a customized system to track infections and prevention process measures in a systematic way.\"}',1,'2024-06-03 21:51:25','2024-06-03 21:51:25','76b5bd25-f142-47d4-9ca2-4a55380ebbe1'),(19973,19973,1,NULL,'point-of-care-laboratory-reporting-pathway-within-the-nhsn-long-term-care-covid-19-module-now-available',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"CDC’s NHSN provides healthcare facilities, such as long-term care facilities (LTCFs), with a customized system to track infections and prevention process measures in a systematic way.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Point of Care Laboratory Reporting Pathway within the NHSN Long-Term Care COVID-19 Module Now Available\"}',1,'2024-06-03 21:51:25','2024-06-03 21:51:25','fc6b43a1-a0ef-4d44-81c7-95c539b5d229'),(19974,19974,1,'Asymptomatic and Presymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 Infection Rates in a Multistate Sample of Skilled Nursing Facilities','asymptomatic-and-presymptomatic-severe-acute-respiratory-syndrome-coronavirus-2-infection-rates-in-a-multistate-sample-of-skilled-nursing-facilities','news/asymptomatic-and-presymptomatic-severe-acute-respiratory-syndrome-coronavirus-2-infection-rates-in-a-multistate-sample-of-skilled-nursing-facilities','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"Asymptomatic transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may be a major contributing factor in skilled nursing facility (SNF) outbreaks. However, limited knowledge exists regarding the prevalence of asymptomatic and presymptomatic infection in this setting. Although an estimated 40% to 45% of SARS-CoV-2 infections in the general population are asymptomatic at time of testing, a small number of US and international reports have documented higher asymptomatic rates in SNFs. Researchers examined asymptomatic and presymptomatic infection rates in a large multistate sample of US SNFs, and examined variation in case counts by SARS-CoV-2 prevalence in the counties where SNFs are located.\"}',1,'2024-06-03 21:51:26','2024-06-03 21:51:26','558a7962-dc58-44a1-b42e-6cfb96b9057e'),(19975,19975,1,NULL,'asymptomatic-and-presymptomatic-severe-acute-respiratory-syndrome-coronavirus-2-infection-rates-in-a-multistate-sample-of-skilled-nursing-facilities',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"Asymptomatic transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may be a major contributing factor in skilled nursing facility (SNF) outbreaks. However, limited knowledge exists regarding the prevalence of asymptomatic and presymptomatic infection in this setting. Although an estimated 40% to 45% of SARS-CoV-2 infections in the general population are asymptomatic at time of testing, a small number of US and international reports have documented higher asymptomatic rates in SNFs. Researchers examined asymptomatic and presymptomatic infection rates in a large multistate sample of US SNFs, and examined variation in case counts by SARS-CoV-2 prevalence in the counties where SNFs are located.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Asymptomatic and Presymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 Infection Rates in a Multistate Sample of Skilled Nursing Facilities\"}',1,'2024-06-03 21:51:26','2024-06-03 21:51:26','3ee85933-dd0d-496b-a8c6-474d66c2689b'),(19976,19976,1,'Asymptomatic and Presymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 Infection Rates in a Multistate Sample of Skilled Nursing Facilities','asymptomatic-and-presymptomatic-severe-acute-respiratory-syndrome-coronavirus-2-infection-rates-in-a-multistate-sample-of-skilled-nursing-facilities','news/asymptomatic-and-presymptomatic-severe-acute-respiratory-syndrome-coronavirus-2-infection-rates-in-a-multistate-sample-of-skilled-nursing-facilities','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"Asymptomatic transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may be a major contributing factor in skilled nursing facility (SNF) outbreaks. However, limited knowledge exists regarding the prevalence of asymptomatic and presymptomatic infection in this setting. Although an estimated 40% to 45% of SARS-CoV-2 infections in the general population are asymptomatic at time of testing, a small number of US and international reports have documented higher asymptomatic rates in SNFs. Researchers examined asymptomatic and presymptomatic infection rates in a large multistate sample of US SNFs, and examined variation in case counts by SARS-CoV-2 prevalence in the counties where SNFs are located.\"}',1,'2024-06-03 21:51:26','2024-06-03 21:51:26','5e7af942-e566-4c73-b663-78eaed4c1c8d'),(19977,19977,1,NULL,'asymptomatic-and-presymptomatic-severe-acute-respiratory-syndrome-coronavirus-2-infection-rates-in-a-multistate-sample-of-skilled-nursing-facilities',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"Asymptomatic transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may be a major contributing factor in skilled nursing facility (SNF) outbreaks. However, limited knowledge exists regarding the prevalence of asymptomatic and presymptomatic infection in this setting. Although an estimated 40% to 45% of SARS-CoV-2 infections in the general population are asymptomatic at time of testing, a small number of US and international reports have documented higher asymptomatic rates in SNFs. Researchers examined asymptomatic and presymptomatic infection rates in a large multistate sample of US SNFs, and examined variation in case counts by SARS-CoV-2 prevalence in the counties where SNFs are located.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Asymptomatic and Presymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 Infection Rates in a Multistate Sample of Skilled Nursing Facilities\"}',1,'2024-06-03 21:51:26','2024-06-03 21:51:26','3613d02b-2647-44dd-98df-58c2af5fc3ae'),(19978,19978,1,'Congratulations to Dr. Maureen Tierney on Receiving the McKnight Prize for Healthcare Outbreak Heroes','congratulations-to-dr-maureen-tierney-on-receiving-the-mcknight-prize-for-healthcare-outbreak-heroes','news/congratulations-to-dr-maureen-tierney-on-receiving-the-mcknight-prize-for-healthcare-outbreak-heroes','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"The McKnight Prize for Healthcare Outbreak Heroes, given by the CDC Foundation, in partnership with the Evelyn and Thomas McKnight Family Fund for Patient Safety and Creighton University, honors and recognizes people who are doing important work to promote safe injection practices or patient safety.\"}',1,'2024-06-03 21:51:26','2024-06-03 21:51:26','f3c60946-6daa-4c64-8d92-128497ff0d4f'),(19979,19979,1,NULL,'congratulations-to-dr-maureen-tierney-on-receiving-the-mcknight-prize-for-healthcare-outbreak-heroes',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"The McKnight Prize for Healthcare Outbreak Heroes, given by the CDC Foundation, in partnership with the Evelyn and Thomas McKnight Family Fund for Patient Safety and Creighton University, honors and recognizes people who are doing important work to promote safe injection practices or patient safety.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Congratulations to Dr. Maureen Tierney on Receiving the McKnight Prize for Healthcare Outbreak Heroes\"}',1,'2024-06-03 21:51:26','2024-06-03 21:51:26','3c9aae85-fedc-417f-be94-1014b5e7334c'),(19980,19980,1,'Congratulations to Dr. Maureen Tierney on Receiving the McKnight Prize for Healthcare Outbreak Heroes','congratulations-to-dr-maureen-tierney-on-receiving-the-mcknight-prize-for-healthcare-outbreak-heroes','news/congratulations-to-dr-maureen-tierney-on-receiving-the-mcknight-prize-for-healthcare-outbreak-heroes','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"The McKnight Prize for Healthcare Outbreak Heroes, given by the CDC Foundation, in partnership with the Evelyn and Thomas McKnight Family Fund for Patient Safety and Creighton University, honors and recognizes people who are doing important work to promote safe injection practices or patient safety.\"}',1,'2024-06-03 21:51:26','2024-06-03 21:51:26','c545cc4c-bc85-424e-86a2-fda92e53ab0f'),(19981,19981,1,NULL,'congratulations-to-dr-maureen-tierney-on-receiving-the-mcknight-prize-for-healthcare-outbreak-heroes',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"The McKnight Prize for Healthcare Outbreak Heroes, given by the CDC Foundation, in partnership with the Evelyn and Thomas McKnight Family Fund for Patient Safety and Creighton University, honors and recognizes people who are doing important work to promote safe injection practices or patient safety.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Congratulations to Dr. Maureen Tierney on Receiving the McKnight Prize for Healthcare Outbreak Heroes\"}',1,'2024-06-03 21:51:26','2024-06-03 21:51:26','ff290a67-269c-4ceb-8d73-24798346516f'),(19982,19982,1,'MMWR on Multiple COVID-19 Outbreaks Linked to a Wedding Reception in Rural Maine — August 7–September 14, 2020','multiple-covid-19-outbreaks-linked-to-a-wedding-reception-in-rural-maine-august-7-september-14-2020','news/multiple-covid-19-outbreaks-linked-to-a-wedding-reception-in-rural-maine-august-7-september-14-2020','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"An MMWR report on multiple COVID-19 outbreaks linked to a wedding reception in a rural Maine town that led to COVID-19 outbreaks in the local community, as well as at a long-term care facility, and a correctional facility in other counties.\"}',1,'2024-06-03 21:51:26','2024-06-03 21:51:26','5d080240-547a-46cf-af99-bbdc7322b7b4'),(19983,19983,1,NULL,'multiple-covid-19-outbreaks-linked-to-a-wedding-reception-in-rural-maine-august-7-september-14-2020',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"An MMWR report on multiple COVID-19 outbreaks linked to a wedding reception in a rural Maine town that led to COVID-19 outbreaks in the local community, as well as at a long-term care facility, and a correctional facility in other counties.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"MMWR on Multiple COVID-19 Outbreaks Linked to a Wedding Reception in Rural Maine — August 7–September 14, 2020\"}',1,'2024-06-03 21:51:26','2024-06-03 21:51:26','23c86d7d-6850-4574-b2c3-809722d1b696'),(19984,19984,1,'MMWR on Multiple COVID-19 Outbreaks Linked to a Wedding Reception in Rural Maine — August 7–September 14, 2020','multiple-covid-19-outbreaks-linked-to-a-wedding-reception-in-rural-maine-august-7-september-14-2020','news/multiple-covid-19-outbreaks-linked-to-a-wedding-reception-in-rural-maine-august-7-september-14-2020','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"An MMWR report on multiple COVID-19 outbreaks linked to a wedding reception in a rural Maine town that led to COVID-19 outbreaks in the local community, as well as at a long-term care facility, and a correctional facility in other counties.\"}',1,'2024-06-03 21:51:26','2024-06-03 21:51:26','df86d916-eacf-4418-97a1-0584c4c7d1b1'),(19985,19985,1,NULL,'multiple-covid-19-outbreaks-linked-to-a-wedding-reception-in-rural-maine-august-7-september-14-2020',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"An MMWR report on multiple COVID-19 outbreaks linked to a wedding reception in a rural Maine town that led to COVID-19 outbreaks in the local community, as well as at a long-term care facility, and a correctional facility in other counties.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"MMWR on Multiple COVID-19 Outbreaks Linked to a Wedding Reception in Rural Maine — August 7–September 14, 2020\"}',1,'2024-06-03 21:51:26','2024-06-03 21:51:26','7533ad4b-4c89-4c78-a89a-8ac8ac49fc4b'),(19986,19986,1,'Register for Upcoming Webinar on Nov. 19: Responding to Difficult-to-treat Infections: Role and Responsibilities of Governments, Researchers, Industry, and Patients','responding-to-difficult-to-treat-infections-role-and-responsibilities-of-governments-researchers-industry-and-patients-webinar-final-webinar-in-amr-in-the-light-of-covid-19-webinar-series','news/responding-to-difficult-to-treat-infections-role-and-responsibilities-of-governments-researchers-industry-and-patients-webinar-final-webinar-in-amr-in-the-light-of-covid-19-webinar-series','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"Join the CDC on Thursday, November 19, 2020 at 9 a.m. EST for the final webinar in the AMR in the Light of COVID-19 four-part series. Speakers from CDC, GSK, and others dive into roles and responsibilities around difficult-to-treat infections and discuss what changes are needed to reshape strategies for combatting antimicrobial resistance globally.\"}',1,'2024-06-03 21:51:26','2024-06-03 21:51:26','19481f6b-ee66-4b2e-9ae5-024541da5bbf'),(19987,19987,1,NULL,'responding-to-difficult-to-treat-infections-role-and-responsibilities-of-governments-researchers-industry-and-patients-webinar-final-webinar-in-amr-in-the-light-of-covid-19-webinar-series',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"Join the CDC on Thursday, November 19, 2020 at 9 a.m. EST for the final webinar in the AMR in the Light of COVID-19 four-part series. Speakers from CDC, GSK, and others dive into roles and responsibilities around difficult-to-treat infections and discuss what changes are needed to reshape strategies for combatting antimicrobial resistance globally.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Register for Upcoming Webinar on Nov. 19: Responding to Difficult-to-treat Infections: Role and Responsibilities of Governments, Researchers, Industry, and Patients\"}',1,'2024-06-03 21:51:26','2024-06-03 21:51:26','c5ed0fd4-ec56-4e80-a1c3-b2357b7c46ae'),(19988,19988,1,'Register for Upcoming Webinar on Nov. 19: Responding to Difficult-to-treat Infections: Role and Responsibilities of Governments, Researchers, Industry, and Patients','responding-to-difficult-to-treat-infections-role-and-responsibilities-of-governments-researchers-industry-and-patients-webinar-final-webinar-in-amr-in-the-light-of-covid-19-webinar-series','news/responding-to-difficult-to-treat-infections-role-and-responsibilities-of-governments-researchers-industry-and-patients-webinar-final-webinar-in-amr-in-the-light-of-covid-19-webinar-series','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"Join the CDC on Thursday, November 19, 2020 at 9 a.m. EST for the final webinar in the AMR in the Light of COVID-19 four-part series. Speakers from CDC, GSK, and others dive into roles and responsibilities around difficult-to-treat infections and discuss what changes are needed to reshape strategies for combatting antimicrobial resistance globally.\"}',1,'2024-06-03 21:51:26','2024-06-03 21:51:26','58b9e91e-1062-4a5a-90db-72a171505d49'),(19989,19989,1,NULL,'responding-to-difficult-to-treat-infections-role-and-responsibilities-of-governments-researchers-industry-and-patients-webinar-final-webinar-in-amr-in-the-light-of-covid-19-webinar-series',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"Join the CDC on Thursday, November 19, 2020 at 9 a.m. EST for the final webinar in the AMR in the Light of COVID-19 four-part series. Speakers from CDC, GSK, and others dive into roles and responsibilities around difficult-to-treat infections and discuss what changes are needed to reshape strategies for combatting antimicrobial resistance globally.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Register for Upcoming Webinar on Nov. 19: Responding to Difficult-to-treat Infections: Role and Responsibilities of Governments, Researchers, Industry, and Patients\"}',1,'2024-06-03 21:51:26','2024-06-03 21:51:26','258b8d8b-6fb0-44a5-aae9-040b8948326c'),(19990,19990,1,'New CORHA Resource: Proposed Investigation/Reporting Thresholds and Outbreak Definitions for COVID-19 in Healthcare Settings','new-corha-resource-proposed-investigation-reporting-thresholds-and-outbreak-definitions-for-covid-19-in-healthcare-settings','news/new-corha-resource-proposed-investigation-reporting-thresholds-and-outbreak-definitions-for-covid-19-in-healthcare-settings','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\"}',1,'2024-06-03 21:51:26','2024-06-03 21:51:26','4d2f3c32-2ef8-47f6-83d7-2eb50c7adcc6'),(19991,19991,1,NULL,'new-corha-resource-proposed-investigation-reporting-thresholds-and-outbreak-definitions-for-covid-19-in-healthcare-settings',NULL,'{\"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"New CORHA Resource: Proposed Investigation/Reporting Thresholds and Outbreak Definitions for COVID-19 in Healthcare Settings\"}',1,'2024-06-03 21:51:26','2024-06-03 21:51:26','1d85cf0c-3326-413e-8294-b27bcdb4f2d2'),(19992,19992,1,'New CORHA Resource: Proposed Investigation/Reporting Thresholds and Outbreak Definitions for COVID-19 in Healthcare Settings','new-corha-resource-proposed-investigation-reporting-thresholds-and-outbreak-definitions-for-covid-19-in-healthcare-settings','news/new-corha-resource-proposed-investigation-reporting-thresholds-and-outbreak-definitions-for-covid-19-in-healthcare-settings','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\"}',1,'2024-06-03 21:51:27','2024-06-03 21:51:27','0fa8786c-adde-4cf2-8954-7cc1f307fc7b'),(19993,19993,1,NULL,'new-corha-resource-proposed-investigation-reporting-thresholds-and-outbreak-definitions-for-covid-19-in-healthcare-settings',NULL,'{\"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"New CORHA Resource: Proposed Investigation/Reporting Thresholds and Outbreak Definitions for COVID-19 in Healthcare Settings\"}',1,'2024-06-03 21:51:27','2024-06-03 21:51:27','f14eff46-2a5e-45b4-b8d0-80e395a9eed9'),(19994,19994,1,'Register for AHA LLN Micro-Learning Session on Dec. 10: Infection Prevention and Control Protocols in the Emergency Department','register-for-aha-lln-micro-learning-session-on-dec-10-infection-prevention-and-control-protocols-in-the-emergency-department','news/register-for-aha-lln-micro-learning-session-on-dec-10-infection-prevention-and-control-protocols-in-the-emergency-department','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"During this micro-learning session on December 10, 2020 from 2-3:00 p.m. ET, AHA, the Centers for Disease Control and Prevention (CDC) and the American College of Emergency Physicians (ACEP) will share the most up-to-date CDC IPC guidance and ACEP resources. Additionally, there will be an opportunity for ED staff participants to discuss their challenges with, and creative solutions for, implementing and maintaining IPC protocols during COVID-19.\"}',1,'2024-06-03 21:51:27','2024-06-03 21:51:27','13b3428b-ce4a-4cdd-95f7-ea218c420ed4'),(19995,19995,1,NULL,'register-for-aha-lln-micro-learning-session-on-dec-10-infection-prevention-and-control-protocols-in-the-emergency-department',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"During this micro-learning session on December 10, 2020 from 2-3:00 p.m. ET, AHA, the Centers for Disease Control and Prevention (CDC) and the American College of Emergency Physicians (ACEP) will share the most up-to-date CDC IPC guidance and ACEP resources. Additionally, there will be an opportunity for ED staff participants to discuss their challenges with, and creative solutions for, implementing and maintaining IPC protocols during COVID-19.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Register for AHA LLN Micro-Learning Session on Dec. 10: Infection Prevention and Control Protocols in the Emergency Department\"}',1,'2024-06-03 21:51:27','2024-06-03 21:51:27','3c48538b-9d7b-4269-8b2e-a6a333a38a99'),(19996,19996,1,'Register for AHA LLN Micro-Learning Session on Dec. 10: Infection Prevention and Control Protocols in the Emergency Department','register-for-aha-lln-micro-learning-session-on-dec-10-infection-prevention-and-control-protocols-in-the-emergency-department','news/register-for-aha-lln-micro-learning-session-on-dec-10-infection-prevention-and-control-protocols-in-the-emergency-department','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"During this micro-learning session on December 10, 2020 from 2-3:00 p.m. ET, AHA, the Centers for Disease Control and Prevention (CDC) and the American College of Emergency Physicians (ACEP) will share the most up-to-date CDC IPC guidance and ACEP resources. Additionally, there will be an opportunity for ED staff participants to discuss their challenges with, and creative solutions for, implementing and maintaining IPC protocols during COVID-19.\"}',1,'2024-06-03 21:51:27','2024-06-03 21:51:27','b20d6d9a-d47a-4a02-83a6-0b9ffe8e1c8f'),(19997,19997,1,NULL,'register-for-aha-lln-micro-learning-session-on-dec-10-infection-prevention-and-control-protocols-in-the-emergency-department',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"During this micro-learning session on December 10, 2020 from 2-3:00 p.m. ET, AHA, the Centers for Disease Control and Prevention (CDC) and the American College of Emergency Physicians (ACEP) will share the most up-to-date CDC IPC guidance and ACEP resources. Additionally, there will be an opportunity for ED staff participants to discuss their challenges with, and creative solutions for, implementing and maintaining IPC protocols during COVID-19.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Register for AHA LLN Micro-Learning Session on Dec. 10: Infection Prevention and Control Protocols in the Emergency Department\"}',1,'2024-06-03 21:51:27','2024-06-03 21:51:27','3179bcbc-82a9-4dd2-a40f-c4ad22981cb0'),(19998,19998,1,'Moderna\'s COVID-19 Vaccine Webinar Recording','modernas-covid-19-vaccine-webinar-recording','news/modernas-covid-19-vaccine-webinar-recording','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\"}',1,'2024-06-03 21:51:27','2024-06-03 21:51:27','4cb5c4c6-f042-473c-b4ad-411e58b9f4e8'),(19999,19999,1,NULL,'modernas-covid-19-vaccine-webinar-recording',NULL,'{\"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Moderna\'s COVID-19 Vaccine Webinar Recording\"}',1,'2024-06-03 21:51:27','2024-06-03 21:51:27','67fe7747-e864-42f8-b9d9-30825f7ac1d4'),(20000,20000,1,'Moderna\'s COVID-19 Vaccine Webinar Recording','modernas-covid-19-vaccine-webinar-recording','news/modernas-covid-19-vaccine-webinar-recording','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\"}',1,'2024-06-03 21:51:27','2024-06-03 21:51:27','0763f29a-37ed-48bd-b52f-3a34501cd52a'),(20001,20001,1,NULL,'modernas-covid-19-vaccine-webinar-recording',NULL,'{\"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Moderna\'s COVID-19 Vaccine Webinar Recording\"}',1,'2024-06-03 21:51:27','2024-06-03 21:51:27','1b5eefbc-e0f2-43d5-af7e-02d94597d554'),(20002,20002,1,'MMWR on Increase in Hospital-Acquired Carbapenem-Resistant Acinetobacter baumannii Infection and Colonization in an Acute Care Hospital During a Surge in COVID-19 Admissions — New Jersey, February–July 2020','mmwr-on-increase-in-hospital-acquired-carbapenem-resistant-acinetobacter-baumannii-infection-and-colonization-in-an-acute-care-hospital-during-a-surge-in-covid-19-admissions-new-jersey-febr','news/mmwr-on-increase-in-hospital-acquired-carbapenem-resistant-acinetobacter-baumannii-infection-and-colonization-in-an-acute-care-hospital-during-a-surge-in-covid-19-admissions-new-jersey-febr','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\"}',1,'2024-06-03 21:51:27','2024-06-03 21:51:27','5ea2ee07-a73f-4f82-86a6-e3c4340ac0c2'),(20003,20003,1,NULL,'mmwr-on-increase-in-hospital-acquired-carbapenem-resistant-acinetobacter-baumannii-infection-and-colonization-in-an-acute-care-hospital-during-a-surge-in-covid-19-admissions-new-jersey-febr',NULL,'{\"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"MMWR on Increase in Hospital-Acquired Carbapenem-Resistant Acinetobacter baumannii Infection and Colonization in an Acute Care Hospital During a Surge in COVID-19 Admissions — New Jersey, February–July 2020\"}',1,'2024-06-03 21:51:27','2024-06-03 21:51:27','a83d94b8-49cd-4b91-9f89-5a51c03f3132'),(20004,20004,1,'MMWR on Increase in Hospital-Acquired Carbapenem-Resistant Acinetobacter baumannii Infection and Colonization in an Acute Care Hospital During a Surge in COVID-19 Admissions — New Jersey, February–July 2020','mmwr-on-increase-in-hospital-acquired-carbapenem-resistant-acinetobacter-baumannii-infection-and-colonization-in-an-acute-care-hospital-during-a-surge-in-covid-19-admissions-new-jersey-febr','news/mmwr-on-increase-in-hospital-acquired-carbapenem-resistant-acinetobacter-baumannii-infection-and-colonization-in-an-acute-care-hospital-during-a-surge-in-covid-19-admissions-new-jersey-febr','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\"}',1,'2024-06-03 21:51:27','2024-06-03 21:51:27','03c923a7-7a9e-44d7-af77-533534959503'),(20005,20005,1,NULL,'mmwr-on-increase-in-hospital-acquired-carbapenem-resistant-acinetobacter-baumannii-infection-and-colonization-in-an-acute-care-hospital-during-a-surge-in-covid-19-admissions-new-jersey-febr',NULL,'{\"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"MMWR on Increase in Hospital-Acquired Carbapenem-Resistant Acinetobacter baumannii Infection and Colonization in an Acute Care Hospital During a Surge in COVID-19 Admissions — New Jersey, February–July 2020\"}',1,'2024-06-03 21:51:27','2024-06-03 21:51:27','11eab0e5-07ab-4b53-ad4f-da105e081ef8'),(20006,20006,1,'MMWR on Disproportionate Incidence of COVID-19 Infection, Hospitalizations, and Deaths Among Persons Identifying as Hispanic or Latino — Denver, Colorado March–October 2020','mmwr-on-disproportionate-incidence-of-covid-19-infection-hospitalizations-and-deaths-among-persons-identifying-as-hispanic-or-latino-denver-colorado-march-october-2020','news/mmwr-on-disproportionate-incidence-of-covid-19-infection-hospitalizations-and-deaths-among-persons-identifying-as-hispanic-or-latino-denver-colorado-march-october-2020','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\"}',1,'2024-06-03 21:51:27','2024-06-03 21:51:27','29f8ef21-dbbd-4524-a292-751d05a1b1e2'),(20007,20007,1,NULL,'mmwr-on-disproportionate-incidence-of-covid-19-infection-hospitalizations-and-deaths-among-persons-identifying-as-hispanic-or-latino-denver-colorado-march-october-2020',NULL,'{\"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"MMWR on Disproportionate Incidence of COVID-19 Infection, Hospitalizations, and Deaths Among Persons Identifying as Hispanic or Latino — Denver, Colorado March–October 2020\"}',1,'2024-06-03 21:51:27','2024-06-03 21:51:27','7729f510-c63f-464c-9219-1ccf92d3fefe'),(20008,20008,1,'MMWR on Disproportionate Incidence of COVID-19 Infection, Hospitalizations, and Deaths Among Persons Identifying as Hispanic or Latino — Denver, Colorado March–October 2020','mmwr-on-disproportionate-incidence-of-covid-19-infection-hospitalizations-and-deaths-among-persons-identifying-as-hispanic-or-latino-denver-colorado-march-october-2020','news/mmwr-on-disproportionate-incidence-of-covid-19-infection-hospitalizations-and-deaths-among-persons-identifying-as-hispanic-or-latino-denver-colorado-march-october-2020','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\"}',1,'2024-06-03 21:51:27','2024-06-03 21:51:27','aab8f231-b5c2-43dc-af98-b3095f2618cd'),(20009,20009,1,NULL,'mmwr-on-disproportionate-incidence-of-covid-19-infection-hospitalizations-and-deaths-among-persons-identifying-as-hispanic-or-latino-denver-colorado-march-october-2020',NULL,'{\"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"MMWR on Disproportionate Incidence of COVID-19 Infection, Hospitalizations, and Deaths Among Persons Identifying as Hispanic or Latino — Denver, Colorado March–October 2020\"}',1,'2024-06-03 21:51:27','2024-06-03 21:51:27','5ba81336-9cd4-4ef3-bb1a-23465a93d55d'),(20010,20010,1,'Digital Resources on The Difference Between eCR and Traditional Case Reporting','digital-resources-on-the-difference-between-ecr-and-traditional-case-reporting','news/digital-resources-on-the-difference-between-ecr-and-traditional-case-reporting','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"The CDC\'s electronic case reporting (eCR) team offers a video, fact sheets, and other resources for learning about eCR and communicating its importance to healthcare organizations and public health agencies.\"}',1,'2024-06-03 21:51:27','2024-06-03 21:51:27','a3c248bf-6f3d-4e95-b805-3e2855d5e84b'),(20011,20011,1,NULL,'digital-resources-on-the-difference-between-ecr-and-traditional-case-reporting',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"The CDC\'s electronic case reporting (eCR) team offers a video, fact sheets, and other resources for learning about eCR and communicating its importance to healthcare organizations and public health agencies.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Digital Resources on The Difference Between eCR and Traditional Case Reporting\"}',1,'2024-06-03 21:51:27','2024-06-03 21:51:27','ae6f17ac-3c50-4836-919d-e9c84419eb5a'),(20012,20012,1,'Digital Resources on The Difference Between eCR and Traditional Case Reporting','digital-resources-on-the-difference-between-ecr-and-traditional-case-reporting','news/digital-resources-on-the-difference-between-ecr-and-traditional-case-reporting','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"The CDC\'s electronic case reporting (eCR) team offers a video, fact sheets, and other resources for learning about eCR and communicating its importance to healthcare organizations and public health agencies.\"}',1,'2024-06-03 21:51:28','2024-06-03 21:51:28','0fff2b75-a0ff-41ef-b813-d0a19af165f3'),(20013,20013,1,NULL,'digital-resources-on-the-difference-between-ecr-and-traditional-case-reporting',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"The CDC\'s electronic case reporting (eCR) team offers a video, fact sheets, and other resources for learning about eCR and communicating its importance to healthcare organizations and public health agencies.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Digital Resources on The Difference Between eCR and Traditional Case Reporting\"}',1,'2024-06-03 21:51:28','2024-06-03 21:51:28','bd7d9d1d-36a7-4f7d-bddd-01b099809ed5'),(20014,20014,1,'Factors That Shape Notification Of Health Care Outbreaks Of COVID-19','factors-that-shape-notification-of-health-care-outbreaks-of-covid-19','news/factors-that-shape-notification-of-health-care-outbreaks-of-covid-19','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\"}',1,'2024-06-03 21:51:28','2024-06-03 21:51:28','bbc47fb3-a05b-4f0d-81c5-37b622f392ab'),(20015,20015,1,NULL,'factors-that-shape-notification-of-health-care-outbreaks-of-covid-19',NULL,'{\"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Factors That Shape Notification Of Health Care Outbreaks Of COVID-19\"}',1,'2024-06-03 21:51:28','2024-06-03 21:51:28','d5a39ae7-9b94-4a61-b6fe-7d3a287ae0e4'),(20016,20016,1,'Factors That Shape Notification Of Health Care Outbreaks Of COVID-19','factors-that-shape-notification-of-health-care-outbreaks-of-covid-19','news/factors-that-shape-notification-of-health-care-outbreaks-of-covid-19','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\"}',1,'2024-06-03 21:51:28','2024-06-03 21:51:28','24e6596f-b413-44f0-8640-ced4340fab60'),(20017,20017,1,NULL,'factors-that-shape-notification-of-health-care-outbreaks-of-covid-19',NULL,'{\"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Factors That Shape Notification Of Health Care Outbreaks Of COVID-19\"}',1,'2024-06-03 21:51:28','2024-06-03 21:51:28','571d5c44-15e1-40b9-963f-b1b2d0620afd'),(20018,20018,1,'Predictors of Hospital-acquired Bacterial and Fungal Superinfections in COVID-19: a Prospective Observational Study','predictors-of-hospital-acquired-bacterial-and-fungal-superinfections-in-covid-19-a-prospective-observational-study','news/predictors-of-hospital-acquired-bacterial-and-fungal-superinfections-in-covid-19-a-prospective-observational-study','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\"}',1,'2024-06-03 21:51:28','2024-06-03 21:51:28','254f889f-8b6b-419a-8933-c17dece317bb'),(20019,20019,1,NULL,'predictors-of-hospital-acquired-bacterial-and-fungal-superinfections-in-covid-19-a-prospective-observational-study',NULL,'{\"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Predictors of Hospital-acquired Bacterial and Fungal Superinfections in COVID-19: a Prospective Observational Study\"}',1,'2024-06-03 21:51:28','2024-06-03 21:51:28','cd4ad121-65f0-449f-850c-c8462d433d73'),(20020,20020,1,'Predictors of Hospital-acquired Bacterial and Fungal Superinfections in COVID-19: a Prospective Observational Study','predictors-of-hospital-acquired-bacterial-and-fungal-superinfections-in-covid-19-a-prospective-observational-study','news/predictors-of-hospital-acquired-bacterial-and-fungal-superinfections-in-covid-19-a-prospective-observational-study','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\"}',1,'2024-06-03 21:51:28','2024-06-03 21:51:28','8a3683c6-8bf0-4f1d-bdba-b001556aebc5'),(20021,20021,1,NULL,'predictors-of-hospital-acquired-bacterial-and-fungal-superinfections-in-covid-19-a-prospective-observational-study',NULL,'{\"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Predictors of Hospital-acquired Bacterial and Fungal Superinfections in COVID-19: a Prospective Observational Study\"}',1,'2024-06-03 21:51:28','2024-06-03 21:51:28','490369cd-f6db-4b4e-838b-d325ffa659ad'),(20022,20022,1,'Post Vaccine Considerations for Healthcare Personnel','post-vaccine-considerations-for-healthcare-personnel','news/post-vaccine-considerations-for-healthcare-personnel','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"CDC guidance for healthcare facilities to appropriately evaluate and manage post-vaccination signs and symptoms among healthcare personnel (HCP).\"}',1,'2024-06-03 21:51:28','2024-06-03 21:51:28','eb037ded-ff74-47b0-b21e-a7466c96e457'),(20023,20023,1,NULL,'post-vaccine-considerations-for-healthcare-personnel',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"CDC guidance for healthcare facilities to appropriately evaluate and manage post-vaccination signs and symptoms among healthcare personnel (HCP).\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Post Vaccine Considerations for Healthcare Personnel\"}',1,'2024-06-03 21:51:28','2024-06-03 21:51:28','09a5ff9f-5add-4db0-bbfc-ef262fb2ab93'),(20024,20024,1,'Post Vaccine Considerations for Healthcare Personnel','post-vaccine-considerations-for-healthcare-personnel','news/post-vaccine-considerations-for-healthcare-personnel','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"CDC guidance for healthcare facilities to appropriately evaluate and manage post-vaccination signs and symptoms among healthcare personnel (HCP).\"}',1,'2024-06-03 21:51:28','2024-06-03 21:51:28','9d795201-bff6-4a53-a340-2ebb0563f5b4'),(20025,20025,1,NULL,'post-vaccine-considerations-for-healthcare-personnel',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"CDC guidance for healthcare facilities to appropriately evaluate and manage post-vaccination signs and symptoms among healthcare personnel (HCP).\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Post Vaccine Considerations for Healthcare Personnel\"}',1,'2024-06-03 21:51:28','2024-06-03 21:51:28','830391a3-8485-487f-b6a9-5466464ce673'),(20026,20026,1,'Post Vaccine Considerations for Residents','post-vaccine-considerations-for-residents','news/post-vaccine-considerations-for-residents','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"CDC guidance for long-term care facilities on post-vaccine considerations for residents.\"}',1,'2024-06-03 21:51:28','2024-06-03 21:51:28','38259319-5db4-437c-a1d8-453b2dc065a4'),(20027,20027,1,NULL,'post-vaccine-considerations-for-residents',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"CDC guidance for long-term care facilities on post-vaccine considerations for residents.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Post Vaccine Considerations for Residents\"}',1,'2024-06-03 21:51:28','2024-06-03 21:51:28','0eb55690-26f5-495f-b305-c210d43896bf'),(20028,20028,1,'Post Vaccine Considerations for Residents','post-vaccine-considerations-for-residents','news/post-vaccine-considerations-for-residents','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"CDC guidance for long-term care facilities on post-vaccine considerations for residents.\"}',1,'2024-06-03 21:51:28','2024-06-03 21:51:28','446eeab2-3935-45c8-b0cb-076cd4269016'),(20029,20029,1,NULL,'post-vaccine-considerations-for-residents',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"CDC guidance for long-term care facilities on post-vaccine considerations for residents.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Post Vaccine Considerations for Residents\"}',1,'2024-06-03 21:51:28','2024-06-03 21:51:28','59db4a2b-4d39-426c-a27d-b48b5022a167'),(20030,20030,1,'Vaccination Toolkit for Long-term Care Facilities','vaccination-toolkit-for-long-term-care-facilities','news/vaccination-toolkit-for-long-term-care-facilities','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"This CDC toolkit provides long-term care facility (LTCF) administrators and clinical leadership with information and resources to help build vaccine confidence among healthcare personnel (HCP) and residents.\"}',1,'2024-06-03 21:51:28','2024-06-03 21:51:28','633532af-33fd-48a8-b3f2-addf42acda64'),(20031,20031,1,NULL,'vaccination-toolkit-for-long-term-care-facilities',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"This CDC toolkit provides long-term care facility (LTCF) administrators and clinical leadership with information and resources to help build vaccine confidence among healthcare personnel (HCP) and residents.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Vaccination Toolkit for Long-term Care Facilities\"}',1,'2024-06-03 21:51:28','2024-06-03 21:51:28','0b84941e-11a9-4968-89a9-cff9a4b50bff'),(20032,20032,1,'Vaccination Toolkit for Long-term Care Facilities','vaccination-toolkit-for-long-term-care-facilities','news/vaccination-toolkit-for-long-term-care-facilities','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"This CDC toolkit provides long-term care facility (LTCF) administrators and clinical leadership with information and resources to help build vaccine confidence among healthcare personnel (HCP) and residents.\"}',1,'2024-06-03 21:51:28','2024-06-03 21:51:28','76802953-9869-458a-9f2f-3e2ae4a54e90'),(20033,20033,1,NULL,'vaccination-toolkit-for-long-term-care-facilities',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"This CDC toolkit provides long-term care facility (LTCF) administrators and clinical leadership with information and resources to help build vaccine confidence among healthcare personnel (HCP) and residents.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Vaccination Toolkit for Long-term Care Facilities\"}',1,'2024-06-03 21:51:29','2024-06-03 21:51:29','4e70f332-058e-4120-91e3-f12fd27ae4d2'),(20034,20034,1,'Abbott BinaxNOWTM COVID-19 Ag Card Test Helpful Testing Tips','abbott-binaxnowtm-covid-cb-9c19-ag-card-test-helpful-testing-tips','news/abbott-binaxnowtm-covid-cb-9c19-ag-card-test-helpful-testing-tips','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"This document is a supplement to the manufacturer\'s instructions and is intended to provide helpful testing tips when using the Abbott BinaxNOW™ COVID-19 Ag Card test.\"}',1,'2024-06-03 21:51:29','2024-06-03 21:51:29','c61447c5-88fe-475b-9bd5-32153e64cd31'),(20035,20035,1,NULL,'abbott-binaxnowtm-covid-cb-9c19-ag-card-test-helpful-testing-tips',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"This document is a supplement to the manufacturer\'s instructions and is intended to provide helpful testing tips when using the Abbott BinaxNOW™ COVID-19 Ag Card test.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Abbott BinaxNOWTM COVID-19 Ag Card Test Helpful Testing Tips\"}',1,'2024-06-03 21:51:29','2024-06-03 21:51:29','f335ee3f-0395-47fd-a983-0edf81a56e67'),(20036,20036,1,'Abbott BinaxNOWTM COVID-19 Ag Card Test Helpful Testing Tips','abbott-binaxnowtm-covid-cb-9c19-ag-card-test-helpful-testing-tips','news/abbott-binaxnowtm-covid-cb-9c19-ag-card-test-helpful-testing-tips','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"This document is a supplement to the manufacturer\'s instructions and is intended to provide helpful testing tips when using the Abbott BinaxNOW™ COVID-19 Ag Card test.\"}',1,'2024-06-03 21:51:29','2024-06-03 21:51:29','a9f972ad-1039-49e8-8717-312971f89e54'),(20037,20037,1,NULL,'abbott-binaxnowtm-covid-cb-9c19-ag-card-test-helpful-testing-tips',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"This document is a supplement to the manufacturer\'s instructions and is intended to provide helpful testing tips when using the Abbott BinaxNOW™ COVID-19 Ag Card test.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Abbott BinaxNOWTM COVID-19 Ag Card Test Helpful Testing Tips\"}',1,'2024-06-03 21:51:29','2024-06-03 21:51:29','e349dba5-a808-4ba2-a277-321d539c1029'),(20038,20038,1,'Quidel® Sofia® SARS Antigen Fluorescent Immunoassay (FIA) And Quidel® Sofia2® Flu + SARS Antigen FIA Helpful Testing Tips','quidel-sofia-sars-antigen-fluorescent-immunoassay-fia-and-quidel-sofia2-flu-sars-antigen-fia-helpful-testing-tips','news/quidel-sofia-sars-antigen-fluorescent-immunoassay-fia-and-quidel-sofia2-flu-sars-antigen-fia-helpful-testing-tips','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"This document is a supplement to the manufacturer’s instructions and is intended to provide helpful testing tips when using the Quidel® Soa® Antigen Immunoassays.\"}',1,'2024-06-03 21:51:29','2024-06-03 21:51:29','628a5c17-8e9a-452e-84d3-51de34292bce'),(20039,20039,1,NULL,'quidel-sofia-sars-antigen-fluorescent-immunoassay-fia-and-quidel-sofia2-flu-sars-antigen-fia-helpful-testing-tips',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"This document is a supplement to the manufacturer’s instructions and is intended to provide helpful testing tips when using the Quidel® Soa® Antigen Immunoassays.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Quidel® Sofia® SARS Antigen Fluorescent Immunoassay (FIA) And Quidel® Sofia2® Flu + SARS Antigen FIA Helpful Testing Tips\"}',1,'2024-06-03 21:51:29','2024-06-03 21:51:29','3912c0e2-1188-4d6c-afcd-5bfa1e7d179e'),(20040,20040,1,'Quidel® Sofia® SARS Antigen Fluorescent Immunoassay (FIA) And Quidel® Sofia2® Flu + SARS Antigen FIA Helpful Testing Tips','quidel-sofia-sars-antigen-fluorescent-immunoassay-fia-and-quidel-sofia2-flu-sars-antigen-fia-helpful-testing-tips','news/quidel-sofia-sars-antigen-fluorescent-immunoassay-fia-and-quidel-sofia2-flu-sars-antigen-fia-helpful-testing-tips','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"This document is a supplement to the manufacturer’s instructions and is intended to provide helpful testing tips when using the Quidel® Soa® Antigen Immunoassays.\"}',1,'2024-06-03 21:51:29','2024-06-03 21:51:29','ec2fa07b-4430-49f3-88d2-1ef9cbb64ff1'),(20041,20041,1,NULL,'quidel-sofia-sars-antigen-fluorescent-immunoassay-fia-and-quidel-sofia2-flu-sars-antigen-fia-helpful-testing-tips',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"This document is a supplement to the manufacturer’s instructions and is intended to provide helpful testing tips when using the Quidel® Soa® Antigen Immunoassays.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Quidel® Sofia® SARS Antigen Fluorescent Immunoassay (FIA) And Quidel® Sofia2® Flu + SARS Antigen FIA Helpful Testing Tips\"}',1,'2024-06-03 21:51:29','2024-06-03 21:51:29','6875f238-4cf4-45cd-9e8b-bff6fc3f8b76'),(20042,20042,1,'BD VeritorTM Plus System for Rapid Detection Of SARS-CoV-2 Helpful Testing Tips','bd-veritortm-plus-system-for-rapid-detection-of-sars-cov-2-helpful-testing-tips','news/bd-veritortm-plus-system-for-rapid-detection-of-sars-cov-2-helpful-testing-tips','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"This document is a supplement to the manufacturer’s instructions and is intended to provide helpful testing tips when using the BD Veritor™ Plus System for Rapid Detection of SARS-CoV-2.\"}',1,'2024-06-03 21:51:29','2024-06-03 21:51:29','e6629dc6-21ac-4939-9ad7-6cefd4a95266'),(20043,20043,1,NULL,'bd-veritortm-plus-system-for-rapid-detection-of-sars-cov-2-helpful-testing-tips',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"This document is a supplement to the manufacturer’s instructions and is intended to provide helpful testing tips when using the BD Veritor™ Plus System for Rapid Detection of SARS-CoV-2.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"BD VeritorTM Plus System for Rapid Detection Of SARS-CoV-2 Helpful Testing Tips\"}',1,'2024-06-03 21:51:29','2024-06-03 21:51:29','e6dbbfda-b0e3-42be-8630-1454d7e768ad'),(20044,20044,1,'BD VeritorTM Plus System for Rapid Detection Of SARS-CoV-2 Helpful Testing Tips','bd-veritortm-plus-system-for-rapid-detection-of-sars-cov-2-helpful-testing-tips','news/bd-veritortm-plus-system-for-rapid-detection-of-sars-cov-2-helpful-testing-tips','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"This document is a supplement to the manufacturer’s instructions and is intended to provide helpful testing tips when using the BD Veritor™ Plus System for Rapid Detection of SARS-CoV-2.\"}',1,'2024-06-03 21:51:29','2024-06-03 21:51:29','6cf1917f-791d-4b4c-8234-2904d699c836'),(20045,20045,1,NULL,'bd-veritortm-plus-system-for-rapid-detection-of-sars-cov-2-helpful-testing-tips',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"This document is a supplement to the manufacturer’s instructions and is intended to provide helpful testing tips when using the BD Veritor™ Plus System for Rapid Detection of SARS-CoV-2.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"BD VeritorTM Plus System for Rapid Detection Of SARS-CoV-2 Helpful Testing Tips\"}',1,'2024-06-03 21:51:29','2024-06-03 21:51:29','add88bbf-87de-4201-b5c3-76343ca5ddbe'),(20046,20046,1,'MMWR on Performance of an Antigen-Based Test for Asymptomatic and Symptomatic SARS-CoV-2 Testing at Two University Campuses — Wisconsin, September–October 2020','performance-of-an-antigen-based-test-for-asymptomatic-and-symptomatic-sars-cov-2-testing-at-two-university-campuses-wisconsin-september-october-2020','news/performance-of-an-antigen-based-test-for-asymptomatic-and-symptomatic-sars-cov-2-testing-at-two-university-campuses-wisconsin-september-october-2020','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\"}',1,'2024-06-03 21:51:29','2024-06-03 21:51:29','e59bcb71-8425-4ffb-bdb3-122947a0edcb'),(20047,20047,1,NULL,'performance-of-an-antigen-based-test-for-asymptomatic-and-symptomatic-sars-cov-2-testing-at-two-university-campuses-wisconsin-september-october-2020',NULL,'{\"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"MMWR on Performance of an Antigen-Based Test for Asymptomatic and Symptomatic SARS-CoV-2 Testing at Two University Campuses — Wisconsin, September–October 2020\"}',1,'2024-06-03 21:51:29','2024-06-03 21:51:29','cb26e68e-f70a-4a1b-9210-e9404e10e413'),(20048,20048,1,'MMWR on Performance of an Antigen-Based Test for Asymptomatic and Symptomatic SARS-CoV-2 Testing at Two University Campuses — Wisconsin, September–October 2020','performance-of-an-antigen-based-test-for-asymptomatic-and-symptomatic-sars-cov-2-testing-at-two-university-campuses-wisconsin-september-october-2020','news/performance-of-an-antigen-based-test-for-asymptomatic-and-symptomatic-sars-cov-2-testing-at-two-university-campuses-wisconsin-september-october-2020','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\"}',1,'2024-06-03 21:51:29','2024-06-03 21:51:29','a5c07cab-e30b-4aa7-a33d-b000800947c0'),(20049,20049,1,NULL,'performance-of-an-antigen-based-test-for-asymptomatic-and-symptomatic-sars-cov-2-testing-at-two-university-campuses-wisconsin-september-october-2020',NULL,'{\"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"MMWR on Performance of an Antigen-Based Test for Asymptomatic and Symptomatic SARS-CoV-2 Testing at Two University Campuses — Wisconsin, September–October 2020\"}',1,'2024-06-03 21:51:29','2024-06-03 21:51:29','608c87b1-b797-431a-b085-beba80845dd2'),(20050,20050,1,'CDI Recommendations for Healthcare Outbreak Response','cdi-recommendations-for-healthcare-outbreak-response','news/cdi-recommendations-for-healthcare-outbreak-response','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\"}',1,'2024-06-03 21:51:29','2024-06-03 21:51:29','e4490186-7c5c-4930-86e2-b57f47cf01ec'),(20051,20051,1,NULL,'cdi-recommendations-for-healthcare-outbreak-response',NULL,'{\"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"CDI Recommendations for Healthcare Outbreak Response\"}',1,'2024-06-03 21:51:29','2024-06-03 21:51:29','8745d56d-4f7a-4afb-9c3f-d8264ab04cf2'),(20052,20052,1,'CDI Recommendations for Healthcare Outbreak Response','cdi-recommendations-for-healthcare-outbreak-response','news/cdi-recommendations-for-healthcare-outbreak-response','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\"}',1,'2024-06-03 21:51:29','2024-06-03 21:51:29','51109ab3-8ad9-45a8-9cda-90402cf36432'),(20053,20053,1,NULL,'cdi-recommendations-for-healthcare-outbreak-response',NULL,'{\"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"CDI Recommendations for Healthcare Outbreak Response\"}',1,'2024-06-03 21:51:29','2024-06-03 21:51:29','99181851-c273-4ae2-b175-60118ffbf504'),(20054,20054,1,'CORHA Framework for Healthcare-Associated Infection Outbreak Notification','corha-framework-for-healthcare-associated-infection-outbreak-notification','news/corha-framework-for-healthcare-associated-infection-outbreak-notification','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\"}',1,'2024-06-03 21:51:29','2024-06-03 21:51:29','363bb1e3-7086-4d49-8de8-0d1e163d8e37'),(20055,20055,1,NULL,'corha-framework-for-healthcare-associated-infection-outbreak-notification',NULL,'{\"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"CORHA Framework for Healthcare-Associated Infection Outbreak Notification\"}',1,'2024-06-03 21:51:29','2024-06-03 21:51:29','ef9df66d-2eef-46b9-9556-6c4eb2c67e0c'),(20056,20056,1,'CORHA Framework for Healthcare-Associated Infection Outbreak Notification','corha-framework-for-healthcare-associated-infection-outbreak-notification','news/corha-framework-for-healthcare-associated-infection-outbreak-notification','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\"}',1,'2024-06-03 21:51:30','2024-06-03 21:51:30','4e0b9396-2b1f-4cdb-9303-4cb4b409b22c'),(20057,20057,1,NULL,'corha-framework-for-healthcare-associated-infection-outbreak-notification',NULL,'{\"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"CORHA Framework for Healthcare-Associated Infection Outbreak Notification\"}',1,'2024-06-03 21:51:30','2024-06-03 21:51:30','75b99de5-f1c9-46e1-a458-8f997f5e1a1f'),(20058,20058,1,'Long-term Care Facilities (LTCFs) COVID-19 Module','long-term-care-facilities-ltcfs-covid-19-module','news/long-term-care-facilities-ltcfs-covid-19-module','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\"}',1,'2024-06-03 21:51:30','2024-06-03 21:51:30','b7b08716-ef20-4b10-8da0-5b26ef0253ea'),(20059,20059,1,NULL,'long-term-care-facilities-ltcfs-covid-19-module',NULL,'{\"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Long-term Care Facilities (LTCFs) COVID-19 Module\"}',1,'2024-06-03 21:51:30','2024-06-03 21:51:30','e3fbcabb-9a3e-412c-a859-ab13b2ccb924'),(20060,20060,1,'Long-term Care Facilities (LTCFs) COVID-19 Module','long-term-care-facilities-ltcfs-covid-19-module','news/long-term-care-facilities-ltcfs-covid-19-module','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\"}',1,'2024-06-03 21:51:30','2024-06-03 21:51:30','dfffbfc1-ff31-404c-a333-25f7d3ef02dd'),(20061,20061,1,NULL,'long-term-care-facilities-ltcfs-covid-19-module',NULL,'{\"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Long-term Care Facilities (LTCFs) COVID-19 Module\"}',1,'2024-06-03 21:51:30','2024-06-03 21:51:30','0931a00d-8027-40d2-b354-bf9aa4f8ffec'),(20062,20062,1,'MMWR on Candida auris Outbreak in a COVID-19 Specialty Care Unit — Florida, July–August 2020','mmwr-on-candida-auris-outbreak-in-a-covid-19-specialty-care-unit-florida-july-august-2020','news/mmwr-on-candida-auris-outbreak-in-a-covid-19-specialty-care-unit-florida-july-august-2020','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\"}',1,'2024-06-03 21:51:30','2024-06-03 21:51:30','cbebe737-4681-4ab8-8dfd-95ad90fa94f2'),(20063,20063,1,NULL,'mmwr-on-candida-auris-outbreak-in-a-covid-19-specialty-care-unit-florida-july-august-2020',NULL,'{\"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"MMWR on Candida auris Outbreak in a COVID-19 Specialty Care Unit — Florida, July–August 2020\"}',1,'2024-06-03 21:51:30','2024-06-03 21:51:30','cc840a78-3986-4e62-bd8b-b39c0a39461d'),(20064,20064,1,'MMWR on Candida auris Outbreak in a COVID-19 Specialty Care Unit — Florida, July–August 2020','mmwr-on-candida-auris-outbreak-in-a-covid-19-specialty-care-unit-florida-july-august-2020','news/mmwr-on-candida-auris-outbreak-in-a-covid-19-specialty-care-unit-florida-july-august-2020','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\"}',1,'2024-06-03 21:51:30','2024-06-03 21:51:30','9009cd5e-5f89-41bd-93e0-1ff050988bc8'),(20065,20065,1,NULL,'mmwr-on-candida-auris-outbreak-in-a-covid-19-specialty-care-unit-florida-july-august-2020',NULL,'{\"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"MMWR on Candida auris Outbreak in a COVID-19 Specialty Care Unit — Florida, July–August 2020\"}',1,'2024-06-03 21:51:30','2024-06-03 21:51:30','9f0ad266-71e1-4368-87b7-a27ef79bf0b7'),(20066,20066,1,'Upcoming Webinar on Feb. 10: Enhancing Hospital Infection Control During and Post-Pandemic','webinar-on-feb-10-enhancing-hospital-infection-control-during-and-post-pandemic','news/webinar-on-feb-10-enhancing-hospital-infection-control-during-and-post-pandemic','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"At this complimentary HIMSS webinar, Linda R. Greene, RN, MPS, CIC, Shereef Elnahal, and Patty Enrado discuss what to consider when revamping your infection prevention/control program, the role of communication and coordination among multiple stakeholders, the role of health IT and medical equipment providers, how to future-proof your updated program, and more. Registration required.\"}',1,'2024-06-03 21:51:30','2024-06-03 21:51:30','00e14329-9cc0-40b3-bd06-c1ab2f4d1ebe'),(20067,20067,1,NULL,'webinar-on-feb-10-enhancing-hospital-infection-control-during-and-post-pandemic',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"At this complimentary HIMSS webinar, Linda R. Greene, RN, MPS, CIC, Shereef Elnahal, and Patty Enrado discuss what to consider when revamping your infection prevention/control program, the role of communication and coordination among multiple stakeholders, the role of health IT and medical equipment providers, how to future-proof your updated program, and more. Registration required.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Upcoming Webinar on Feb. 10: Enhancing Hospital Infection Control During and Post-Pandemic\"}',1,'2024-06-03 21:51:30','2024-06-03 21:51:30','51a92310-878f-473a-b244-d13829cc4eb3'),(20068,20068,1,'Upcoming Webinar on Feb. 10: Enhancing Hospital Infection Control During and Post-Pandemic','webinar-on-feb-10-enhancing-hospital-infection-control-during-and-post-pandemic','news/webinar-on-feb-10-enhancing-hospital-infection-control-during-and-post-pandemic','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"At this complimentary HIMSS webinar, Linda R. Greene, RN, MPS, CIC, Shereef Elnahal, and Patty Enrado discuss what to consider when revamping your infection prevention/control program, the role of communication and coordination among multiple stakeholders, the role of health IT and medical equipment providers, how to future-proof your updated program, and more. Registration required.\"}',1,'2024-06-03 21:51:30','2024-06-03 21:51:30','a689dc01-e6b6-4dd6-9191-54ecf4604c8b'),(20069,20069,1,NULL,'webinar-on-feb-10-enhancing-hospital-infection-control-during-and-post-pandemic',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"At this complimentary HIMSS webinar, Linda R. Greene, RN, MPS, CIC, Shereef Elnahal, and Patty Enrado discuss what to consider when revamping your infection prevention/control program, the role of communication and coordination among multiple stakeholders, the role of health IT and medical equipment providers, how to future-proof your updated program, and more. Registration required.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Upcoming Webinar on Feb. 10: Enhancing Hospital Infection Control During and Post-Pandemic\"}',1,'2024-06-03 21:51:30','2024-06-03 21:51:30','fe07c4bc-fe6c-4857-b85c-f279ea550176'),(20070,20070,1,'Project Firstline: Inside Infection Control Videos','project-firstline-inside-infection-control-videos','news/project-firstline-inside-infection-control-videos','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"These CDC Project Frontline videos cover the basic ideas behind infection control, how they work to prevent COVID-19, and how using infection control actions while you’re at work can protect you, your patients, your coworkers and your community.\"}',1,'2024-06-03 21:51:30','2024-06-03 21:51:30','80aafd6b-f32d-4452-95ee-dc7101a6c363'),(20071,20071,1,NULL,'project-firstline-inside-infection-control-videos',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"These CDC Project Frontline videos cover the basic ideas behind infection control, how they work to prevent COVID-19, and how using infection control actions while you’re at work can protect you, your patients, your coworkers and your community.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Project Firstline: Inside Infection Control Videos\"}',1,'2024-06-03 21:51:30','2024-06-03 21:51:30','8f99c90d-35ad-4a17-911e-ab61b61d666a'),(20072,20072,1,'Project Firstline: Inside Infection Control Videos','project-firstline-inside-infection-control-videos','news/project-firstline-inside-infection-control-videos','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"These CDC Project Frontline videos cover the basic ideas behind infection control, how they work to prevent COVID-19, and how using infection control actions while you’re at work can protect you, your patients, your coworkers and your community.\"}',1,'2024-06-03 21:51:30','2024-06-03 21:51:30','45a7dae6-c257-411b-8544-ded2cf37f342'),(20073,20073,1,NULL,'project-firstline-inside-infection-control-videos',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"These CDC Project Frontline videos cover the basic ideas behind infection control, how they work to prevent COVID-19, and how using infection control actions while you’re at work can protect you, your patients, your coworkers and your community.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Project Firstline: Inside Infection Control Videos\"}',1,'2024-06-03 21:51:30','2024-06-03 21:51:30','36f9366c-6d94-4554-a867-21483b60a9aa'),(20074,20074,1,'National Healthcare Safety Network Factsheet: Tracking Healthcare-Associated Infections, and Antibiotic Resistance Infections','national-healthcare-safety-network-factsheet-tracking-healthcare-associated-infections-and-antibiotic-resistance-infections','news/national-healthcare-safety-network-factsheet-tracking-healthcare-associated-infections-and-antibiotic-resistance-infections','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\"}',1,'2024-06-03 21:51:30','2024-06-03 21:51:30','e7979de3-92c5-4697-ab1a-51199b5e7d17'),(20075,20075,1,NULL,'national-healthcare-safety-network-factsheet-tracking-healthcare-associated-infections-and-antibiotic-resistance-infections',NULL,'{\"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"National Healthcare Safety Network Factsheet: Tracking Healthcare-Associated Infections, and Antibiotic Resistance Infections\"}',1,'2024-06-03 21:51:30','2024-06-03 21:51:30','417ecf79-b798-4cc3-9879-eb7fafaeb11b'),(20076,20076,1,'National Healthcare Safety Network Factsheet: Tracking Healthcare-Associated Infections, and Antibiotic Resistance Infections','national-healthcare-safety-network-factsheet-tracking-healthcare-associated-infections-and-antibiotic-resistance-infections','news/national-healthcare-safety-network-factsheet-tracking-healthcare-associated-infections-and-antibiotic-resistance-infections','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\"}',1,'2024-06-03 21:51:30','2024-06-03 21:51:30','1939c395-7c88-48cd-8699-61329a16f02b'),(20077,20077,1,NULL,'national-healthcare-safety-network-factsheet-tracking-healthcare-associated-infections-and-antibiotic-resistance-infections',NULL,'{\"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"National Healthcare Safety Network Factsheet: Tracking Healthcare-Associated Infections, and Antibiotic Resistance Infections\"}',1,'2024-06-03 21:51:31','2024-06-03 21:51:31','69670d89-87f4-4f62-ae43-7102e34779a1'),(20078,20078,1,'Updated Interim Infection Prevention and Control Recommendations for Healthcare Personnel During the Coronavirus Disease 2019 (COVID-19) Pandemic','updated-interim-infection-prevention-and-control-recommendations-for-healthcare-personnel-during-the-coronavirus-disease-2019-covid-19-pandemic','news/updated-interim-infection-prevention-and-control-recommendations-for-healthcare-personnel-during-the-coronavirus-disease-2019-covid-19-pandemic','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"CDC updated its interim infection prevention and control recommendations for healthcare personnel during the coronavirus disease 2019 pandemic that includes updates to the implement universal use of PPE section.\"}',1,'2024-06-03 21:51:31','2024-06-03 21:51:31','3f431361-fde0-4ccb-ae27-fe22807863cd'),(20079,20079,1,NULL,'updated-interim-infection-prevention-and-control-recommendations-for-healthcare-personnel-during-the-coronavirus-disease-2019-covid-19-pandemic',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"CDC updated its interim infection prevention and control recommendations for healthcare personnel during the coronavirus disease 2019 pandemic that includes updates to the implement universal use of PPE section.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Updated Interim Infection Prevention and Control Recommendations for Healthcare Personnel During the Coronavirus Disease 2019 (COVID-19) Pandemic\"}',1,'2024-06-03 21:51:31','2024-06-03 21:51:31','08e33a12-909f-4520-96bf-17578d53d3b5'),(20080,20080,1,'Updated Interim Infection Prevention and Control Recommendations for Healthcare Personnel During the Coronavirus Disease 2019 (COVID-19) Pandemic','updated-interim-infection-prevention-and-control-recommendations-for-healthcare-personnel-during-the-coronavirus-disease-2019-covid-19-pandemic','news/updated-interim-infection-prevention-and-control-recommendations-for-healthcare-personnel-during-the-coronavirus-disease-2019-covid-19-pandemic','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"CDC updated its interim infection prevention and control recommendations for healthcare personnel during the coronavirus disease 2019 pandemic that includes updates to the implement universal use of PPE section.\"}',1,'2024-06-03 21:51:31','2024-06-03 21:51:31','ce0f7694-6b4d-492c-b4cb-f57043f5d54c'),(20081,20081,1,NULL,'updated-interim-infection-prevention-and-control-recommendations-for-healthcare-personnel-during-the-coronavirus-disease-2019-covid-19-pandemic',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"CDC updated its interim infection prevention and control recommendations for healthcare personnel during the coronavirus disease 2019 pandemic that includes updates to the implement universal use of PPE section.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Updated Interim Infection Prevention and Control Recommendations for Healthcare Personnel During the Coronavirus Disease 2019 (COVID-19) Pandemic\"}',1,'2024-06-03 21:51:31','2024-06-03 21:51:31','04628257-b020-4923-aaa3-1330fd5ffdb9'),(20082,20082,1,'Ensuring Access to COVID-19 Vaccine in Long-Term Care Facilities','ensuring-access-to-covid-19-vaccine-in-long-term-care-facilities','news/ensuring-access-to-covid-19-vaccine-in-long-term-care-facilities','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\"}',1,'2024-06-03 21:51:31','2024-06-03 21:51:31','35df545e-ad4e-4e9c-9bd1-cff7956c39d3'),(20083,20083,1,NULL,'ensuring-access-to-covid-19-vaccine-in-long-term-care-facilities',NULL,'{\"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Ensuring Access to COVID-19 Vaccine in Long-Term Care Facilities\"}',1,'2024-06-03 21:51:31','2024-06-03 21:51:31','fe3fa8ca-9d13-45fc-af38-8f78f802e853'),(20084,20084,1,'Ensuring Access to COVID-19 Vaccine in Long-Term Care Facilities','ensuring-access-to-covid-19-vaccine-in-long-term-care-facilities','news/ensuring-access-to-covid-19-vaccine-in-long-term-care-facilities','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\"}',1,'2024-06-03 21:51:31','2024-06-03 21:51:31','a9fcb621-12df-477f-970a-98be60ffa6a2'),(20085,20085,1,NULL,'ensuring-access-to-covid-19-vaccine-in-long-term-care-facilities',NULL,'{\"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Ensuring Access to COVID-19 Vaccine in Long-Term Care Facilities\"}',1,'2024-06-03 21:51:31','2024-06-03 21:51:31','21e6af5c-a658-4639-b7e4-a513f793efc3'),(20086,20086,1,'MMWR on Early COVID-19 First-Dose Vaccination Coverage Among Residents and Staff Members of Skilled Nursing Facilities','mmwr-on-early-covid-19-first-dose-vaccination-coverage-among-residents-and-staff-members-of-skilled-nursing-facilities','news/mmwr-on-early-covid-19-first-dose-vaccination-coverage-among-residents-and-staff-members-of-skilled-nursing-facilities','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\"}',1,'2024-06-03 21:51:31','2024-06-03 21:51:31','6e714e34-6c3f-4b28-a90c-6a0068ffa2d8'),(20087,20087,1,NULL,'mmwr-on-early-covid-19-first-dose-vaccination-coverage-among-residents-and-staff-members-of-skilled-nursing-facilities',NULL,'{\"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"MMWR on Early COVID-19 First-Dose Vaccination Coverage Among Residents and Staff Members of Skilled Nursing Facilities\"}',1,'2024-06-03 21:51:31','2024-06-03 21:51:31','a22422bc-06bd-4ca5-8cae-73b085f1f0d7'),(20088,20088,1,'MMWR on Early COVID-19 First-Dose Vaccination Coverage Among Residents and Staff Members of Skilled Nursing Facilities','mmwr-on-early-covid-19-first-dose-vaccination-coverage-among-residents-and-staff-members-of-skilled-nursing-facilities','news/mmwr-on-early-covid-19-first-dose-vaccination-coverage-among-residents-and-staff-members-of-skilled-nursing-facilities','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\"}',1,'2024-06-03 21:51:31','2024-06-03 21:51:31','115bd1c0-dd20-4f52-a0a6-1347e0bb4033'),(20089,20089,1,NULL,'mmwr-on-early-covid-19-first-dose-vaccination-coverage-among-residents-and-staff-members-of-skilled-nursing-facilities',NULL,'{\"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"MMWR on Early COVID-19 First-Dose Vaccination Coverage Among Residents and Staff Members of Skilled Nursing Facilities\"}',1,'2024-06-03 21:51:31','2024-06-03 21:51:31','b97b9c64-ce4f-40fe-91fd-2cce7cabcec9'),(20090,20090,1,'Congo Confirms Two New Ebola Cases, Including One Far From Centre of Outbreak','congo-confirms-two-new-ebola-cases-including-one-far-from-centre-of-outbreak','news/congo-confirms-two-new-ebola-cases-including-one-far-from-centre-of-outbreak','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\"}',1,'2024-06-03 21:51:31','2024-06-03 21:51:31','8ddefd88-113b-4037-ac90-d38ff1a401a9'),(20091,20091,1,NULL,'congo-confirms-two-new-ebola-cases-including-one-far-from-centre-of-outbreak',NULL,'{\"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Congo Confirms Two New Ebola Cases, Including One Far From Centre of Outbreak\"}',1,'2024-06-03 21:51:31','2024-06-03 21:51:31','084b3d7e-6ca6-4b04-9c57-9b662d491899'),(20092,20092,1,'Congo Confirms Two New Ebola Cases, Including One Far From Centre of Outbreak','congo-confirms-two-new-ebola-cases-including-one-far-from-centre-of-outbreak','news/congo-confirms-two-new-ebola-cases-including-one-far-from-centre-of-outbreak','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\"}',1,'2024-06-03 21:51:31','2024-06-03 21:51:31','4c23d394-6201-4e21-a342-3201ab401384'),(20093,20093,1,NULL,'congo-confirms-two-new-ebola-cases-including-one-far-from-centre-of-outbreak',NULL,'{\"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Congo Confirms Two New Ebola Cases, Including One Far From Centre of Outbreak\"}',1,'2024-06-03 21:51:31','2024-06-03 21:51:31','427abc9e-7069-402a-8256-00300de8a6f0'),(20094,20094,1,'With All Eyes on COVID-19, Drug-Resistant Infections Crept In','with-all-eyes-on-covid-19-drug-resistant-infections-crept-in','news/with-all-eyes-on-covid-19-drug-resistant-infections-crept-in','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"This article discusses how the spread of other dangerous germs is surging, partly as a result of the chaotic response to the pandemic.\"}',1,'2024-06-03 21:51:31','2024-06-03 21:51:31','0c5a672a-5f71-42a2-ad38-f85fa2693d40'),(20095,20095,1,NULL,'with-all-eyes-on-covid-19-drug-resistant-infections-crept-in',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"This article discusses how the spread of other dangerous germs is surging, partly as a result of the chaotic response to the pandemic.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"With All Eyes on COVID-19, Drug-Resistant Infections Crept In\"}',1,'2024-06-03 21:51:31','2024-06-03 21:51:31','cbffb18b-7fda-4e63-a090-574a2ee85172'),(20096,20096,1,'With All Eyes on COVID-19, Drug-Resistant Infections Crept In','with-all-eyes-on-covid-19-drug-resistant-infections-crept-in','news/with-all-eyes-on-covid-19-drug-resistant-infections-crept-in','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"This article discusses how the spread of other dangerous germs is surging, partly as a result of the chaotic response to the pandemic.\"}',1,'2024-06-03 21:51:31','2024-06-03 21:51:31','42f79120-da16-460e-b3eb-32de6c555448'),(20097,20097,1,NULL,'with-all-eyes-on-covid-19-drug-resistant-infections-crept-in',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"This article discusses how the spread of other dangerous germs is surging, partly as a result of the chaotic response to the pandemic.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"With All Eyes on COVID-19, Drug-Resistant Infections Crept In\"}',1,'2024-06-03 21:51:31','2024-06-03 21:51:31','df489f3b-eec4-4eec-8b1e-2b0fb7e62b96'),(20098,20098,1,'Association of a Safety Program for Improving Antibiotic Use With Antibiotic Use and Hospital-Onset Clostridioides difficile Infection Rates Among US Hospitals','association-of-a-safety-program-for-improving-antibiotic-use-with-antibiotic-use-and-hospital-onset-clostridioides-difficile-infection-rates-among-us-hospitals','news/association-of-a-safety-program-for-improving-antibiotic-use-with-antibiotic-use-and-hospital-onset-clostridioides-difficile-infection-rates-among-us-hospitals','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\"}',1,'2024-06-03 21:51:31','2024-06-03 21:51:31','0e3d5f99-9b39-41f3-bd8c-55ae3fd64142'),(20099,20099,1,NULL,'association-of-a-safety-program-for-improving-antibiotic-use-with-antibiotic-use-and-hospital-onset-clostridioides-difficile-infection-rates-among-us-hospitals',NULL,'{\"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Association of a Safety Program for Improving Antibiotic Use With Antibiotic Use and Hospital-Onset Clostridioides difficile Infection Rates Among US Hospitals\"}',1,'2024-06-03 21:51:31','2024-06-03 21:51:31','05be47c6-db87-43cf-8fee-dad34e91c1d5'),(20100,20100,1,'Association of a Safety Program for Improving Antibiotic Use With Antibiotic Use and Hospital-Onset Clostridioides difficile Infection Rates Among US Hospitals','association-of-a-safety-program-for-improving-antibiotic-use-with-antibiotic-use-and-hospital-onset-clostridioides-difficile-infection-rates-among-us-hospitals','news/association-of-a-safety-program-for-improving-antibiotic-use-with-antibiotic-use-and-hospital-onset-clostridioides-difficile-infection-rates-among-us-hospitals','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\"}',1,'2024-06-03 21:51:31','2024-06-03 21:51:31','17e97d6a-3e4d-4866-8e50-ab3b8ef64072'),(20101,20101,1,NULL,'association-of-a-safety-program-for-improving-antibiotic-use-with-antibiotic-use-and-hospital-onset-clostridioides-difficile-infection-rates-among-us-hospitals',NULL,'{\"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Association of a Safety Program for Improving Antibiotic Use With Antibiotic Use and Hospital-Onset Clostridioides difficile Infection Rates Among US Hospitals\"}',1,'2024-06-03 21:51:31','2024-06-03 21:51:31','a5080a42-2ce7-4f17-98d5-5b540d5f8221'),(20102,20102,1,'MMWR on Suspected Recurrent SARS-CoV-2 Infections Among Residents of a Skilled Nursing Facility During a Second COVID-19 Outbreak — Kentucky, July–November 2020','mmwr-on-suspected-recurrent-sars-cov-2-infections-among-residents-of-a-skilled-nursing-facility-during-a-second-covid-19-outbreak-kentucky-july-november-2020','news/mmwr-on-suspected-recurrent-sars-cov-2-infections-among-residents-of-a-skilled-nursing-facility-during-a-second-covid-19-outbreak-kentucky-july-november-2020','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"This Morbidity and Mortality Weekly Report describes possible reoccurring SARS-CoV-2 infections among nursing facility residents.\"}',1,'2024-06-03 21:51:31','2024-06-03 21:51:31','50490c50-81e9-4590-86b9-5271beae23c9'),(20103,20103,1,NULL,'mmwr-on-suspected-recurrent-sars-cov-2-infections-among-residents-of-a-skilled-nursing-facility-during-a-second-covid-19-outbreak-kentucky-july-november-2020',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"This Morbidity and Mortality Weekly Report describes possible reoccurring SARS-CoV-2 infections among nursing facility residents.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"MMWR on Suspected Recurrent SARS-CoV-2 Infections Among Residents of a Skilled Nursing Facility During a Second COVID-19 Outbreak — Kentucky, July–November 2020\"}',1,'2024-06-03 21:51:32','2024-06-03 21:51:32','a819ddd0-895d-4c96-9719-738afe87cfac'),(20104,20104,1,'MMWR on Suspected Recurrent SARS-CoV-2 Infections Among Residents of a Skilled Nursing Facility During a Second COVID-19 Outbreak — Kentucky, July–November 2020','mmwr-on-suspected-recurrent-sars-cov-2-infections-among-residents-of-a-skilled-nursing-facility-during-a-second-covid-19-outbreak-kentucky-july-november-2020','news/mmwr-on-suspected-recurrent-sars-cov-2-infections-among-residents-of-a-skilled-nursing-facility-during-a-second-covid-19-outbreak-kentucky-july-november-2020','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"This Morbidity and Mortality Weekly Report describes possible reoccurring SARS-CoV-2 infections among nursing facility residents.\"}',1,'2024-06-03 21:51:32','2024-06-03 21:51:32','15d0ec85-a71b-41b0-beb5-be6ecc1e0d44'),(20105,20105,1,NULL,'mmwr-on-suspected-recurrent-sars-cov-2-infections-among-residents-of-a-skilled-nursing-facility-during-a-second-covid-19-outbreak-kentucky-july-november-2020',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"This Morbidity and Mortality Weekly Report describes possible reoccurring SARS-CoV-2 infections among nursing facility residents.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"MMWR on Suspected Recurrent SARS-CoV-2 Infections Among Residents of a Skilled Nursing Facility During a Second COVID-19 Outbreak — Kentucky, July–November 2020\"}',1,'2024-06-03 21:51:32','2024-06-03 21:51:32','b3f1dd0a-cc41-45f5-b3a6-bfab7c401a67'),(20106,20106,1,'COVID-19 Cases and Deaths Among Nursing Home Residents Have Declined Markedly Following the Introduction of Vaccines','covid-19-cases-and-deaths-among-nursing-home-residents-have-declined-markedly-following-the-introduction-of-vaccines','news/covid-19-cases-and-deaths-among-nursing-home-residents-have-declined-markedly-following-the-introduction-of-vaccines','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"KFF analysis finds the number of residents contracting and dying of COVID-19 in nursing homes has decreased by two-thirds since December, with new cases among residents falling by 83 percent.\"}',1,'2024-06-03 21:51:32','2024-06-03 21:51:32','1824ea56-e1cf-4212-8a94-7f47d4da6cbb'),(20107,20107,1,NULL,'covid-19-cases-and-deaths-among-nursing-home-residents-have-declined-markedly-following-the-introduction-of-vaccines',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"KFF analysis finds the number of residents contracting and dying of COVID-19 in nursing homes has decreased by two-thirds since December, with new cases among residents falling by 83 percent.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"COVID-19 Cases and Deaths Among Nursing Home Residents Have Declined Markedly Following the Introduction of Vaccines\"}',1,'2024-06-03 21:51:32','2024-06-03 21:51:32','f78e9927-7f52-4644-978a-b7be076e9d2c'),(20108,20108,1,'COVID-19 Cases and Deaths Among Nursing Home Residents Have Declined Markedly Following the Introduction of Vaccines','covid-19-cases-and-deaths-among-nursing-home-residents-have-declined-markedly-following-the-introduction-of-vaccines','news/covid-19-cases-and-deaths-among-nursing-home-residents-have-declined-markedly-following-the-introduction-of-vaccines','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"KFF analysis finds the number of residents contracting and dying of COVID-19 in nursing homes has decreased by two-thirds since December, with new cases among residents falling by 83 percent.\"}',1,'2024-06-03 21:51:32','2024-06-03 21:51:32','96d1a0fd-92ba-4ec8-8ed1-b52539c96538'),(20109,20109,1,NULL,'covid-19-cases-and-deaths-among-nursing-home-residents-have-declined-markedly-following-the-introduction-of-vaccines',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"KFF analysis finds the number of residents contracting and dying of COVID-19 in nursing homes has decreased by two-thirds since December, with new cases among residents falling by 83 percent.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"COVID-19 Cases and Deaths Among Nursing Home Residents Have Declined Markedly Following the Introduction of Vaccines\"}',1,'2024-06-03 21:51:32','2024-06-03 21:51:32','727bf6e5-f2e8-4717-a888-7464079b55a9'),(20110,20110,1,'Pennsylvania Extends Nursing Home Virus Response Program','pennsylvania-extends-nursing-home-virus-response-program','news/pennsylvania-extends-nursing-home-virus-response-program','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"Pennsylvania extends its nursing home virus response program. Regional Congregate Care Assistance Teams now will run through May 2021.\"}',1,'2024-06-03 21:51:32','2024-06-03 21:51:32','ca4128b2-07d5-40ca-9dba-60a3d6836936'),(20111,20111,1,NULL,'pennsylvania-extends-nursing-home-virus-response-program',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"Pennsylvania extends its nursing home virus response program. Regional Congregate Care Assistance Teams now will run through May 2021.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Pennsylvania Extends Nursing Home Virus Response Program\"}',1,'2024-06-03 21:51:32','2024-06-03 21:51:32','1b0a32fe-2267-4a7e-8ca5-3e640be7baeb'),(20112,20112,1,'Pennsylvania Extends Nursing Home Virus Response Program','pennsylvania-extends-nursing-home-virus-response-program','news/pennsylvania-extends-nursing-home-virus-response-program','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"Pennsylvania extends its nursing home virus response program. Regional Congregate Care Assistance Teams now will run through May 2021.\"}',1,'2024-06-03 21:51:32','2024-06-03 21:51:32','e4f4b619-2963-48d1-91d7-d048f39ea594'),(20113,20113,1,NULL,'pennsylvania-extends-nursing-home-virus-response-program',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"Pennsylvania extends its nursing home virus response program. Regional Congregate Care Assistance Teams now will run through May 2021.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Pennsylvania Extends Nursing Home Virus Response Program\"}',1,'2024-06-03 21:51:32','2024-06-03 21:51:32','b5d0bcfb-67a4-4f92-b2ae-32ee4898ff21'),(20114,20114,1,'High Nursing Staff Turnover In Nursing Homes Offers Important Quality Information','high-nursing-staff-turnover-in-nursing-homes-offers-important-quality-information','news/high-nursing-staff-turnover-in-nursing-homes-offers-important-quality-information','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\"}',1,'2024-06-03 21:51:32','2024-06-03 21:51:32','51de2649-7dea-44fc-aeef-a5f5cf82fd4b'),(20115,20115,1,NULL,'high-nursing-staff-turnover-in-nursing-homes-offers-important-quality-information',NULL,'{\"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"High Nursing Staff Turnover In Nursing Homes Offers Important Quality Information\"}',1,'2024-06-03 21:51:32','2024-06-03 21:51:32','29c50176-523f-4262-aacc-592b3b4faf0b'),(20116,20116,1,'High Nursing Staff Turnover In Nursing Homes Offers Important Quality Information','high-nursing-staff-turnover-in-nursing-homes-offers-important-quality-information','news/high-nursing-staff-turnover-in-nursing-homes-offers-important-quality-information','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\"}',1,'2024-06-03 21:51:32','2024-06-03 21:51:32','ebe60e48-797d-471c-9042-cef65f211018'),(20117,20117,1,NULL,'high-nursing-staff-turnover-in-nursing-homes-offers-important-quality-information',NULL,'{\"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"High Nursing Staff Turnover In Nursing Homes Offers Important Quality Information\"}',1,'2024-06-03 21:51:32','2024-06-03 21:51:32','7477cf95-4001-42d8-84cf-4d67f04a7566'),(20118,20118,1,'Updated Strategies to Mitigate Healthcare Personnel Staffing Shortages','updated-strategies-to-mitigate-healthcare-personnel-staffing-shortages','news/updated-strategies-to-mitigate-healthcare-personnel-staffing-shortages','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\"}',1,'2024-06-03 21:51:32','2024-06-03 21:51:32','0fb47dba-51e1-4148-a83b-2ade1eb2cf41'),(20119,20119,1,NULL,'updated-strategies-to-mitigate-healthcare-personnel-staffing-shortages',NULL,'{\"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Updated Strategies to Mitigate Healthcare Personnel Staffing Shortages\"}',1,'2024-06-03 21:51:32','2024-06-03 21:51:32','e4630de2-c785-4765-a7e1-65cf0a278e10'),(20120,20120,1,'Updated Strategies to Mitigate Healthcare Personnel Staffing Shortages','updated-strategies-to-mitigate-healthcare-personnel-staffing-shortages','news/updated-strategies-to-mitigate-healthcare-personnel-staffing-shortages','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\"}',1,'2024-06-03 21:51:32','2024-06-03 21:51:32','b58e74be-d32f-4226-a5ca-8b37902d3cc3'),(20121,20121,1,NULL,'updated-strategies-to-mitigate-healthcare-personnel-staffing-shortages',NULL,'{\"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Updated Strategies to Mitigate Healthcare Personnel Staffing Shortages\"}',1,'2024-06-03 21:51:32','2024-06-03 21:51:32','8e3b01c3-650b-4292-9c6e-a3f1f105c524'),(20122,20122,1,'Updated Discontinuation of Transmission-Based Precautions and Disposition of Patients with SARS-CoV-2 Infection in Healthcare Settings','updated-discontinuation-of-transmission-based-precautions-and-disposition-of-patients-with-sars-cov-2-infection-in-healthcare-settings','news/updated-discontinuation-of-transmission-based-precautions-and-disposition-of-patients-with-sars-cov-2-infection-in-healthcare-settings','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\"}',1,'2024-06-03 21:51:32','2024-06-03 21:51:32','ec707129-c000-41ea-8b7f-571c5fc3ecba'),(20123,20123,1,NULL,'updated-discontinuation-of-transmission-based-precautions-and-disposition-of-patients-with-sars-cov-2-infection-in-healthcare-settings',NULL,'{\"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Updated Discontinuation of Transmission-Based Precautions and Disposition of Patients with SARS-CoV-2 Infection in Healthcare Settings\"}',1,'2024-06-03 21:51:32','2024-06-03 21:51:32','4228cd2e-6299-43c5-b2e1-eca484f7410a'),(20124,20124,1,'Updated Discontinuation of Transmission-Based Precautions and Disposition of Patients with SARS-CoV-2 Infection in Healthcare Settings','updated-discontinuation-of-transmission-based-precautions-and-disposition-of-patients-with-sars-cov-2-infection-in-healthcare-settings','news/updated-discontinuation-of-transmission-based-precautions-and-disposition-of-patients-with-sars-cov-2-infection-in-healthcare-settings','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\"}',1,'2024-06-03 21:51:32','2024-06-03 21:51:32','be623575-dbbc-417f-8f11-7ea5ac0c8df6'),(20125,20125,1,NULL,'updated-discontinuation-of-transmission-based-precautions-and-disposition-of-patients-with-sars-cov-2-infection-in-healthcare-settings',NULL,'{\"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Updated Discontinuation of Transmission-Based Precautions and Disposition of Patients with SARS-CoV-2 Infection in Healthcare Settings\"}',1,'2024-06-03 21:51:32','2024-06-03 21:51:32','04dd1fb4-8ed2-4a66-9cd4-e0d2fbbe58fb'),(20126,20126,1,'CORHA Governance Committee Member, Dr. Dawn Terashita, Recognized as NACCHO Infection Prevention and Control Champion','corha-governance-committee-member-dr-dawn-terashita-recognized-as-naccho-infection-prevention-and-control-champion','news/corha-governance-committee-member-dr-dawn-terashita-recognized-as-naccho-infection-prevention-and-control-champion','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"Dr. Dawn Terashita, MD, MPH, FACPM, CORHA Governance Committee Member and Associate Director for the Acute Communicable Disease Control Program within the Los Angeles County Department of Public Health (LACDPH) has been selected as a NACCHO Infection Prevention and Control (IPC) Champion. This recognition highlights the IPC achievements of local health departments and honors the staff leading this work.\"}',1,'2024-06-03 21:51:32','2024-06-03 21:51:32','16179cd4-f10f-4142-8784-7a13d58e5776'),(20127,20127,1,NULL,'corha-governance-committee-member-dr-dawn-terashita-recognized-as-naccho-infection-prevention-and-control-champion',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"Dr. Dawn Terashita, MD, MPH, FACPM, CORHA Governance Committee Member and Associate Director for the Acute Communicable Disease Control Program within the Los Angeles County Department of Public Health (LACDPH) has been selected as a NACCHO Infection Prevention and Control (IPC) Champion. This recognition highlights the IPC achievements of local health departments and honors the staff leading this work.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"CORHA Governance Committee Member, Dr. Dawn Terashita, Recognized as NACCHO Infection Prevention and Control Champion\"}',1,'2024-06-03 21:51:32','2024-06-03 21:51:32','4167f12f-0301-4b85-b77c-ef3cb5f46eae'),(20128,20128,1,'CORHA Governance Committee Member, Dr. Dawn Terashita, Recognized as NACCHO Infection Prevention and Control Champion','corha-governance-committee-member-dr-dawn-terashita-recognized-as-naccho-infection-prevention-and-control-champion','news/corha-governance-committee-member-dr-dawn-terashita-recognized-as-naccho-infection-prevention-and-control-champion','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"Dr. Dawn Terashita, MD, MPH, FACPM, CORHA Governance Committee Member and Associate Director for the Acute Communicable Disease Control Program within the Los Angeles County Department of Public Health (LACDPH) has been selected as a NACCHO Infection Prevention and Control (IPC) Champion. This recognition highlights the IPC achievements of local health departments and honors the staff leading this work.\"}',1,'2024-06-03 21:51:32','2024-06-03 21:51:32','46eeb2b4-1fb6-4ece-b03a-539c44681b3a'),(20129,20129,1,NULL,'corha-governance-committee-member-dr-dawn-terashita-recognized-as-naccho-infection-prevention-and-control-champion',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"Dr. Dawn Terashita, MD, MPH, FACPM, CORHA Governance Committee Member and Associate Director for the Acute Communicable Disease Control Program within the Los Angeles County Department of Public Health (LACDPH) has been selected as a NACCHO Infection Prevention and Control (IPC) Champion. This recognition highlights the IPC achievements of local health departments and honors the staff leading this work.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"CORHA Governance Committee Member, Dr. Dawn Terashita, Recognized as NACCHO Infection Prevention and Control Champion\"}',1,'2024-06-03 21:51:32','2024-06-03 21:51:32','66838542-f8ca-4227-9c94-f5c824e1d569'),(20130,20130,1,'Study Adds More Evidence of Antibiotic Overuse in COVID-19 Patients','study-adds-more-evidence-of-antibiotic-overuse-in-covid-19-patients','news/study-adds-more-evidence-of-antibiotic-overuse-in-covid-19-patients','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\"}',1,'2024-06-03 21:51:33','2024-06-03 21:51:33','7ce26b2c-3980-4aab-a798-8d180d737d04'),(20131,20131,1,NULL,'study-adds-more-evidence-of-antibiotic-overuse-in-covid-19-patients',NULL,'{\"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Study Adds More Evidence of Antibiotic Overuse in COVID-19 Patients\"}',1,'2024-06-03 21:51:33','2024-06-03 21:51:33','cc91eee1-a455-4fe9-94f1-1e849794402e'),(20132,20132,1,'Study Adds More Evidence of Antibiotic Overuse in COVID-19 Patients','study-adds-more-evidence-of-antibiotic-overuse-in-covid-19-patients','news/study-adds-more-evidence-of-antibiotic-overuse-in-covid-19-patients','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\"}',1,'2024-06-03 21:51:33','2024-06-03 21:51:33','a599a682-0ed8-496f-92b3-9a9dfdadb27f'),(20133,20133,1,NULL,'study-adds-more-evidence-of-antibiotic-overuse-in-covid-19-patients',NULL,'{\"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Study Adds More Evidence of Antibiotic Overuse in COVID-19 Patients\"}',1,'2024-06-03 21:51:33','2024-06-03 21:51:33','f6ef2bd4-fc50-4c78-ad5e-c0bcef677d68'),(20134,20134,1,'CMS Updates Nursing Home Guidance with Revised Visitation Recommendations','cms-updates-nursing-home-guidance-with-revised-visitation-recommendations','news/cms-updates-nursing-home-guidance-with-revised-visitation-recommendations','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"This CMS press release is on updated guidance for nursing homes to safely expand visitation options during the COVID-19 pandemic public health emergency (PHE).\"}',1,'2024-06-03 21:51:33','2024-06-03 21:51:33','6ccfcba4-2320-427e-a527-32f285a5374b'),(20135,20135,1,NULL,'cms-updates-nursing-home-guidance-with-revised-visitation-recommendations',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"This CMS press release is on updated guidance for nursing homes to safely expand visitation options during the COVID-19 pandemic public health emergency (PHE).\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"CMS Updates Nursing Home Guidance with Revised Visitation Recommendations\"}',1,'2024-06-03 21:51:33','2024-06-03 21:51:33','03e955c2-555b-480f-a821-5364a8c6bd77'),(20136,20136,1,'CMS Updates Nursing Home Guidance with Revised Visitation Recommendations','cms-updates-nursing-home-guidance-with-revised-visitation-recommendations','news/cms-updates-nursing-home-guidance-with-revised-visitation-recommendations','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"This CMS press release is on updated guidance for nursing homes to safely expand visitation options during the COVID-19 pandemic public health emergency (PHE).\"}',1,'2024-06-03 21:51:33','2024-06-03 21:51:33','d7159825-3b37-4761-ba1f-803274013b41'),(20137,20137,1,NULL,'cms-updates-nursing-home-guidance-with-revised-visitation-recommendations',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"This CMS press release is on updated guidance for nursing homes to safely expand visitation options during the COVID-19 pandemic public health emergency (PHE).\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"CMS Updates Nursing Home Guidance with Revised Visitation Recommendations\"}',1,'2024-06-03 21:51:33','2024-06-03 21:51:33','46517b12-7897-4a7d-828f-181340581a7a'),(20138,20138,1,'Covid Cases Plummet 83% Among Nursing Home Staffers Despite Vaccine Hesitancy','covid-cases-plummet-83-among-nursing-home-staffers-despite-vaccine-hesitancy','news/covid-cases-plummet-83-among-nursing-home-staffers-despite-vaccine-hesitancy','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\"}',1,'2024-06-03 21:51:33','2024-06-03 21:51:33','55169a10-1776-4d06-97a7-8ce4046e7e45'),(20139,20139,1,NULL,'covid-cases-plummet-83-among-nursing-home-staffers-despite-vaccine-hesitancy',NULL,'{\"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Covid Cases Plummet 83% Among Nursing Home Staffers Despite Vaccine Hesitancy\"}',1,'2024-06-03 21:51:33','2024-06-03 21:51:33','b01abde5-7c0e-4e3d-8397-7dd00450ef6f'),(20140,20140,1,'Covid Cases Plummet 83% Among Nursing Home Staffers Despite Vaccine Hesitancy','covid-cases-plummet-83-among-nursing-home-staffers-despite-vaccine-hesitancy','news/covid-cases-plummet-83-among-nursing-home-staffers-despite-vaccine-hesitancy','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\"}',1,'2024-06-03 21:51:33','2024-06-03 21:51:33','2001e5ab-3c58-4c72-9c91-d1aca37ac239'),(20141,20141,1,NULL,'covid-cases-plummet-83-among-nursing-home-staffers-despite-vaccine-hesitancy',NULL,'{\"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Covid Cases Plummet 83% Among Nursing Home Staffers Despite Vaccine Hesitancy\"}',1,'2024-06-03 21:51:33','2024-06-03 21:51:33','0adcc372-cde9-4a6b-a285-0541b289f769'),(20142,20142,1,'MMWR on Effectiveness of the Pfizer-BioNTech COVID-19 Vaccine Among Residents of Two Skilled Nursing Facilities Experiencing COVID-19 Outbreaks — Connecticut, December 2020–February 2021','mmwr-on-effectiveness-of-the-pfizer-biontech-covid-19-vaccine-among-residents-of-two-skilled-nursing-facilities-experiencing-covid-19-outbreaks-connecticut-december-2020-february-20','news/mmwr-on-effectiveness-of-the-pfizer-biontech-covid-19-vaccine-among-residents-of-two-skilled-nursing-facilities-experiencing-covid-19-outbreaks-connecticut-december-2020-february-20','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\"}',1,'2024-06-03 21:51:33','2024-06-03 21:51:33','ac22fc83-35e5-4c28-8db6-0f179bef7ac5'),(20143,20143,1,NULL,'mmwr-on-effectiveness-of-the-pfizer-biontech-covid-19-vaccine-among-residents-of-two-skilled-nursing-facilities-experiencing-covid-19-outbreaks-connecticut-december-2020-february-20',NULL,'{\"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"MMWR on Effectiveness of the Pfizer-BioNTech COVID-19 Vaccine Among Residents of Two Skilled Nursing Facilities Experiencing COVID-19 Outbreaks — Connecticut, December 2020–February 2021\"}',1,'2024-06-03 21:51:33','2024-06-03 21:51:33','0b950d70-a8eb-4473-aec5-f4c5ea94b4c2'),(20144,20144,1,'MMWR on Effectiveness of the Pfizer-BioNTech COVID-19 Vaccine Among Residents of Two Skilled Nursing Facilities Experiencing COVID-19 Outbreaks — Connecticut, December 2020–February 2021','mmwr-on-effectiveness-of-the-pfizer-biontech-covid-19-vaccine-among-residents-of-two-skilled-nursing-facilities-experiencing-covid-19-outbreaks-connecticut-december-2020-february-20','news/mmwr-on-effectiveness-of-the-pfizer-biontech-covid-19-vaccine-among-residents-of-two-skilled-nursing-facilities-experiencing-covid-19-outbreaks-connecticut-december-2020-february-20','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\"}',1,'2024-06-03 21:51:33','2024-06-03 21:51:33','1e76a8ce-bd22-4e64-bbed-ebecea7d458e'),(20145,20145,1,NULL,'mmwr-on-effectiveness-of-the-pfizer-biontech-covid-19-vaccine-among-residents-of-two-skilled-nursing-facilities-experiencing-covid-19-outbreaks-connecticut-december-2020-february-20',NULL,'{\"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"MMWR on Effectiveness of the Pfizer-BioNTech COVID-19 Vaccine Among Residents of Two Skilled Nursing Facilities Experiencing COVID-19 Outbreaks — Connecticut, December 2020–February 2021\"}',1,'2024-06-03 21:51:33','2024-06-03 21:51:33','2420b03f-9fac-4a24-88da-e63e71eb2144'),(20146,20146,1,'Impact of COVID-19 Pandemic on Central Line-Associated Bloodstream Infections During the Early Months of 2020, National Healthcare Safety Network','impact-of-covid-19-pandemic-on-central-line-associated-bloodstream-infections-during-the-early-months-of-2020-national-healthcare-safety-network','news/impact-of-covid-19-pandemic-on-central-line-associated-bloodstream-infections-during-the-early-months-of-2020-national-healthcare-safety-network','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\"}',1,'2024-06-03 21:51:33','2024-06-03 21:51:33','eaf7bcd4-b27c-4aa3-96ad-c04f2993e671'),(20147,20147,1,NULL,'impact-of-covid-19-pandemic-on-central-line-associated-bloodstream-infections-during-the-early-months-of-2020-national-healthcare-safety-network',NULL,'{\"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Impact of COVID-19 Pandemic on Central Line-Associated Bloodstream Infections During the Early Months of 2020, National Healthcare Safety Network\"}',1,'2024-06-03 21:51:33','2024-06-03 21:51:33','c116f4e0-149b-4583-85d0-e2e2b07a8ab3'),(20148,20148,1,'Impact of COVID-19 Pandemic on Central Line-Associated Bloodstream Infections During the Early Months of 2020, National Healthcare Safety Network','impact-of-covid-19-pandemic-on-central-line-associated-bloodstream-infections-during-the-early-months-of-2020-national-healthcare-safety-network','news/impact-of-covid-19-pandemic-on-central-line-associated-bloodstream-infections-during-the-early-months-of-2020-national-healthcare-safety-network','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\"}',1,'2024-06-03 21:51:33','2024-06-03 21:51:33','b310e9ee-60aa-44e1-8c53-ddb531e8df3b'),(20149,20149,1,NULL,'impact-of-covid-19-pandemic-on-central-line-associated-bloodstream-infections-during-the-early-months-of-2020-national-healthcare-safety-network',NULL,'{\"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Impact of COVID-19 Pandemic on Central Line-Associated Bloodstream Infections During the Early Months of 2020, National Healthcare Safety Network\"}',1,'2024-06-03 21:51:33','2024-06-03 21:51:33','add3ea05-af04-4b4b-90fb-d237461aee34'),(20150,20150,1,'CORHA Releases a Planning and Preparation High-Level Guidance Chapter','corha-releases-chapter-3-of-high-level-guidance','news/corha-releases-chapter-3-of-high-level-guidance','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"CORHA released Chapter 3: Planning and Preparation for Healthcare-Associated Infection and Antimicrobial-Resistant Pathogen Outbreak Response. The resource includes information on agency roles, outbreak response team, resources, records management, communication, escalation, and more.\"}',1,'2024-06-03 21:51:33','2024-06-03 21:51:33','b7bd4c99-a431-4bb9-aed0-05d40fbc341f'),(20151,20151,1,NULL,'corha-releases-chapter-3-of-high-level-guidance',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"CORHA released Chapter 3: Planning and Preparation for Healthcare-Associated Infection and Antimicrobial-Resistant Pathogen Outbreak Response. The resource includes information on agency roles, outbreak response team, resources, records management, communication, escalation, and more.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"CORHA Releases a Planning and Preparation High-Level Guidance Chapter\"}',1,'2024-06-03 21:51:33','2024-06-03 21:51:33','4bd184e9-aa32-449a-bfd9-ee33692a05cd'),(20152,20152,1,'CORHA Releases a Planning and Preparation High-Level Guidance Chapter','corha-releases-chapter-3-of-high-level-guidance','news/corha-releases-chapter-3-of-high-level-guidance','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"CORHA released Chapter 3: Planning and Preparation for Healthcare-Associated Infection and Antimicrobial-Resistant Pathogen Outbreak Response. The resource includes information on agency roles, outbreak response team, resources, records management, communication, escalation, and more.\"}',1,'2024-06-03 21:51:33','2024-06-03 21:51:33','e5b0eb72-a1a0-42a0-87e2-6623b9f5339a'),(20153,20153,1,NULL,'corha-releases-chapter-3-of-high-level-guidance',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"CORHA released Chapter 3: Planning and Preparation for Healthcare-Associated Infection and Antimicrobial-Resistant Pathogen Outbreak Response. The resource includes information on agency roles, outbreak response team, resources, records management, communication, escalation, and more.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"CORHA Releases a Planning and Preparation High-Level Guidance Chapter\"}',1,'2024-06-03 21:51:33','2024-06-03 21:51:33','0faae514-a457-49f7-88ea-6b953d618c6a'),(20154,20154,1,'How Long-Term Care Facilities Can Help Monitor COVID-19 Vaccine Safety','how-long-term-care-facilities-can-help-monitor-covid-19-vaccine-safety','news/how-long-term-care-facilities-can-help-monitor-covid-19-vaccine-safety','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\"}',1,'2024-06-03 21:51:34','2024-06-03 21:51:34','09d44d1a-b516-4a99-b53d-78c7682fe77a'),(20155,20155,1,NULL,'how-long-term-care-facilities-can-help-monitor-covid-19-vaccine-safety',NULL,'{\"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"How Long-Term Care Facilities Can Help Monitor COVID-19 Vaccine Safety\"}',1,'2024-06-03 21:51:34','2024-06-03 21:51:34','65d66f40-4e98-4bd2-a77f-88ce14a3a368'),(20156,20156,1,'How Long-Term Care Facilities Can Help Monitor COVID-19 Vaccine Safety','how-long-term-care-facilities-can-help-monitor-covid-19-vaccine-safety','news/how-long-term-care-facilities-can-help-monitor-covid-19-vaccine-safety','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\"}',1,'2024-06-03 21:51:34','2024-06-03 21:51:34','b3a27bd7-f269-4c87-8044-ad021934bfea'),(20157,20157,1,NULL,'how-long-term-care-facilities-can-help-monitor-covid-19-vaccine-safety',NULL,'{\"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"How Long-Term Care Facilities Can Help Monitor COVID-19 Vaccine Safety\"}',1,'2024-06-03 21:51:34','2024-06-03 21:51:34','a98a3a86-718c-411b-9a3e-dafb5f4a57ba'),(20158,20158,1,'Health Department Partnership Coordination Strategies to Enhance Surveillance, Increase Resources and Staffing, and Improve Communication and Collaboration','health-department-partnership-coordination-strategies-to-enhance-surveillance-increase-resources-and-staffing-and-improve-communication-and-collaboration','news/health-department-partnership-coordination-strategies-to-enhance-surveillance-increase-resources-and-staffing-and-improve-communication-and-collaboration','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"This report by the Associaton of State and Territorial Health Officials (ASTHO) highlights examples of health department partnership coordination strategies to enhance surveillance, increase resource and staffing capacity, and improve communication and collaboration in order to strengthen infection prevention and control practices during the COVID-19 response.\"}',1,'2024-06-03 21:51:34','2024-06-03 21:51:34','5c7f9c30-d31b-48b1-ad64-294a7cfc69a9'),(20159,20159,1,NULL,'health-department-partnership-coordination-strategies-to-enhance-surveillance-increase-resources-and-staffing-and-improve-communication-and-collaboration',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"This report by the Associaton of State and Territorial Health Officials (ASTHO) highlights examples of health department partnership coordination strategies to enhance surveillance, increase resource and staffing capacity, and improve communication and collaboration in order to strengthen infection prevention and control practices during the COVID-19 response.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Health Department Partnership Coordination Strategies to Enhance Surveillance, Increase Resources and Staffing, and Improve Communication and Collaboration\"}',1,'2024-06-03 21:51:34','2024-06-03 21:51:34','2876f39f-fb7d-4041-b383-978b3b1ea9c0'),(20160,20160,1,'Health Department Partnership Coordination Strategies to Enhance Surveillance, Increase Resources and Staffing, and Improve Communication and Collaboration','health-department-partnership-coordination-strategies-to-enhance-surveillance-increase-resources-and-staffing-and-improve-communication-and-collaboration','news/health-department-partnership-coordination-strategies-to-enhance-surveillance-increase-resources-and-staffing-and-improve-communication-and-collaboration','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"This report by the Associaton of State and Territorial Health Officials (ASTHO) highlights examples of health department partnership coordination strategies to enhance surveillance, increase resource and staffing capacity, and improve communication and collaboration in order to strengthen infection prevention and control practices during the COVID-19 response.\"}',1,'2024-06-03 21:51:34','2024-06-03 21:51:34','dea548f5-7fb8-4477-8d25-6cf20977c03e'),(20161,20161,1,NULL,'health-department-partnership-coordination-strategies-to-enhance-surveillance-increase-resources-and-staffing-and-improve-communication-and-collaboration',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"This report by the Associaton of State and Territorial Health Officials (ASTHO) highlights examples of health department partnership coordination strategies to enhance surveillance, increase resource and staffing capacity, and improve communication and collaboration in order to strengthen infection prevention and control practices during the COVID-19 response.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Health Department Partnership Coordination Strategies to Enhance Surveillance, Increase Resources and Staffing, and Improve Communication and Collaboration\"}',1,'2024-06-03 21:51:34','2024-06-03 21:51:34','078a6bd6-e0a1-43b3-8390-adb65bd032fb'),(20162,20162,1,'Feds Say Doc\'s Offices in SF and San Mateo Provided Knock-Off Cosmetic Treatments','feds-say-docs-offices-in-sf-and-san-mateo-provided-knock-off-cosmetic-treatments','news/feds-say-docs-offices-in-sf-and-san-mateo-provided-knock-off-cosmetic-treatments','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\"}',1,'2024-06-03 21:51:34','2024-06-03 21:51:34','cf72278d-aeaf-44f4-b1ed-92672596ea0c'),(20163,20163,1,NULL,'feds-say-docs-offices-in-sf-and-san-mateo-provided-knock-off-cosmetic-treatments',NULL,'{\"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Feds Say Doc\'s Offices in SF and San Mateo Provided Knock-Off Cosmetic Treatments\"}',1,'2024-06-03 21:51:34','2024-06-03 21:51:34','96d7dbd7-ea1d-474f-9092-d4555b5561b1'),(20164,20164,1,'Feds Say Doc\'s Offices in SF and San Mateo Provided Knock-Off Cosmetic Treatments','feds-say-docs-offices-in-sf-and-san-mateo-provided-knock-off-cosmetic-treatments','news/feds-say-docs-offices-in-sf-and-san-mateo-provided-knock-off-cosmetic-treatments','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\"}',1,'2024-06-03 21:51:34','2024-06-03 21:51:34','fda07738-7c2b-4531-a38b-d30ec8607a0b'),(20165,20165,1,NULL,'feds-say-docs-offices-in-sf-and-san-mateo-provided-knock-off-cosmetic-treatments',NULL,'{\"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Feds Say Doc\'s Offices in SF and San Mateo Provided Knock-Off Cosmetic Treatments\"}',1,'2024-06-03 21:51:34','2024-06-03 21:51:34','13a7f8d0-9953-435b-96e2-38099cc4c6e8'),(20166,20166,1,'MMWR on Postvaccination SARS-CoV-2 Infections Among Skilled Nursing Facility Residents and Staff Members — Chicago, Illinois, December 2020–March 2021','mmwr-on-postvaccination-sars-cov-2-infections-among-skilled-nursing-facility-residents-and-staff-members-chicago-illinois-december-2020-march-2021','news/mmwr-on-postvaccination-sars-cov-2-infections-among-skilled-nursing-facility-residents-and-staff-members-chicago-illinois-december-2020-march-2021','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\"}',1,'2024-06-03 21:51:34','2024-06-03 21:51:34','ba3cf1f8-3b73-403c-bf7b-cf27c1e4f267'),(20167,20167,1,NULL,'mmwr-on-postvaccination-sars-cov-2-infections-among-skilled-nursing-facility-residents-and-staff-members-chicago-illinois-december-2020-march-2021',NULL,'{\"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"MMWR on Postvaccination SARS-CoV-2 Infections Among Skilled Nursing Facility Residents and Staff Members — Chicago, Illinois, December 2020–March 2021\"}',1,'2024-06-03 21:51:34','2024-06-03 21:51:34','ae1d09c7-fad3-4af6-a9d9-f23f09f5d813'),(20168,20168,1,'MMWR on Postvaccination SARS-CoV-2 Infections Among Skilled Nursing Facility Residents and Staff Members — Chicago, Illinois, December 2020–March 2021','mmwr-on-postvaccination-sars-cov-2-infections-among-skilled-nursing-facility-residents-and-staff-members-chicago-illinois-december-2020-march-2021','news/mmwr-on-postvaccination-sars-cov-2-infections-among-skilled-nursing-facility-residents-and-staff-members-chicago-illinois-december-2020-march-2021','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\"}',1,'2024-06-03 21:51:34','2024-06-03 21:51:34','d8217919-e934-4322-8ed8-34d5041c82cb'),(20169,20169,1,NULL,'mmwr-on-postvaccination-sars-cov-2-infections-among-skilled-nursing-facility-residents-and-staff-members-chicago-illinois-december-2020-march-2021',NULL,'{\"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"MMWR on Postvaccination SARS-CoV-2 Infections Among Skilled Nursing Facility Residents and Staff Members — Chicago, Illinois, December 2020–March 2021\"}',1,'2024-06-03 21:51:34','2024-06-03 21:51:34','e3225d71-a018-4c9b-9a20-0a3ef86f1a20'),(20170,20170,1,'MMWR on COVID-19 Outbreak Associated with a SARS-CoV-2 R.1 Lineage Variant in a Skilled Nursing Facility After Vaccination Program — Kentucky, March 2021','mmwr-on-covid-19-outbreak-associated-with-a-sars-cov-2-r-1-lineage-variant-in-a-skilled-nursing-facility-after-vaccination-program-kentucky-march-2021','news/mmwr-on-covid-19-outbreak-associated-with-a-sars-cov-2-r-1-lineage-variant-in-a-skilled-nursing-facility-after-vaccination-program-kentucky-march-2021','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\"}',1,'2024-06-03 21:51:34','2024-06-03 21:51:34','3b669efc-5ff1-4573-8b4c-341d1170321c'),(20171,20171,1,NULL,'mmwr-on-covid-19-outbreak-associated-with-a-sars-cov-2-r-1-lineage-variant-in-a-skilled-nursing-facility-after-vaccination-program-kentucky-march-2021',NULL,'{\"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"MMWR on COVID-19 Outbreak Associated with a SARS-CoV-2 R.1 Lineage Variant in a Skilled Nursing Facility After Vaccination Program — Kentucky, March 2021\"}',1,'2024-06-03 21:51:34','2024-06-03 21:51:34','e27eb92c-d7c9-4fca-b52e-4b942fc77ae2'),(20172,20172,1,'MMWR on COVID-19 Outbreak Associated with a SARS-CoV-2 R.1 Lineage Variant in a Skilled Nursing Facility After Vaccination Program — Kentucky, March 2021','mmwr-on-covid-19-outbreak-associated-with-a-sars-cov-2-r-1-lineage-variant-in-a-skilled-nursing-facility-after-vaccination-program-kentucky-march-2021','news/mmwr-on-covid-19-outbreak-associated-with-a-sars-cov-2-r-1-lineage-variant-in-a-skilled-nursing-facility-after-vaccination-program-kentucky-march-2021','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\"}',1,'2024-06-03 21:51:34','2024-06-03 21:51:34','87e0b3df-a03f-47c6-ae47-fa18ea2a626a'),(20173,20173,1,NULL,'mmwr-on-covid-19-outbreak-associated-with-a-sars-cov-2-r-1-lineage-variant-in-a-skilled-nursing-facility-after-vaccination-program-kentucky-march-2021',NULL,'{\"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"MMWR on COVID-19 Outbreak Associated with a SARS-CoV-2 R.1 Lineage Variant in a Skilled Nursing Facility After Vaccination Program — Kentucky, March 2021\"}',1,'2024-06-03 21:51:34','2024-06-03 21:51:34','53470d36-deb7-48f0-b443-9ffb25f76c0f'),(20174,20174,1,'National Estimates of Healthcare Costs Associated With Multidrug-Resistant Bacterial Infections Among Hospitalized Patients in the United States','national-estimates-of-healthcare-costs-associated-with-multidrug-resistant-bacterial-infections-among-hospitalized-patients-in-the-united-states','news/national-estimates-of-healthcare-costs-associated-with-multidrug-resistant-bacterial-infections-among-hospitalized-patients-in-the-united-states','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\"}',1,'2024-06-03 21:51:34','2024-06-03 21:51:34','31e036f4-4e74-44f2-bc17-e27ccdf22afd'),(20175,20175,1,NULL,'national-estimates-of-healthcare-costs-associated-with-multidrug-resistant-bacterial-infections-among-hospitalized-patients-in-the-united-states',NULL,'{\"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"National Estimates of Healthcare Costs Associated With Multidrug-Resistant Bacterial Infections Among Hospitalized Patients in the United States\"}',1,'2024-06-03 21:51:34','2024-06-03 21:51:34','f927e9e6-9b5c-458a-beaa-3f86c5cd70cb'),(20176,20176,1,'National Estimates of Healthcare Costs Associated With Multidrug-Resistant Bacterial Infections Among Hospitalized Patients in the United States','national-estimates-of-healthcare-costs-associated-with-multidrug-resistant-bacterial-infections-among-hospitalized-patients-in-the-united-states','news/national-estimates-of-healthcare-costs-associated-with-multidrug-resistant-bacterial-infections-among-hospitalized-patients-in-the-united-states','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\"}',1,'2024-06-03 21:51:35','2024-06-03 21:51:35','380bc4a4-3020-4768-9f1b-3a7487a79c22'),(20177,20177,1,NULL,'national-estimates-of-healthcare-costs-associated-with-multidrug-resistant-bacterial-infections-among-hospitalized-patients-in-the-united-states',NULL,'{\"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"National Estimates of Healthcare Costs Associated With Multidrug-Resistant Bacterial Infections Among Hospitalized Patients in the United States\"}',1,'2024-06-03 21:51:35','2024-06-03 21:51:35','4bbcb82e-dc16-4137-a2ca-296b46db9626'),(20178,20178,1,'State Spotlight: How Montana Leverages Partnerships to Manage COVID-19 Outbreaks in Long-Term Care Facilities','state-spotlight-how-montana-leverages-partnerships-to-manage-covid-19-outbreaks-in-long-term-care-facilities','news/state-spotlight-how-montana-leverages-partnerships-to-manage-covid-19-outbreaks-in-long-term-care-facilities','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\"}',1,'2024-06-03 21:51:35','2024-06-03 21:51:35','5a061634-69b9-41d7-89f9-b0ebbb623839'),(20179,20179,1,NULL,'state-spotlight-how-montana-leverages-partnerships-to-manage-covid-19-outbreaks-in-long-term-care-facilities',NULL,'{\"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"State Spotlight: How Montana Leverages Partnerships to Manage COVID-19 Outbreaks in Long-Term Care Facilities\"}',1,'2024-06-03 21:51:35','2024-06-03 21:51:35','d81497eb-4ff3-47f5-8236-1a4b76412dec'),(20180,20180,1,'State Spotlight: How Montana Leverages Partnerships to Manage COVID-19 Outbreaks in Long-Term Care Facilities','state-spotlight-how-montana-leverages-partnerships-to-manage-covid-19-outbreaks-in-long-term-care-facilities','news/state-spotlight-how-montana-leverages-partnerships-to-manage-covid-19-outbreaks-in-long-term-care-facilities','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\"}',1,'2024-06-03 21:51:35','2024-06-03 21:51:35','93a04fba-c337-463f-82eb-7ca0ec98f93b'),(20181,20181,1,NULL,'state-spotlight-how-montana-leverages-partnerships-to-manage-covid-19-outbreaks-in-long-term-care-facilities',NULL,'{\"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"State Spotlight: How Montana Leverages Partnerships to Manage COVID-19 Outbreaks in Long-Term Care Facilities\"}',1,'2024-06-03 21:51:35','2024-06-03 21:51:35','3cd1d400-7feb-4f52-a12b-075b087ee5ce'),(20182,20182,1,'MMWR on Modeling of Future COVID-19 Cases, Hospitalizations, and Deaths, by Vaccination Rates and Nonpharmaceutical Intervention Scenarios — United States, April–September 2021','mmwr-on-modeling-of-future-covid-19-cases-hospitalizations-and-deaths-by-vaccination-rates-and-nonpharmaceutical-intervention-scenarios-united-states-april-september-2021','news/mmwr-on-modeling-of-future-covid-19-cases-hospitalizations-and-deaths-by-vaccination-rates-and-nonpharmaceutical-intervention-scenarios-united-states-april-september-2021','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\"}',1,'2024-06-03 21:51:35','2024-06-03 21:51:35','d0053579-bb47-4c03-8cdf-b9e30ec42512'),(20183,20183,1,NULL,'mmwr-on-modeling-of-future-covid-19-cases-hospitalizations-and-deaths-by-vaccination-rates-and-nonpharmaceutical-intervention-scenarios-united-states-april-september-2021',NULL,'{\"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"MMWR on Modeling of Future COVID-19 Cases, Hospitalizations, and Deaths, by Vaccination Rates and Nonpharmaceutical Intervention Scenarios — United States, April–September 2021\"}',1,'2024-06-03 21:51:35','2024-06-03 21:51:35','37e471bb-c9b8-435f-8cba-c86b325af9ee'),(20184,20184,1,'MMWR on Modeling of Future COVID-19 Cases, Hospitalizations, and Deaths, by Vaccination Rates and Nonpharmaceutical Intervention Scenarios — United States, April–September 2021','mmwr-on-modeling-of-future-covid-19-cases-hospitalizations-and-deaths-by-vaccination-rates-and-nonpharmaceutical-intervention-scenarios-united-states-april-september-2021','news/mmwr-on-modeling-of-future-covid-19-cases-hospitalizations-and-deaths-by-vaccination-rates-and-nonpharmaceutical-intervention-scenarios-united-states-april-september-2021','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\"}',1,'2024-06-03 21:51:35','2024-06-03 21:51:35','fa90302c-990d-4684-b922-c83ad807653d'),(20185,20185,1,NULL,'mmwr-on-modeling-of-future-covid-19-cases-hospitalizations-and-deaths-by-vaccination-rates-and-nonpharmaceutical-intervention-scenarios-united-states-april-september-2021',NULL,'{\"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"MMWR on Modeling of Future COVID-19 Cases, Hospitalizations, and Deaths, by Vaccination Rates and Nonpharmaceutical Intervention Scenarios — United States, April–September 2021\"}',1,'2024-06-03 21:51:35','2024-06-03 21:51:35','24b0b952-ced1-4da4-846f-a5ac976dfdbe'),(20186,20186,1,'Long-Term Care Community Champions: Voices From the Front Line','long-term-care-community-champions-voices-from-the-front-line','news/long-term-care-community-champions-voices-from-the-front-line','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\"}',1,'2024-06-03 21:51:35','2024-06-03 21:51:35','5bbddd57-cb4e-45c5-8d0f-2e11447548ad'),(20187,20187,1,NULL,'long-term-care-community-champions-voices-from-the-front-line',NULL,'{\"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Long-Term Care Community Champions: Voices From the Front Line\"}',1,'2024-06-03 21:51:35','2024-06-03 21:51:35','0b11dcb5-5833-4e89-a8b1-b41e9a1404c4'),(20188,20188,1,'Long-Term Care Community Champions: Voices From the Front Line','long-term-care-community-champions-voices-from-the-front-line','news/long-term-care-community-champions-voices-from-the-front-line','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\"}',1,'2024-06-03 21:51:35','2024-06-03 21:51:35','48ff7f60-902a-4116-9880-a12820d27a63'),(20189,20189,1,NULL,'long-term-care-community-champions-voices-from-the-front-line',NULL,'{\"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Long-Term Care Community Champions: Voices From the Front Line\"}',1,'2024-06-03 21:51:35','2024-06-03 21:51:35','d433a8a5-6165-4b02-9192-72d010c90429'),(20190,20190,1,'Two New Pieces of Legislation Will Require “Safe Staffing” Measures in New York Hospitals and Nursing Homes','two-new-pieces-of-legislation-will-require-safe-staffing-measures-in-new-york-hospitals-and-nursing-homes','news/two-new-pieces-of-legislation-will-require-safe-staffing-measures-in-new-york-hospitals-and-nursing-homes','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\"}',1,'2024-06-03 21:51:35','2024-06-03 21:51:35','ab2ade98-c5f5-45a7-8186-7816f370c524'),(20191,20191,1,NULL,'two-new-pieces-of-legislation-will-require-safe-staffing-measures-in-new-york-hospitals-and-nursing-homes',NULL,'{\"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Two New Pieces of Legislation Will Require “Safe Staffing” Measures in New York Hospitals and Nursing Homes\"}',1,'2024-06-03 21:51:36','2024-06-03 21:51:36','f4f66269-8e7e-40d7-bdc5-16fd81a69a88'),(20192,20192,1,'Two New Pieces of Legislation Will Require “Safe Staffing” Measures in New York Hospitals and Nursing Homes','two-new-pieces-of-legislation-will-require-safe-staffing-measures-in-new-york-hospitals-and-nursing-homes','news/two-new-pieces-of-legislation-will-require-safe-staffing-measures-in-new-york-hospitals-and-nursing-homes','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\"}',1,'2024-06-03 21:51:36','2024-06-03 21:51:36','2240315d-9d73-44ea-93b7-9b8a6c4cedbf'),(20193,20193,1,NULL,'two-new-pieces-of-legislation-will-require-safe-staffing-measures-in-new-york-hospitals-and-nursing-homes',NULL,'{\"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Two New Pieces of Legislation Will Require “Safe Staffing” Measures in New York Hospitals and Nursing Homes\"}',1,'2024-06-03 21:51:36','2024-06-03 21:51:36','d876de66-2cef-492e-bb9d-131bc0fbbd2c'),(20194,20194,1,'Celebrating National Skilled Nursing Care Week 2021','celebrating-national-skilled-nursing-care-week-2021','news/celebrating-national-skilled-nursing-care-week-2021','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\"}',1,'2024-06-03 21:51:36','2024-06-03 21:51:36','0681749e-1fda-45e0-a076-8fbcc381a8b1'),(20195,20195,1,NULL,'celebrating-national-skilled-nursing-care-week-2021',NULL,'{\"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Celebrating National Skilled Nursing Care Week 2021\"}',1,'2024-06-03 21:51:36','2024-06-03 21:51:36','98f67e60-588c-4ef3-b105-3e2f44a4b0c7'),(20196,20196,1,'Celebrating National Skilled Nursing Care Week 2021','celebrating-national-skilled-nursing-care-week-2021','news/celebrating-national-skilled-nursing-care-week-2021','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\"}',1,'2024-06-03 21:51:36','2024-06-03 21:51:36','324874dd-87c7-435a-b14b-ba9a766bbf80'),(20197,20197,1,NULL,'celebrating-national-skilled-nursing-care-week-2021',NULL,'{\"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Celebrating National Skilled Nursing Care Week 2021\"}',1,'2024-06-03 21:51:36','2024-06-03 21:51:36','65986cbe-5859-445e-8a15-3123585fb797'),(20198,20198,1,'CMS Expanding Efforts to Grow COVID-19 Vaccine Confidence and Uptake Amongst Nation’s Most Vulnerable','cms-expanding-efforts-to-grow-covid-19-vaccine-confidence-and-uptake-amongst-nations-most-vulnerable','news/cms-expanding-efforts-to-grow-covid-19-vaccine-confidence-and-uptake-amongst-nations-most-vulnerable','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\"}',1,'2024-06-03 21:51:36','2024-06-03 21:51:36','2d2e4782-4b55-4186-a12b-dc603ad750a6'),(20199,20199,1,NULL,'cms-expanding-efforts-to-grow-covid-19-vaccine-confidence-and-uptake-amongst-nations-most-vulnerable',NULL,'{\"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"CMS Expanding Efforts to Grow COVID-19 Vaccine Confidence and Uptake Amongst Nation’s Most Vulnerable\"}',1,'2024-06-03 21:51:36','2024-06-03 21:51:36','42b21dd9-6565-4bfc-83fc-7c1722143280'),(20200,20200,1,'CMS Expanding Efforts to Grow COVID-19 Vaccine Confidence and Uptake Amongst Nation’s Most Vulnerable','cms-expanding-efforts-to-grow-covid-19-vaccine-confidence-and-uptake-amongst-nations-most-vulnerable','news/cms-expanding-efforts-to-grow-covid-19-vaccine-confidence-and-uptake-amongst-nations-most-vulnerable','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\"}',1,'2024-06-03 21:51:36','2024-06-03 21:51:36','6685f0a8-15d4-4369-9740-064e02838999'),(20201,20201,1,NULL,'cms-expanding-efforts-to-grow-covid-19-vaccine-confidence-and-uptake-amongst-nations-most-vulnerable',NULL,'{\"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"CMS Expanding Efforts to Grow COVID-19 Vaccine Confidence and Uptake Amongst Nation’s Most Vulnerable\"}',1,'2024-06-03 21:51:36','2024-06-03 21:51:36','21e1fba3-3b1f-4322-9919-56c89c6e03c4'),(20202,20202,1,'The CDC Foundation Recognizes All Frontline Nursing Home Staff In The U.S. With The 2021 McKnight Prize For Healthcare Outbreak Heroes','the-cdc-foundation-recognizes-all-frontline-nursing-home-staff-in-the-u-s-with-the-2021-mcknight-prize-for-healthcare-outbreak-heroes','news/the-cdc-foundation-recognizes-all-frontline-nursing-home-staff-in-the-u-s-with-the-2021-mcknight-prize-for-healthcare-outbreak-heroes','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\"}',1,'2024-06-03 21:51:36','2024-06-03 21:51:36','963adf76-699a-470c-8913-e08c971e13fa'),(20203,20203,1,NULL,'the-cdc-foundation-recognizes-all-frontline-nursing-home-staff-in-the-u-s-with-the-2021-mcknight-prize-for-healthcare-outbreak-heroes',NULL,'{\"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"The CDC Foundation Recognizes All Frontline Nursing Home Staff In The U.S. With The 2021 McKnight Prize For Healthcare Outbreak Heroes\"}',1,'2024-06-03 21:51:36','2024-06-03 21:51:36','8a854b4e-121d-45a6-9132-adbac74879ec'),(20204,20204,1,'The CDC Foundation Recognizes All Frontline Nursing Home Staff In The U.S. With The 2021 McKnight Prize For Healthcare Outbreak Heroes','the-cdc-foundation-recognizes-all-frontline-nursing-home-staff-in-the-u-s-with-the-2021-mcknight-prize-for-healthcare-outbreak-heroes','news/the-cdc-foundation-recognizes-all-frontline-nursing-home-staff-in-the-u-s-with-the-2021-mcknight-prize-for-healthcare-outbreak-heroes','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\"}',1,'2024-06-03 21:51:36','2024-06-03 21:51:36','26bf1f30-a2d8-4210-b5ab-df107c7dd7be'),(20205,20205,1,NULL,'the-cdc-foundation-recognizes-all-frontline-nursing-home-staff-in-the-u-s-with-the-2021-mcknight-prize-for-healthcare-outbreak-heroes',NULL,'{\"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"The CDC Foundation Recognizes All Frontline Nursing Home Staff In The U.S. With The 2021 McKnight Prize For Healthcare Outbreak Heroes\"}',1,'2024-06-03 21:51:36','2024-06-03 21:51:36','f8494808-a794-447b-9208-36ec9da727f8'),(20206,20206,1,'State Spotlight: How the Texas State Healthcare-Associated Infections (HAI) Program Increased Capacity in Public Health Regions to Support Healthcare Facilities During the COVID-19 Response','state-spotlight-how-the-texas-state-healthcare-associated-infections-hai-program-increased-capacity-in-public-health-regions-to-support-healthcare-facilities-during-the-covid-19-response','news/state-spotlight-how-the-texas-state-healthcare-associated-infections-hai-program-increased-capacity-in-public-health-regions-to-support-healthcare-facilities-during-the-covid-19-response','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\"}',1,'2024-06-03 21:51:36','2024-06-03 21:51:36','f7e6bb76-a246-42e4-bcb1-7f2e00a6460f'),(20207,20207,1,NULL,'state-spotlight-how-the-texas-state-healthcare-associated-infections-hai-program-increased-capacity-in-public-health-regions-to-support-healthcare-facilities-during-the-covid-19-response',NULL,'{\"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"State Spotlight: How the Texas State Healthcare-Associated Infections (HAI) Program Increased Capacity in Public Health Regions to Support Healthcare Facilities During the COVID-19 Response\"}',1,'2024-06-03 21:51:36','2024-06-03 21:51:36','e787d9f1-e1da-45d1-8eb3-1552fabecc9d'),(20208,20208,1,'State Spotlight: How the Texas State Healthcare-Associated Infections (HAI) Program Increased Capacity in Public Health Regions to Support Healthcare Facilities During the COVID-19 Response','state-spotlight-how-the-texas-state-healthcare-associated-infections-hai-program-increased-capacity-in-public-health-regions-to-support-healthcare-facilities-during-the-covid-19-response','news/state-spotlight-how-the-texas-state-healthcare-associated-infections-hai-program-increased-capacity-in-public-health-regions-to-support-healthcare-facilities-during-the-covid-19-response','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\"}',1,'2024-06-03 21:51:36','2024-06-03 21:51:36','6bfe8860-7e2d-4fd1-aff4-f1bf7bc9699d'),(20209,20209,1,NULL,'state-spotlight-how-the-texas-state-healthcare-associated-infections-hai-program-increased-capacity-in-public-health-regions-to-support-healthcare-facilities-during-the-covid-19-response',NULL,'{\"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"State Spotlight: How the Texas State Healthcare-Associated Infections (HAI) Program Increased Capacity in Public Health Regions to Support Healthcare Facilities During the COVID-19 Response\"}',1,'2024-06-03 21:51:36','2024-06-03 21:51:36','d8d08a1c-4705-4587-9ff6-bcdb06b891d4'),(20210,20210,1,'Outbreak of Hepatitis B and Hepatitis C Virus Infections Associated With a Cardiology Clinic, West Virginia, 2012-2014','outbreak-of-hepatitis-b-and-hepatitis-c-virus-infections-associated-with-a-cardiology-clinic-west-virginia-2012-2014','news/outbreak-of-hepatitis-b-and-hepatitis-c-virus-infections-associated-with-a-cardiology-clinic-west-virginia-2012-2014','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\"}',1,'2024-06-03 21:51:36','2024-06-03 21:51:36','22a48aef-9929-4382-9e80-15548a61fd39'),(20211,20211,1,NULL,'outbreak-of-hepatitis-b-and-hepatitis-c-virus-infections-associated-with-a-cardiology-clinic-west-virginia-2012-2014',NULL,'{\"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Outbreak of Hepatitis B and Hepatitis C Virus Infections Associated With a Cardiology Clinic, West Virginia, 2012-2014\"}',1,'2024-06-03 21:51:36','2024-06-03 21:51:36','6c2a201a-2cd8-452c-b87b-5f021ec603d4'),(20212,20212,1,'Outbreak of Hepatitis B and Hepatitis C Virus Infections Associated With a Cardiology Clinic, West Virginia, 2012-2014','outbreak-of-hepatitis-b-and-hepatitis-c-virus-infections-associated-with-a-cardiology-clinic-west-virginia-2012-2014','news/outbreak-of-hepatitis-b-and-hepatitis-c-virus-infections-associated-with-a-cardiology-clinic-west-virginia-2012-2014','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\"}',1,'2024-06-03 21:51:36','2024-06-03 21:51:36','26739955-c4b7-4c29-8c4f-87caf84af410'),(20213,20213,1,NULL,'outbreak-of-hepatitis-b-and-hepatitis-c-virus-infections-associated-with-a-cardiology-clinic-west-virginia-2012-2014',NULL,'{\"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Outbreak of Hepatitis B and Hepatitis C Virus Infections Associated With a Cardiology Clinic, West Virginia, 2012-2014\"}',1,'2024-06-03 21:51:36','2024-06-03 21:51:36','f5130fac-9d64-4dde-b17c-aff1085da90b'),(20214,20214,1,'COVID-19 in Nursing Homes: Most Homes Had Multiple Outbreaks and Weeks of Sustained Transmission from May 2020 through January 2021','covid-19-in-nursing-homes-most-homes-had-multiple-outbreaks-and-weeks-of-sustained-transmission-from-may-2020-through-january-2021','news/covid-19-in-nursing-homes-most-homes-had-multiple-outbreaks-and-weeks-of-sustained-transmission-from-may-2020-through-january-2021','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\"}',1,'2024-06-03 21:51:36','2024-06-03 21:51:36','cc7f8679-45c5-46bc-87d9-24852d1447a1'),(20215,20215,1,NULL,'covid-19-in-nursing-homes-most-homes-had-multiple-outbreaks-and-weeks-of-sustained-transmission-from-may-2020-through-january-2021',NULL,'{\"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"COVID-19 in Nursing Homes: Most Homes Had Multiple Outbreaks and Weeks of Sustained Transmission from May 2020 through January 2021\"}',1,'2024-06-03 21:51:36','2024-06-03 21:51:36','fd025bec-1f6c-48d8-a196-f502414f8c2a'),(20216,20216,1,'COVID-19 in Nursing Homes: Most Homes Had Multiple Outbreaks and Weeks of Sustained Transmission from May 2020 through January 2021','covid-19-in-nursing-homes-most-homes-had-multiple-outbreaks-and-weeks-of-sustained-transmission-from-may-2020-through-january-2021','news/covid-19-in-nursing-homes-most-homes-had-multiple-outbreaks-and-weeks-of-sustained-transmission-from-may-2020-through-january-2021','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\"}',1,'2024-06-03 21:51:37','2024-06-03 21:51:37','3331cae6-5e1d-4014-9570-f0ecf9b49673'),(20217,20217,1,NULL,'covid-19-in-nursing-homes-most-homes-had-multiple-outbreaks-and-weeks-of-sustained-transmission-from-may-2020-through-january-2021',NULL,'{\"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"COVID-19 in Nursing Homes: Most Homes Had Multiple Outbreaks and Weeks of Sustained Transmission from May 2020 through January 2021\"}',1,'2024-06-03 21:51:37','2024-06-03 21:51:37','5b172896-3ab6-496c-93c1-8008b1db9531'),(20218,20218,1,'Updated Clinical Care Quick Reference for COVID-19: Post-COVID Conditions','updated-clinical-care-quick-reference-for-covid-19-post-covid-conditions','news/updated-clinical-care-quick-reference-for-covid-19-post-covid-conditions','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\"}',1,'2024-06-03 21:51:37','2024-06-03 21:51:37','29ec0be0-497a-46ee-84d5-6e5fcf23465c'),(20219,20219,1,NULL,'updated-clinical-care-quick-reference-for-covid-19-post-covid-conditions',NULL,'{\"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Updated Clinical Care Quick Reference for COVID-19: Post-COVID Conditions\"}',1,'2024-06-03 21:51:37','2024-06-03 21:51:37','fc929bb4-7200-4a78-a3fb-692d2b8fdc24'),(20220,20220,1,'Updated Clinical Care Quick Reference for COVID-19: Post-COVID Conditions','updated-clinical-care-quick-reference-for-covid-19-post-covid-conditions','news/updated-clinical-care-quick-reference-for-covid-19-post-covid-conditions','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\"}',1,'2024-06-03 21:51:37','2024-06-03 21:51:37','c1d50da7-1fa1-4161-af74-71dccc761579'),(20221,20221,1,NULL,'updated-clinical-care-quick-reference-for-covid-19-post-covid-conditions',NULL,'{\"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Updated Clinical Care Quick Reference for COVID-19: Post-COVID Conditions\"}',1,'2024-06-03 21:51:37','2024-06-03 21:51:37','230d40c4-1c8b-42ec-9e00-889b96b52892'),(20222,20222,1,'MMWR on Interim Estimates of Vaccine Effectiveness of Pfizer-BioNTech and Moderna COVID-19 Vaccines Among Health Care Personnel — 33 U.S. Sites, January–March 2021','mmwr-on-interim-estimates-of-vaccine-effectiveness-of-pfizer-biontech-and-moderna-covid-19-vaccines-among-health-care-personnel-33-u-s-sites-january-march-2021','news/mmwr-on-interim-estimates-of-vaccine-effectiveness-of-pfizer-biontech-and-moderna-covid-19-vaccines-among-health-care-personnel-33-u-s-sites-january-march-2021','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\"}',1,'2024-06-03 21:51:37','2024-06-03 21:51:37','25b87dc7-0024-4a01-b6a9-3c28ad0e96d6'),(20223,20223,1,NULL,'mmwr-on-interim-estimates-of-vaccine-effectiveness-of-pfizer-biontech-and-moderna-covid-19-vaccines-among-health-care-personnel-33-u-s-sites-january-march-2021',NULL,'{\"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"MMWR on Interim Estimates of Vaccine Effectiveness of Pfizer-BioNTech and Moderna COVID-19 Vaccines Among Health Care Personnel — 33 U.S. Sites, January–March 2021\"}',1,'2024-06-03 21:51:37','2024-06-03 21:51:37','6c8877cd-8f11-4a65-b934-b2e43dd0dede'),(20224,20224,1,'MMWR on Interim Estimates of Vaccine Effectiveness of Pfizer-BioNTech and Moderna COVID-19 Vaccines Among Health Care Personnel — 33 U.S. Sites, January–March 2021','mmwr-on-interim-estimates-of-vaccine-effectiveness-of-pfizer-biontech-and-moderna-covid-19-vaccines-among-health-care-personnel-33-u-s-sites-january-march-2021','news/mmwr-on-interim-estimates-of-vaccine-effectiveness-of-pfizer-biontech-and-moderna-covid-19-vaccines-among-health-care-personnel-33-u-s-sites-january-march-2021','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\"}',1,'2024-06-03 21:51:37','2024-06-03 21:51:37','71015f0a-66a3-4975-83ed-3fd843fcdb75'),(20225,20225,1,NULL,'mmwr-on-interim-estimates-of-vaccine-effectiveness-of-pfizer-biontech-and-moderna-covid-19-vaccines-among-health-care-personnel-33-u-s-sites-january-march-2021',NULL,'{\"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"MMWR on Interim Estimates of Vaccine Effectiveness of Pfizer-BioNTech and Moderna COVID-19 Vaccines Among Health Care Personnel — 33 U.S. Sites, January–March 2021\"}',1,'2024-06-03 21:51:37','2024-06-03 21:51:37','f5d74e95-e7f9-40c7-ad86-68c4982cc253'),(20226,20226,1,'SARS-CoV-2 Outbreak in Medical Employees in a Large Urologic Department: Spread, Containment and Outcome','sars-cov-2-outbreak-in-medical-employees-in-a-large-urologic-department-spread-containment-and-outcome','news/sars-cov-2-outbreak-in-medical-employees-in-a-large-urologic-department-spread-containment-and-outcome','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\"}',1,'2024-06-03 21:51:37','2024-06-03 21:51:37','21277d4d-df21-4fe6-aa21-77128f16e876'),(20227,20227,1,NULL,'sars-cov-2-outbreak-in-medical-employees-in-a-large-urologic-department-spread-containment-and-outcome',NULL,'{\"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"SARS-CoV-2 Outbreak in Medical Employees in a Large Urologic Department: Spread, Containment and Outcome\"}',1,'2024-06-03 21:51:37','2024-06-03 21:51:37','c3e9c749-ec5a-4e10-bffb-f1bfa67572ae'),(20228,20228,1,'SARS-CoV-2 Outbreak in Medical Employees in a Large Urologic Department: Spread, Containment and Outcome','sars-cov-2-outbreak-in-medical-employees-in-a-large-urologic-department-spread-containment-and-outcome','news/sars-cov-2-outbreak-in-medical-employees-in-a-large-urologic-department-spread-containment-and-outcome','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\"}',1,'2024-06-03 21:51:37','2024-06-03 21:51:37','a95c9341-f8ac-4bf7-a1ad-d5e45e8d5e19'),(20229,20229,1,NULL,'sars-cov-2-outbreak-in-medical-employees-in-a-large-urologic-department-spread-containment-and-outcome',NULL,'{\"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"SARS-CoV-2 Outbreak in Medical Employees in a Large Urologic Department: Spread, Containment and Outcome\"}',1,'2024-06-03 21:51:37','2024-06-03 21:51:37','b57f54a8-a863-459d-aa45-62f7b33e6745'),(20230,20230,1,'Bamlanivimab Reduces Risk of COVID-19 in Nursing Homes','bamlanivimab-reduces-risk-of-covid-19-in-nursing-homes','news/bamlanivimab-reduces-risk-of-covid-19-in-nursing-homes','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\"}',1,'2024-06-03 21:51:37','2024-06-03 21:51:37','511aaedb-f3db-47b0-841a-c6e7254e3647'),(20231,20231,1,NULL,'bamlanivimab-reduces-risk-of-covid-19-in-nursing-homes',NULL,'{\"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Bamlanivimab Reduces Risk of COVID-19 in Nursing Homes\"}',1,'2024-06-03 21:51:37','2024-06-03 21:51:37','66def6f2-2b10-4cc9-b18d-96d1b4d80f9a'),(20232,20232,1,'Bamlanivimab Reduces Risk of COVID-19 in Nursing Homes','bamlanivimab-reduces-risk-of-covid-19-in-nursing-homes','news/bamlanivimab-reduces-risk-of-covid-19-in-nursing-homes','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\"}',1,'2024-06-03 21:51:37','2024-06-03 21:51:37','72f57d81-49fd-44d5-999a-9ab2cecda9f1'),(20233,20233,1,NULL,'bamlanivimab-reduces-risk-of-covid-19-in-nursing-homes',NULL,'{\"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Bamlanivimab Reduces Risk of COVID-19 in Nursing Homes\"}',1,'2024-06-03 21:51:37','2024-06-03 21:51:37','8760458f-ca90-4dc7-a7dc-d391e0321278'),(20234,20234,1,'Preventive Measures Stopped C. auris Outbreaks at Two California Hospitals','preventive-measures-stopped-c-auris-outbreaks-at-two-california-hospitals','news/preventive-measures-stopped-c-auris-outbreaks-at-two-california-hospitals','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\"}',1,'2024-06-03 21:51:37','2024-06-03 21:51:37','d897e4bb-2fc2-4977-9dd5-fefb2830dec4'),(20235,20235,1,NULL,'preventive-measures-stopped-c-auris-outbreaks-at-two-california-hospitals',NULL,'{\"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Preventive Measures Stopped C. auris Outbreaks at Two California Hospitals\"}',1,'2024-06-03 21:51:37','2024-06-03 21:51:37','2566d8d5-8b46-45da-acc0-da786252f7cc'),(20236,20236,1,'Preventive Measures Stopped C. auris Outbreaks at Two California Hospitals','preventive-measures-stopped-c-auris-outbreaks-at-two-california-hospitals','news/preventive-measures-stopped-c-auris-outbreaks-at-two-california-hospitals','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\"}',1,'2024-06-03 21:51:37','2024-06-03 21:51:37','57df2e61-836a-44d1-9d31-bf1a947826e8'),(20237,20237,1,NULL,'preventive-measures-stopped-c-auris-outbreaks-at-two-california-hospitals',NULL,'{\"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Preventive Measures Stopped C. auris Outbreaks at Two California Hospitals\"}',1,'2024-06-03 21:51:37','2024-06-03 21:51:37','ee94cabc-c142-4ed8-a177-39089cc02320'),(20238,20238,1,'MMWR on Transmission of Pan-Resistant and Echinocandin-Resistant Candida auris in Health Care Facilities ― Texas and the District of Columbia, January–April 2021','mmwr-on-transmission-of-pan-resistant-and-echinocandin-resistant-candida-auris-in-health-care-facilities-texas-and-the-district-of-columbia-january-april-2021','news/mmwr-on-transmission-of-pan-resistant-and-echinocandin-resistant-candida-auris-in-health-care-facilities-texas-and-the-district-of-columbia-january-april-2021','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\"}',1,'2024-06-03 21:51:38','2024-06-03 21:51:38','b7423e47-5b33-4fce-87c3-58847a67664a'),(20239,20239,1,NULL,'mmwr-on-transmission-of-pan-resistant-and-echinocandin-resistant-candida-auris-in-health-care-facilities-texas-and-the-district-of-columbia-january-april-2021',NULL,'{\"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"MMWR on Transmission of Pan-Resistant and Echinocandin-Resistant Candida auris in Health Care Facilities ― Texas and the District of Columbia, January–April 2021\"}',1,'2024-06-03 21:51:38','2024-06-03 21:51:38','01713ae8-ac94-423e-b91c-af7c92cbd244'),(20240,20240,1,'MMWR on Transmission of Pan-Resistant and Echinocandin-Resistant Candida auris in Health Care Facilities ― Texas and the District of Columbia, January–April 2021','mmwr-on-transmission-of-pan-resistant-and-echinocandin-resistant-candida-auris-in-health-care-facilities-texas-and-the-district-of-columbia-january-april-2021','news/mmwr-on-transmission-of-pan-resistant-and-echinocandin-resistant-candida-auris-in-health-care-facilities-texas-and-the-district-of-columbia-january-april-2021','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\"}',1,'2024-06-03 21:51:38','2024-06-03 21:51:38','198d6203-1ead-4815-9ec1-c76309837b0d'),(20241,20241,1,NULL,'mmwr-on-transmission-of-pan-resistant-and-echinocandin-resistant-candida-auris-in-health-care-facilities-texas-and-the-district-of-columbia-january-april-2021',NULL,'{\"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"MMWR on Transmission of Pan-Resistant and Echinocandin-Resistant Candida auris in Health Care Facilities ― Texas and the District of Columbia, January–April 2021\"}',1,'2024-06-03 21:51:38','2024-06-03 21:51:38','62dd77db-a4e6-4514-b037-86f603d50740'),(20242,20242,1,'North Carolina Hepatitis A Outbreak Surpasses 1,000 Cases with 16 Deaths','north-carolina-hepatitis-a-outbreak-surpasses-1000-cases-with-16-deaths','news/north-carolina-hepatitis-a-outbreak-surpasses-1000-cases-with-16-deaths','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\"}',1,'2024-06-03 21:51:38','2024-06-03 21:51:38','0058a9bb-c61c-4690-8de1-07f1c3fa109d'),(20243,20243,1,NULL,'north-carolina-hepatitis-a-outbreak-surpasses-1000-cases-with-16-deaths',NULL,'{\"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"North Carolina Hepatitis A Outbreak Surpasses 1,000 Cases with 16 Deaths\"}',1,'2024-06-03 21:51:38','2024-06-03 21:51:38','746a5828-4923-4348-ae17-dbe26c4f57db'),(20244,20244,1,'North Carolina Hepatitis A Outbreak Surpasses 1,000 Cases with 16 Deaths','north-carolina-hepatitis-a-outbreak-surpasses-1000-cases-with-16-deaths','news/north-carolina-hepatitis-a-outbreak-surpasses-1000-cases-with-16-deaths','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\"}',1,'2024-06-03 21:51:38','2024-06-03 21:51:38','76889620-b0ff-4fd0-aaa3-234fbde0f19c'),(20245,20245,1,NULL,'north-carolina-hepatitis-a-outbreak-surpasses-1000-cases-with-16-deaths',NULL,'{\"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"North Carolina Hepatitis A Outbreak Surpasses 1,000 Cases with 16 Deaths\"}',1,'2024-06-03 21:51:38','2024-06-03 21:51:38','0bbb0f59-fb6f-4fd8-8274-e719f7db45bb'),(20246,20246,1,'Why are Health Agencies Hiding Deadly Infection Raging in Hospitals','why-are-health-agencies-hiding-deadly-infection-raging-in-hospitals','news/why-are-health-agencies-hiding-deadly-infection-raging-in-hospitals','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\"}',1,'2024-06-03 21:51:38','2024-06-03 21:51:38','6f8024fc-d44b-4758-82e2-15690368dd84'),(20247,20247,1,NULL,'why-are-health-agencies-hiding-deadly-infection-raging-in-hospitals',NULL,'{\"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Why are Health Agencies Hiding Deadly Infection Raging in Hospitals\"}',1,'2024-06-03 21:51:38','2024-06-03 21:51:38','b9367863-39db-4f33-a6fc-ddb03a31d3a8'),(20248,20248,1,'Why are Health Agencies Hiding Deadly Infection Raging in Hospitals','why-are-health-agencies-hiding-deadly-infection-raging-in-hospitals','news/why-are-health-agencies-hiding-deadly-infection-raging-in-hospitals','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\"}',1,'2024-06-03 21:51:38','2024-06-03 21:51:38','71da62e7-8f82-43ec-bd08-12d53f7b823d'),(20249,20249,1,NULL,'why-are-health-agencies-hiding-deadly-infection-raging-in-hospitals',NULL,'{\"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Why are Health Agencies Hiding Deadly Infection Raging in Hospitals\"}',1,'2024-06-03 21:51:38','2024-06-03 21:51:38','ee5afa9e-311f-48f8-87e9-f8dd883963f0'),(20250,20250,1,'Healthcare Personnel Experiences Implementing Carbapenem-resistant Enterobacterales Infection Control Measures at a Ventilator-capable Skilled Nursing Facility—a Qualitative Analysis','healthcare-personnel-experiences-implementing-carbapenem-resistant-enterobacterales-infection-control-measures-at-a-ventilator-capable-skilled-nursing-facility-a-qualitative-analysis','news/healthcare-personnel-experiences-implementing-carbapenem-resistant-enterobacterales-infection-control-measures-at-a-ventilator-capable-skilled-nursing-facility-a-qualitative-analysis','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\"}',1,'2024-06-03 21:51:38','2024-06-03 21:51:38','4649ad29-4f74-4efa-82de-6be9d188b5a6'),(20251,20251,1,NULL,'healthcare-personnel-experiences-implementing-carbapenem-resistant-enterobacterales-infection-control-measures-at-a-ventilator-capable-skilled-nursing-facility-a-qualitative-analysis',NULL,'{\"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Healthcare Personnel Experiences Implementing Carbapenem-resistant Enterobacterales Infection Control Measures at a Ventilator-capable Skilled Nursing Facility—a Qualitative Analysis\"}',1,'2024-06-03 21:51:38','2024-06-03 21:51:38','c1abe78b-f5c4-4b65-b299-e759c9538e60'),(20252,20252,1,'Healthcare Personnel Experiences Implementing Carbapenem-resistant Enterobacterales Infection Control Measures at a Ventilator-capable Skilled Nursing Facility—a Qualitative Analysis','healthcare-personnel-experiences-implementing-carbapenem-resistant-enterobacterales-infection-control-measures-at-a-ventilator-capable-skilled-nursing-facility-a-qualitative-analysis','news/healthcare-personnel-experiences-implementing-carbapenem-resistant-enterobacterales-infection-control-measures-at-a-ventilator-capable-skilled-nursing-facility-a-qualitative-analysis','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\"}',1,'2024-06-03 21:51:38','2024-06-03 21:51:38','f62d8127-1829-4695-a801-cbe728778ddc'),(20253,20253,1,NULL,'healthcare-personnel-experiences-implementing-carbapenem-resistant-enterobacterales-infection-control-measures-at-a-ventilator-capable-skilled-nursing-facility-a-qualitative-analysis',NULL,'{\"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Healthcare Personnel Experiences Implementing Carbapenem-resistant Enterobacterales Infection Control Measures at a Ventilator-capable Skilled Nursing Facility—a Qualitative Analysis\"}',1,'2024-06-03 21:51:38','2024-06-03 21:51:38','e14b9c2f-4c1f-4339-9663-03c9aefe6a73'),(20254,20254,1,'MMWR on Disparities in COVID-19 Vaccination Coverage Among Health Care Personnel Working in Long-Term Care Facilities, by Job Category, National Healthcare Safety Network — United States, March 2021','mmwr-on-disparities-in-covid-19-vaccination-coverage-among-health-care-personnel-working-in-long-term-care-facilities-by-job-category-national-healthcare-safety-network-united-states-marc','news/mmwr-on-disparities-in-covid-19-vaccination-coverage-among-health-care-personnel-working-in-long-term-care-facilities-by-job-category-national-healthcare-safety-network-united-states-marc','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\"}',1,'2024-06-03 21:51:38','2024-06-03 21:51:38','514e7311-a38b-4626-af9c-96247b95edae'),(20255,20255,1,NULL,'mmwr-on-disparities-in-covid-19-vaccination-coverage-among-health-care-personnel-working-in-long-term-care-facilities-by-job-category-national-healthcare-safety-network-united-states-marc',NULL,'{\"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"MMWR on Disparities in COVID-19 Vaccination Coverage Among Health Care Personnel Working in Long-Term Care Facilities, by Job Category, National Healthcare Safety Network — United States, March 2021\"}',1,'2024-06-03 21:51:38','2024-06-03 21:51:38','bae2b79a-c43d-43af-bb40-a20957b656dc'),(20256,20256,1,'MMWR on Disparities in COVID-19 Vaccination Coverage Among Health Care Personnel Working in Long-Term Care Facilities, by Job Category, National Healthcare Safety Network — United States, March 2021','mmwr-on-disparities-in-covid-19-vaccination-coverage-among-health-care-personnel-working-in-long-term-care-facilities-by-job-category-national-healthcare-safety-network-united-states-marc','news/mmwr-on-disparities-in-covid-19-vaccination-coverage-among-health-care-personnel-working-in-long-term-care-facilities-by-job-category-national-healthcare-safety-network-united-states-marc','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\"}',1,'2024-06-03 21:51:38','2024-06-03 21:51:38','046b7d75-f23c-461d-a7bd-f339248b2964'),(20257,20257,1,NULL,'mmwr-on-disparities-in-covid-19-vaccination-coverage-among-health-care-personnel-working-in-long-term-care-facilities-by-job-category-national-healthcare-safety-network-united-states-marc',NULL,'{\"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"MMWR on Disparities in COVID-19 Vaccination Coverage Among Health Care Personnel Working in Long-Term Care Facilities, by Job Category, National Healthcare Safety Network — United States, March 2021\"}',1,'2024-06-03 21:51:38','2024-06-03 21:51:38','b80d3ec3-6341-41d8-85bc-08944dc883c1'),(20258,20258,1,'100 Johnson City Medical Center Patients Informed of Possible Exposure to Hepatitis, HIV','100-johnson-city-medical-center-patients-informed-of-possible-exposure-to-hepatitis-hiv','news/100-johnson-city-medical-center-patients-informed-of-possible-exposure-to-hepatitis-hiv','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\"}',1,'2024-06-03 21:51:38','2024-06-03 21:51:38','72e45e24-ed2b-4aec-8380-61f76bf78513'),(20259,20259,1,NULL,'100-johnson-city-medical-center-patients-informed-of-possible-exposure-to-hepatitis-hiv',NULL,'{\"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"100 Johnson City Medical Center Patients Informed of Possible Exposure to Hepatitis, HIV\"}',1,'2024-06-03 21:51:38','2024-06-03 21:51:38','f7fdc5db-2af9-46ca-a985-42f2a0b5e7aa'),(20260,20260,1,'100 Johnson City Medical Center Patients Informed of Possible Exposure to Hepatitis, HIV','100-johnson-city-medical-center-patients-informed-of-possible-exposure-to-hepatitis-hiv','news/100-johnson-city-medical-center-patients-informed-of-possible-exposure-to-hepatitis-hiv','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\"}',1,'2024-06-03 21:51:38','2024-06-03 21:51:38','c5048f4a-5365-4092-a747-3ded4a3c4eee'),(20261,20261,1,NULL,'100-johnson-city-medical-center-patients-informed-of-possible-exposure-to-hepatitis-hiv',NULL,'{\"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"100 Johnson City Medical Center Patients Informed of Possible Exposure to Hepatitis, HIV\"}',1,'2024-06-03 21:51:38','2024-06-03 21:51:38','fce65b94-cff9-46b2-84a6-e278206d7c44'),(20262,20262,1,'Johnson City Medical Center Patient Plans to Sue Over Risk of HIV, Hepatitis Exposure','johnson-city-medical-center-patient-plans-to-sue-over-risk-of-hiv-hepatitis-exposure','news/johnson-city-medical-center-patient-plans-to-sue-over-risk-of-hiv-hepatitis-exposure','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\"}',1,'2024-06-03 21:51:38','2024-06-03 21:51:38','3eac4ea0-416d-4068-ac1e-8aa7f85b7c81'),(20263,20263,1,NULL,'johnson-city-medical-center-patient-plans-to-sue-over-risk-of-hiv-hepatitis-exposure',NULL,'{\"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Johnson City Medical Center Patient Plans to Sue Over Risk of HIV, Hepatitis Exposure\"}',1,'2024-06-03 21:51:38','2024-06-03 21:51:38','af66a051-ddfa-4ffc-bf3d-668af35b4842'),(20264,20264,1,'Johnson City Medical Center Patient Plans to Sue Over Risk of HIV, Hepatitis Exposure','johnson-city-medical-center-patient-plans-to-sue-over-risk-of-hiv-hepatitis-exposure','news/johnson-city-medical-center-patient-plans-to-sue-over-risk-of-hiv-hepatitis-exposure','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\"}',1,'2024-06-03 21:51:38','2024-06-03 21:51:38','e875bd88-8263-42a3-8600-716e84da99f8'),(20265,20265,1,NULL,'johnson-city-medical-center-patient-plans-to-sue-over-risk-of-hiv-hepatitis-exposure',NULL,'{\"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Johnson City Medical Center Patient Plans to Sue Over Risk of HIV, Hepatitis Exposure\"}',1,'2024-06-03 21:51:38','2024-06-03 21:51:38','6b879e46-ac5c-4250-9965-fb783126b077'),(20266,20266,1,'CDC Investigating TB Cases Linked to Tainted Bone Repair Product Used in More Than 100 Patients','cdc-investigating-tb-cases-linked-to-tainted-bone-repair-product-used-in-more-than-100-patients','news/cdc-investigating-tb-cases-linked-to-tainted-bone-repair-product-used-in-more-than-100-patients','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"Federal and state health officials are investigating a rare tuberculosis outbreak among more than 100 patients who may have been infected after having spinal surgery or fracture repairs this spring with a bone product contaminated with the bacteria that causes TB.\"}',1,'2024-06-03 21:51:39','2024-06-03 21:51:39','06107af1-2cf9-49cb-88f4-fa136cc3fbef'),(20267,20267,1,NULL,'cdc-investigating-tb-cases-linked-to-tainted-bone-repair-product-used-in-more-than-100-patients',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"Federal and state health officials are investigating a rare tuberculosis outbreak among more than 100 patients who may have been infected after having spinal surgery or fracture repairs this spring with a bone product contaminated with the bacteria that causes TB.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"CDC Investigating TB Cases Linked to Tainted Bone Repair Product Used in More Than 100 Patients\"}',1,'2024-06-03 21:51:39','2024-06-03 21:51:39','3eb23dca-d649-4cd8-8707-df8f42202347'),(20268,20268,1,'CDC Investigating TB Cases Linked to Tainted Bone Repair Product Used in More Than 100 Patients','cdc-investigating-tb-cases-linked-to-tainted-bone-repair-product-used-in-more-than-100-patients','news/cdc-investigating-tb-cases-linked-to-tainted-bone-repair-product-used-in-more-than-100-patients','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"Federal and state health officials are investigating a rare tuberculosis outbreak among more than 100 patients who may have been infected after having spinal surgery or fracture repairs this spring with a bone product contaminated with the bacteria that causes TB.\"}',1,'2024-06-03 21:51:39','2024-06-03 21:51:39','106e55e6-c0ef-4f9e-b710-84b2e77bebb5'),(20269,20269,1,NULL,'cdc-investigating-tb-cases-linked-to-tainted-bone-repair-product-used-in-more-than-100-patients',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"Federal and state health officials are investigating a rare tuberculosis outbreak among more than 100 patients who may have been infected after having spinal surgery or fracture repairs this spring with a bone product contaminated with the bacteria that causes TB.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"CDC Investigating TB Cases Linked to Tainted Bone Repair Product Used in More Than 100 Patients\"}',1,'2024-06-03 21:51:39','2024-06-03 21:51:39','a0002d59-3519-4faa-bed1-6bd898304c57'),(20270,20270,1,'CDC Reports Burkholderia Cepacia And B Pseudomallei Outbreaks','cdc-reports-burkholderia-cepacia-and-b-pseudomallei-outbreaks','news/cdc-reports-burkholderia-cepacia-and-b-pseudomallei-outbreaks','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"The CDC and FDA have announced an outbreak of at least 15 Burkholderia cepacia infections associated with contaminated ultrasound gel used to guide invasive procedures as well as an unrelated outbreak of Burkholderia pseudomallei that caused two deaths.\"}',1,'2024-06-03 21:51:39','2024-06-03 21:51:39','07a28a96-10c8-4baa-b41f-536cde7cc6b3'),(20271,20271,1,NULL,'cdc-reports-burkholderia-cepacia-and-b-pseudomallei-outbreaks',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"The CDC and FDA have announced an outbreak of at least 15 Burkholderia cepacia infections associated with contaminated ultrasound gel used to guide invasive procedures as well as an unrelated outbreak of Burkholderia pseudomallei that caused two deaths.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"CDC Reports Burkholderia Cepacia And B Pseudomallei Outbreaks\"}',1,'2024-06-03 21:51:39','2024-06-03 21:51:39','e8d4c984-eaa5-47b7-99a3-c63a73d9056d'),(20272,20272,1,'CDC Reports Burkholderia Cepacia And B Pseudomallei Outbreaks','cdc-reports-burkholderia-cepacia-and-b-pseudomallei-outbreaks','news/cdc-reports-burkholderia-cepacia-and-b-pseudomallei-outbreaks','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"The CDC and FDA have announced an outbreak of at least 15 Burkholderia cepacia infections associated with contaminated ultrasound gel used to guide invasive procedures as well as an unrelated outbreak of Burkholderia pseudomallei that caused two deaths.\"}',1,'2024-06-03 21:51:39','2024-06-03 21:51:39','3f8282e2-a268-49d0-a097-2afcdd4eaeca'),(20273,20273,1,NULL,'cdc-reports-burkholderia-cepacia-and-b-pseudomallei-outbreaks',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"The CDC and FDA have announced an outbreak of at least 15 Burkholderia cepacia infections associated with contaminated ultrasound gel used to guide invasive procedures as well as an unrelated outbreak of Burkholderia pseudomallei that caused two deaths.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"CDC Reports Burkholderia Cepacia And B Pseudomallei Outbreaks\"}',1,'2024-06-03 21:51:39','2024-06-03 21:51:39','9e41e0a9-3435-4d8a-81b9-1b94d0a2a5a0'),(20274,20274,1,'Biden-Harris Administration Takes Additional Action to Protect America’s Nursing Home Residents from COVID-19','biden-harris-administration-takes-additional-action-to-protect-americas-nursing-home-residents-from-covid-19','news/biden-harris-administration-takes-additional-action-to-protect-americas-nursing-home-residents-from-covid-19','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"CMS, in collaboration with the CDC, is developing an emergency regulation requiring staff vaccinations within the nation’s more than 15,000 Medicare and Medicaid-participating nursing homes.\"}',1,'2024-06-03 21:51:39','2024-06-03 21:51:39','0fc59018-9090-4f9c-aa66-d52547375471'),(20275,20275,1,NULL,'biden-harris-administration-takes-additional-action-to-protect-americas-nursing-home-residents-from-covid-19',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"CMS, in collaboration with the CDC, is developing an emergency regulation requiring staff vaccinations within the nation’s more than 15,000 Medicare and Medicaid-participating nursing homes.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Biden-Harris Administration Takes Additional Action to Protect America’s Nursing Home Residents from COVID-19\"}',1,'2024-06-03 21:51:39','2024-06-03 21:51:39','dc0a5970-e011-4292-b82b-a0c293b5c788'),(20276,20276,1,'Biden-Harris Administration Takes Additional Action to Protect America’s Nursing Home Residents from COVID-19','biden-harris-administration-takes-additional-action-to-protect-americas-nursing-home-residents-from-covid-19','news/biden-harris-administration-takes-additional-action-to-protect-americas-nursing-home-residents-from-covid-19','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"CMS, in collaboration with the CDC, is developing an emergency regulation requiring staff vaccinations within the nation’s more than 15,000 Medicare and Medicaid-participating nursing homes.\"}',1,'2024-06-03 21:51:39','2024-06-03 21:51:39','5793af0b-e67c-42e2-8ada-da77d8cfa7ec'),(20277,20277,1,NULL,'biden-harris-administration-takes-additional-action-to-protect-americas-nursing-home-residents-from-covid-19',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"CMS, in collaboration with the CDC, is developing an emergency regulation requiring staff vaccinations within the nation’s more than 15,000 Medicare and Medicaid-participating nursing homes.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Biden-Harris Administration Takes Additional Action to Protect America’s Nursing Home Residents from COVID-19\"}',1,'2024-06-03 21:51:39','2024-06-03 21:51:39','28c0179d-ae5f-4df3-9498-c39d30409f0f'),(20278,20278,1,'Preventing a Candida Auris Outbreak in the Health Care Setting','preventing-a-candida-auris-outbreak-in-the-health-care-setting','news/preventing-a-candida-auris-outbreak-in-the-health-care-setting','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\"}',1,'2024-06-03 21:51:39','2024-06-03 21:51:39','936c1af3-37be-4cb6-80f6-0ce3952efa56'),(20279,20279,1,NULL,'preventing-a-candida-auris-outbreak-in-the-health-care-setting',NULL,'{\"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Preventing a Candida Auris Outbreak in the Health Care Setting\"}',1,'2024-06-03 21:51:39','2024-06-03 21:51:39','022487ef-239e-48a8-ad8e-9ea3a5adcb59'),(20280,20280,1,'Preventing a Candida Auris Outbreak in the Health Care Setting','preventing-a-candida-auris-outbreak-in-the-health-care-setting','news/preventing-a-candida-auris-outbreak-in-the-health-care-setting','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\"}',1,'2024-06-03 21:51:39','2024-06-03 21:51:39','a4e5e94e-479f-4225-b595-f42f5676ea3f'),(20281,20281,1,NULL,'preventing-a-candida-auris-outbreak-in-the-health-care-setting',NULL,'{\"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Preventing a Candida Auris Outbreak in the Health Care Setting\"}',1,'2024-06-03 21:51:39','2024-06-03 21:51:39','4e12668e-ebf9-4b33-99b9-b2468b020219'),(20282,20282,1,'The Impact of Coronavirus Disease 2019 (COVID-19) On Healthcare-Associated Infections in 2020: A Summary of Data Reported to the National Healthcare Safety Network','the-impact-of-coronavirus-disease-2019-covid-19-on-healthcare-associated-infections-in-2020-a-summary-of-data-reported-to-the-national-healthcare-safety-network','news/the-impact-of-coronavirus-disease-2019-covid-19-on-healthcare-associated-infections-in-2020-a-summary-of-data-reported-to-the-national-healthcare-safety-network','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\"}',1,'2024-06-03 21:51:39','2024-06-03 21:51:39','3840f075-cac6-4e13-9d81-d00d67a10a80'),(20283,20283,1,NULL,'the-impact-of-coronavirus-disease-2019-covid-19-on-healthcare-associated-infections-in-2020-a-summary-of-data-reported-to-the-national-healthcare-safety-network',NULL,'{\"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"The Impact of Coronavirus Disease 2019 (COVID-19) On Healthcare-Associated Infections in 2020: A Summary of Data Reported to the National Healthcare Safety Network\"}',1,'2024-06-03 21:51:39','2024-06-03 21:51:39','23702d0a-2425-4ba7-9b57-14779ffa67da'),(20284,20284,1,'The Impact of Coronavirus Disease 2019 (COVID-19) On Healthcare-Associated Infections in 2020: A Summary of Data Reported to the National Healthcare Safety Network','the-impact-of-coronavirus-disease-2019-covid-19-on-healthcare-associated-infections-in-2020-a-summary-of-data-reported-to-the-national-healthcare-safety-network','news/the-impact-of-coronavirus-disease-2019-covid-19-on-healthcare-associated-infections-in-2020-a-summary-of-data-reported-to-the-national-healthcare-safety-network','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"hsatter\"}',1,'2024-06-03 21:51:39','2024-06-03 21:51:39','0bbd008a-f1d4-43ac-be6e-50a171b2c6ad'),(20285,20285,1,NULL,'the-impact-of-coronavirus-disease-2019-covid-19-on-healthcare-associated-infections-in-2020-a-summary-of-data-reported-to-the-national-healthcare-safety-network',NULL,'{\"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"The Impact of Coronavirus Disease 2019 (COVID-19) On Healthcare-Associated Infections in 2020: A Summary of Data Reported to the National Healthcare Safety Network\"}',1,'2024-06-03 21:51:39','2024-06-03 21:51:39','c3d181a7-70a0-425b-adc2-5b450de0c914'),(20286,20286,1,'Interim Infection Prevention and Control Recommendations for Healthcare Personnel During the Coronavirus Disease 2019 (COVID-19) Pandemic','interim-infection-prevention-and-control-recommendations-for-healthcare-personnel-during-the-coronavirus-disease-2019-covid-19-pandemic','news/interim-infection-prevention-and-control-recommendations-for-healthcare-personnel-during-the-coronavirus-disease-2019-covid-19-pandemic','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"amcpherson\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"CDC has updated select healthcare infection prevention and control (IPC) recommendations in response to COVID-19 vaccination, which are now summarized in this guidance.\"}',1,'2024-06-03 21:51:39','2024-06-03 21:51:39','f0b4eb96-5a3a-4d5e-b408-4322c8f52be2'),(20287,20287,1,NULL,'interim-infection-prevention-and-control-recommendations-for-healthcare-personnel-during-the-coronavirus-disease-2019-covid-19-pandemic',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"CDC has updated select healthcare infection prevention and control (IPC) recommendations in response to COVID-19 vaccination, which are now summarized in this guidance.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Interim Infection Prevention and Control Recommendations for Healthcare Personnel During the Coronavirus Disease 2019 (COVID-19) Pandemic\"}',1,'2024-06-03 21:51:39','2024-06-03 21:51:39','34b5d525-0040-49e4-a797-3768ab485505'),(20288,20288,1,'Interim Infection Prevention and Control Recommendations for Healthcare Personnel During the Coronavirus Disease 2019 (COVID-19) Pandemic','interim-infection-prevention-and-control-recommendations-for-healthcare-personnel-during-the-coronavirus-disease-2019-covid-19-pandemic','news/interim-infection-prevention-and-control-recommendations-for-healthcare-personnel-during-the-coronavirus-disease-2019-covid-19-pandemic','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"amcpherson\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"CDC has updated select healthcare infection prevention and control (IPC) recommendations in response to COVID-19 vaccination, which are now summarized in this guidance.\"}',1,'2024-06-03 21:51:39','2024-06-03 21:51:39','de644b58-0365-4f07-a37e-5643df1aee85'),(20289,20289,1,NULL,'interim-infection-prevention-and-control-recommendations-for-healthcare-personnel-during-the-coronavirus-disease-2019-covid-19-pandemic',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"CDC has updated select healthcare infection prevention and control (IPC) recommendations in response to COVID-19 vaccination, which are now summarized in this guidance.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Interim Infection Prevention and Control Recommendations for Healthcare Personnel During the Coronavirus Disease 2019 (COVID-19) Pandemic\"}',1,'2024-06-03 21:51:39','2024-06-03 21:51:39','b19103ee-8d80-4f3c-8260-50d718a4bd39'),(20290,20290,1,'Drugs in Development Might Help Fight Deadly Candida Auris','drugs-in-development-might-help-fight-deadly-candida-auris','news/drugs-in-development-might-help-fight-deadly-candida-auris','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"jabramson\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"New antifungal agents that are being investigated for possible use against C. auris, such as Ibrexafungerp (Brexafemme), show promise—so far.\"}',1,'2024-06-03 21:51:39','2024-06-03 21:51:39','d51265d9-c29a-46ed-8155-0de80a8236bb'),(20291,20291,1,NULL,'drugs-in-development-might-help-fight-deadly-candida-auris',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"New antifungal agents that are being investigated for possible use against C. auris, such as Ibrexafungerp (Brexafemme), show promise—so far.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Drugs in Development Might Help Fight Deadly Candida Auris\"}',1,'2024-06-03 21:51:40','2024-06-03 21:51:40','25c03d3a-66f1-45ae-90d6-48d26fadc8ee'),(20292,20292,1,'Drugs in Development Might Help Fight Deadly Candida Auris','drugs-in-development-might-help-fight-deadly-candida-auris','news/drugs-in-development-might-help-fight-deadly-candida-auris','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"jabramson\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"New antifungal agents that are being investigated for possible use against C. auris, such as Ibrexafungerp (Brexafemme), show promise—so far.\"}',1,'2024-06-03 21:51:40','2024-06-03 21:51:40','a196b256-2d9f-4011-b9b0-b6199e7968c4'),(20293,20293,1,NULL,'drugs-in-development-might-help-fight-deadly-candida-auris',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"New antifungal agents that are being investigated for possible use against C. auris, such as Ibrexafungerp (Brexafemme), show promise—so far.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Drugs in Development Might Help Fight Deadly Candida Auris\"}',1,'2024-06-03 21:51:40','2024-06-03 21:51:40','076e16cb-c56a-4fa1-b52b-4b87d59cf622'),(20294,20294,1,'Candida Auris: An Enigmatic and Difficult-to-Treat Fungal Pathogen','candida-auris-an-enigmatic-and-difficult-to-treat-fungal-pathogen','news/candida-auris-an-enigmatic-and-difficult-to-treat-fungal-pathogen','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"jabramson\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"With the unpredictability of when it will appear, and its propensity to be multidrug-resistant, this particular pathogen is challenging to diagnose and treat.\"}',1,'2024-06-03 21:51:40','2024-06-03 21:51:40','da85fd84-f05f-4408-9b87-34928505b2b1'),(20295,20295,1,NULL,'candida-auris-an-enigmatic-and-difficult-to-treat-fungal-pathogen',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"With the unpredictability of when it will appear, and its propensity to be multidrug-resistant, this particular pathogen is challenging to diagnose and treat.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Candida Auris: An Enigmatic and Difficult-to-Treat Fungal Pathogen\"}',1,'2024-06-03 21:51:40','2024-06-03 21:51:40','1cca7875-7d26-47fa-8c92-7afab2742d44'),(20296,20296,1,'Candida Auris: An Enigmatic and Difficult-to-Treat Fungal Pathogen','candida-auris-an-enigmatic-and-difficult-to-treat-fungal-pathogen','news/candida-auris-an-enigmatic-and-difficult-to-treat-fungal-pathogen','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"jabramson\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"With the unpredictability of when it will appear, and its propensity to be multidrug-resistant, this particular pathogen is challenging to diagnose and treat.\"}',1,'2024-06-03 21:51:40','2024-06-03 21:51:40','5a63e458-a875-4b3c-a4e5-678a0b1d3d1e'),(20297,20297,1,NULL,'candida-auris-an-enigmatic-and-difficult-to-treat-fungal-pathogen',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"With the unpredictability of when it will appear, and its propensity to be multidrug-resistant, this particular pathogen is challenging to diagnose and treat.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Candida Auris: An Enigmatic and Difficult-to-Treat Fungal Pathogen\"}',1,'2024-06-03 21:51:40','2024-06-03 21:51:40','b03d8d07-f5ff-4480-8d7c-01511038f283'),(20298,20298,1,'Health Officials Urge Public to get Influenza Shots as Flu Season gets Underway','health-officials-urge-public-to-get-influenza-shots-as-flu-season-gets-underway','news/health-officials-urge-public-to-get-influenza-shots-as-flu-season-gets-underway','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"jabramson\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"As flu season begins, health officials and local vaccinators emphasized getting the influenza vaccine to prevent further strain in already packed hospitals.\"}',1,'2024-06-03 21:51:40','2024-06-03 21:51:40','06d9a049-7a12-4b1b-a68f-50e774907c85'),(20299,20299,1,NULL,'health-officials-urge-public-to-get-influenza-shots-as-flu-season-gets-underway',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"As flu season begins, health officials and local vaccinators emphasized getting the influenza vaccine to prevent further strain in already packed hospitals.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Health Officials Urge Public to get Influenza Shots as Flu Season gets Underway\"}',1,'2024-06-03 21:51:40','2024-06-03 21:51:40','55598961-55a6-45ff-a23a-40be4690a05e'),(20300,20300,1,'Health Officials Urge Public to get Influenza Shots as Flu Season gets Underway','health-officials-urge-public-to-get-influenza-shots-as-flu-season-gets-underway','news/health-officials-urge-public-to-get-influenza-shots-as-flu-season-gets-underway','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"jabramson\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"As flu season begins, health officials and local vaccinators emphasized getting the influenza vaccine to prevent further strain in already packed hospitals.\"}',1,'2024-06-03 21:51:40','2024-06-03 21:51:40','e754b7b7-1fb4-4784-9333-0d7ef007a5c4'),(20301,20301,1,NULL,'health-officials-urge-public-to-get-influenza-shots-as-flu-season-gets-underway',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"As flu season begins, health officials and local vaccinators emphasized getting the influenza vaccine to prevent further strain in already packed hospitals.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Health Officials Urge Public to get Influenza Shots as Flu Season gets Underway\"}',1,'2024-06-03 21:51:40','2024-06-03 21:51:40','2b72fec9-b5df-42cd-a0b4-6c3f48eb4983'),(20302,20302,1,'CDC to Invest $2.1 Billion to Protect Patients and Healthcare Workers from COVID-19 and Future Infectious Diseases','cdc-to-invest-2-1-billion-to-protect-patients-and-healthcare-workers-from-covid-19-and-future-infectious-diseases','news/cdc-to-invest-2-1-billion-to-protect-patients-and-healthcare-workers-from-covid-19-and-future-infectious-diseases','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"jabramson\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"The Biden-Harris Administration, working through the Centers for Disease Control and Prevention (CDC), is investing American Rescue Plan funding to strengthen and equip state, local, and territorial public health departments and other partner organizations with the resources needed to better fight infections in U.S. healthcare facilities, including COVID-19 and other known and emerging infectious diseases.\"}',1,'2024-06-03 21:51:40','2024-06-03 21:51:40','19749099-c490-4535-92d4-b6788cb223f0'),(20303,20303,1,NULL,'cdc-to-invest-2-1-billion-to-protect-patients-and-healthcare-workers-from-covid-19-and-future-infectious-diseases',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"The Biden-Harris Administration, working through the Centers for Disease Control and Prevention (CDC), is investing American Rescue Plan funding to strengthen and equip state, local, and territorial public health departments and other partner organizations with the resources needed to better fight infections in U.S. healthcare facilities, including COVID-19 and other known and emerging infectious diseases.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"CDC to Invest $2.1 Billion to Protect Patients and Healthcare Workers from COVID-19 and Future Infectious Diseases\"}',1,'2024-06-03 21:51:40','2024-06-03 21:51:40','0f0c5c5e-9a03-44f6-8f31-fa5658fa7acd'),(20304,20304,1,'CDC to Invest $2.1 Billion to Protect Patients and Healthcare Workers from COVID-19 and Future Infectious Diseases','cdc-to-invest-2-1-billion-to-protect-patients-and-healthcare-workers-from-covid-19-and-future-infectious-diseases','news/cdc-to-invest-2-1-billion-to-protect-patients-and-healthcare-workers-from-covid-19-and-future-infectious-diseases','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"jabramson\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"The Biden-Harris Administration, working through the Centers for Disease Control and Prevention (CDC), is investing American Rescue Plan funding to strengthen and equip state, local, and territorial public health departments and other partner organizations with the resources needed to better fight infections in U.S. healthcare facilities, including COVID-19 and other known and emerging infectious diseases.\"}',1,'2024-06-03 21:51:40','2024-06-03 21:51:40','c6df71ad-5377-4421-ba12-486b1929de66'),(20305,20305,1,NULL,'cdc-to-invest-2-1-billion-to-protect-patients-and-healthcare-workers-from-covid-19-and-future-infectious-diseases',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"The Biden-Harris Administration, working through the Centers for Disease Control and Prevention (CDC), is investing American Rescue Plan funding to strengthen and equip state, local, and territorial public health departments and other partner organizations with the resources needed to better fight infections in U.S. healthcare facilities, including COVID-19 and other known and emerging infectious diseases.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"CDC to Invest $2.1 Billion to Protect Patients and Healthcare Workers from COVID-19 and Future Infectious Diseases\"}',1,'2024-06-03 21:51:40','2024-06-03 21:51:40','bed95146-c368-4aab-a2b6-0291d65c09e9'),(20306,20306,1,'Updated Skin Antisepsis Guidelines Aim to Reduce Surgical Site Infections','updated-skin-antisepsis-guidelines-aim-to-reduce-surgical-site-infections','news/updated-skin-antisepsis-guidelines-aim-to-reduce-surgical-site-infections','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"jabramson\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"Updated guidelines from the Association of periOperative Registered Nurses (AORN) now offer new evidence to help interdisciplinary teams make decisions and standardize preoperative skin antisepsis protocols.\"}',1,'2024-06-03 21:51:40','2024-06-03 21:51:40','ebffc0d1-605f-41e9-a099-7e2f0c1bf0db'),(20307,20307,1,NULL,'updated-skin-antisepsis-guidelines-aim-to-reduce-surgical-site-infections',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"Updated guidelines from the Association of periOperative Registered Nurses (AORN) now offer new evidence to help interdisciplinary teams make decisions and standardize preoperative skin antisepsis protocols.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Updated Skin Antisepsis Guidelines Aim to Reduce Surgical Site Infections\"}',1,'2024-06-03 21:51:40','2024-06-03 21:51:40','4e10b58f-d360-4cb1-b70b-6021fbaad06b'),(20308,20308,1,'Updated Skin Antisepsis Guidelines Aim to Reduce Surgical Site Infections','updated-skin-antisepsis-guidelines-aim-to-reduce-surgical-site-infections','news/updated-skin-antisepsis-guidelines-aim-to-reduce-surgical-site-infections','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"jabramson\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"Updated guidelines from the Association of periOperative Registered Nurses (AORN) now offer new evidence to help interdisciplinary teams make decisions and standardize preoperative skin antisepsis protocols.\"}',1,'2024-06-03 21:51:40','2024-06-03 21:51:40','1466815f-9509-4fe0-a094-46458141473c'),(20309,20309,1,NULL,'updated-skin-antisepsis-guidelines-aim-to-reduce-surgical-site-infections',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"Updated guidelines from the Association of periOperative Registered Nurses (AORN) now offer new evidence to help interdisciplinary teams make decisions and standardize preoperative skin antisepsis protocols.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Updated Skin Antisepsis Guidelines Aim to Reduce Surgical Site Infections\"}',1,'2024-06-03 21:51:40','2024-06-03 21:51:40','c8a2c885-e8bd-49c5-aef1-6aca8e60026b'),(20310,20310,1,'Value of Pneumococcal Vaccination in Controlling the Development of Antimicrobial Resistance (AMR): Case Study Using DREAMR in Ethiopia','value-of-pneumococcal-vaccination-in-controlling-the-development-of-antimicrobial-resistance-amr-case-study-using-dreamr-in-ethiopia','news/value-of-pneumococcal-vaccination-in-controlling-the-development-of-antimicrobial-resistance-amr-case-study-using-dreamr-in-ethiopia','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"jabramson\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"Antimicrobial resistance (AMR) poses an imminent threat to global health security. Pneumococcal vaccination reduces disease incidence, prevents antibiotic use, and decreases antibiotic-resistant infections. However, the benefit of vaccination in reducing AMR has been poorly quantified to date.\"}',1,'2024-06-03 21:51:40','2024-06-03 21:51:40','5e38e123-eee6-4f3e-940c-417c582e5376'),(20311,20311,1,NULL,'value-of-pneumococcal-vaccination-in-controlling-the-development-of-antimicrobial-resistance-amr-case-study-using-dreamr-in-ethiopia',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"Antimicrobial resistance (AMR) poses an imminent threat to global health security. Pneumococcal vaccination reduces disease incidence, prevents antibiotic use, and decreases antibiotic-resistant infections. However, the benefit of vaccination in reducing AMR has been poorly quantified to date.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Value of Pneumococcal Vaccination in Controlling the Development of Antimicrobial Resistance (AMR): Case Study Using DREAMR in Ethiopia\"}',1,'2024-06-03 21:51:40','2024-06-03 21:51:40','7af8497a-7454-4201-b6f7-bdba7c45cb58'),(20312,20312,1,'Value of Pneumococcal Vaccination in Controlling the Development of Antimicrobial Resistance (AMR): Case Study Using DREAMR in Ethiopia','value-of-pneumococcal-vaccination-in-controlling-the-development-of-antimicrobial-resistance-amr-case-study-using-dreamr-in-ethiopia','news/value-of-pneumococcal-vaccination-in-controlling-the-development-of-antimicrobial-resistance-amr-case-study-using-dreamr-in-ethiopia','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"jabramson\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"Antimicrobial resistance (AMR) poses an imminent threat to global health security. Pneumococcal vaccination reduces disease incidence, prevents antibiotic use, and decreases antibiotic-resistant infections. However, the benefit of vaccination in reducing AMR has been poorly quantified to date.\"}',1,'2024-06-03 21:51:40','2024-06-03 21:51:40','5d839618-ea60-4b54-a9f6-f1d05956e280'),(20313,20313,1,NULL,'value-of-pneumococcal-vaccination-in-controlling-the-development-of-antimicrobial-resistance-amr-case-study-using-dreamr-in-ethiopia',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"Antimicrobial resistance (AMR) poses an imminent threat to global health security. Pneumococcal vaccination reduces disease incidence, prevents antibiotic use, and decreases antibiotic-resistant infections. However, the benefit of vaccination in reducing AMR has been poorly quantified to date.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Value of Pneumococcal Vaccination in Controlling the Development of Antimicrobial Resistance (AMR): Case Study Using DREAMR in Ethiopia\"}',1,'2024-06-03 21:51:40','2024-06-03 21:51:40','923cec36-494c-4aad-89fc-d251c133ec91'),(20314,20314,1,'The Impact of Real-Time Whole Genome Sequencing in Controlling Healthcare-Associated SARS-CoV-2 Outbreaks','the-impact-of-real-time-whole-genome-sequencing-in-controlling-healthcare-associated-sars-cov-2-outbreaks','news/the-impact-of-real-time-whole-genome-sequencing-in-controlling-healthcare-associated-sars-cov-2-outbreaks','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"jabramson\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"Nosocomial SARS-CoV-2 infections have severely affected bed capacity and patient flow. We utilized whole genome sequencing (WGS) to identify outbreaks and focus infection control resources and intervention during the UK\'s second pandemic wave in late 2020.\"}',1,'2024-06-03 21:51:40','2024-06-03 21:51:40','05213362-04b9-4b22-89a5-1b8911d541d7'),(20315,20315,1,NULL,'the-impact-of-real-time-whole-genome-sequencing-in-controlling-healthcare-associated-sars-cov-2-outbreaks',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"Nosocomial SARS-CoV-2 infections have severely affected bed capacity and patient flow. We utilized whole genome sequencing (WGS) to identify outbreaks and focus infection control resources and intervention during the UK\'s second pandemic wave in late 2020.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"The Impact of Real-Time Whole Genome Sequencing in Controlling Healthcare-Associated SARS-CoV-2 Outbreaks\"}',1,'2024-06-03 21:51:40','2024-06-03 21:51:40','d4e111fd-9bb0-485e-aa37-70c85e06f8a0'),(20316,20316,1,'The Impact of Real-Time Whole Genome Sequencing in Controlling Healthcare-Associated SARS-CoV-2 Outbreaks','the-impact-of-real-time-whole-genome-sequencing-in-controlling-healthcare-associated-sars-cov-2-outbreaks','news/the-impact-of-real-time-whole-genome-sequencing-in-controlling-healthcare-associated-sars-cov-2-outbreaks','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"jabramson\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"Nosocomial SARS-CoV-2 infections have severely affected bed capacity and patient flow. We utilized whole genome sequencing (WGS) to identify outbreaks and focus infection control resources and intervention during the UK\'s second pandemic wave in late 2020.\"}',1,'2024-06-03 21:51:40','2024-06-03 21:51:40','acd31131-e9ce-494c-b2ec-ed52cae911ba'),(20317,20317,1,NULL,'the-impact-of-real-time-whole-genome-sequencing-in-controlling-healthcare-associated-sars-cov-2-outbreaks',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"Nosocomial SARS-CoV-2 infections have severely affected bed capacity and patient flow. We utilized whole genome sequencing (WGS) to identify outbreaks and focus infection control resources and intervention during the UK\'s second pandemic wave in late 2020.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"The Impact of Real-Time Whole Genome Sequencing in Controlling Healthcare-Associated SARS-CoV-2 Outbreaks\"}',1,'2024-06-03 21:51:41','2024-06-03 21:51:41','ae9fc153-3058-4843-a818-06500f74366f'),(20318,20318,1,'Research Reveals New Evolutive Mechanism of Bacteria that Expands Pathogenic Potential','research-reveals-new-evolutive-mechanism-of-bacteria-that-expands-pathogenic-potential','news/research-reveals-new-evolutive-mechanism-of-bacteria-that-expands-pathogenic-potential','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"jabramson\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"In this study, the team of professor Penadés found a new mechanism that activates and transmits genetic material between the pathogenicity islands found in the chromosomes of bacteria and super bacteria, to award them greater virulence and resistance. This new evolutive mechanism has been identified in the Staphylococcus aureus genus, which is of critical priority for the WHO due to its multi-resistance to antibiotics and its ability to cause severe infections.\"}',1,'2024-06-03 21:51:41','2024-06-03 21:51:41','5be857c5-26c3-4636-b708-3e4bfe034779'),(20319,20319,1,NULL,'research-reveals-new-evolutive-mechanism-of-bacteria-that-expands-pathogenic-potential',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"In this study, the team of professor Penadés found a new mechanism that activates and transmits genetic material between the pathogenicity islands found in the chromosomes of bacteria and super bacteria, to award them greater virulence and resistance. This new evolutive mechanism has been identified in the Staphylococcus aureus genus, which is of critical priority for the WHO due to its multi-resistance to antibiotics and its ability to cause severe infections.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Research Reveals New Evolutive Mechanism of Bacteria that Expands Pathogenic Potential\"}',1,'2024-06-03 21:51:41','2024-06-03 21:51:41','ea915137-fcd2-4dc1-8b5f-e779b7047a24'),(20320,20320,1,'Research Reveals New Evolutive Mechanism of Bacteria that Expands Pathogenic Potential','research-reveals-new-evolutive-mechanism-of-bacteria-that-expands-pathogenic-potential','news/research-reveals-new-evolutive-mechanism-of-bacteria-that-expands-pathogenic-potential','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"jabramson\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"In this study, the team of professor Penadés found a new mechanism that activates and transmits genetic material between the pathogenicity islands found in the chromosomes of bacteria and super bacteria, to award them greater virulence and resistance. This new evolutive mechanism has been identified in the Staphylococcus aureus genus, which is of critical priority for the WHO due to its multi-resistance to antibiotics and its ability to cause severe infections.\"}',1,'2024-06-03 21:51:41','2024-06-03 21:51:41','74591550-ab6a-4598-b778-90b707e4c59d'),(20321,20321,1,NULL,'research-reveals-new-evolutive-mechanism-of-bacteria-that-expands-pathogenic-potential',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"In this study, the team of professor Penadés found a new mechanism that activates and transmits genetic material between the pathogenicity islands found in the chromosomes of bacteria and super bacteria, to award them greater virulence and resistance. This new evolutive mechanism has been identified in the Staphylococcus aureus genus, which is of critical priority for the WHO due to its multi-resistance to antibiotics and its ability to cause severe infections.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Research Reveals New Evolutive Mechanism of Bacteria that Expands Pathogenic Potential\"}',1,'2024-06-03 21:51:41','2024-06-03 21:51:41','3b8c4ff0-1f9f-48c3-a306-f71ef2ec8227'),(20322,20322,1,'Vaccination Guards Against Certain Bacterial Infections and Slows the Spread of Superbugs in Populations','vaccination-guards-against-certain-bacterial-infections-and-slows-the-spread-of-superbugs-in-populations','news/vaccination-guards-against-certain-bacterial-infections-and-slows-the-spread-of-superbugs-in-populations','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"jabramson\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"Vaccines that boost immunity against bacteria can protect the immunized from contracting drug-resistant infections, according to a team of scientists in the U.K. who also underscore that the shots can slow the spread of resistant strains in populations.\"}',1,'2024-06-03 21:51:41','2024-06-03 21:51:41','996456f1-b71c-42ae-8ec9-cbb55b51776c'),(20323,20323,1,NULL,'vaccination-guards-against-certain-bacterial-infections-and-slows-the-spread-of-superbugs-in-populations',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"Vaccines that boost immunity against bacteria can protect the immunized from contracting drug-resistant infections, according to a team of scientists in the U.K. who also underscore that the shots can slow the spread of resistant strains in populations.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Vaccination Guards Against Certain Bacterial Infections and Slows the Spread of Superbugs in Populations\"}',1,'2024-06-03 21:51:41','2024-06-03 21:51:41','e53b92bf-6e7d-42b1-b68d-4957be67657f'),(20324,20324,1,'Vaccination Guards Against Certain Bacterial Infections and Slows the Spread of Superbugs in Populations','vaccination-guards-against-certain-bacterial-infections-and-slows-the-spread-of-superbugs-in-populations','news/vaccination-guards-against-certain-bacterial-infections-and-slows-the-spread-of-superbugs-in-populations','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"jabramson\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"Vaccines that boost immunity against bacteria can protect the immunized from contracting drug-resistant infections, according to a team of scientists in the U.K. who also underscore that the shots can slow the spread of resistant strains in populations.\"}',1,'2024-06-03 21:51:41','2024-06-03 21:51:41','687fd350-065f-48d0-bf00-cee6017701fd'),(20325,20325,1,NULL,'vaccination-guards-against-certain-bacterial-infections-and-slows-the-spread-of-superbugs-in-populations',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"Vaccines that boost immunity against bacteria can protect the immunized from contracting drug-resistant infections, according to a team of scientists in the U.K. who also underscore that the shots can slow the spread of resistant strains in populations.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Vaccination Guards Against Certain Bacterial Infections and Slows the Spread of Superbugs in Populations\"}',1,'2024-06-03 21:51:41','2024-06-03 21:51:41','9f8915f8-5f92-49ec-b589-18f16adeb4f1'),(20326,20326,1,'Association of Changes in Seasonal Respiratory Virus Activity and Ambulatory Antibiotic Prescriptions With the COVID-19 Pandemic','association-of-changes-in-seasonal-respiratory-virus-activity-and-ambulatory-antibiotic-prescriptions-with-the-covid-19-pandemic','news/association-of-changes-in-seasonal-respiratory-virus-activity-and-ambulatory-antibiotic-prescriptions-with-the-covid-19-pandemic','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"jabramson\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"This study demonstrated a marked decrease in respiratory virus detections, with a concomitant 79% decline in ambulatory antibiotic prescribing rates for RTI, during the COVID-19 pandemic.\"}',1,'2024-06-03 21:51:41','2024-06-03 21:51:41','c3d3a276-12d1-4ea3-be2e-dc1a443fd98f'),(20327,20327,1,NULL,'association-of-changes-in-seasonal-respiratory-virus-activity-and-ambulatory-antibiotic-prescriptions-with-the-covid-19-pandemic',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"This study demonstrated a marked decrease in respiratory virus detections, with a concomitant 79% decline in ambulatory antibiotic prescribing rates for RTI, during the COVID-19 pandemic.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Association of Changes in Seasonal Respiratory Virus Activity and Ambulatory Antibiotic Prescriptions With the COVID-19 Pandemic\"}',1,'2024-06-03 21:51:41','2024-06-03 21:51:41','699ee915-22be-407f-bbfe-58a10c2f6b22'),(20328,20328,1,'Association of Changes in Seasonal Respiratory Virus Activity and Ambulatory Antibiotic Prescriptions With the COVID-19 Pandemic','association-of-changes-in-seasonal-respiratory-virus-activity-and-ambulatory-antibiotic-prescriptions-with-the-covid-19-pandemic','news/association-of-changes-in-seasonal-respiratory-virus-activity-and-ambulatory-antibiotic-prescriptions-with-the-covid-19-pandemic','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"jabramson\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"This study demonstrated a marked decrease in respiratory virus detections, with a concomitant 79% decline in ambulatory antibiotic prescribing rates for RTI, during the COVID-19 pandemic.\"}',1,'2024-06-03 21:51:41','2024-06-03 21:51:41','c74db859-7826-4e29-b382-4a9b6e85c4b2'),(20329,20329,1,NULL,'association-of-changes-in-seasonal-respiratory-virus-activity-and-ambulatory-antibiotic-prescriptions-with-the-covid-19-pandemic',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"This study demonstrated a marked decrease in respiratory virus detections, with a concomitant 79% decline in ambulatory antibiotic prescribing rates for RTI, during the COVID-19 pandemic.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Association of Changes in Seasonal Respiratory Virus Activity and Ambulatory Antibiotic Prescriptions With the COVID-19 Pandemic\"}',1,'2024-06-03 21:51:41','2024-06-03 21:51:41','c8dfb6b3-87d9-43d8-830c-0daf1f2a7337'),(20330,20330,1,'Acute Respiratory Illness across Race and Ethnicity in Disparate Healthcare Settings','acute-respiratory-illness-across-race-and-ethnicity-in-disparate-healthcare-settings','news/acute-respiratory-illness-across-race-and-ethnicity-in-disparate-healthcare-settings','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"jabramson\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"A study found similar rates of acute respiratory illness-related visits across race/ethnicity when all healthcare settings were combined, but ARI visits differed for race/ethnicity groups across ambulatory, emergency, and hospital settings.\"}',1,'2024-06-03 21:51:41','2024-06-03 21:51:41','e2d96a3c-e599-4071-95bc-c85f66c39a47'),(20331,20331,1,NULL,'acute-respiratory-illness-across-race-and-ethnicity-in-disparate-healthcare-settings',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"A study found similar rates of acute respiratory illness-related visits across race/ethnicity when all healthcare settings were combined, but ARI visits differed for race/ethnicity groups across ambulatory, emergency, and hospital settings.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Acute Respiratory Illness across Race and Ethnicity in Disparate Healthcare Settings\"}',1,'2024-06-03 21:51:41','2024-06-03 21:51:41','4b5b1dfa-aa8f-42c7-8c61-17b73023aa96'),(20332,20332,1,'Acute Respiratory Illness across Race and Ethnicity in Disparate Healthcare Settings','acute-respiratory-illness-across-race-and-ethnicity-in-disparate-healthcare-settings','news/acute-respiratory-illness-across-race-and-ethnicity-in-disparate-healthcare-settings','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"jabramson\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"A study found similar rates of acute respiratory illness-related visits across race/ethnicity when all healthcare settings were combined, but ARI visits differed for race/ethnicity groups across ambulatory, emergency, and hospital settings.\"}',1,'2024-06-03 21:51:41','2024-06-03 21:51:41','dddfe339-dd2a-499a-83c3-6c0adbaf90e7'),(20333,20333,1,NULL,'acute-respiratory-illness-across-race-and-ethnicity-in-disparate-healthcare-settings',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"A study found similar rates of acute respiratory illness-related visits across race/ethnicity when all healthcare settings were combined, but ARI visits differed for race/ethnicity groups across ambulatory, emergency, and hospital settings.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Acute Respiratory Illness across Race and Ethnicity in Disparate Healthcare Settings\"}',1,'2024-06-03 21:51:41','2024-06-03 21:51:41','20feb55f-c2a2-43d2-a765-4287e0dea65d'),(20334,20334,1,'Increased Hygiene, Motivated by COVID-19, Led to Fewer C Difficile Cases','increased-hygiene-motivated-by-covid-19-led-to-fewer-c-difficile-cases','news/increased-hygiene-motivated-by-covid-19-led-to-fewer-c-difficile-cases','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"jabramson\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"The COVID-19 pandemic led people to take hygiene and sanitation more seriously, causing a decrease in C difficile infections.\"}',1,'2024-06-03 21:51:41','2024-06-03 21:51:41','79d559c1-93bc-472c-a793-c9604a6bbb5c'),(20335,20335,1,NULL,'increased-hygiene-motivated-by-covid-19-led-to-fewer-c-difficile-cases',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"The COVID-19 pandemic led people to take hygiene and sanitation more seriously, causing a decrease in C difficile infections.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Increased Hygiene, Motivated by COVID-19, Led to Fewer C Difficile Cases\"}',1,'2024-06-03 21:51:41','2024-06-03 21:51:41','9a1c7a80-c3ea-4f09-b3a4-5a8c1bd59113'),(20336,20336,1,'Increased Hygiene, Motivated by COVID-19, Led to Fewer C Difficile Cases','increased-hygiene-motivated-by-covid-19-led-to-fewer-c-difficile-cases','news/increased-hygiene-motivated-by-covid-19-led-to-fewer-c-difficile-cases','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"jabramson\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"The COVID-19 pandemic led people to take hygiene and sanitation more seriously, causing a decrease in C difficile infections.\"}',1,'2024-06-03 21:51:41','2024-06-03 21:51:41','b7cbc5dd-5dfb-4dcd-b0d9-a88946f7bac4'),(20337,20337,1,NULL,'increased-hygiene-motivated-by-covid-19-led-to-fewer-c-difficile-cases',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"The COVID-19 pandemic led people to take hygiene and sanitation more seriously, causing a decrease in C difficile infections.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Increased Hygiene, Motivated by COVID-19, Led to Fewer C Difficile Cases\"}',1,'2024-06-03 21:51:41','2024-06-03 21:51:41','e1a7ffad-67ab-4e2f-8dd4-fef167afdbdd'),(20338,20338,1,'Rapid Assessment and Containment of Candida auris Transmission in Postacute Care Settings—Orange County, California, 2019','rapid-assessment-and-containment-of-candida-auris-transmission-in-postacute-care-settings-orange-county-california-2019','news/rapid-assessment-and-containment-of-candida-auris-transmission-in-postacute-care-settings-orange-county-california-2019','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"jabramson\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"The study assessed the prevalence of C auris and infection control practices at 14 ventilator-capable skilled-nursing facilities and three long-term acute care hospitals in southern California.\"}',1,'2024-06-03 21:51:41','2024-06-03 21:51:41','5c38e0b7-6ef1-4b4e-b8a7-0a2ba913f334'),(20339,20339,1,NULL,'rapid-assessment-and-containment-of-candida-auris-transmission-in-postacute-care-settings-orange-county-california-2019',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"The study assessed the prevalence of C auris and infection control practices at 14 ventilator-capable skilled-nursing facilities and three long-term acute care hospitals in southern California.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Rapid Assessment and Containment of Candida auris Transmission in Postacute Care Settings—Orange County, California, 2019\"}',1,'2024-06-03 21:51:42','2024-06-03 21:51:42','9516a3dc-7c03-43d3-943a-8a4079bcbeb7'),(20340,20340,1,'Rapid Assessment and Containment of Candida auris Transmission in Postacute Care Settings—Orange County, California, 2019','rapid-assessment-and-containment-of-candida-auris-transmission-in-postacute-care-settings-orange-county-california-2019','news/rapid-assessment-and-containment-of-candida-auris-transmission-in-postacute-care-settings-orange-county-california-2019','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"jabramson\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"The study assessed the prevalence of C auris and infection control practices at 14 ventilator-capable skilled-nursing facilities and three long-term acute care hospitals in southern California.\"}',1,'2024-06-03 21:51:42','2024-06-03 21:51:42','a3843599-e8bf-470f-8b11-6e0fec38d6f4'),(20341,20341,1,NULL,'rapid-assessment-and-containment-of-candida-auris-transmission-in-postacute-care-settings-orange-county-california-2019',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"The study assessed the prevalence of C auris and infection control practices at 14 ventilator-capable skilled-nursing facilities and three long-term acute care hospitals in southern California.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Rapid Assessment and Containment of Candida auris Transmission in Postacute Care Settings—Orange County, California, 2019\"}',1,'2024-06-03 21:51:42','2024-06-03 21:51:42','2d34a112-6eb8-4691-b27c-d2c5adf143a8'),(20342,20342,1,'Thanks to COVID-19, MRSA Makes a Comeback','thanks-to-covid-19-mrsa-makes-a-comeback','news/thanks-to-covid-19-mrsa-makes-a-comeback','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"jabramson\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"Preliminary data for the last quarter of 2020 revealed a jump of 34% in methicillin-resistant Staphylococcus aureus (MRSA) compared with the same quarter in 2019. Several states had much higher increases. In Arizona, for instance, rates leapt 80%; in New Jersey, that figure was 99%.\"}',1,'2024-06-03 21:51:42','2024-06-03 21:51:42','73cc5b8f-e243-45dc-bd4d-45a62af25803'),(20343,20343,1,NULL,'thanks-to-covid-19-mrsa-makes-a-comeback',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"Preliminary data for the last quarter of 2020 revealed a jump of 34% in methicillin-resistant Staphylococcus aureus (MRSA) compared with the same quarter in 2019. Several states had much higher increases. In Arizona, for instance, rates leapt 80%; in New Jersey, that figure was 99%.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Thanks to COVID-19, MRSA Makes a Comeback\"}',1,'2024-06-03 21:51:42','2024-06-03 21:51:42','f013d28e-8d55-40c8-ba3c-5603cd6dddbd'),(20344,20344,1,'Thanks to COVID-19, MRSA Makes a Comeback','thanks-to-covid-19-mrsa-makes-a-comeback','news/thanks-to-covid-19-mrsa-makes-a-comeback','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"jabramson\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"Preliminary data for the last quarter of 2020 revealed a jump of 34% in methicillin-resistant Staphylococcus aureus (MRSA) compared with the same quarter in 2019. Several states had much higher increases. In Arizona, for instance, rates leapt 80%; in New Jersey, that figure was 99%.\"}',1,'2024-06-03 21:51:42','2024-06-03 21:51:42','a02040aa-9e86-4d83-941a-57d29da0fe2a'),(20345,20345,1,NULL,'thanks-to-covid-19-mrsa-makes-a-comeback',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"Preliminary data for the last quarter of 2020 revealed a jump of 34% in methicillin-resistant Staphylococcus aureus (MRSA) compared with the same quarter in 2019. Several states had much higher increases. In Arizona, for instance, rates leapt 80%; in New Jersey, that figure was 99%.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Thanks to COVID-19, MRSA Makes a Comeback\"}',1,'2024-06-03 21:51:42','2024-06-03 21:51:42','c6fe96a3-e78c-44d6-a4c7-f4a60c2db6bb'),(20346,20346,1,'Mortality, Length of Stay, and Healthcare Costs Associated With Multidrug-Resistant Bacterial Infections Among Elderly Hospitalized Patients in the United States','mortality-length-of-stay-and-healthcare-costs-associated-with-multidrug-resistant-bacterial-infections-among-elderly-hospitalized-patients-in-the-united-states','news/mortality-length-of-stay-and-healthcare-costs-associated-with-multidrug-resistant-bacterial-infections-among-elderly-hospitalized-patients-in-the-united-states','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"jabramson\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"This study reports estimates of the healthcare costs, length of stay, and mortality associated with infections due to multidrug-resistant bacteria among elderly individuals in the United States.\"}',1,'2024-06-03 21:51:42','2024-06-03 21:51:42','ed17ff38-74aa-44bf-9481-f08d343d7568'),(20347,20347,1,NULL,'mortality-length-of-stay-and-healthcare-costs-associated-with-multidrug-resistant-bacterial-infections-among-elderly-hospitalized-patients-in-the-united-states',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"This study reports estimates of the healthcare costs, length of stay, and mortality associated with infections due to multidrug-resistant bacteria among elderly individuals in the United States.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Mortality, Length of Stay, and Healthcare Costs Associated With Multidrug-Resistant Bacterial Infections Among Elderly Hospitalized Patients in the United States\"}',1,'2024-06-03 21:51:42','2024-06-03 21:51:42','04beb028-2c85-4e47-a89e-7512f640d652'),(20348,20348,1,'Mortality, Length of Stay, and Healthcare Costs Associated With Multidrug-Resistant Bacterial Infections Among Elderly Hospitalized Patients in the United States','mortality-length-of-stay-and-healthcare-costs-associated-with-multidrug-resistant-bacterial-infections-among-elderly-hospitalized-patients-in-the-united-states','news/mortality-length-of-stay-and-healthcare-costs-associated-with-multidrug-resistant-bacterial-infections-among-elderly-hospitalized-patients-in-the-united-states','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"jabramson\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"This study reports estimates of the healthcare costs, length of stay, and mortality associated with infections due to multidrug-resistant bacteria among elderly individuals in the United States.\"}',1,'2024-06-03 21:51:42','2024-06-03 21:51:42','60f12911-283d-414b-9c16-d02726f92853'),(20349,20349,1,NULL,'mortality-length-of-stay-and-healthcare-costs-associated-with-multidrug-resistant-bacterial-infections-among-elderly-hospitalized-patients-in-the-united-states',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"This study reports estimates of the healthcare costs, length of stay, and mortality associated with infections due to multidrug-resistant bacteria among elderly individuals in the United States.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Mortality, Length of Stay, and Healthcare Costs Associated With Multidrug-Resistant Bacterial Infections Among Elderly Hospitalized Patients in the United States\"}',1,'2024-06-03 21:51:42','2024-06-03 21:51:42','1b42eb98-c36b-4aea-a5ac-3fe4cd3944fe'),(20350,20350,1,'Associations of facility-level antibiotic use and hospital-onset Clostridioides difficile infection in US acute-care hospitals, 2012–2018','associations-of-facility-level-antibiotic-use-and-hospital-onset-clostridioides-difficile-infection-in-us-acute-care-hospitals-2012-2018','news/associations-of-facility-level-antibiotic-use-and-hospital-onset-clostridioides-difficile-infection-in-us-acute-care-hospitals-2012-2018','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"jabramson\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"Previously reported associations between hospital-level antibiotic use and hospital-onset Clostridioides difficile infection (HO-CDI) were reexamined using 2012–2018 data from a new cohort of US acute-care hospitals. This analysis revealed significant positive associations between total, third-generation, and fourth-generation cephalosporin, fluoroquinolone, carbapenem, and piperacillin-tazobactam use and HO-CDI rates, confirming previous findings.\"}',1,'2024-06-03 21:51:42','2024-06-03 21:51:42','dd848bbb-613a-4446-b133-1d6b76ec0d3d'),(20351,20351,1,NULL,'associations-of-facility-level-antibiotic-use-and-hospital-onset-clostridioides-difficile-infection-in-us-acute-care-hospitals-2012-2018',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"Previously reported associations between hospital-level antibiotic use and hospital-onset Clostridioides difficile infection (HO-CDI) were reexamined using 2012–2018 data from a new cohort of US acute-care hospitals. This analysis revealed significant positive associations between total, third-generation, and fourth-generation cephalosporin, fluoroquinolone, carbapenem, and piperacillin-tazobactam use and HO-CDI rates, confirming previous findings.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Associations of facility-level antibiotic use and hospital-onset Clostridioides difficile infection in US acute-care hospitals, 2012–2018\"}',1,'2024-06-03 21:51:42','2024-06-03 21:51:42','49bfc641-216d-4425-8ea5-3f6bc8c7bed8'),(20352,20352,1,'Associations of facility-level antibiotic use and hospital-onset Clostridioides difficile infection in US acute-care hospitals, 2012–2018','associations-of-facility-level-antibiotic-use-and-hospital-onset-clostridioides-difficile-infection-in-us-acute-care-hospitals-2012-2018','news/associations-of-facility-level-antibiotic-use-and-hospital-onset-clostridioides-difficile-infection-in-us-acute-care-hospitals-2012-2018','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"jabramson\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"Previously reported associations between hospital-level antibiotic use and hospital-onset Clostridioides difficile infection (HO-CDI) were reexamined using 2012–2018 data from a new cohort of US acute-care hospitals. This analysis revealed significant positive associations between total, third-generation, and fourth-generation cephalosporin, fluoroquinolone, carbapenem, and piperacillin-tazobactam use and HO-CDI rates, confirming previous findings.\"}',1,'2024-06-03 21:51:42','2024-06-03 21:51:42','3b4070bd-28e6-4502-973d-794eeae7a779'),(20353,20353,1,NULL,'associations-of-facility-level-antibiotic-use-and-hospital-onset-clostridioides-difficile-infection-in-us-acute-care-hospitals-2012-2018',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"Previously reported associations between hospital-level antibiotic use and hospital-onset Clostridioides difficile infection (HO-CDI) were reexamined using 2012–2018 data from a new cohort of US acute-care hospitals. This analysis revealed significant positive associations between total, third-generation, and fourth-generation cephalosporin, fluoroquinolone, carbapenem, and piperacillin-tazobactam use and HO-CDI rates, confirming previous findings.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Associations of facility-level antibiotic use and hospital-onset Clostridioides difficile infection in US acute-care hospitals, 2012–2018\"}',1,'2024-06-03 21:51:42','2024-06-03 21:51:42','1c967be9-1e78-4fe3-8506-c656fdb64a26'),(20354,20354,1,'Reducing Peripheral Venous Catheter Infections','reducing-peripheral-venous-catheter-infections','news/reducing-peripheral-venous-catheter-infections','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"jabramson\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"Peripheral venous catheters (PVCs) are one of the most frequently used medical devices. Approximately 350 million PVCs are sold in the United States each year. Patients receive PVCs in many clinical settings, including outpatient infusions, emergency medical care, and inpatient care, with 30% to 80% of hospitalized patients requiring PVC insertion during their stay.\"}',1,'2024-06-03 21:51:42','2024-06-03 21:51:42','ad751dd3-88c8-40c8-9afc-1f8ac4a8bd16'),(20355,20355,1,NULL,'reducing-peripheral-venous-catheter-infections',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"Peripheral venous catheters (PVCs) are one of the most frequently used medical devices. Approximately 350 million PVCs are sold in the United States each year. Patients receive PVCs in many clinical settings, including outpatient infusions, emergency medical care, and inpatient care, with 30% to 80% of hospitalized patients requiring PVC insertion during their stay.\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Reducing Peripheral Venous Catheter Infections\"}',1,'2024-06-03 21:51:42','2024-06-03 21:51:42','427b1f81-3f3e-49e3-8d70-c4a2ceb1bac6'),(20356,20356,1,'Reducing Peripheral Venous Catheter Infections','reducing-peripheral-venous-catheter-infections','news/reducing-peripheral-venous-catheter-infections','{\"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"jabramson\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"Peripheral venous catheters (PVCs) are one of the most frequently used medical devices. Approximately 350 million PVCs are sold in the United States each year. Patients receive PVCs in many clinical settings, including outpatient infusions, emergency medical care, and inpatient care, with 30% to 80% of hospitalized patients requiring PVC insertion during their stay.\"}',1,'2024-06-03 21:51:42','2024-06-03 21:51:42','d1850e36-8cc1-48c8-a1c1-383fffab984e');
